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H uman, animal and plant health is a fi eld of work which offers opportunities for in-ter- and trans-disciplinary research. The whole topic bridges the natural and social 
sciences. Today, in a world of global environmental change it is widely recognized that 
human societies and their wellbeing depend on a sustainable equilibrium of ecosystem 
services and the possibility of cultural adaptation to global environmental change. The 
need to identify and quantify health risks related to global environmental change is 
now one of the most important challenges of humankind. 
Describing spatial (geographic, intra/inter-population) and temporal differences in 
health risks is an urgent task to understand societies’ vulnerabilities and priorities for 
interventions better. The Göttingen International Health Network (GIHN) is a research 
and teaching network in relation to this cross-cutting topic. The book provides a coll-
ection of articles which contribute to this issue of overriding importance and presents 
an overview of the GIHN launch event.
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1 Editorial  
Global Health  
A challenge for interdisciplinary research 
International health, global health or one health, are in general synonyms for the 
same holistic view of human, animal and environmental issues which is not really a 
new idea over the past decades. The first veterinary schools for instance were cre-
ated 250 years ago as a response to concerns over food security in and the threat 
from zoonotic diseases. But over the last decades research lost track of this holistic 
view on the interconnectedness of all health related issues. In consideration of the 
fact that climate change is happening and endangering our planet (e.g. AR4-climate 
report of IPCC 2007) many initiatives have been created to adapt to the projected 
impacts on the 21st century. The whole range of requirements for human liveli-
hood is at risk and the focus of our future health should be on human, animal and 
plant diseases together. 
Most of the new infectious diseases (around 75%) are of animal origin and the cost 
of controlling outbreaks can be extremely high. In relation to the risk that a major 
disease outbreak poses, the costs of prevention are negligible. For this reason deci-
sion makers have implemented measures for regulation, surveillance and research 
networks (like Eurolife or GIHN) to promote prevention. The main health risk 
drivers are at present:  
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• Non-Communicable Diseases; Allergies 
• Emerging Diseases 
• Climate Change, Water Cycle Change and Disturbances of Ecosystem Services 
• Food and Agriculture 
• Urban Environment (continuation of urbanization to Mega-Cities) 
Considering the impact of the above mentioned health risks, a holistic and integra-
tive perspective will be a prerequisite for successful management of Global Health 
risks in an era of climate change, air pollution, emerging allergies and zoonotic 
diseases, malnutrition and other development challenges. The integrative approach 
of global health means the consideration of both the environmental/geo-bio-



















The following list highlights important topics (in bold) and their association with 
health and global change - related keywords that make the whole story of the 
flowchart above more complex:  
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• Public Health:  healthcare services – pandemics - pet animals – pharmaceuticals -
vaccination & resistances - sanitation & hygiene - socio-economic determinants 
• Diseases: allergies - communicable diseases - emerging diseases - lifestyle diseases 
- mental illnesses - non-communicable diseases - wildlife diseases – zoonoses 
• Food and Agriculture:  agricultural production - agro chemistry – biofuel - food 
design - food safety & security - genetically modified organisms - livestock      
• Environment: biodiversity - ecosystem goods & services - fisheries & wildlife - 
land degradation - logistics & transportation – natural hazards – pollution - re-
source – depletion - water & energy 
• Global Change: climate change – demographics - displacement & migration – 
globalization – poverty - sustainable development - urbanization 
• Prevention: early warning - monitoring, surveillance & early detection - predictive 
modelling - preparedness 
• Health Risk Management: best practice - ethics & stewardship - integrative risk 
management - intervention/response - recovery/rehabilitation - resilience & 
adaptation 
• Capacity Enhancement: capacity building – education - research, innovation & 
technology - social learning & behavioural change 
• Financial Tools: financing methods - funding strategies – insurance - sustainable 
investments 
• International Cooperation: alliances & partnerships (Eurolife, GIHN) – communi-
cation - corporate social responsibility – institutions - global health strategies - 
policy & governance - public diplomacy 
 
The assigning of keywords from the above indicates the broad field of intercon-
nected drivers for global health and illustrates relevant scientific disciplines ranging 
from medicine to geography, sociology, economy and agricultural sciences. 
The new Göttingen International Health Network (GIHN) looks at the emer-
gence of “One World, One Medicine, One Health” as the latest instance in a long 
history of attempts to bring research and treatment of human, animal and plant 
diseases together. This concept tries to diminish disciplinary and institutional barri-
ers of collaboration. On the other side interdisciplinary research is still weakly 
elaborated and is often not the focus of funding agencies. What is needed here is a 
new awareness on the part of politics and funding agencies. Therefore this concept 
is on probation and has first to show if it could deliver solutions for complex envi-
ronmental-health problems. 
GIHN involves various disciplines in establishing how they could interact and 
what contemporary interests lead to their co-operation and problem solving. Ad-
dressing human, animal and plant diseases within the framework of global change 
issues (climate change, land use change, lifestyle change) is the outstanding topic of 
GIHN. 
The background for establishing GIHN in 2011 was the strong wish to create 
a shared vision and to build up the capability of people and institutions in solving 
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rising health problems which cannot be handled by a mono-discipline view. The 
global health approach should become the new norm for addressing these complex 
health issues. Furthermore GIHN encourages bringing together researchers in the 
relevant areas and facilitating exchange of experience and development of new 
projects. Networks work best when legitimate interests of different partners com-
bine to further a common goal. 
Moreover the implementation of global health approaches are seen as a pre-
requisite for sustainable life. The adoption of global health itself has a unique value 
to address health issues at the interface of human and animal ecosystems. For this 
task cross-sectoral partnerships are needed. The ceremonial launch event of the 
Göttingen International Health Network on May 24, 2011 was a first response to 
this challenge. It is no surprise that at the same time other huge joint projects like 
“Global Strategic Alliances for the Coordination of Research on the Major Infec-
tious Diseases of Animals and Zoonoses” (STAR IDAZ) were created (STAR 
IDAZ launched in May 2011). Research questions of today read like “Influenza 
and other Emerging Zoonotic Diseases at the Human-Animal Interface” or “Risk 
Assessment on West Nile Virus Infection in the European Union” or “Alternatives 
to Antibiotics” or “Viruses on the Move”. Just a few examples of relevant research 
questions directly connected to Global Health. 
The Grand Opening of GIHN was dedicated to the unresolved millennium 
goal of reducing mother and child mortality in the world. An interdisciplinary re-
search group should deliver approaches for improving maternal and child health. 
In the light of this a few chapters of the book directly focus on maternal mortality. 
Other chapters deliver a more general view of conceptual vistas or offer infor-
mation about very specific health problems such as infectious diseases or the travel 
behaviour of people and related illnesses. Therefore the book is divided into three 
sections (I: “Setting the Scene”, II: “Health Risks related to Maternal and Child mortality – 
examples from Africa and India”, III: “Specific initiatives and research topics under the vision of 
GIHN”). The chapters of the book reflect the broad variety of topics under the 
umbrella of global health presented at the GIHN opening event, May 24th /25th 
2011 at Göttingen University. 
Setting up GIHN and the present book was a great challenge and we should 
like to thank the members of Eurolife and GIHN and all contributing authors to 
this book. Finally, in the name of the entire network, we should also like to express 
our gratitude to the outstanding commitment of Ms Christiane Hennecke (Univer-
sity Medical Center Göttingen, International Affairs) and Ms Martina Beck (Insti-
tute of Geography, Göttingen University) for their help in setting up the Göttingen 
International Health Network and creating a first joint publication dedicated to the 




Göttingen, Juli 2012  Martin Kappas, Uwe Groß, Dermot Kelleher 
 
 
I. Setting the scene

2 Knowledge based approaches to  
international health:  
The Eurolife International Health Alliance 
Dermot Kelleher 
1 Introduction 
The world of biomedical science is rapidly changing at an international level at a 
rate which is frequently not fully appreciated.  Arising out of the genome project, 
we now understand in a lot more detail both the causes of monogenic disorders 
and  the complexities of the genetic components of common human diseases such 
as diabetes, inflammatory arthropathies and gastrointestinal diseases such as celiac 
disease or inflammatory bowel disease.  However, the genome project although 
providing huge quantities of data has only provided us with an introduction and a 
framework on which to base our understanding of human disease.  Most im-
portantly, we now appreciate that many diseases occur as a result of an interaction 
of a series of both environmental and genetic effects.  Such interactions could best 
be illustrated by the example of coeliac disease, a condition also known as gluten-
sensitive enteropathy, in which the host’s genetic background determines the sus-
ceptibility, but exposure to gliadin and related proteins from wheat and other cere-
als in the diet is the factor which provokes disease.  On this background, we can 
begin to identify a very complex history of evolution of the condition, which is 
non-fatal and which has developed in geographically distinct parts of the world, 
including Punjab, North Africa (1) and Ireland (2).  
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We now have to begin to develop an understanding of the “exposome” (3), ie the 
disease provoking factors to which we are exposed and to develop the tools to 
catalogue such interactions and to understand their relationships with the genetic 
component of disease. The influence of such gene- environment interactions over 
generations can lead to development of populations which are skewed in a particu-
lar direction, as a result of both genetic and environmental factors. Hence, genes 
which contribute to auto-immune disease might also be favourable in terms of 
their capacity to skew immune responses towards stronger responses to bacterial 
or viral infection. In the international health arena conditions such as sickle cell 
disease represent the outcome of generations of interactions with infectious agents 
and the processes of natural selection which have enabled survival of the host. 
2 The paradigm of gene-environment interactions 
Therefore, the concept of gene environment interactions in terms of conventional, 
common diseases in man has led to an evolving understanding of disease.  Most 
notably, in recent times, we have been able to determine that multiple genes are 
involved in disease causation, through genome-wide association studies (4). Fur-
thermore, in recent times, we have also been able to identify the cell biology result-
ing from gene-gene interactions and from protein-protein interactions and the 
potential for pathogenic processes to have clear pathways towards disease causa-
tion. We now increasingly, in terms of modern day science, utilise animal models 
of disease to determine the true extent of gene-environment interactions in an in 
vivo setting and such models have provided us with very exciting insights into the 
causation of diseases such as childhood eczema, multiple sclerosis, among others. 
Ultimately, the process of drug development typically involves the requirement for 
such animal models, prior to testing of a therapeutic entity in a murine system 
before our well developed processes for clinical trials. 
However, we do know that this paradigm, while extremely valuable in coun-
tries with economic resources to take advantage, has limited applicability when it 
comes to the implementation of change in terms of poverty related disease.  At this 
moment in time, the world is seeing an emergence of a range of epidemic diseases, 
including conditions such as West Nile Fever, SARS coronavirus, multi-drug re-
sistant salmonella, multi-drug resistant TB and the factors that determine suscepti-
bility and outcome frequently relate to situations over which we have less and less 
control. Furthermore, the factors that influence health are dependent on such basic 
environmental issues as the economy, the weather and the food and water supply. 
Global climate change is emerging as an important factor in the pathogenesis of 
disease, increasing the migration of disease-causing vectors to areas of the world 
where they have not been endemic, having substantial effects on water supplies 
and on food supplies in areas which are vulnerable and hence increasing the poten-
tial for food and water borne disease at a global level. 
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3 Millenium development goals 
For these reasons 193 member states of the United Nations and 23 international 
agencies agreed in 2000 on eight Millenium Development Goals to be achieved by 
2015 all of which have substantial impacts on the health of the global populations 
(5): -  
 eradicating extreme poverty and hunger, 
 achieving universal primary education, 
 promoting gender equality and empowering women 
 reducing child mortality rates, 
 improving maternal health, 
 combating HIV/AIDS, malaria, and other diseases, 
 ensuring environmental sustainability, and 
 developing a global partnership for development 
 
There has been considerable debate as to the best mechanisms to achieve these 
goals and it is fair to say that political complexities both North and South have not 
always been conducive to the delivery of these goals. International health has not 
traditionally been attractive to the pharmaceutical industry or to the biotechnology 
industry, because the returns on investments in this sphere have been considerably 
less than the returns with regard to conditions of the more prosperous nations. 
Hence, although there is enormous scientific interest in the areas of international 
infectious disease, very strongly supported by funding bodies and by philanthropic 
sources, there are a series of bottlenecks in the delivery process including for ex-
ample a bottleneck at the level of large, controlled clinical trials, which are neces-
sary in order to determine efficacy of drugs, prior to implementation of therapeutic 
processes in terms of poverty-related disease. The ethical issues involved in the 
construct of clinical trials with regard to conditions impacting on international 
health have come to the fore in recent years with consensus that common ethical 
principles apply at a global level (6). 
In this regard, while pharma and biotech and the global medical and political 
community are frequently dealing with conditions for which many of the mecha-
nisms are known, the outcome does not depend on a simple paradigm, but is 
strongly influenced by issues such as economics, politics, climate, energy and, in-
deed, health systems at a global level.  Hence, there is an increasing need for new 
approaches towards the development of synergies in the international health arena, 
which can contribute to improved outcomes for patients and populations at a 
global level. In this regard the global academic community has a substantial role to 
play in developing the agenda not only for the science but also for delivery in the 
sphere of international health. 
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4 Biomedical science and international health 
There is a very pressing need to substantially facilitate our capacity to make mean-
ingful interventions in the biomedical space in terms of poverty-related disease. 
Success in this area will require a concerted approach involving Science, Policy and 
Implementation (Fig 1) and there are important considerations in how we progress 
across these three themes. Firstly, discovery science is paramount in terms of iden-
tifying new mechanisms of disease and in identifying the types of therapeutic ap-
proaches that may make a difference at an international level.  Secondly, there is an 
increasing requirement to look at the continuum of activities in international health 
and to examine such activities in terms of their capacity to substantially modify 
outcomes.  In this context, the development of North-South partnerships in re-
search and education, particularly with regard to the biomedical sciences will have 
substantial impact on the capacity of countries in the south to develop their own 
analytical and scientific programmes, which will strongly influence our knowledge 
of disease. 
In this context, the barriers are substantial and they include the very high cost 
of equipment and reagents necessary to perform biomedical science at the highest 
level and also the education of staff at PhD and postdoctoral level, in addition to 
the principal investigator level, to create the human resource capacity to perform 
such studies in a scenario of real critical mass.  Hence, we do need to strongly ad-
dress our ability to deliver high quality educational programmes at an international 
level. 
 
Figure 1: The integration of Science, Policy and Implementation is key to success 
in the International Health arena 
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There are even more pressing issues with regard to policy and implementation. 
Firstly, the capacity to develop and deliver new therapeutic approaches is only of 
benefit, if such approaches can be advanced and implemented.  Laboratory re-
searchers must develop an understanding of the barriers to implementation of 
successful developments and aim to optimise the discovery process. An example 
of this is in the field of vaccine design where due concern is needed to ensure that 
vaccines can be delivered to areas where there is limited capacity for refrigeration. 
It is critical that these issues are at least considered at an early stage in the devel-
opment process in order that policy implementation is facilitated at the stage of 
delivery. In the policy arena, it is critical that all partners must work together to 
ensure that policy is developed at a sufficient level to deliver across global popula-
tions. 
It is also critically important that implementation of policies at national and 
trans-national levels must be accompanied by the introduction of high quality met-
rics to assess and evaluate the impact of such implementations in a formal and 
rigorous way. This is the domain in which the academic community typically excels 
and in which it may have even further potential to develop partnerships that facili-
tate a growth in knowledge that facilitates delivery. The application of formal met-
rics to intervention and the examination of case studies of interventions are critical 
so that we can understand not only what makes us feel good but also what does 
good. 
Thus, it is important that within health systems that the individual components 
for effective management of health and health-care are brought together in a way 
that ensures a delivery of the highest possible care at an international level. With-
out formal implementation science (7,8) to ensure that we are effectively providing 
improved outcomes, it is highly possible to fool ourselves that well-meaning and 
benign interventions are making a difference.  Hence, the critical components that 
are needed are an increasing cohesion between north and south, an increasing 
cohesion between the biomedical sciences and public health and policy and the 
development and strengthening of bridges to individual networks and institutions 
and to policy drivers within multiple populations. 
5 Eurolife 
Eurolife is a consortium of universities in the biomedical space, which includes 
Leiden University Medical Centre, the University of Barcelona, the Karolinska 
Institutet, the Université de Strasbourg, the Medizinische Universität Innsbruck, 
the University of Edinburgh, the Universitätsmedizin Gottingen and Trinity Col-
lege Dublin (9). This consortium of universities is strongly committed to working 
together in the biomedical areas in both research and education, and have collabo-
rated substantially in areas such as inflammation, neuroscience, nanotechnology 
and imaging in the past. 
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The Eurolife Universities have established strengths in International Health in 
areas related to both the biomedical sciences and the public health. Some of these 
strengths are summarised below: -  
 
 CRESIB (www.cresib.cat) The Barcelona Centre for International Health.  
Universidad de Barcelona  
 Division of International Health (IHCAR) Karolinska International Research 
and Training (KIRT [ki.se/ki/jsp/polopoly.jsp?d=25542&l=en]) Program and 
the Centre for Global Health (KICGH [ki.se/ki/jsp/polopoly.jsp?d=12350&a 
= 29787&f=sv&l=en]) Karolinska Institutet,   
 Centre for International Public Health Policy (www.health.ed.ac.uk/CIPHP) 
University of Edinburgh 
 Centre for Global Health (www.medicine.tcd.ie/global-health ), Trinity Interna-
tional Development Initiative (TIDI), Trinity College Dublin; INDIGO, the 
International Doctoral School in Global Health 
 Female Cancer Programme (FCP) LUMC 
(www.femalecancerprogram.org/FCP/ The LUMC Center for Infectious Dis-
eases (a center for departments of microbiology, infectious diseases and para-
sitology  to work together and organise education, research and patient care.) 
web link http://www.lumc.nl/rep/cod/redirect/2010/algemeen/cid-nl.html 
 Gottingen University Medical Centre: DAAD Physician Program (between 
UMG and Banda Aceh/Indonesia) 
(www.daad.de/entwicklung/de/12.2.8.10.html). Coordinated by the Institute 
for Medical Microbiology. 
 
Hence, within the academic institutions we have considerable expertise in interna-
tional health focussed in a number of complementary areas. Hence, we have de-
veloped an alliance in the area of international health called the Eurolife Interna-
tional Health Alliance, with a mission statement as follows: 
 
„The Eurolife International Health Alliance will combine its’ complimentary 
expertise in international health to deliver innovative transnational interdiscipli-
nary education and research programmes in health, healthcare policy and care 
delivery that best serve the needs of the developing world. The EIHA will uti-
lise its’ resources to champion international health as a key priority for improv-
ing the health of the human population and will actively engage with policy 
makers to ensure the realisation of this vision“.  
 
This mission statement encompasses the need to not only deliver research pro-
grammes but also to utilise our resources to improve the health of the human 
population. Hence, implicit within the mission statement, is an active engagement 
with the process of translation into the international health arena. 
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6 Delivering the EIHA vision 
The Eurolife International Health Alliance commits to maximising synergies be-
tween the different partners in order to address key international health priorities 
and develop innovative solutions for poverty related health deficits using our 
strengths in the areas of Education and Training, Research, Health Care Policy and Care 
Delivery. An unique feature is the ability of EIHA partners to combine research and 
training. EIHA will engineer capacity building alliances with appropriate partner 
organisations and stakeholders in both developing and developed countries, ad-
vancing a coherent agenda through a series of initiatives in the fight against global 
disease.  
 
These initiatives will include: 
 
 A Research Partnership that builds on existing programmes of research be-
tween individual institutions within Eurolife and their partners in the develop-
ing world and provides added value to maximise research excellence in areas of 
mutual interest that will have broad international application. 
 An Educational Alliance that will promulgate innovative inter-institutional pro-
grammes of education and training between Eurolife Institutions and Partner 
Institutions in the developing world, underpinning capacity building within the 
developing world. 
 A Policy Forum that will be nurtured in close partnership with stakeholders in 
the developing world to position International Health as a key challenge in so-
ciety. 
 A commitment to advancing solutions to particular healthcare problems and 
healthcare access within partner developing countries. 
 
In this respect we feel that it is important that we utilise our combined strength to 
leverage an evolving alliance between EIHA and other high profile International 
Health partners within the developed world to enhance the production of relevant 
quality solutions in research, education, health care policy and care delivery in In-
ternational Health for the developing world. Recognising the value of strength 
through unity and the need to advance the international agenda at a political level, 
EIHA undertakes to utilise its collective strengths to lobby for the required Inter-
national Health priorities to be recognised and appropriately resourced at both 
local and international levels. 
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7 The importance of networks 
It is now critically important that we aim to look at international health problems 
in an integrated way. There are a range of issues which relate to the interface be-
tween Biomedical Sciences and Public Health and in which both components are 
absolutely required and synergistic in terms of outcomes. Hence multiple skills are 
needed to address complex problems and the nature of the skills that are required 
may not be apparent until these issues are addressed. In this respect, we need to 
identify new modus operandi for the global health space. We need to identify a 
matrix of both research and educational programmes with international health 
elements in order to facilitate integration. With regard to research and delivery of 
health care we also need to develop a real critical mass in interdisciplinary working 
within the international health space with researchers in public health arena work-
ing side by side with the biomedical space and also with educationalists in terms of 
the delivery of new understanding and knowledge.  The European Academic 
Global Health Alliance has as its two major aims: 
 
 To create a forum for interested academic institutions with involvement in 
Global Health to exchange views and ideas, so as to develop a European voice 
on Global Health issues and influence relevant policies. 
 To bring together International Health/Tropical Medicine and Public Health 
institutions 
 
Eurolife members serve as partners in EAGHA while the Eurolife EIHA is itself 
an affiliated member of EAGHA, emphasizing our strong commitment to inter-
disciplinary and international work in the field of International Health.  Similarly 
the EIHA aims to work closely with TropEd to promote new educational experi-
ences in International Health. In addition EIHA has liaised directly with the US 
Consortium of Universities in Global Health to find common ground. Such inter-
actions were best exemplified at a jointly hosted colloquium at the FESTMIH 
meeting in Barcelona in October 2011 entitled “Embracing pluralism: Networks 
dedicated to improving global health. In this regard EIHA is positioned very much 
on the biomedical side of the continuum and sees its interactions with other net-
works as extremely valuable as we all seek to succeed in the common goal of im-
proving health for the global population. 
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8 Conclusion 
Academic Institutions have made an enormous contribution to research and health 
care delivery in international health. It is important that we now move to consoli-
date and develop from such gains by working in an interdisciplinary manner across 
a range of academic areas including biomedical sciences, public health and educa-
tion. Key to success will be the capacity to generate and translate new knowledge 
across disciplines in a manner that creates new knowledge and translates such 
knowledge into measurable benefits for the health of global populations. Such 
interactions are key to progress towards the Millenium development Goals and 
also to our capacity to generate and forge new and more effective ways of working 
across disciplinary and national boundaries to make substantial improvements in 
the prevention, diagnosis and cure of poverty-related disease.  Our academic social 
responsibility (10) demands that we should aim to not simply make transitory in-
terventions but to also improve educational and research capacity through our 
combined interactions.  
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3 The One Health Concept in a  
development context  
Kerstin Wydra 
1 Population increase, climate change, hunger, poverty, 
inequality and health 
The challenges mankind is facing in the next decades are manifold, encompassing 
world population growth predicted to reach 9 billion by 2050, climate change with 
temperature increases and changes in precipitation patterns, and more extreme and 
unpredictable weather events, which occur with increasingly higher amplitudes and 
frequencies. Additionally, environmental degradation, in combination with inade-
quate political frameworks, further contribute to food insecurity, malnutrition, bad 
health and depletion of natural resources. Among the regions most affected by and 
most vulnerable to climate change is Sub-Saharan Africa, where variability in onset 
and extent of rainy seasons, and significant reductions in the length of growing 
periods forecasted by many of the Global Climate Models as well as steadily in-
creasing desertification and land use and land cover change will have direct impact 
on agricultural production. Besides the effects of exploitation and further loss of 
natural resources, the direct drivers of agricultural change, the growing food de-
mand and changes in consumption patterns, are enhanced by factors such as global 
energy shortage, which further aggravate the situation (IAASTD 2008). As a result, 
Africa’s agriculture, particularly in arid and semi-arid areas, is facing increased abi-
otic and biotic stress with disease outbreaks and insect epidemics, leading to a 
decline in crop yields, a decrease in forest and cultivated area shares, and a reduc-
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tion in ecosystem integrity, associated with a decline in biodiversity. Thus, for large 
parts of the Sub-Saharan African region, the percentage of “failing seasons” is 
likely to be in the range of 20-50% by 2050 (Thornton et al. 2006). Existing farm 
and pastoralist systems and their agricultural practices and pest control measures 
are not resilient enough to cope with these challenges. In 2010, Sub-Saharan Africa 
had with 30 % the highest percentage of undernourished population comparing 
continents and an extremely alarming global hunger index in some countries, 
among them East and Central Africa with 25% to more than 35% of the popula-
tion being undernourished, respectively (FAO 2010). One of the most evident 
effects of the climate-related, unforeseen disturbancies are the regional disasters in 
form of hunger catastrophes.  
Additionally to the increasing exposure to environmental stress, small-scale 
farmers are further challenged by changing socio-economic conditions, which 
increase risk, as there are population growth, large-scale farming and foreign in-
vestment (‘land grabbing’). In a vicious circle low agricultural production leads to 
undernourishment and malnutrition as primary causes of illnesses and death, which 
further negatively impact food production. In these aspects, the linkages between 
agriculture and health are obvious.  
Associated with hunger is poverty. Sub-Saharan Africa counts for about 75% 
of the ultrapoor of the world, who live on less than 0.50 US$ per day (Ahmed et al. 
2007). In combination with low food production, related low water quality, insuffi-
cient sanitation and health facilities and lack of education, specifically of mothers, 
poverty contributes to a high vulnerability of households and an overall poor live-
lihood. This interrelatedness of factors governing the living conditions in develop-
ing countries demands innovative, integrated and interdisciplinary approaches to 
reach development goals. One prerequisite to reduce poverty and improve nutri-
tion and health is building on agricultural knowledge and innovation in local and 
traditional societies (IAASTD 2008). 
2 Climate change and health 
Climate change will have impact on the distribution, epidemiology and severity of 
diseases, and make controlling existing diseases more difficult (Campbell-Lendrum, 
2011). The impact of climate change on health will manifest in direct effects, such 
as outbreaks of diseases among human populations, and indirect influences such as 
disease calamities of domesticated animals or plants, which endanger food security, 
economic stability and trade. Disease control under changing conditions in agricul-
tural production has to be adapted, since host resistance and pathogen virulence 
may change. Further impacts on crop yields and the environment which indirectly 
affect health are given below. 




3 Millenium Development Goals 
As a response to the challenges of global change and population growth, in year 
2000 the eight millennium development goals (MDGs) were defined and adopted 
by 170 heads of state. To achieve the MDGs as prospected for year 2015, the de-
velopment of an intersectoral framework is needed that facilitates the exploitation 
of synergies between agriculture and health and supports joint policy formulation 
(von Braun et al. 2010). Therefore, the one health concept linking the sectors agri-
culture, environment and health is important for most of the MDGs. As outlined 
below, the interactions between the different sectors are numerous, and policy-
makers, scientists and donors need to be convinced of the enormous opportunities 
for development through synergistic effects by a close collaboration between the 
various sectors. 
4 The One Health Concept 
Existing and emerging challenges and threats encompassing plant, animal and hu-
man diseases, water scarcity, chemicals in the environment, loss of biodiversity and 
land degradation and loss of agricultural land need to be addressed in a one-health 
approach which also considers measures to mitigate climate change and socio-
economic conditions. The one health concept integrates human medicine, veteri-
nary medicine, plant pathology and plant protection and environmental health, 
encompassing the natural and the human environment, the latter covering the 
social, political, structural and institutional framework. Not the overlap of disci-
plines is searched, but one holistic approach entangling the diverse aspects of each 
discipline. 
One Health is the collaborative effort of multiple disciplines-working locally, 
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5 Linkages between agriculture and health 
Agriculture is related to many of the world’s major health problems, through food 
production and the environmental impact of agriculture. In the food systems link-
ages to health occur at all steps along the value chain, from natural resources and 
inputs to primary production, transport, storage, processing, followed by second-
ary production, further transport and storage, to consumption (Pinstrup-Anderson 
2010). The conceptual framework of linkages between agriculture and health is 
operating on three levels: across the top level the agricultural supply chain with 
agricultural producers, agricultural systems and agricultural outputs, which are 
linked through intermediary processes to the second level – labor processes, access 
to and impact on natural resources (water, land, biodiversity), income generation 
and provision of health-related services, and to the bottom level, representing the 
health problems, undernutrition, water-associated, vector-borne diseases (e.g. in 
relation to irrigation and land degradation), foodborne diseases and occupational 
health hazards (Hawkes and Ruel 2006). Through linking the agriculture and food 
system to health, health becomes a critical driver of agricultural change (Hawkes-
worth et al. 2010). Health issues linked to agriculture encompass direct effects of 
low and insufficiently diverse agricultural production such as hunger and malnutri-
tion, and also cover health related indirect consequences of unsustainable produc-
tion, which can cause foodborne diseases resulting from infections and intoxica-
tions, and vector-borne diseases, which are enhanced under specific production 
systems and occupational health hazards. Nevertheless, agricultural policy to date 
has been focussing on maximizing production, thereby neglecting environmental 
health issues as well as biodiversity, which are an important basis for sustainability 
and sufficient micronutrient supply. The often bidirectional cause-effect relation-
ships between agriculture and health are outlined in detail in the following. 
5.1 Hunger and malnutrition 
Hunger is the most obvious and direct effect of failed agricultural production on 
human health. Besides hunger the fact of malnutrition as most important cause of 
diseases and death worldwide is often neglected. About 53% of deaths among 
children of below five can be attributed to malnutrition (Caulfield et al. 2004). In 
the recommendation of the Copenhagen consensus 2008 
(http://www.copenhagenconsensus.com), eight world leading economists identi-
fied the top ten solutions for the world problems, of which five involve nutrition 
issues. A balance of nutrients forms the basis of a healthy diet, which should in-
clude the four micronutrients zinc, iodine, iron, and vitamin A which are in chron-
ically short supply. This hidden hunger in form of micronutrient deficiencies af-
fects more people – about 2 billion - than the lack of calories which about 800 Mio 
people in the world suffer from. The promotion of micronutrient-rich food com-
bined with behavioural change is a recommended strategy which has to be fol-




lowed in an intersectorial approach, between farmers, traders and consumers, and 
on policy level (Hawkes and Ruel 2006). 
5.2 Food safety and water safety 
Food-borne diseases caused by contaminations through pathogenic micro-
organisms and toxic organic and inorganic compounds are among the most im-
portant reasons for illnesses in the population of the developing world. Many of 
these microbiological and chemical hazards originate from agricultural production, 
such as zoonotic pathogens or toxins, and contaminated water. Specifically aflatox-
icoses caused by mycotoxins may be one of the most important and least recog-
nized health problems (Williams et al. 2004). Staple crops such as maize and 
groundnut can contain highly toxic metabolites from pathogenic and saprophytic 
fungi, which develop in the field under conditions of drought stress and erratic 
high rainfall or high moisture, and proliferate under unsuitable storage conditions, 
favoured by high temperature and humidity (see also below). Generally, contami-
nations can occur along the whole value chain, from primary production to har-
vest, storage, processing and transport, and during food preparation. 
Water-borne and water-associated, vector-borne diseases are the cause of death 
for 3.2 million people per year, which to a significant part are due to the impact of 
agricultural activity (Nugent and Drescher 2006). Irrigation water and stagnant 
water are related to agricultural practices and provide breeding ground for disease 
vectors. Further impacts on food safety derive from pesticide residues in intense 
agricultural production, which endanger humans and the environment. Water-
borne diseases including zoonoses as well as contamination of water supplies with 
chemicals, toxins and by-products of drugs and hormones are typical examples, 
which demand a solution under the paradigm of an one health approach. 
5.3 Zoonotic diseases 
Zoonotic diseases are the main factor of infectious illnesses in the developing 
world. They originate with animals and are transmitted directly from animals or 
through a large number of pathogen-transmitting insect vectors, contaminated 
water, or bad sanitary conditions with humans and livestock living closely in the 
same space. Pathogen transmission for livestock-related zoonoses in more densely 
populated areas with frequent contact between animals and humans will be in-
creasing, the rate of development of pathogens may become enhanced, the geo-
graphic range of vectors and their competence may change with variations in 
weather (temperature, humidity, rainfall, precipitation) and land use, increasing 
suitable habitats for water-related vectors. Recent emergence of serious zoonotic 
diseases such as Salmonella spp. and Campylobacter spp. from poultry, bovine 
spongiform encephalopathy (BSE), E. coli infections, the severe acute respiratory 
syndrome (SARS) and avian influenza are all related to animal production practices 
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(Todd and Narrot 2006). Transmission can be through vectors, but also through 
contaminated water, crops, other animals, specifically where animals are kept in 
dense populations and close to human living grounds. All these hazards related to 
livestock production are expected to increase in the coming decades due to a rapid-
ly increasing demand for animal products. About 21 billion food animals are being 
produced with 15 millions of tons of animal and agricultural products being trans-
ported worldwide. The future increase in animal production will occur predomi-
nantly in developing countries which have major deficits in monitoring and con-
trolling disease and thus pose a threat to the global food system and human health 
worldwide. 
5.4 Crop protection and health 
Occupational hazards related to crop protection include health risks from pest 
control through use of chemical pesticides, with both acute effects and long-term 
harms to health (Williamson et al. 2008). Besides the exposure of farmers during 
application, toxic compounds occur as residues in the food supply, in the envi-
ronment and in the water. A wide array of abiotic and biotic factors such as insects 
and pathogens causes major yield losses through the impact on quantity and quality 
of crops, which in turn leads to malnutrition and hunger, thereby closing the vi-
cious cycle of negative health-agriculture feedbacks leading to poverty with subse-
quent negative impact on agricultural production. Mycotoxins produced by patho-
genic and saprophytic fungi such as Fusarium spp., and Aspergillus and Penicilli-
um, respectively, have a direct negative health effect on consumers and can cause 
liver cancer, stunting, low birth weight and other severe impacts on health. Some 
measures are available to reduce mycotoxin contamination before harvest and in 
the storage, as recent development of a biological control through application of 
atoxigenic strains of Aspergillus flavus by the International Institute of Tropical 
Agriculture (IITA), while awareness among farmers and consumers and suitable 
monitoring systems are still insufficient or missing. 
In reaction to the high pressure from increased populations, climate change 
and global change, traditional, more resilient production systems are more and 
more abandoned in favour of high input mostly monocultures based agriculture, 
which reacts highly sensitive to any stress and to lack of external input, when not 
available. Only sustainable intensification considering the principles of integrated 
pest management and biological control, in combination with measures to support 
soil health and mixed cropping systems, as part of an integrated crop management 
can contribute to enhanced human, plant and environmental health, and thereby 
supporting human wellbeing and rural development. 




6 Natural environment and health 
6.1 Ecosystem degradation 
The impact of the environment on health of children < 14 is higher than for the 
general population. Children are 44% more likely to die as a result of environmen-
tal factors. Globally, almost 25% of the diseases are related to environmental fac-
tors, with 94% for diarrhoea, 42% for malaria and 41% for lower respiratory infec-
tions (Prüss-Üstün and Corvalán 2007). Ecosystem degradation will be enhanced 
by a predicted 30-85% increase in water withdrawal and a 100 to 1000 fold in-
creased extinction of species for the next 40 years (Millennium Ecosystem As-
sessment 2005: http://www.millenniumassessment.org/en/index.html). Environ-
mental degradation such as erosion, salinisation, soil nutrient depletion and water 
contamination and scarcity caused by agricultural practices will contribute to de-
clining agricultural productivity, resulting in malnutrition and illnesses, which again 
will reduce labour productivity, resulting in unsustainable agricultural production 
and further negative impact on the environment. The health effects range from 
undernutrition to increased occurrence of water-borne diseases, altered transmis-
sion mechanisms for infectious diseases and intestinal, respiratory and other disor-
ders, leading to decline of farm income with its negative effects on health and 
health care (Nugent and Drescher 2006). 
6.2 Agrobiodiversity and health 
Agrobiodiversity is a basis for food security and provides famine food in times of 
hunger as well as micronutrients to alleviate the effects of malnutrition. Inter- and 
intraspecific biodiversity is a source of genetic resources and the basis for breeding 
for more resilience to biotic and abiotic stress and to increase the content of mico-
nutrients. Neglected crops, specifically vegetables, contain high levels of caroti-
noids such as lycopene and lutein, and beneficial compounds with functional 
properties, such as flavonoids and phenolics which act as antioxidants and con-
tribute to reducing the risk of chronic diseases and cancer. Successful examples of 
increased content of micronutrients through introduction of genes from neglected 
species through classical breeding are available and already propagated in various 
African countries, such as the Vitamin A rich sweet potato. When plant produce 
enters the market chain agrobiodiversity can directly contribute to income genera-
tion. Moreover, biodiverse systems improve environmental quality and ecosystem 
services for agriculture, such as nutrient cycling, soil fertility, provisioning services 
supplying food, water, wood and fiber, regulating services such as climate regula-
tion, disease regulation, water purification and cultural services, which all directly 
or indirectly impact human health. Thus, agrobiodiversity combined with indige-
nous knowledge as part of locally available resources has the potential to positively 
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influence the entire agriculture-food-nutrition-health structure (Gari and Villarreal 
2002). 
6.3 Environmental pollution 
Hazards to the environment and thereby to human health can originate from in-
tense agricultural production, such as contamination of water with fertilizers (ni-
trates and others), pesticide residues and pollution of water and air through intense 
livestock production systems with huge amounts of livestock-derived waste (Catelo 
2006). Agricultural chemicals accumulate in environmental sinks such as soil, air, 
water and plants, to which humans are exposed. 
6.4 Agroforestry, nutrition and health 
Agroforestry systems represent through integration of crop and tree diversity in a 
production system a sustainable basis for environmentally sound agricultural activi-
ty and increase the flexibility and adaptability of the system. They are a source of 
medicinal products from trees, shrubs and herbs used in traditional medicine 
across much of Asia, Latin America and Africa. Moreover, agroforestry systems 
provide fruits, leaves and other products of high nutritious value which increase 
the dietary diversity for the rural and, if marketed, also the urban population, and 
which serve as animal feed. Fruits and berries are preferably consumed by children 
as a study in Zimbabwe showed (cited in Swallow and Ochola 2006) and also con-
tribute to household income when entering the market chain. In terms of envi-
ronmental impacts, agroforestry systems are the basis for a sustainable crop pro-
duction by providing niches for beneficial insects such as bees or parasitoids and 
predators, which have the potential to balance the outbreaks of pests, and by a 
sustainable nutrient cycling process with positive effects on soil fertility. 
7 Human environment: Socio-economic and structural factors 
influencing health 
Demographic factors and conflicts surely play major roles in human welfare in 
developing countries. Though not neglecting these circumstances, long term 
changes need sustainable solutions based on well functioning structures. Obstacles 
for improved strategies in developing countries are besides a lack of coordination 
and a poor infrastructure the knowledge gaps on the ways of contamination of 
food, on epidemiological cycles of zoonotic diseases, and thus of adequate man-
agement strategies. Successful strategies developed elsewhere, such as agricultural 
interventions to control the spread of water-associated diseases, are available and 
can be transferred and adapted to local conditions (Mutero et al. 2006). This im-
plies that a major effort is needed on all levels, from research to implementation, 




from community to policy level, including organizational and infrastructure devel-
opment. To develop efficient intervention strategies to improve food security and 
food safety in relation to health, risk analyses are one tool to choose among vari-
ous management options to reduce foodborne diseases and other hazards related 
to agriculture, which affect human health. 
8 Opportunities linking agriculture, environment, food 
security and health 
Linking the agricultural and the health sector provide unique opportunities to im-
prove health and human welfare in the poor countries. Thereby, promotion of 
agriculture considering health aspects and, in a two-ways approach, improving 
health-related problems considering their impact on agricultural production and 
the environment has the potential to significantly and sustainably enhance the nu-
trition and health status of the poor population. As stated by the IAASTD (2008), 
a report accomplished by several hundred scientists, signed by 58 countries, agri-
cultural growth of small-scale farms is the best way to generate income and reduce 
global poverty. Considering environmental factors, as outlined above, the vulnera-
bility of the ecosystem to climate change and changes in land use patterns will 
clearly influence agricultural production and biodiversity, and thus improvements 
on one side will positively affect the entangled sectors. 
To achieve considerable impact, linked agri-food and health governance struc-
tures have to be established, which reduce institutional barriers and are the basis 
for intersectoral research and policymaking. Encouraging intersectoral initiatives 
are being developed in the recent years by the World Health Organization (WHO), 
the Consultative Group on International Agricultural Research (CGIAR) with a 
platform on ‘Agriculture and Health’, and by the International Food Policy Re-
search Institute (IFRPI) which organized international conferences on the subject, 
to name only few. 
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4 Commitments on a global level translating  
into actions locally  
Andrea Holzäpfel 
1 Maternal and child health:  
The commitments of the international community 
In the year 2000, political leaders from around the world gave the world’s biggest 
promise – to achieve the Millennium Development Goals (MDGs). The MDGs 
are a global pledge to reduce extreme poverty and human deprivation by half until 
2015 through collaborative multilateral action. The MDGs comprise 8 quantifiable 
goals of which MDG 4,5 and 6 are directly related to improving health outcomes 
(improving child and maternal health and combating HIV/AIDS). As we move 
towards the target date of 2015 the critical question needs to be asked whether the 
MDGs have been a successful approach and what can be learned from the past 10 
years for the formulation of the Post-MDG agenda. 
Certainly, the MDGs have generated great commitments from governments, 
international organizations, civil society, and even the private sector (Manning 
2010). They have focused attention on key dimensions of human development and 
progress has been made in many areas. The 2010 UN-MDG Summit however 
drew attention to the fact that progress towards MDG 5 – improving maternal 
health – has been unacceptably slow. Child mortality also still remains dramatically 
high with 9 million children dying each year before their fifth birthday (WHO 
2010). At the G8 summit in 2010 the support to significantly reduce maternal and 
child mortality was reaffirmed by announcing the G8-Muskoka Initiative. In the 
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framework of the Muskoka-Initiative the G8 states together with other countries, 
the Gates-Foundation and UN Foundations pledged to mobilize US$ 7.3 billion to 
improve maternal and child health (BMBF 2010). Germany will contribute US$ 
500 million (BMBF 2010). Research and innovation are explicitly part of the initia-
tive. New funding mechanisms however have not been foreseen. Instead each 
donor is free to choose the mechanisms they consider most effective, like for ex-
ample placing the focus of funding programmes on reducing the burden of diseas-
es that mainly affect mothers and children. As welcome the renewal of the com-
mitment is, one should realize that for both, the MDGs and Muskoka, much atten-
tion is paid to the formulation of goals but less to their implementation. 
2 Dimensions of poverty 
The prime aim of the MDGs is halving extreme poverty. Poverty is now widely 
considered to be a multidimensional problem stemming from a complex set of 
deprivations. In fact, new perspectives on poverty have challenged the focus on 
income as the defining condition of poor people (Fukuda-Parr 2006). According to 
the 2000 World Development Report, “poverty is pronounced deprivation in well-
being” (Kakwani 2006). Subjective wellbeing in turn seems closely related to peo-
ple’s capabilities and achievements. UNDP’s Human Development Report views 
poverty as “reflecting lack of choices and opportunities in the key areas of educa-
tion, health, and command over resources, as well as voice related to democratic 
processes” (Kakwani 2006). Consequently, strategies aiming to reduce poverty 
require not only economic growth but also direct interventions in many areas such 
as health and education. As these dimensions are closely intertwined new ap-
proaches are needed. For example human health cannot be considered holistically 
without also looking at the health of animals and plants. Apart from the bodily 
wellbeing, healthy social relations play an important role for the wellbeing of indi-
viduals and communities as a whole. The complexity of the matter therefore calls 
for holistic approaches to alleviate poverty. In fact, the multidimensional nature of 
poverty implies that progress is not realistic or sustainable if only one dimension of 
the problem is addressed in exclusion of others.  
It is true that the idea of interdisciplinary projects is not new. Over the past 
years, funding agencies have become much more receptive and proactive about 
supporting interdisciplinary approaches. Programmes have been initiated to en-
courage scientists from various disciplines to work together. However, despite the 
recognition of the need and potential of interdisciplinary projects their implemen-
tation still remains a great challenge. 




3 The contribution of GIHN  
The Göttingen International health Network (GIHN) has set out to meet this 
challenge. The Network brings together scientists from disciplines ranging from 
life sciences to geosciences and economics. Together they design and implement 
projects aiming to improve maternal and child health. As the health of mothers 
and children is influenced by a wide range of factors such as the quality of nutri-
tion and water, economic determinants, implications of climate change, social  
relations and spiritual wellbeing all partners of the network can contribute their 
expertise to joint projects. Furthermore, GIHN embraces the concept of fostering 
South-South partnership by bringing together scientists from Ghana, Tanzania and 
India in equal partnerships. The aims of the Göttingen International Health Net-
work are thus not only in line with the MDG 4,5 but also MDG 8 that calls for 
global partnership. Its collaborative approach ensures a mutual learning experience 
and the expansion of knowledge of all partners. 
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5 Linkages between economic and  
health outcomes:  
Options for interventions for better health 
Elena Gross and Stephan Klasen 
The United Nations and its member countries have agreed in the year 2000 on the 
8 Millennium Development Goals. MDG 4 and 5 are specific sub-targets related to 
improved morbidity and mortality for children and women. A status of good 
health is essential for a human’s overall well-being, and thus of intrinsic im-
portance. In addition, poor health places significant economic burdens on families. 
Health costs are often high in developing countries and access to health services is 
lacking (WDR, 2004). As a result, higher disease prevalence in a poor environment 
can cause poverty traps where people are too unhealthy to earn money and too 
poor to pay health costs. Conversely, policies to reduce poverty can be one way to 
escape this trap. Poor people in developing countries face a higher diseases burden 
than richer people in the same countries. They also suffer from poor housing con-
ditions and lack of improved water and sanitation facilities which increases the risk 
of falling ill. Prüss-Üstün et al. (2008) estimate that almost 70% of deaths are relat-
ed to unhygienic water and sanitation practices.  
This chapter briefly discusses how economic factors affect health and vice ver-
sa. In a second step, we discuss policy options to improve maternal and child 
health in developing countries. 
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1 Why is good health important for economic outcomes? 
Under-five mortality in developing countries is still high and many children and 
adults are malnourished. Table 1 reports economic and health indicators in several 
regions of the world from the World Development Indicators1. Sub-Sahara Africa 
performs worst among all regions with low income and health expenditure per 
capita, but high malnutrition and mortality rates. Maternal mortality is more than 
twice as high as the world average. Stunting (low height for age) is highest in South 
Asia and Sub-Sahara Africa. Bad health outcomes in nourishment and mortality go 
in line with low income and health expenditure per capita.  
 
The Human Development Report (1993) and, more recently, the Commission on 
Macroeconomics and Health (2004) addresses 4 crucial factors why good health is 
essential for economic success:  
 
                                                     






























29.820,5 4.189,3 5,0 5,7 15 
South 
Asia 




618,5 53,5 28,7 146,3 650 
World 6.023,6 724,4 14,1 67,8 260 
   
Table 1: GDP and Health Indicators 
Data Sources: Col1-4 World Development Indicators, Col. 5 WHO/World 
Bank/UNICEF 




1. Good health increases production and productivity of workers because of few-
er workdays lost healthier workers 
2. Children in school attend class more frequently and learn easier which has posi-
tive effects for their future 
3. Resources can be used more productively as otherwise they had been used for 
treating diseases  
4. In general, good health increases the efficient use of natural resources, e.g. the 
use of arable land due to the eradication of insects which transmit diseases as 
malaria, dengue, river blindness… 
 
On the one hand economic output can be produced more efficiently and produc-
tion increases because of a lower disease burden. On the other hand people can 
save time and money when requiring fewer visits to health services.  
2 Why are economic conditions important for good health 
outcomes? 
Economic conditions are critical for better health outcomes. At the household 
level, better-off households benefit from the ability to purchase better nutrition, 
housing, and other amenities with direct health implications. 
Moreover, the richer households often have better access to health services. 
Often necessary health services are not available for poor people (WDR, 2004). 
Table 2 shows selected indicators to measure service levels for the population. In 
Sub-Sahara Africa and South Asia birth attendance is only done for 41-45 percent 
of births. Similarly, the hospital bed per population rate is very low. Due to illness, 
households remain or fall into poverty through high spending on disease treatment 
and lost wages.  
There is evidence that in the poorest countries (e.g. Burkina Faso) the share of 
household expenditures on health items is even higher than that of the rich 
(Makinen et al, 2000). Out of pocket expenditure is highest in East and South Asia 
and higher in poor than in rich countries, see Table 2. In high income countries 
most people are insured and out of pocket health expenditure only account for 
36% of total private expenditure. The poor face a higher financial burden in health 
payments and similarly have a higher disease burden because of poor living condi-
tions.  




In case of illness, services fail to reach the poorest. Income inequality translates 
into inequalities in the health sector (Wagstaff, 2002). Contributors to health ine-
qualities between the rich and the poor lie in economic as well in social factors. 
Income and assets are economic determinants of receiving treatment more fre-
quently and of better quality. For women and children, the economic gradient of 
health and health access is often particularly strong. 
3 Why do services fail to reach the poorest? 
The following discussion will be on maternal and child health.  Here, women are 
still disadvantaged in many health perspectives and access to services. The World 
Bank (2004) addresses 4 major factors why women do not seek adequate health 
care for themselves and their children: 
 
Births attended by 






penditure (% of private ex-
penditure on health) 
East Asia 
& Pacific 




99,5 6,1 36,6 
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45,3 1,2 46,4 
World 65,4 2,6 43,7 
   
  Data Sources: World Development Indicators 
Table 2: Indicator of Health Services 




- Distance from health facilities (Babianard and Roberts, 2006) 
- Cost (for services and transport) 
- Multiple demands on a woman’s time (Blackden and Wodon, 2006) 
- Women’s lack of decision-making power within the family 
- Poor quality and availability of services 
 
Distances to health facilities are often very large. Only 40-75% of women in Sub-
Sahara Africa were found to have a facility within 5 km distance. This makes it 
hard to get to the health center in time, especially when (public) transport and 
roads are poor (Babianard and Roberts, 2006; Gabrysh and Campell, 2009). 
Transport costs are estimated to be around 25% of total health costs related to the 
disease (Ensor and Cooper, 2004). As there is often no public insurance available, 
often health payments are out-of pocket payments (WDR, 2004).  
Recent literature on time use data shows that women in developing countries 
have a double burden of work in agriculture and domestic activities. This burden 
inhibits them from taking their children to health facilities at the right time (Black-
den and Wodon, 2006).  
One important finding of economic research is that women rather spend 
household income on nutritional and health items (Thomas, 1990, 1997) and in-
creasing women‘s share in income increases expenditure for food and raises an-
thropometric measures of children in general and for girls relative to boys (Thom-
as, 1990, 1997). Whether women can earn or increase their income largely depends 
on the female status in society, as well as their educational opportunities. 
As a result, the education of women has been found to be an important de-
terminant for the good health of children (Hill and King, 1995; Klasen, 1999, 
Murthi et al, 1995). Moreover, gender gaps in education and employment further 
reduce economic growth (Klasen and Lamann, 2009). Thus promoting female 
education and employment will help boost overall resources of the family plus the 
share controlled by women. Both would serve to improve women’s and children’s 
health. 
Lastly, poor quality or often unavailable services are a major barrier for effec-
tive health systems in many developing countries. Often clinics are not staffed, 
staff morale is low, opening hours are not kept, medicines are unavailable.  The 
problems are deep-seated and not only relate to a lack of resources, but also often 
a lack of accountability of the health system providers to its users as well as poor 
incentives for providers (World Bank, 2004). 
4 Approaches to improving health conditions  
Given the health conditions identified, a natural reaction would be to try to address 
these using direct medical interventions. In the case of maternal and child health, 
one would naturally think of acute obstetric care facilities, comprehensive prenatal 
 Elena Gross and Stephan Klasen 
 
42 
and post-natal care as well as nutrition interventions, immunization programs, and 
oral rehydration.  While all of these programs are proven to effectively address the 
targeted medical condition, they only address part of the wider problems of poor 
health and poor health systems in developing countries. Often the health problems 
are more related to socioeconomic than health issues, and improved health does 
not necessarily have to be mainly about improved health services. Lastly, existence 
of health services does not guarantee their effective use. 
As a result, identifying the most appropriate interventions to improve maternal 
and child health is not straight-forward. It first requires a country-specific analysis 
of the key constraints to better health. Are the main health problems related to 
poverty and inability to secure adequate nutrition and shelter? To poor sanitary 
conditions? Are the poor sanitary conditions related to a lack of clean water and 
adequate sanitation or poor hygienic practices?  Is poor health related to a lack of 
health services or poor quality of available services? In a second step, one can then 
identify priority interventions which can range from conditional cash transfer pro-
grams to the provision of clean water, changing the structures of accountability in 
the health care system, to the design of direct interventions such as nutrition sup-
plements or immunization programs. Possible interventions of governments and 
donor agencies can take place on community, household and individual level. For 
example, community interventions can focus on improved water and sanitation 
supply. Water, sanitation and hygiene practices can have an impact on health and 
economic outcomes. However, community level water interventions have been 
found not as effective as are household level interventions. The provision of a 
clean public water point does not necessarily lead to the consumption of clean 
water at the point of use as water gets contaminated during transport and storage 
(Fewtrell et al, 2005; Wright et al 2004). More effective are point of use interven-
tions as storage containers or chlorination (Schipper et al, 2011; Wright et al. 2004). 
Other possible health interventions can be combined with conditional cash 
transfer (CCT) programs. Households receive financial support if certain condi-
tions are met. One example is the Mexican PROGRESA program. Here house-
holds receive a cash transfer of 20-30% of household income every 2 months if 
children are immunized and get nutrition monitoring; pregnant and lactating wom-
en visit clinics; and all family members participate in meetings on health, hygiene 
and nutrition regularly. There is evidence that health outcomes can be improved in 
cause of CCT programs. Morbidity of children younger than 3 years is reported to 
be lower if households participate in the program. Also anemia in children age 12-
48 months was found to be less likely due to participation. No effect was found for 
the anthropometric measure of stunting (Gertler, 2004). 
In short, improving health can be the results of a large variety of interventions. 
Which ones should receive priority is a complex question and will likely depend on 
local conditions. 





Health and economic outcomes are closely related and affect each other. Better 
health can produce better economic outcomes and more money brings more in-
vestment in health services, especially if more money is given in the hands of 
mothers. Given this intricate linkage, there are many avenues to break the vicious 
cycle of poverty and poor health.  They range from direct interventions to address 
a particular health problem to much wider socioeconomic interventions to combat 
poverty or improve access to nutrition and clean water.  Much research remains to 
be done to determine the precise priority in different country and local settings.   
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6 Cross-cultural bioethics as an  
interdisciplinary approach 
Julia Inthorn 
1 Health – universally valued? 
Health is recognised as a valuable good throughout the world. From an individual 
standpoint, being healthy serves as a basis to pursue individual goals. When we are 
sick, our possibilities to work, to care for ourselves or a family, and simply to do 
what we want are limited. We cannot move properly, are quickly tired, or feel 
overwhelmed by pain. Therefore, health as a value is closely related to other values 
that can be pursued much easier when we feel fit and healthy. From the point of 
view of the state, health is part of human resources, with public health as a neces-
sary condition for a prospering state. A healthy population can be more productive 
and prospering and needs less support. The value of health seems to be universally 
shared and can be seen as a shared starting point of cross-cultural bioethics. At the 
same time, cultural differences play a vital role when it comes to the understanding 
of illness and disease, the role of the patient, and health care systems. Migration 
brings together people with different cultural backgrounds who meet as profes-
sionals and patients in hospitals; globalisation enables a quick transfer of 
knowledge and technologies between health care systems. We find Ayurvedic Med-
icine in London, clients from all over the world in a beauty clinic in Taiwan, and 
transfer patients to specialists all over the world. Though health can be seen as 
universally valued, the understanding of health differs between those cultural con-
texts.  
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2 Cultural and social dimension of health 
In order to understand what makes health so valuable, it is necessary to take a step 
back and ask what is meant when we talk about health, illness and disease. The 
WHO provides one of the most cited and at the same time most controversial 
definitions of health. It defines health as “a state of complete physical, mental, and 
social well-being and not merely the absence of disease or infirmity.” (WHO 2006, 
1) Health, understood in this way, is seen as a multidimensional phenomenon. 
Physical and mental aspects are combined with social dimensions of well-being. 
Only well-being in all three dimensions classifies as health in this understanding. 
Even a person who is free of medical conditions or of pain might not count as 
healthy if the person is socially isolated, discriminated against, or cannot pursue his 
or her goals. Health defined as the complete well-being turns the concept of health 
into an ideal, meaning that only very few people - if any - classify as healthy. In this 
understanding minor changes in physical or mental conditions as well as other 
conditions like losing one’s job might lead to loss of health. Health is thus integrat-
ed into a multi-causal scheme of influences that combines classical medical circum-
stances like infections, vaccinations and health treatment with questions of social 
security, access to water or education. 
This leads to the question of responsibility for health. If health is so hard to 
achieve, the question arises how much effort a state or a community must make to 
ensure the health of people and which aspects of health are part of an individual’s 
self-responsibility. The definition doesn’t give a clear answer to the question of 
responsibility. This can be seen as an advantage as well as a disadvantage of the 
definition. The definition opens up the perspective of multiple influences on health 
and thus makes it possible to identify various different causes of health problems. 
Problems can be approached under the perspective and legitimisation of health as 
an aim. Not only questions of health care but also questions of nutrition, housing, 
social participation or safety can be discussed under the perspective of health. Be-
cause of the generally acknowledged value of health, tasks can be prioritised that 
might otherwise be regarded as less important. On the other hand, the apparent 
broadness of this definition makes it impossible to approach all problems simulta-
neously. Various institutions and individuals share the responsibility for the health 
of one person. A working security system, trust in partnerships, a healthy envi-
ronment, health care access, food security and access to drinking water are only a 
few factors to be addressed under the perspective of health. Since health is influ-
enced by various factors it becomes very difficult to address those responsible for 
ill health in a particular case or to deduce political strategies for the improvement 
of health from the WHO-definition of health.  
From an intercultural perspective, this openness of the definition can be seen as an 
advantage as well. It recognizes different priorities within the various dimensions 
of health in different local settings. Thus, WHO’s broad definition of health en-
compasses culturally different understandings of health without singling out one 
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special perspective. For example, the idea of illness as inflicted upon someone by 
ancestors because of an individual’s failure to partake in religious rituals, a stroke, 
and Ayurvedic ideas of balance can be accommodated without difficulties by the 
WHO definition. Thus the WHO description of health can be used as a starting 
point for intercultural dialogue on health issues (Inthorn at al. 2009, 17). At the 
same time concrete, culture specific understandings of health need to be taken into 
account in intercultural dialogue.  
3 Health, illness and disease 
Understanding health as an ideal or aim, like suggested by the WHO definition, 
rather than a condition, puts a focus on the desirability of health. The WHO defi-
nition already entails that health is valuable by linking it to the well-being of a per-
son. This very open-ended concept of health can be further analysed by looking at 
the opposing concepts of illness and disease. The WHO definition of health leaves 
it open as to who is to define whether a person is healthy. Talking about well-being 
can imply that the individual and his or her subjective view is essential to under-
stand if a person is healthy. But of course a medical diagnosis can also contribute 
to this question. The subjective understanding of lack of health is usually referred 
to as illness while the perspective of medical professionals on medical conditions is 
referred to as disease. We all know from experience that illness and disease are not 
necessarily the same. A person can feel well and at the same time have an undis-
covered tumour, or a person can feel sick without a medical condition. In most 
languages we find terms indicating such conditions like being heart broken. Wik-
man et al. (2005) show for the Swedish population that illness, disease, and sick-
ness absence from work have to be seen as representing different realities (Wik-
man 2005: 452). There is only a very loose relation between these three concepts. 
The difference between illness, disease and sickness absence is neither gradually 
nor can it be simplified as three different descriptions of one single objective state 
because the empirically found overlap between them is only very small. Wikman et 
al. give empirical evidence that there is an irreducible difference between illness 
and disease that needs to be carefully accessed if we want to get a better under-
standing of outcome variables of health care linked to the quality of life. 
The difference of health and disease is also relevant for intercultural questions 
of medicine and bioethics. Medical professionals world-wide seek to define the 
difference between health and disease by diagnosis based on scientific methods. 
Their understanding of disease is largely influenced or even based upon a Western 
model of medicine which understands disease as the malfunctioning of organs or 
the disturbance of body systems. This concept of disease is often seen as universal 
while the concept of illness represents culturally different notions. “Most non-
Western cultures tend to perceive illness in a much broader and far less tangible 
manner. Illness is often viewed as being linked to social, spiritual, and environmen-
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tal determinants” (Bowman 2004: 665). As Bowman points out the difference be-
tween a concept of disease that comes along with Western medicine and illness is 
even broader in non-Western cultures than it already is in Western cultures. 
Whereas disease needs to be understood within a framework of medical profes-
sional knowledge, illness can only be analysed within a cultural and social frame-
work. 
4 Intercultural competencies as professional standard 
In the interaction of healthcare professionals and patients, both dimensions of 
being unwell, i.e. disease and illness play an important role. While the patient talks 
about his or her state in terms of illness by using lay-expressions, professionals 
need to understand the disease-dimension of the patient’s state. Communication 
between professionals and patients usually takes place within a shared cultural 
setting that makes it easier for professionals to translate the descriptions and narra-
tives of illness, pain or being unwell into a professional understanding of disease. 
Due to globalisation and migration processes, this shared cultural context cannot 
be taken for granted anymore. People from different cultural backgrounds come 
together in hospitals as patients as well as professionals and need to be aware of 
this problem. Intercultural misunderstandings may have unwanted consequences 
for the outcome of health care; they might lead to misdiagnosis, lack of compli-
ance, or simply add to the misery of a patient.  
This reality has been recognized as a problem by different parties. Hospitals 
have begun to address this issue by implementing tools like a ‘migrant friendly 
hospital’ (MFH Project group 2004). Sensitivity towards cultural as well as religious 
differences is growing and special needs of patients with regard to religion or cul-
ture are met by the offer of religious services, special food, or interpreters. Health 
care professionals have begun to include intercultural issues into education and, by 
doing so, raise sensitivity for the special needs of all patients – not only migrants – 
but patients in general. Cultural sensitivity implies to take cultural differences seri-
ously but at the same time to avoid new stereotypes. E.g. just because someone is 
Roman Catholic doesn’t necessarily mean the person wants a vegetarian dish on a 
Friday or is happy to be visited by a priest. 
Leininger defines cultural sensitivity as a professional attitude for the field of 
nursing. The author explains: Trans-cultural nursing is “a formal area of study and 
practice which takes into account the specific values, beliefs and ways of life of 
people of diverse and similar cultures with the goal to use this knowledge in crea-
tive ways to provide culturally congruent care.” (Leininger 1994: 209) As Leininger 
points out a culture-sensitive approach needs to take values and often religious 
beliefs into account. Hallenback and Goldstein strengthen this point further and 
move this aspect into the centre of their reflection. The authors argue for the need 
for cultural competence of healthcare workers because of significant different val-
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ues in intercultural settings (Hallenbeck/Goldstein 1999: 28). Cultural differences 
need to be understood and made understood in order to be able to react specifical-
ly. Therefore, cultural competence starts with the ability to explain as well as to 
listen to explanations about cultural, religious, and social characteristics. This con-
cerns not only the understanding of health and disease but also values and the idea 
of a good life and life quality. Cultural competence in practice means the ability to 
communicate and understand differences on those levels. One very prominent 
example of culture-sensitive communication can be seen in the problem of the 
different importance of truth-telling between doctor and patient in different con-
texts. In Western contexts it is thought to be essential to give full information to a 
patient about his or her condition. In other contexts, offering information about a 
bad diagnosis can be seen as too much for the patient who should not be dis-
tressed by bad news. A culture-sensitive approach cannot take any of these posi-
tions for granted but needs to find out the individual need for information of a 
patient. 
This example shows that cultural competence cannot be acquired like technical 
skills, or applied like a gold standard. Since values and a person’s cultural back-
ground are individual, a culture-sensitive approach has its basis in good communi-
cation and aims at mutual understanding of needs and differences. But cultural 
competence exceeds good communication skills: Being open for the explanation of 
cultural or social differences also implies self-reflection about one’s own culture. 
By pointing at differences, the contingency of what is seen as normal within one’s 
own culture needs to be understood. Besides explaining differences there is also a 
need for mutual respect within conversations between different culturally motivat-
ed standpoints. Especially culturally embedded values need to be taken seriously. 
The dialogue of values might however lead to conflicts: A consensus between con-
flicting positions cannot always be found and room for tolerance and dissenting 
positions needs to be negotiated in a professional setting. Knowing that intercul-
tural conflicts may not always be avoidable, Pinto and Upshur suggest humility as 
well as introspection as principles in intercultural relations (2009: 7ff.). These atti-
tudes strengthen the idea of tolerance further. Applying the principle of humility 
helps to avoid to see one’s own perspective as more important or better than the 
other, and to accept the position of a learning person who still needs to understand 
more about a different position. Introspection helps to clarify one’s own position 
and to reflect on the values and reasons for one’s standpoint that is often simply 
taken for granted.  
Intercultural sensitivity and competence is needed in personal encounters be-
tween health care professionals and patients but also within research groups, for 
example, in multi-centre trails. The mutual understanding of viewpoints, values 
and concepts of health, illness and disease helps professionals in multinational 
teams to combine forces for the benefit of patients. Within multinational tails, not 
only a culture-sensitive approach is necessary but differences in health care systems 
also need to be taken into account.  
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5 Cross-country medical research and intercultural ethics 
Research ethics, a part of medical ethics, studies the normative questions that arise 
when new pharmaceuticals or techniques are tested in patients. Evidence based 
medicine asks for large numbers so that studies provide statistically valid data. This 
is often realised by doing multi-centre tails in different countries, where cross-
cultural aspects need to be considered. Similar questions arise when products and 
knowledge from one part of the world is tested in another part of the world, like it 
is often the case in HIV/AIDS research. Most countries have developed ethical 
standards and regulations for this type of research. “Ethical standards vary signifi-
cantly between cultures as a result of differences for instance in history, religion, 
ethnicity, economic situation and traditions”(Aagaard-Hansen et al. 2004: 117). 
The difference in ethical standards is not only a question of culture. Some are 
simply stricter, or less strict, than others. Aagaard-Hansen et al. (2004) closely in-
vestigated the already existing variety of codes of ethics for medical research. Since 
the existing variety of codes is quite large, it is, especially in cross-cultural trails, 
often difficult to know which code to apply for a particular trial. The authors sug-
gest as a rule at least to comply with the ethical standards of the researcher’s home 
country and the country of research. 
Besides the local ethical standards, the four bioethical principles established by 
Beauchamp and Childress (1994) can serve as heuristics to get a better idea of 
where ethical problems might occur in intercultural contexts. Within this frame-
work, four cross-cultural challenges for research outside the home country can be 
identified: 
Patient Autonomy: To ensure patient autonomy in clinical trails in a Western context, 
usually an informed consent is sought from the patients. Patients are provided with 
the necessary information about what a trail is about, possible risks and benefits, 
and then decide for themselves whether to participate or not. While there already is 
a broad discussion about how to ensure and empower autonomous decisions, and 
how to deal with non-competent patients, the concept of informed consent might 
give rise to new difficulties in varying cultural contexts. Fagan (2004) for example 
points out that letting people act according to their religious or cultural beliefs may 
imply a constraint of their autonomy. Another example is the problem of informed 
consent with women and children in cultural contexts with mainly male dominated 
family structures. Here the question arises how the tradition can be respected and 
at the same time the informed consent be given by the person participating whose 
autonomy is thereby strengthened. 
Non-maleficience: Following the Non-maleficience principle, the idea of avoiding 
harm has to be translated into different cultural contexts. Besides the risk assess-
ment that should be part of any trail, special respect needs to be paid to the vulner-
ability of special groups as well as power relations. Participating in a trail can bring 
benefits to a person like general access to health care services that, in some coun-
tries, cannot be accessed otherwise. This might lead to uncritically agreeing to par-
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ticipate in a trail because the person doesn’t want to loose the hereto connected 
benefits. This might be especially the case with mothers trying to provide for their 
children. 
Beneficience: Taking part in a trail should be beneficial for those participating. Thus, 
the structure and funding of the trail have to take into account that some health 
care systems might not provide for needs that occur within or under the circum-
stances of the research. Funding for unforeseeable events needs to be factored in 
and the team has to be able to provide support, or by co-operating with other insti-
tutions, refer a person to other supporting authorities. 
Justice: Multi-centre trails might take place in areas where health care services are 
provided at a lower level than in the researcher’s country. Therefore, considera-
tions of ethical obligations based on the idea of justice are needed for the time 
when the research has been completed. The subsequent withdrawal of health care 
provided throughout the research might lead to disappointment within the re-
search area or study population. The study population might think that it is not just 
to be used for research without continuous care for their health, and thus being 
treated perhaps differently from participants in other countries. Considerations 
have to be made as how to help bridge this gap in the provision of health care. 
This might be done by ensuring that health care is provided for the trail-relevant 
disease afterwards, that people benefit from the results in the long run, and maybe 
equipment or know how be transferred through the research (see also Aagaard-
Hansen et al. 2004: 118). 
As briefly sketched above the discussion of the four principles can provide ex-
amples why multi-centre trails as well as trails in different cultural settings create 
new intercultural problems. Besides intercultural questions in doctor-patient rela-
tionships, the structure and effectiveness of existing health care systems has to be 
taken into account. Likewise, questions of justice and the benefits provided by the 
research for the participants and their region need to be addressed. 
6 Shortcomings of Western bioethics  
Intercultural and crosscultural bioethics try to make visible that ethical considera-
tions are culture relative and cannot automatically be seen as universal. Since the 
development of bioethics is strongly connected to Western medicine, at the mo-
ment, Western approaches of bioethics are dominant within the crosscultural bio-
ethical discourse. This might lead to problems and shortcomings. Bowman de-
scribes several limits to the application of (Western) bioethical theory within an 
intercultural context (Bowman 2004). First, he points out that cultural and psycho-
social issues are often only described as limitations of decisions within ethical theo-
ry. Without taking a closer look at the lifeworld situation, the description of the 
influence of culture on decision making processes might be oversimplified. Cultur-
al issues are not seen as a framework for decisions and ethical problems but cap-
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tured as one of many variables influencing a decision. This description is unable to 
encompass how decisions are always embedded within a cultural framework and 
how within this framework decisions are shaped. 
Second, Bowman shows that there is a discrepancy between a mainly secular 
focus within bioethics and a world that for the greater part is non-secular. At pre-
sent, no-secular arguments aren’t heard within the bioethical discourse. Western 
bioethics does not address the worldviews of religious agents, moral obligations 
motivated by religion, and religious concepts of death and dying. This point is 
further stressed by Hedayat in his comparison between Western and Islamic con-
cepts of autonomy in cases of elective abortions. Though Hedayat points out many 
similarities, he comes to the conclusion that a universal standpoint is not possible 
in this question. The author criticises Western bioethics in this regard: “What is 
problematic are the declarations from a numerically small but disproportionately 
influential group of secular thinkers using nomenclature such as universal, where 
large sections of the world adhere to theocentric ethics, including many Christians 
and Jews in Western countries.” (Hedayat 2007: 20) 
Bowman (2004) points out that there are also methodological shortcomings of 
Western bioethics. Western bioethics focuses on dichotomies and not on equilibri-
um. A typical example is the Western dichotomous distinction between health and 
disease, whereas in other contexts a person can be considered healthy and ill at the 
same time. As already mentioned above, the Western focus on autonomy and truth 
telling can also not be regarded as a cross-culturally shared viewpoint. Marshall and 
Koenig (2004) mention another methodological problem of Western bioethics. 
The researches detect a reductionist approach in biomedicine that predominantly 
focuses on mechanical models of the human body. Because of the close relation of 
Western medicine and Western bioethics, Western bioethics has adopted this re-
ductionist mechanical approach. 
Even when bioethics is encompassing cultural factors, these are often over-
simplified. The concepts of culture and social identity used in bioethics often lack 
sophistication (Marshall/Koenig 2004: 259). Cultural comparisons tend to focus 
on major differences such as family centred versus individual centred approaches, 
making differences very appealing by stressing opposite values. The complexity of 
culture is reduced to simple opposites. A thorough understanding of the context is 
often left to anthropologists but goes far beyond the idea of culture in bioethics. 
Therefore, Macer demands: “We really need to have in-depth cross-cultural dia-
logue and study rather than defining one ethics as Asian and one as not. The inter-
esting point is at what point do you call something distinctly ‘Japanese’ or ‘Asian’ 
or ‘British’.”(Macer 1999: 293) This means to be sensitive not to reduce cultural 
differences, and to carefully differentiate between cultural and social factors in 
order to avoid cultural stereotypes.  
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7 Cross-cultural bioethics as an interdisciplinary approach 
The brief overview above has shown that social, religious, and cultural factors 
should play an important role in addressing bioethical issues in cross-cultural con-
texts. As a discipline, cross-cultural bioethics renders a contribution hereto by 
providing a platform for interdisciplinary intercultural research. Interdisciplinary 
work in bioethics, first, needs to understand medical practise. The analysis of core 
concepts like health, illness, and disease can be a first step to gain a better under-
standing of cultural differences in health care practice and the influence of cultural 
and social factors on health. Working together with health care professionals from 
various disciplines and backgrounds gives an insight into current new develop-
ments and new ethical issues that are raised by medical research across cultures. 
In order to provide information for cultural sensitive communication between 
patients and health care professionals cross-cultural bioethics needs a solid empiri-
cal basis. Culture-sensitive descriptions of an understanding of health and illness 
and cultural patterns of the social role of a patient can be accessed in an interdisci-
plinary approach between bioethics and social sciences combining concept analysis 
and empirical research. “Stronger ties between bioethics and the social sciences are 
also likely to lead to more fruitful explorations of the relationship between cultural 
models and modes of moral deliberation.” (Turner 2005: 306) As Turner points 
out, cross-cultural understanding also aims at the level of values and norms. Cross-
cultural understanding can start with the description of values related to medical 
decision making and the decision making processes itself. Values may have their 
foundation in secular as well as religious worldviews. A thorough understanding of 
norms and values in relation to concepts like health and disease, on the one hand, 
and medical practise and decision making, on the other hand, builds the frame-
work for cross-cultural approaches in bioethics. An interdisciplinary approach can 
help to get a richer understanding of how concepts of health and disease, medical 
practise and norms come together in decision making processes or ethical dilemma 
situations. In co-operation with other disciplines, like religious studies or econom-
ics, different factors related to health, health seeking behaviour and health care can 
be analysed in depth. 
The expansion of knowledge proves helpful for medical practise as well as for 
research. A thorough understanding of different cultural practises can help to im-
prove intercultural sensitivity for the effective training of professionals. Another 
reason to have a closer look at culture is that “the concept of culture serves as a 
reminder of local variations in understanding of health, illness, suffering, and 
death.” (Turner 2005: 308) Integrating the notion of culture into research leads to a 
more thorough look at what can count as contingent and what can be seen as 
shared or even universal. Sensitivity for cultural differences within and between 
cultures helps to overcome simplistic concepts of culture. This may also serve as a 
framework to initiate discussions on shared values between cultures and the ques-
tion of universally shared norms. 
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7 The role of  plant health for human health 
Elke Pawelzik   
 
1 Introduction 
Healthy plants products are essential factors for human health. In many developing 
countries people suffer from limited access to food and especially to healthy food. 
Climatic changes and variability as well as population growth may aggravate the 
problems of food insecurity and consumption of contaminated food. 
Plant health is mainly determined by the resistance against fungal and bacterial 
diseases as well as by adequate plant nutrition and water supply. The development 
of fungi and bacteria on plants interfere their growth and development and may 
lead to lower yield and lower quality of the harvested products. Some of the fungal 
species are able to produce mycotoxins which may cause adverse effects on human 
and animal health (Bhat and Vashanti, 1999). The WHO estimates that worldwide 
approximately 1.5 billion episodes of diarrhea occur each year and about 70% of 
them have been caused by biologically contaminated food (Unnevehr, 2003). Also, 
the FAO estimates a worldwide loss of about one billion tons of foodstuff per year 
resulting from mycotoxin contamination (Salay, 2003).  
In Africa, mycotoxins constitute the second greatest hazard after food-borne 
bacteria for the safety of food (Bankole and Adebanjo, 2003). However, in oppo-
site to developed countries, in developing countries mycotoxins have not been 
strong considered in relation to human health effects. The reasons for that are 
incompletely studied but some of them are stated in a previous published article: 
first, incomplete knowledge of mycotoxins and their effects on human health and 
inadequate communication of the known risks in regions with high contamination 
 Elke Pawelzik 
 
58 
risks; second, relative low attention to measures to reduce mycotoxin contamina-
tion compared to vaccination programmes; third, insufficient consideration of 
control mechanisms for mycotoxin contamination at different steps in the pre- and 
post-harvest period; fourth, in communities that produce and consume their own 
food occurs the highest burden with mycotoxins and therefore, general regulations 
to control are mostly not effective; fifth, the mycotoxin contamination is an issue 
concerning agriculture, health and economics (Wild and Gong, 2010).  
2 Mycotoxins in plant products 
Mycotoxins are secondary metabolites mainly produced by fungi as Aspergillus, 
Penicillium and Fusarium spp. (Wagacha and Muthomi, 2008). They contaminate 
agricultural products in the field during growing and in the post-harvest period, e.g. 
during storage, during and after processing. Factors affecting the occurrence of 
mycotoxins can be grouped into climatic, agricultural and food production, and 
socio-economic. At first, one of the most important factors for mycotoxin con-
tamination is the sensitivity of the genotype against fungal contamination. Climatic 
conditions facilitating the fungal development and thus the mycotoxin production, 
include high temperatures and high humidity, unseasonal rains and flash floods. 
Soil types, insect activity and poor harvesting practices are important factors of the 
agricultural production for the likelihood of contamination (Wagacha and Muth-
omi, 2008; Cole et al., 1995). During post-harvest period again high humidity but 
also improper drying methods and storage conditions will facilitate fungal growth 
(Wagacha and Muthomi, 2008). Poor education level especially in the rural areas of 
developing countries and lack of skilled human resources are important socio-
economic factors (Bankole and Adebanjo, 2003).  
Aflatoxin, fumonisin, deoxynivalenol (DON), ochratoxin A (OTA) and zeara-
lenon (ZEA) are worldwide accepted as the most important agricultural mycotox-
ins (Shephard, 2008). The consumption of contaminated food leads to adverse 
human health effects. Several diseases are caused by mycotoxins (Table 1). These 
diseases can lead to reduced life expectancy and loss of productivity, whereby 40% 
of this loss is caused by diseases exacerbated by aflatoxins (Miller, 1996).
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Table 1: Some human diseases in which mycotoxins are involved (Bryden, 2007) 
 
Disease Source of mycotoxin  Fungus  
Akakabio-byo  Wheat, barley, oats, 
rice  
Fusarium spp.  
Alimentary toxic 
aleukia  
Cereal grains (toxic 
bread)  
Fusarium spp.  
Balkan nephropathy  Cereal grains  Penicillium spp.  
Cardiac beriberi  Rice  Aspergillus spp., Penicillium spp.  
Hepatocarcinoma  Cereal grains, peanuts  Aspergillus flavus, A. parasiticus  
Kwashiorkor  Cereal grains  Aspergillus flavus, A. parasiticus  
Neural tube defects  Maize  Fusarium verticillioides, F. prolifera-
tum  
Oesophageal tumors  Corn  Fusarium verticillioides, F. prolifera-
tum  
Onyalai  Millet  Phoma sorghina  





Cereal grains (grain 
dust)  
Stachybotrys atra  
 
In the regions of sub-Saharan Africa, the inhabitants are mainly exposed to high 
levels of aflatoxins and fumonisins through their daily consumption of maize, 
groundnuts and other plant products (Table 2). 
 
Table 2: Food commodities and aflatoxin contamination in Africa: examples from 
the literature (summarized by Wagacha and Muthomi, 2008) 
Country  Commodity  Frequency of aflatoxin 





Raw peanut  78% contained aflatoxins  Concentration: 12 – 
329 mg/kg  




A. flavus isolated from 
65% of samples  
Total aflatoxins in 
positive samples: 3 – 
138 mg/kg  
Mean concentration 
of aflatoxin B1: 27.1 
µg/kg 
Senegal  Peanut oil  Aflatoxin B1 in over 85% 
of samples  
Mean contents 
about 40 µg/kg 
Kenya  Maize  Samples from local market  
Samples from government 
warehouses, 350 maize 
products 
Up to 46,400 g/kgp 
Up to 1800 µg/kg  
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For comparison, the Kenyan regulatory limit for aflatoxins in food is at 20µg/kg 
(Wagacha and Muthomi, 2008), whereas the EU maximum value amounts for total 
aflatoxins in nuts and cereals is 4.0 µg/kg (EC, 2006). According to a World Bank 
study, these strict European standards, the strictest in standard worldwide (Wu, 
2006), cost African countries about 670 million US dollars each year in export 
losses (Wilson and Otsuki, 2003). 
Aflatoxins occur mainly in maize and groundnuts whereas fumonisins are al-
most found in maize (Bankole et al., 2006). Limited surveys indicate the presence 
of OTA, DON and ZEA but in Africa they are less widespread than aflatoxins and 
fumonisins (Bankole et al., 2006).  
The current knowledge about diseases associated with exposure to aflatoxins 
and fumonisins is summarized in Table 3. 
 
Table 3: Disease associations with exposure to aflatoxins and fumonisins  
(Wild and Gong, 2010) 












tures of aflatoxins: 
group 1 
Aflatoxin M1: group 2B  
Toxins from F. moniliforme, 
fumonisin B1, B2 and fusarin 
C: group 2B;  
Fumonisin B1: group 2B     
Main tumor sites 
reported in animals  
Liver  Liver and kidney  
Other main adverse 





cia, pulmonary oedema in 
pigs, hepatotoxicity and ne-
phrotoxocity  
Main tumor sites 
reported in humans  
Liver  Oesophagus (?)*, liver (?)  
Other main adverse 
effects in humans  
Aflatoxicosis, cirrhosis 
(?), growth impairment 
(?), immune suppres-
sion (?)  
Aspergillus flavus, A. parasiticus  
Main plant contami-
nates  
Cereal grains (grain 
dust)  
Stachybotrys atra  
*(?) the relationship is not established  
 
To the present, the evidence about diseases caused by mycotoxins in developing 
countries is not very strong because of lack of data collection and assessment and 
limitation in the number and diversity of studied regions. However, some epidemi-
ological studies of human populations, e.g. in Africa, exposed to contaminated 
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foods with aflatoxins revealed a relationship between a high incidence of liver can-
cer and dietary intake of aflatoxins (MERCK, 2006). Especially, if people are in-
fected with hepatitis B and C, consumption of aflatoxin contaminated food rises 
the risk of liver cancer by more than ten-fold compared to either infection alone 
(Turner et al., 2003). Other studies suppose an interaction between permanent 
mycotoxin exposure and malnutrition, immune-suppression, affected growth and 
diseases, e.g. malaria and HIV/AIDS (Gong et al., 2003, 2004). 
3 Mycotoxin control and prevention strategies 
Besides the direct health risks, economic losses in the present and implications for 
next generations are serious. Meanwhile, many developing countries realized the 
importance of reducing mycotoxin contamination because of long-term health 
benefits to the local population and to international trade advantages.  However, it 
needs enormous efforts to establish long-term strategies for mycotoxin control and 
prevention which include the following measures: prevention of exposure to my-
cotoxins, decontamination and constant surveillance and monitoring of fungi in 
contaminated food and feed stuff (Wagacha and Muthomi, 2008). Prevention of 
exposure to mycotoxins to the greatest possible extend can be achieved by differ-
ent measures over all steps of the food production chain, e.g. in the agricultural 
production, at harvest, during storage, transportation, marketing and processing as 
well as by legislation (Milićević, 2009, Wagacha and Muthomi, 2008, Williams et al., 
2004). Measures of good agricultural practice include chemical control (application 
of fungicides), early harvesting, rapid and adequate drying to ensure storability, 
physical treatments (e.g. sorting and dehulling of maize), sanitation, insect man-
agement and cultural practices, e.g. crop rotation, management of irrigation and 
fertilization (Wagacha and Muthomi, 2008). Methods of decontamination after 
harvest are known but from the current knowledge, the application seems to be 
not very realistic because of high costs and possible side effects (Wagacha and 
Muthomi, 2008). Breeding for resistance is recognized as one of the most promis-
ing long-term strategies in mycotoxin threat in Africa. So far, only few maize culti-
vars have adequate levels of resistance to fungi producing mycotoxins (Munkvold, 
2003).  
Many of the environmental conditions cannot be controlled and therefore, 
surveillance of susceptible crops will be of greatest importance. But, depending on 
the mycotoxin producing fungi, pre- and/or post-harvest conditions have to be 
controlled. Fuminosins producing Fusarium spp. infect the maize plant during 
growing in the field and thus control of fumonisins requires special attention to 
pre-harvest practices and to effects of food processing (Humpf and Voss, 2004). 
However, aflatoxins are produced during the post-harvest period if the environ-
mental conditions facilitate fungal growth and subsequently mycotoxin formation 
(Wild and Hall, 2000). Therefore, an understanding of the plant/fungus interaction 
is necessary to develop prevention strategies for reduction of human exposure to 
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mycotoxins (Wild and Gong, 2010). Finally, to ensure that food and feed com-
modities are harvested correctly, dried sufficiently and stored appropriately 
(Wagucha and Muthomi, 2008), the countries have to strengthen their surveillance 
and awareness as well as the education of all actors in the food production chain 
and the consumer e.g. via governmental and non-governmental organizations and 
media.  
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8 Inter-disciplinary health approaches for  
poverty alleviation:  
Control of  neglected zoonoses in  
developing countries 
Anna L. Okello and Susan C. Welburn  
1 Introduction: “One Health”1 in a globalised 21 st century 
In just 200 years, the earth’s population has increased by five billion people: this 
incessant rise is placing significant strain on the world’s natural resources (Gibbs 
2005). In order to cater for rapidly rising human populations, the last few decades 
have witnessed a change in use of ecosystem services, particularly in developing 
countries, amid a rapidly globalised world. Former Norwegian Prime Minister and 
Director of the WHO, Dr. Gro Harlem Brundtland, stated “In the modern world, 
bacteria and viruses travel almost as fast as money. With globalization, a single 
microbial sea washes over all humankind. There are no health sanctuaries” (Brund-
tland, 2001). With such a plethora of information about the threats of emerging 
disease, particularly stemming from animal reservoirs, there seems a strong argu-
ment for implementation of interdisciplinary or “One Health” approaches to glob-
al health, zoonoses in particular. It is perhaps not so much acceptance of the con-
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cept, but agreement upon the political and financial aspects of implementation of 
interdisciplinary strategies that requires further refinement (Okello et al 2011). 
2 Linking zoonotic disease to poverty alleviation strategies 
2.1 The Millennium Development Goals and “other diseases” 
In 2000, the United Nations Millennium Summit agreed upon the eight Millenni-
um Development Goals (MDGs) developed to provide a “policy framework for 
interventions and advocacy for improved health” (Molyneux, 2008). The sixth goal 
“to combat HIV/AIDS, malaria, and other diseases” has led to large scale financial 
interventions aimed to address the issues of infectious disease and their contribu-
tion to poverty; these other diseases are known as the “Neglected Tropical Diseases” 
(NTDs). Within these NTDs lie a sub-group of disease which have been formally 
recognised as “Neglected Zoonotic Diseases” (NZDs) under WHO’s NTD pro-
gramme and include: anthrax, bovine tuberculosis, brucellosis, cysticero-
sis/neurocysticercosis, cystic echinococcus, rabies and human african trypanosimi-
asis (HAT) (WHO, 2009c).  
Neglected Zoonotic Diseases are common in developing and middle income 
countries throughout the world, particularly in rural areas where conditions for 
their transmission and perpetuation are ideal. Poverty, reliance on livestock for 
income or food, and the close proximity in which animals and people live together 
in the developing world are all factors which favour the spread of zoonotic disease 
(Okello et al 2011, WHO 2009). Besides affecting the health of people in these 
poorest communities, livestock productivity losses or death as a result of zoonotic 
disease places an even greater strain on those whose livelihoods depend upon 
them. Although such conditions also favour the development of emerging zoono-
tic diseases such as avian influenza and SARS, it is endemic diseases which fall into 
the category of NTDs and are officially recognised by the WHO as diseases of the 
poor (WHO 2009).  
2.2 Neglected zoonoses and maternal/child health 
There is acknowledgement that further research is required into effects of zoonotic 
diseases on maternal and child health (Welburn, 2011). Women and children, being 
amongst the most vulnerable groups of society, potentially bear the highest burden 
of neglected zoonoses,  due to both extrinsic (food preparation, milking livestock) 
and intrinsic (decreased immunological capacity of pregnant women and young 
children) risk factors being increased in these societal groups.  Rabies for example, 
kills over 55 000 people a year, with children under 15 years accounting for the 
highest affected (WHO 2010). In developing countries, 99% of the reservoir oc-
curs in local dog populations, as such canine vaccination programmes have the 
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potential to save over 22 000 children a year.  More generally speaking, neglected 
zoonoses potentially contribute to a number of symptomatic illnesses which ac-
count for over 70% of child deaths in developing countries, including diarrhoea 
and respiratory illnesses (WHO 2010). In terms of maternal health, it has been 
estimated that over 50% of pregnant women in developing countries suffer from 
iron deficiency anaemia (Ndibazza et al, 2010), of which various NZDs such as 
brucellosis and zoonotic tapeworms could potentially contribute. A lot more inter-
disciplinary research is required to truly assess the burden of NZDs specifically on 
maternal and child health; however positive correlations may further link benefits 
of NZD control to poverty alleviation through contribution to MDG 4 (reduce 
child mortality), MDG 5 (improve maternal health), and others (MDGs 1, 2, 3) 
surrounding poverty eradication, gender equality and improved access to education 
(Welburn, 2011).  
2.3 Prioritising integrated disease control for developing countries 
Integrated interventions for the control of neglected diseases have been described 
as the “‘low hanging fruit’ of disease control interventions: cost effective, effica-
cious, reduce prevalence, are pro-poor and easy to implement” (Molyneux, 2008).   
It has been argued that prioritisation for disease control should be based around 
such “cost effectiveness” rather than tools such as the Disability Adjusted Life 
Year (DALY) (Canning 2006, Maudlin et al 2009). Many feel the DALY calcula-
tion is not an applicable tool for neglected disease, zoonoses in particular (Maudlin 
et al 2009), as “hidden” morbidities (including anaemia, diarrhoea, loss of work 
and education) associated with NTDs are uncounted for (Canning, 2006).  
The other concern for the lack of investment into the Neglected Tropical Dis-
eases, or more specifically the Neglected Zoonotic Diseases subset, is that for 
many of these diseases, the “burden” is either unknown, or under-estimated, often 
due to difficulty in diagnosis, or under-reporting (WHO, 2006). Maudlin et al states, 
“Many zoonotic diseases are notoriously difficult to diagnose as they are often 
confused with other diseases; for example, where malaria is present, fevers owing 
to brucellosis may be misdiagnosed.” (Maudlin et al 2009). This point was re-
iterated in a Ugandan study where community members described drinking raw 
milk (a risk factor for brucellosis) as a cause of malaria (Okello et al 2011).  As a 
result of under-reporting and misdiagnosis, it has been widely accepted that the 
burden of endemic zoonotic disease in poor communities is under-represented, 
resulting in “serious consequences in terms of funding for both research and con-
trol initiatives” (Maudlin et al 2009).  The system of prioritisation for control and 
investment which has been adopted under the MDGs and various other significant 
funding bodies such as the Bill and Melinda Gates Foundation has, despite its 
logic, seen by some as “not universally accepted as being either fair or sensible” 
(Maudlin et al 2009) and could be an explanation as to why NZDs are left out of 
major control programmes and funding for Research and Development.  
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There has been some progress to date addressing such recommendations in the 
years since they were made. In 2008, WHO published their eight year “Global Plan 
to combat Neglected Tropical Diseases”, in which the link between neglected dis-
eases, poverty and the Millennium Development Goals was acknowledged (WHO, 
2007). Innovation, multi-sectoral integrated approaches and a “focus on popula-
tions and interventions rather than specific diseases”, (possibly as a direct result of 
papers published by Canning, Maudlin, Molyneux and others citing the cost effec-
tiveness of interventions aimed at clusters of disease) were a strong component of 
the strategic vision (WHO, 2007). In 2005, the UK Commission for Africa rec-
ommended that the Neglected Tropical Diseases received specific funding as a 
group, however some feel the recommendations have been “slow to take effect” 
with the “big three” still receiving the majority of the world’s attention (Molyneux, 
2008). 
In her keynote speech at the 2007 Nairobi meeting on neglected zoonotic dis-
eases, Esther Schelling described the difficulties faced by developing countries in 
controlling zoonotic diseases, citing “dispersed smallholder livestock systems, pre-
dominance of informal markets and limited capacity and resources to deliver ser-
vices” as challenges (WHO, 2007). The need for a One Health approach for the 
surveillance and control of zoonotic disease in developing countries was reiterated, 
encouraging participants to envisage the future research agenda as “interdiscipli-
nary, participatory and integrated with prevention and control needs” (WHO, 
2007).  
There is therefore undeniable logic for the control of zoonotic disease in de-
veloping countries in order to improve the health of people living in developing 
countries, improve the health and subsequent productivity of their livestock, and 
increase food security and safety. There is also acknowledgement that despite ad-
dressing these “neglected” zoonoses of particular concern in certain communities, 
the capacity for detection of emerging zoonoses will also be increased with com-
munity awareness and participation in surveillance networks. Institutional support 
for the control of neglected zoonoses is growing; several publications have identi-
fied the growing widespread support for their control emulated in this summary 
“by simultaneously saving lives and securing livelihoods, the control of neglected 
zoonotic diseases offers a real and highly cost-effective opportunity for alleviating 
poverty, especially in remote rural communities and marginalized peri-urban com-
munities” (WHO, 2009). 
Global Health – A Challenge for Interdisciplinary Research 
 
69 
3 Raising the international profile of neglected zoonotic 
diseases 
3.1 Geneva, September 2005: “The control of neglected zoonoses: A route 
to poverty alleviation” 
This meeting was held in 2005 by WHO in conjunction with the Department for 
International Development Animal Health Programme (DFID-AHP). Until this 
point, there had been a substantial amount of focus by the international communi-
ty on emerging zoonotic diseases, and to a lesser degree Neglected Tropical Dis-
eases, however this meeting was the first to focus international attention on the 
Neglected Zoonotic Diseases as a separate entity. The main objective of the meet-
ing – “to bring together groups that would not ordinarily meet to address a com-
mon problem of interest” (WHO, 2006) - was very much in keeping with the One 
Health concept. Seven endemic diseases were chosen at this meeting as a “target 
group” upon which to base initial control efforts, these were: anthrax, bovine tu-
berculosis, brucellosis, cysticercosis, cystic echinococcus, rabies and zoonotic tryp-
anosomiasis (WHO, 2006).  
This meeting really set the stage for the ongoing dialogue on the topic of ne-
glected zoonotic disease which has been occurring up to this point. The reasons 
for why the poor suffer disproportionately from zoonotic disease, reasons for un-
der-diagnosis and the associated “neglect” on the international stage, and recom-
mendations for further research and collaborative efforts were all topics discussed 
at this inaugural meeting.   
The growing evidence for the advantages of joint human-animal health sys-
tems in the field of the diagnosis, prevention and control of neglected zoonotic 
diseases was considered tantamount to the successful control of neglected zoono-
ses, leading to an overarching recommendation to “work towards the concept of 
‘One Health’” (WHO, 2006).  
3.2 Nairobi, November 2007: “Integrated control of neglected zoonoses in 
africa: Applying the “One Health” concept” 
This meeting was organised as a timely follow-up to the inaugural 2005 meeting on 
neglected zoonoses. Besides the WHO, the meeting connected a range of addi-
tional stakeholders, including the European Commission (EU), Danish Centre for 
Health Research and Development (DBL), International Livestock Research Insti-
tute (ILRI), the Food and Agriculture Organisation of the United Nations (FAO), 
The World Organisation for Animal Health (OIE) and the African Union (AU).
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There was a large attendance of about ninety people, including not only public 
health and veterinary public health specialists but researchers and representatives 
from international and regional organisations (WHO, 2009). The overall objective 
of the meeting was to develop a strategic framework for the control of Neglected 
Zoonotic Diseases, in keeping with the actions points which arose from the 2005 
meeting and included points surrounding intersectoral collaboration, improvement 
of diagnostic and surveillance capacity and foster research and advocacy.     
In her keynote speech which opened the meeting, Esther Schelling proposed a 
“One Health” approach for the control of neglected zoonotic diseases, recom-
mending this perspective would “enhance detection and control of zoonoses by 
intersectoral surveillance and communication, by contingency planning with all line 
ministries, and by providing novel cost-effective trans-sectoral options for zoono-
ses control in low income countries”(WHO, 2009c). She urged participants to 
consider the “untapped potential of new institutional and operations models” for 
the provision of joint health services in developing countries, and outlined ways in 
which international advocacy efforts could promote the One Health concept in 
order to raise the profile of neglected zoonotic diseases in the future (WHO, 
2009).   
Recommendations were made for action plans at the global, regional and na-
tional-levels to assess the burden of neglected zoonotic diseases in Africa; thus 
providing the framework for future control. It was recommended that a scientific 
advisory committee be formed to work as the “driving force” behind these rec-
ommendations, and that recent high profile initiatives such as the international 
response to avian influenza, and to a growing degree the neglected tropical diseas-
es, be considered as advocacy platforms for “combating NZDs” (WHO 2009) 
3.3 Integrated Control of Neglected Zoonoses (ICONZ) 2009-2013 
This is a seventh framework project funded by the European Commission and 
managed by the University of Edinburgh, which began in 2009. It involves the 
collaboration of 22 European and African universities and research institutes 
working on clusters of zoonotic diseases in case studies in seven African countries; 
Morocco, Mali, Nigeria, Uganda, Tanzania, Mozambique and Zambia. This is the 
first large collaborative project of this nature in the field of neglected zoonotic 
diseases, and it is hoped that the understanding of diagnostics, burden of disease 
and intervention options for their control will be much improved as a result of the 
case studies. This information will fill vital knowledge “gaps” which currently exist 
on the burden of NZDs, providing a strong support basis with which to undertake 
advocacy and policy activities at the international, regional and national levels in 
developing countries.  
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4 Current political and institutional challenges of 
implementing interdisciplinary research for zoonoses 
control in developing countries 
In order for the prevalence of neglected zoonotic diseases to be truly defined, in 
such a way that political and institutional support can be given to develop compre-
hensive diagnostic and intervention tools for their control, human and veterinary 
authorities would benefit from working together in developing countries to im-
plement surveillance and reporting of cases of these diseases. However, the reali-
ties of practically implementing such a strategy are difficult, given the institutional 
and administrative factors which exist in most developing countries. This issue has 
been acknowledged by the FAO/OIE Strategic Framework for One Health (FAO 
2008), despite the focus of this report really being to address emerging infectious 
disease such as avian influenza, rather than the endemic zoonoses. However the 
principles remain the same, and there are positive indications that platforms set up 
under the HPAI control and surveillance program may lead to long term intersec-
toral collaboration for other zoonotic diseases such as rabies and brucellosis (AO, 
Personal Communication, 2010).  
Major constraints in many developing countries to the prioritisation of zoono-
tic disease control include human resources for surveillance and control, finances, 
and discrepancies within government structure such as decentralisation which 
means that often national or regional surveillance and control programmes are 
difficult to undertake on the ground (Okello et al, 2011, FAO, 2008). It is felt that 
government and research institutions, along with animal and human health systems 
(including those in the private sector) all require strengthening if disease control is 
to without long term subsidies from the international community. Additionally, the 
level of advocacy and public awareness to the prevention and control of zoonotic 
disease is important to ensure that community behaviour change occurs for the 
long term prevention and control. The strengthening of animal and human health 
systems is a pivotal component of the successful control of zoonotic disease in 
developing countries.  
An additional challenge for implementation of One Health and functioning bi-
osecurity and animal health systems in developing countries is the smallholder 
farming system which dominates the majority of rural settings, particularly in Afri-
ca (FAO, 2008). Access to public health and veterinary services is poor, with many 
of the free government services providing a lifeline to these communities and their 
animals disbanded after the introduction of structural adjustment in the 1990’s. 
Due to poor sanitation, close living arrangements between humans and animals, 
and often intense farming practices as a result of diminishing land, infectious dis-
eases are often well-established in humans and animals, or in the case of zoonoses, 
both (Okello et al 2011). Enhancement of biosecurity and surveillance mechanisms 
is necessary for the long term sustainable control of infectious disease in poor 
communities. However, cost, tradition, lack of income diversity and lack of alterna-
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tives to current practices are often cited as reasons why surveillance does not oc-
cur, coupled with a lack of incentive for the smallholder farmer who may only own 
a handful of animals, owing to less market share compared to those farmers with 
commercial establishments, where uniform disease control measures may be bene-
ficial (Okello et al, 2011, FAO, 2008). 
5 Integration: What does it mean and how can it be applied in 
the context of One Health and neglected zoonoses? 
Despite much effort to strengthen surveillance systems and control programmes 
for zoonotic diseases worldwide, especially for potential global pandemics such as 
avian influenza, there is wide acknowledgement that still more work is required. 
Many experts are calling for further “integration” within academia, governmental 
and private sector stakeholders involved with zoonotic disease control, and reviews 
of undergraduate and graduate curriculae in both medical and veterinary schools to 
raise awareness and promote greater understanding of the “One Health” concept.  
Due to the many varied disciplines covered by the One Health concept, speak-
ing of an integrated approach could be taken to mean many different things, and 
this is usually the case, depending on the mandate of the organisation promoting it. 
There are many different forms of integration which could be promoted in inter-
ventions for both the prevention and control of zoonotic disease, including inter-
disciplinary, inter-organisational and inter-governmental. A comprehensive defini-
tion of integration refers to the “creation of linkages among existing programs to 
improve the delivery of health interventions given existing commitments and re-
sources” (Grépin & Reich, 2008).   
5.1 Types of programmatic integration which can occur with zoonotic 
disease control 
Integration as a concept has certainly been promoted in the field of Neglected 
Tropical Disease Programmes; single interventions  such as Mass Drug Admin-
istration (MDA) against a number of co-existing infections including lymphatic 
filariasis, soil transmitted Helminthiasis and schistosomiasis has been cited as a 
“natural entry point” for integrated public health programmes (Lammie et al, 2006). 
The concept has been further supported by a variety of high profile funding grants 
from organisations such as the Bill and Melinda Gates Foundation and the United 
States Agency for International Development (USAID). However, there is concern 
that understanding of the basic concept of integration may be lacking, and that 
many organisations show “limited experience in implementing integration and 
even less experience in conducting systemic analysis of these experiences” (Grépin 
& Reich, 2008).  
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Grepin and Reich proposed an “integration framework” which helps differentiate 
different types of integration which could occur in public health programmes and 
follows the concept of integration as domain, level or degree. They stipulate three 
questions which can be asked to ascertain the possibilities for integration, set out in 
this much simplified version of the framework (summarised from Grépin & Reich, 
2008):  
 
Table 1: Summarised version of the “Integration Framework” from Grépin & Reich, 
2008 
 
i) Domain: What is being integrated? Does the recommended integration refer 
to a specific activity, policy process or organisational structure within the given 
programme? 
ii) Level: Where is integration occurring? Is it at the global, regional, national 
or local level? 
iii) Degree: How is integration occurring?  Is it through co-operation (pro-
grammes working together), collaboration (working together and sharing of re-




Under this framework, any disease control programme or project which is being 
described as an “integrated” programme should be able to pinpoint the type of 
integration which is occurring. Some examples include:  
 
a) Joint community training sessions for zoonotic disease prevention: Collabora-
tion in the activity domain at the local level  
b) Surveillance of multiple diseases by one epidemiological unit: Consolidation in 
the organisational domain at the national level 
c) FAO/WHO/OIE strategic framework for the implementation of One Health 
(FAO 2008): Co-operation in the policy domain at the global level  
 
A nice “real life” example of integration - co-operation at the regional level in the 
organisational domain - is the development of Integrated National Action Plans 
(INAPs) for the control of avian influenza in Sub-Saharan Africa. This co-
operation is between the African Partnership for Livestock Development, Poverty 
Alleviation and Sustainable Growth Initiative (ALive) and the Global Framework 
for Progressive Control of Transboundary Animal Diseases (GF-TAD) and pro-
motes regional co-operation of technical experts and donors committed to the 
prevention and control of avian influenza in the region (FAO, 2008).   
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5.2 Inter-disciplinary Research and Teaching Programmes 
Some authors call for more investment and incentives for research in biomedical 
and comparative medicine, amongst fears that this type of research is “losing its 
appeal as a career” for veterinarians and physicians (Kahn, 2006).  There are 
around 25% less research physicians in the United States compared with 20 years 
ago, with a similar picture in the veterinary profession (Kahn, 2006). The reasons 
for this in both fields include lack of mentorship and research opportunities, em-
phasis on clinical care, and a requirement to make money in order to pay off edu-
cational debt (Kahn, 2006). Another author calls for the promotion of inter-
disciplinary science and closer attention paid to “ecology not economy” (Gibbs, 
2005). In order to promote and sustain interest in comparative medicine research, 
there have been recommendations to change the way research funding is set up; 
for example promote “joint funding streams from human, animal and environmen-
tal health sectors to support integrated public health programmes” (Pappaioanou, 
2010), and the prioritisation of research grants to teams promoting professional 
collaboration and inter-disciplinary research projects (Kahn, 2006).  The AMVA is 
however a little more optimistic, citing the changes in the direction of teaching 
over the last five years which have improved linkages between public health and 
veterinary schools; “today, more than half of US veterinary colleges have formal 
dual Doctor of Veterinary Medicine (DVM/VMD)/Master of Public Health 
(MPH) degree programs” (AMVA, 2008).  
6 Conclusion 
In conclusion, a common appreciation for the concept of integration, and what 
type(s) of integration could be carried out at what level, is useful for those involved 
in the development of zoonotic disease control programmes, particularly in re-
source-poor regions.  Grepin and Reich support the “need to accelerate the im-
plementation of integrated NTD control activities, but they also must be evaluated 
in a systematic manner” (Grépin & Reich, 2008). 
Despite the perceived difficulties of application of interdisciplinary approaches 
in developing countries, there are positives. This was recognised over a decade ago, 
when the focus of the 1999 FAO/OIE/WHO Veterinary Public Health confer-





 in order to reach a wider audience. There was acknowledgement 
that despite Veterinary Public Health definitions and priorities were “more limited 
                                                     
2 “Countries whose economies used to be centrally planned by the government but are now changing 
to market-based economies” (FAO, 1999) 
3 Based on the World Bank glossary, a DC is defined as low (64 countries) and middle (93 countries) 
income countries in which most people have a lower standard of living with access to fewer goods 
and services than do most people in high income countries (FAO, 1999) 
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compared to those in developed countries”, the “opportunities for the collabora-
tion of veterinary and human health activities were recognised as existing across all 
countries, and are not confined to specific regions, nor do they respect internation-
al borders, and they may extend across ethnic and political divides” (FAO, 2003). 
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9 Arbovirus infections in cattle 
Claus-Peter Czerny, Eva Schröer-Merker, Jessica Olbrich, Ulrike Diesterbeck 
1 Introduction 
Arboviruses are zoonotic viruses transmitted by hematophagous arthropods (ar-
thropod-borne viruses) and constitute the largest group of biological viruses that 
infect vertebrates (Sang et al., 2006). With about 400 species they can be found in a 
number of virus families and play an important role especially in tropical regions. 
This taxonomically wide-ranging group comprises almost exclusively viruses whose 
genome is present as ribonucleic acid (Weaver, 2006). About 50 % of the arbo-
viruses isolated from vectors originate from mosquitoes and 25 % from ticks. 
However, it has to be considered that more investigations in this regard were done 
on mosquitoes than on ticks. In most agricultural systems, ruminants are wide-
spread and exist in large numbers (Purse et al., 2005). The FAO (2008) specifies 
the number of cattle (including buffaloes) held worldwide in 2006 with more than 
1.5 billion animals. In particular, regarding the progressive processes of globaliza-
tion and climate change, which cause extensive consequences for the international 
transportation of animals as well as for local climate conditions, it is suspected that 
endemic areas of infectious diseases will continue to spread. Arboviruses are very 
climate sensitive (Koeijer et al., 2007; Patz et al., 2005). It is important to identify 
arbovirus infections worldwide and investigate their ways of transmission to estab-
lish efficient surveillance strategies. 




Vectors are living carriers of infectious particles. In tropical and sub-tropical coun-
tries often arthropods transmit germs to vertebrates (Thrusfield, 2005). There are 
two types of vectors, mechanical and biological vectors. In case of mechanical 
vectors, the infectious agent is transmitted mechanically from, e.g., fleas or lice to 
the vertebrate host. That means that the virus does not replicate inside the vector. 
In case of biological vectors, the pathogen undergoes a necessary stage of devel-
opment and multiplication (Kuno and Chang, 2005). To initialize an infection cycle 
various conditions must be met. First, a susceptible vector needs to incorporate 
sufficient virus during its blood meal from a viremic host, so that its infection 
threshold is exceeded (Purse et al., 2005; Thrusfield, 2005). Then the vector has to 
survive the extrinsic incubation period until the next blood meal, which it has to 
take from a susceptible host. All hematophagous arthropods produce saliva con-
taining anticoagulants, which they insert into the wound during the blood sucking 
process. There is a big number of poikilothermic and homothermic organisms, 
which are vectors for different pathogens such as sandflys, lice or rodents. Vector-
borne diseases of ruminants primarily include those, which are attributable to 
midges (mosquitoes, biting midges, gnats) and ticks as vectors. As poikilothermic 
organisms they are very dependent on the ambient temperature. Little empirical 
research has been carried out regarding the relationships between ticks and their 
hosts as well as regarding their contact with humans, habitat-fragmentation, and 
health risks (Estrada-Peña et al., 2007). In addition, the sole isolation of viruses 
does not allow for conclusions of a vector function (Whitehouse, 2004). In many 
cases, as for the numerous species of ticks that are associated with the Crimean-
Congo Haemorrhagic Fever (CCHF), there is no clear proof of the vector compe-
tency. The Bovine Ephemeral Fever (BEF), for example, does not appear over 
wide areas in enzootic countries leading to the indirect conclusion that this is due 
to climatic boundaries of the vectors (St. George, 1990). However, it is also easily 
conceivable that climatic boundaries of virus replication or the interaction between 
virus and vector are the reason for the limited appearance of, e.g., BEF. This em-
phasizes the complexity of the epidemiology of arboviruses. The fact that within 
the same time frame various arboviruses can be transmitted to a population by a 
single vector species, illustrates the risk of misinterpretations regarding the evalua-
tion of the epidemiological situation. In addition, new vectors have been discov-
ered, as in the case of Bluetongue Virus (BTV) in Europe, so that it has to be as-
sumed that for other arboviruses, too, all possible vectors haven’t been identified 
yet. Moreover, through the transport of livestock, zoo animals or non-animal 
goods, vectors can colonize new habitats. During the last ~230 years, at least 11 
arthropod species had been introduced solely to the USA and firmly established,  




another 10 are seen as potential risk for introduction (Little, 2008). Furthermore, 
vectors often function as competent transmitters for more than one disease what 
emphasizes again the complexity of epidemiology of arboviruses. Most vectors 
have a wide host spectrum enabling in principle arbovirus transmission to a num-
ber of susceptible species. The Rift Valley Fever Virus (RVFV) has been isolated 
from 30 species of six genera of Culicidae. But it is important to note that in case 
for some vectors only mechanical transmission has been proven. Because the sus-
pected mechanical transmission paths by arthopods are not clarified by today, 
Lumpy Skin Disease Virus (LSDV) and Bovine Malignant Catarrhal Fever Virus 
(BMCFV) will not be discussed in detail here. Both viruses contain DNA as genet-
ic information and are apart from “classic” arboviruses. Lumpy skin disease is 
caused by a poxvirus and is mainly enzootic in Africa where it has major economic 
effects. The bovine malignant catarrhal fever is a worldwide sporadically occurring 
herpes virus infection with high lethality. 
3 Classification of arboviruses 
Due to the vector-dependent transmission there are typical differences between 
the transmission process of arboviruses and those of contagiously transmitted 
viruses, especially a high dependency on weather conditions and climate (Koeijer et 
al., 2007). Furthermore, they are mostly promiscuous, rapidly replicating patho-
gens, which are transmitted by fast multiplying and ubiquitously occurring vectors 
(Purse et al., 2005). Some of the mentioned diseases are of international im-
portance. For instance, Bluetongue Disease, Rift Valley Fever, and Lumpy Skin 
Disease were recorded by the World Organisation for Animal Health (OIE: “Or-
ganisation Mondiale de la Santé Animale”) as “List-A”-diseases, while the Bovine 
Malignant Catarrhal Fever was recorded as “List-B”-disease (OIE Handistatus II). 
Since 2005, the OIE publishes continuously notifiable diseases. The genetic mate-
rial of the majority of the pathogens described in the following consists of ribonu-
cleic acid (RNA). Replication errors, such as base exchanges, insertions and dele-
tions are common evolution mechanisms in RNA-viruses (Sall et al., 1999). In 
segmented RNA, partly also entire segments are exchanged implying the use of live 
vaccine to face the risk of returning to virulence. The risk of the unintentional 
circulation of life vaccines in the field has already been described (Sailleau et al., 
2005). The examined arboviruses can be divided into two groups according to their 
vectors, comprising arboviruses transmitted by midges (Table 1) and arboviruses 
transmitted by ticks as main vector (Table 2). 
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Table 1: Arbovirus infections of cattle transmitted by midges 
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Table 2: Arbovirus infections of cattle transmitted by ticks 
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-/+ssRNA = negative/positive-sense single standed RNA; dsRNA = double stranded RNA 




3.1 Bluetongue disease 
Pathogen. The bluetongue virus (BTV) belongs to the genus Orbivirus of the family 
Reoviridae and can be considered as a prototype for this genus (Dungu et al., 2004; 
Roy, 1992). Among others the viruses causing African horse sickness and the epi-
zootic haemorrhagic disease of deers belong to this genus (Roy, 1992). Even 
though the pathogen was not known at the beginning of the 20th century, a vec-
tor-dependent transmission was already assumed and its similarity to the African 
horse sickness was emphasized (Bruce, 1905). The virion consists of three protein 
layers and has an outer diameter of 100 nanometers (nm), while the inner double-
layered capsid has a diameter of 60 nm. The capsid contains seven virus-proteins 
(VP) and the double-stranded RNA (dsRNA) can be found in 10 segments inside 
the virion. Furthermore, four non-structural proteins (NS) are encoded. The non-
enveloped virus particles are relatively resistant to solvents such as ether and chlo-
roform but very sensitive to high temperatures and low pH-values. The virus is 
acid labile and stable from pH 6.4 to pH 8.0. So far, 24 serotypes have been known 
and recently a new one called Toggenburg Orbivirus has been discovered (Hoffmann 
et al., 2008). While the VP7 is serogroup-specific, the VP2 represents the serotype-
determining protein (Roy, 1992). On the basis of genetic analyses of segment 2, 
which codes VP2, it was possible to identify 10 evolutionary lines within the 24 
serotypes known until 2004, the so-called nucleotypes (Maan et al., 2004, 2007). 
They are defined by a nucleotide sequence difference of <35 % in segment 2. In 
addition, on the basis of the same segment, two topotypes were identified enabling 
the allocation of the strain of a serotype to an Eastern or Western region of origin. 
This high genetic diversity can be explained by point mutations (‘genetic drift’) and 
by the exchange of entire segments between different serotypes (‘genetic shift’) 
(Saegerman et al., 2007). For BTV, segment exchange was detected in a Holstein 
bull 20 years ago (Stott et al., 1987). In case of a coinfection with two serotypes, 
for example, there are already 1,024 (210) possibilities for an exchange of the 10 
segments (Dungu et al., 2004). Moreover, even within particular serotypes there is 
a great diversity with respect to virulence and pathogenicity that are influenced by 
both the geographic origin as well as the amount of passages in cell cultures (Kirk-
land and Hawkes, 2004). 
Bluetongue disease was first described by Hutcheon as “fever of epizootic ca-
tarrh” in 1880/81 (cited from Goltz, 1978). The term “bluetongue” was intro-
duced later and describes the cyanotic change of the tongue in seriously ill sheep 
(MacLachlan, 2004). The first epizootic outbreak in cattle took place in South Afri-
ca in 1933 (Goltz, 1978). Up to the 1940s, the disease was regarded to be spatially 
limited to the African region in the South of the Sahara. The first documented 
epizootic outbreak outside the continent took place in Cyprus in 1943 and affected 
sheep (MacLachlan, 2004). Subsequently, the South of the United States, the Mid-
dle East, Asia, and Southern Europe were hit. Originally limited to subtropical 
regions, BTV has been established in various serotypes in large parts of Europe 
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since 1998 and has caused there the greatest documented outbreak of all to date by 
killing 1.8 millions of animals (Maan et al., 2007; Meyer et al., 2009). After Europe 
had been considered as free of the disease since 1979 (with few exceptions), BT 
occurred at first on four Greek islands (Sailleau et al., 2005). Subsequently, the 
Mediterranean region was hit. In the Western Mediterranean region, the serotypes 
1, 2, 4, and 16 of African origin occurred and were mainly transmitted by Culcoides 
imicola (Saegerman et al., 2008). In Eastern Mediterranean countries outbreaks of 
the BTV-serotypes 1, 4, 9, and 16 were documented, which originated from the 
Near, Middle and Far East. They were transmitted by additional vector species. In 
August 2006, BTV first occurred in Northern Europe, where it was regarded as 
emerging disease (OIE, 2006). In Northern Europe the serotypes 8 and 6 have 
occured. In the United States, BT has been officially recognized since 1952 (Kirk-
land and Hawkes, 2004). From January 2005 to the end of 2008, BT had been 
reported to the OIE from more than 40 states from all five continents (WAHID 
Interface, 2009). Apart from direct impacts, BT causes high economic losses due 
to necessary trade restrictions (Maan et al., 2007; OIE, 2008). 
Epizootiology and epidemiology. Meanwhile, BT is an ubiquitously occurring, infec-
tious, non-contagious virus disease of ruminants that especially in sheep can lead 
to pronounced clinical symptoms (Conraths et al., 2009; Maan et al., 2007; Saeger-
man et al., 2008). African sheep breeds are resistant or have a mild course of infec-
tion (Dungu et al., 2004). In cattle, goats or some wild ruminants often mild or 
inapparent infections occur (Conraths et al., 2009; Dungu et al., 2004), while in 
cattle even prolonged viremia appears (Singer et al., 2001) and, they are therefore 
regarded as reservoir. The mild course of the infection and the prolonged viremia 
possibly indicate a stronger adaptation of the virus to cattle than to sheep (Taka-
matsu et al., 2003). Moreover, various carnivore species were tested seropositive 
probably by oral intake of meat infected by the virus (Murray et al., 1999). BT is 
not transmissible to humans. The virus is transmitted by gnats of the genus Culi-
coides that consists of 1,260 species of which around 30 are competent vectors of 
diverse orbiviruses (Saegerman et al., 2007 and 2008). Purse et al. (2005) referred 
to 1,400 Culicoides species of which <1 % had been infected by BTV-vectors – with 
the addition that so far only few species had been examined in this context. In 
addition to the original vector Culicoides imicola, gnats of the goups C. obsoletus, C. 
pulicaris, and C. dewulfi appeared in Europe (Koeijer et al., 2007; Saegerman et al., 
2008). Also, species of Aedes as well as the ectoparasitic sheep ked (Melophagus ovi-
nus) can transmit the disease. In these “non-vector” species, the vector competence 
is induced by temperature (Purse et al., 2005). Life expectancy of adult gnats is 
stated differently ranging from less than ten days (Takamatsu et al., 2007) to on 
average three weeks under favorable conditions (Koeijer et al., 2007). Nevertheless, 
the authors point out that a BTV-infection can reduce a vector’s life expectancy. 
There is not any evidence for transovarial transmission (Takamatsu et al., 2003). 
To minimize flying time, gnats live in proximity to its hosts (Koeijer et al., 2007). 
They brood in a variety of humid microhabitats like, e.g., dung heaps, drainage 




pipes or irrigation canals that can be found on most utilized agricultural areas 
(Purse et al., 2005). The development of Culicoides starts at a threshold value of 8 
°C to 10 °C, while ideal temperature for population development is between 25 °C 
and 30 °C. After the intake of infected blood, vectors become infectious as soon as 
the virus has been replicated inside the gnats after it has reached the salivary glands 
(OIE, 2008; Wilson et al., 2008). Then the virus is transmitted by the saliva during 
the blood sucking process and the vector remains permanently infectious. The 
probability of completion of the transmission cycle is seen as relatively low for 
individual vectors, which, however, can be compensated by a high vector density 
and favorable weather conditions (Purse et al., 2005). The occurrence of new dis-
eases, therefore, correlates with the vector prevalence and reaches its peak, for 
example, in Germany between September and October (Conraths et al., 2009). In 
climatically mild regions of Africa, transmission can take place constantly (Dungu 
et al., 2004). There are many details regarding the interaction between virus and 
vector, which still have to be clarified in order to reach a better understanding of 
BT epidemiology (Wilson et al., 2009). It is assumed that some BTV strains are 
able to infect the fetus via the placenta. For instance, a four-week-old calf of a 
BTV-positive dam was tested positive, too (Niedbalske, 2009) and in addition, 
BTV1-RNA was detected in liver and heart of a lama fetus (Meyer et al., 2009). 
The horizontal spread via semen is discussed, too. An Australian study with labora-
tory and field virus strains as well as with young and old bulls showed that primari-
ly laboratory-adapted strains could be found in the excreted semen of bulls (Kirk-
land et al., 2004). This could be of particular interest when using live vaccines, the 
virus, however, was only excreted during or directly after viremia. For the geo-
graphic expansion of the BTV-area, various ways have been presented. The trans-
portation of animal products like semen, the migration of wild and domesticated 
ruminants, infected Culicoides, which reach new areas on animals or plants by flying 
actively or being passively carried by the wind or in planes. Also new vector spe-
cies, and the inapparent infection of cattle contribute to this. Moreover, for a per-
manent establishment of the BTV in Northern Europe, its overwinter survival is of 
major importance (Saegerman et al., 2008; Takamatsu et al., 2003; Wilson et al., 
2008). It is assumed that the virus can hibernate inside an adult vector, can be rein-
troduced annually, persists inside an unknown vector or host species, is transmit-
ted mechanically by living or dead vectors or is resistant due to other mechanisms 
in classical hosts. The persistent infection in bovine and ovine γ/δ T-cells in vitro is 
well known (Takamatsu et al., 2003). Furthermore, the virus is able to persist inside 
the vector in low titers at temperatures of <10 °C for 35 days and is subsequently 
able to replicate at higher temperatures (Purse et al., 2005). Also horizontal trans-
mission paths like transovarial, transplacental, by semen or oral transmission (in-
take of the placenta after calving) are discussed to form the basis of the persistence 
of BTV during symptom-free periods (Wilson et al., 2008). BTV transmission by 
semen is observed only in a part of infected bulls excreting the virus during vire-
mia. Often old animals are shedding discontinuously and with visible impurity of 
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the semen by blood (Kirkland and Hawkes, 2004; Kirkland et al., 2004). Serological 
studies in endemic areas mostly show high incidences of up to >80 % (Karaoglu et 
al., 2007). Purse et al. (2005) identified temperature and humidity as the two most 
important extrinsic variables for BTV transmission. BT transmission ways are 
more diverse and are not limited to the purely vector-borne transmission of a clas-
sical arbovirus. 
Control and combat. There exist mobility and trade restrictions that should avoid 
the occurrence of new foci of infection. However, they are of limited use during 
the vector season (Conraths et al., 2009). Also models for local risk prediction 
depending on weather and vector density are currently under development, e.g., in 
the Netherlands (Koeijer et al., 2007). Two essential instruments for BT control 
are active immunization as well as the avoidance of contact between vertebrate and 
vector (Dungu et al., 2004). In 2008, vaccination was carried out across the whole 
area of Germany reducing the total number of new cases from 59,097 in 2007 to 
1,070 within one year (Conraths et al., 2009). The new cases registered in 2008 in 
the German federal states of Lower Saxony and Baden-Württemberg can be at-
tributed mostly to a later start of the immunization campaign caused by a lack of 
vaccine availability. Nevertheless, a complete eradication of BT in enzootic regions 
is considered as impossible and can be explained by the wide spreading of the virus 
and competent vectors as well as by the broad spectrum of hosts and the variety of 
serotypes (Dungu et al., 2004). In addition, the disease often occurs only sporadi-
cally in endemic areas like, e.g., Israel, where only two to four cases are reported 
annually despite the presence of serotypes 2, 4, 6, 10, 15, and 16 (Brenner et al., 
2008). Furthermore, in endemic areas like Africa, extensive vaccination is hardly 
conceivable because autochthon sheep breeds are relatively resistant to BT, which 
therefore often is not perceived as a problem (Dungu et al., 2004). Costs also con-
tribute to a reluctance regarding vaccination. But also industrial nations in part 
refrain deliberately from control measures. In the USA, for example, there is no 
routine monitoring of BT and only few laboratories carry out virus isolation or 
even typing. The principal control measure in the USA is vector control. Mobility 
restrictions of other countries are there considered as non-tariff trade barriers 
(Wilson et al., 2009). In Central and South America only little information is avail-
able on BTV making an exact assessment of the epidemiological situation impossi-
ble. 
3.2 Rift Valley Fever 
Pathogen. The disease was first described as “hepatitis” causing heavy losses in 
sheep in the Rift Valley (Kenya) in 1930/31 (Gerdes, 2004). Today it is referred to 
as “Rift Valley fever” (RVF) being one of the first known arbovirus species (Cha-
niotis, 2003). The virus (RVFV) belongs to the genus Phlebovirus in the family of 
Bunyaviridae and is a typical representative of that genus, which also includes the 
Toscana virus. The latter is a human pathogenic virus that is transmitted by sand-




flys (Phlebotominae) and is endemic in the Mediterranean region (Collao et al., 2009). 
The family includes another four genera, of which three are associated with ar-
thropods. These are the genus Orthobunyavirus, to which the Akabane virus is as-
signed to, as well as the genus Nairovirus, which comprises the Crimean Congo 
haemorrhagic fever virus, the Dugbe virus, and the Kupe virus. Another genus is 
Hantavirus, a group transmitted by Rodentia that also gains in importance in Europe. 
The genus Tospovirus infects plants (Gerdes, 2004). This broad spectrum of hosts is 
a special feature of that family. The viral envelope carries short glycoprotein spikes, 
the viral core contains three segments of negative-sense single stranded RNA (-
ssRNA) and has a diameter of up to 120 nm. The RNA segments are classified 
according to their size ranging from L (large), through M (medium) to S (small), 
whereby the latter has ambisense RNA and determines the degree of virulence 
(Callao et al., 2009; Davies and Martin, 2003). The RNA segments encode four 
virus proteins (VP) and two non-structural proteins (NS). The virus is sensitive and 
can be inactivated by degreasing solvents or a pH-value of <6 (OIE, 2008). Se-
quence analyses show a close relationship between the individual RVFV strains but 
also geographic differences. After examining all the three segments of the 33 
strains there were identified seven virus lines, which could be classified geograph-
ically (Bird et al., 2007). Tolerance for mutations is low and the strains examined 
have a common recent origin dated between 1880 and 1890. As for other RNA 
viruses also for the RVFV “genetic shift” was described (Sall et al., 1999). The first 
large outbreaks of the disease were registered in 1930/31 in the Rift Valley (Ken-
ya), in 1950/51 in South Africa, from 1951-53, 1961-63, and 1967/68 in Kenya 
again, in 1973/74 in Egypt and Kenya, in 1987/88 in Mauretania and Senegal, in 
1991 in Madagascar, in 1993/94 in Egypt as well as in 1997/98 in the Horn of 
Africa. In 1998, once more there was an epizooty in Mauretania (Nabeth et al., 
2001). In 2000, the disease occurred for the first time outside of Africa in Saudi 
Arabia and Yemen (Sall et al., 1998, Davies and Martin, 2003; Davies et al., 1985; 
Gerdes, 2004; Madani et al., 2003). In 2006/07, there was again an outbreak of the 
disease in East Kenya (CDC, 2007). In April 2008, Madagascar reported another 
occurrence of the disease to the OIE “World Animal Health Information System” 
(OIE WAHID, 2008). Between January 2005 and December 2008, the RVF had 
been reported by 14 states of which only three (namely Madagascar, from 2005 to 
the end of 2008, Yemen from 2005-2008, and Saudi Arabia in 2007/08) were not 
situated on the African continent (WAHID Interface, 2009). 
 
Epizootiology and epidemiology. The RVFV is an enzootically and epizootically occur-
ring pathogen of domesticated ruminants. It is also able to infect a large number of 
other vertebrates as well as humans (Gerdes, 2004). Thus, it can be classified as a 
zoonosis. Cattle and sheep are the most important amplification hosts (Sall et al., 
1998). Since the Rift Valley fever occurred in Egypt in 1977, the epidemiology has 
shifted the emphasis from “veterinary/animal epidemics” to “people epidemics”. 
This is explained by a relatively large population of susceptible people in contrast 
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to a relatively small population of susceptible animals (OIE, 2008). The outbreak 
in 1997/98 resulted in one of the biggest RVF epidemics with 89,000 affected 
people and 250 fatalities in Kenya and Somalia (Gerdes, 2004). This made RVF to 
one of the most serious zoonotic problems in Africa (Davies and Martin, 2003). 
Also the first description of RVF reports high numbers of causality in cattle and 
even more in sheep. There have been large outbreaks in cattle in Sambia and Zim-
babwe, whereas autochthon breeds normally do not show any symptoms and only 
go through a short viremic phase. Poultry and birds are regarded as non-
susceptible. In larger outbreaks, there are many re-infections within eight to 16 
weeks, before infection rates decrease. In semi-arid to arid conditions the epidemic 
curve has been completed after 16 to 20 weeks, even though in humid areas, spo-
radic occurrences are possible during a period of up to two years. Epizootics have 
a cyclic course with long inter-epizootic intervals of five to 30 years, in which the 
virus either persists in an endemic cycle with an unknown host or it circulates on a 
small scale between livestock and mosquitoes (Culicidae) (Gerdes, 2004). These 
cycles correspond to periods with an above average amount of rainfalls following 
on long dry periods, thus they are shorter in semi-arid regions than in arid regions 
(Davies et al., 1985). The virus is transmitted by mosquitoes of the genus Aedes, 
which find ideal breeding conditions in flooded areas because they oviposit in the 
bottom of temporary water-bearing cavities, the so-called “dambos”. Thus the 
occurrence of the disease is neither annually nor seasonally distributed, but has to 
do with the presence of water. Depending on the region, outbreaks of RVF had 
different causes. In the connection with heavy rainfalls in South and East Africa, in 
the vicinity of irrigated areas in dry Northern and Western countries of the African 
continent as well as after the construction of big reservoir dams in Egypt, Senegal, 
and Mauretania. The exact correlation between RVF epizooties and precipitations 
was investigated by Davies et al. (1985). Not short and heavy rainfalls are decisive 
but those which also have an above average persistence. More than 30 RVF-
transmitting mosquito species of six genera are known (Davies and Martin, 2003; 
Martin et al., 2008). Apart from the genus Aedes, these also include the genera Cu-
lex, Anopheles, Eretmapodites, and Mansonia as biological vectors as well as Culicoides, 
Simulium, Stomoxys, Glossina, Tabanidae, and some tick species as mechanical vectors 
(Davies and Martin, 2003; Gerdes, 2004). Ticks, however, are considered as non-
significant vectors (Mellor and Leake, 2000). Moreover, Glossina spp., better known 
as tsetse fly, play an important role as vector of the human sleeping sickness. Dial-
lo et al. (2000) estimated the infection rate of Culex poicilipes in Mauretania to 0.37 
± 0.06 %. For a complete list of all to date identified as well as potential mosquito 
vectors please refer to Pfeiffer et al. (2005). This publication also indicates the 
distribution of known and potential vectors in the European Union (EU) and its 
neighboring states. The RVFV can also be transmitted transovarially and sexually 
in particular between some Aedes members of the Neomelaniconium group. As a 
result, it is possible that a generation hatched out after flooding is able to infect 
animals directly. The infected mosquito eggs can survive several years of drought 




(Martin et al., 2008). Then additional mosquito species follow as secondary vectors 
(Gerdes, 2004). Humans are often infected through the contact with livestock, 
which, in turn, are infected by zoophilic mosquitoes. In urban areas, transmission 
often occurs directly by anthropophilic mosquitoes. Furthermore, human infec-
tions occur contagiously in slaughterhouses, in laboratories without accurate pre-
caution, and possibly through aerosols and raw untreated milk. Contagious trans-
mission between animals, however, seems to be rare, despite virus presence in 
secretions. For the most part, the virus circulates cryptically and can only be ob-
served by means of antibody detection or in sporadically occurring human cases 
(Davies and Martin, 2003). These hypotheses of an endemic, cryptic, enzootic or 
even sylvatic cycle (in ruminants) are supported by phylogenetic investigations. The 
latter found only a low genetic diversity in temporarily separated isolates (Sall et al., 
1998). In case of a given mutation rate, a high genetic diversity implies a relatively 
large effective virus population. Thus, here cycles with low viral activity are in-
volved. These endemic/enzootic cycles, however, are still unclear (Martin et al., 
2008). A possible way of the geographic spreading of the virus is the transport and 
trade of viremic animals (Gerdes, 2004). Shoemaker et al. (2002) assigned Saudi 
Arabian isolates to the East-West-Africa-group of RVF viruses, with which they 
seemed to be nearly identical. The antibody prevalence in humans working in the 
sector of livestock farming and processing was indicated with 14.5 % and reached 
29.6 % in the Egypt population in 1977/78 (Gerdes, 2004). Antibodies could be 
detected during the cryptic circulation of RVF in two to 15 % of livestock (Davies 
and Martin, 2003). The transmission cycle of RVFV is complex and has not been 
clarified completely. Moreover, vector diversity is higher than those of the majority 
of the rest of arboviruses (Mellor and Leake, 2000). 
 
Control and combat. Many African countries have not considered RVF as dangerous 
for livestock farming because autochthon breeds generally do not show clinical 
symptoms, even though high numbers of causality have been registered in local 
breeds during disease outbreaks in West Africa and Egypt (Gerdes, 2004). Fur-
thermore, the low perception of RVF as a potential zoonotic problem in these 
countries led to an insufficient control of the occurrence of the virus (Davies and 
Martin, 2003). The Food and Agriculture Organization (FAO) published a guide-
book for developing an emergency plan for RVF (Geering et al., 2002). Monitoring 
measures are, e.g., keeping of sentinel herds or early warning systems based on 
remote sensing. On the contrary, control measures include primarily trade re-
strictions, vector control by larvicides, and vaccinations (Gerdes, 2004). Both tox-
ins (e.g., of Bacillus thuringiensis) and hormonal inhibitors like the chitin-inhibitor 
methopren can be used as larvicides. Moreover, sentinel herds enhance the genera-
tion of important epidemiologic basic information that would improve the under-
standing of RVFV during inter-epidemic periods (Davies and Martin, 2003). Early 
studies regarding forecasts of possible RVF-epizooties are focused on Kenya be-
cause many important data about outbreaks and precipitation were gathered there 
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over many years, so that a good level of basic knowledge existed. Early warning 
systems are of major importance to carry out emergency vaccinations in time and 
thus to limit the extent of an epizooty. Pastoralists are affected the most by trade 
restrictions, which stay in effect over several years, and by direct causalities, which 
hit them hard as they live almost exclusively on livestock farming. On the Horn of 
Africa, many people live completely on the sale of male sheep and goats for to 
Mecca religious holidays. As RVF is a human pathogen, the distribution of mos-
quito nets, increasing the awareness of the population, and informing the public 
health services in case of impending epizooties or epidemics is recommended. 
3.3 Akabane disease 
Pathogen. The Akabane Virus (AKAV) belongs to the family of Bunyaviridae and to 
the genus of Orthobunyavirus, within which it is part of the Simbu serogroup (Tsuda 
et al., 2004; Yoshida and Tsuda, 1998). The disease caused by AKAV in neonatal 
calves is referred to as Arthrogryposis-Hydranencephaly-Syndrome (AHS) (Uchida 
et al., 2000). Orthobunyavirus is divided into 48 serogroups that include viruses, 
which are enveloped, spherical or pleomorphic particles with a diameter of 80 to 
110 nm. AKAV is the best investigated virus of this genus (OIE, 2008). The ge-
nome contains three segments of negative-sense single stranded RNA (-ssRNA) 
(Yang et al., 2008b). The segments are referred to as L, M, and S (Akashi et al., 
1997), analogously to other viruses of that family. The S segment encodes one 
non-structural protein (NS) and the nucleocapsid-protein (NC), which is the anti-
gen for the complement fixation test (CFT). Another NS and two glycoproteins 
are encoded by the M segment. The L segment encodes the L protein, which acts 
as RNA-polymerase (Kono et al., 2008). A study focusing on the antigenic differ-
ences between 63 strains, groups the virus into five lines that were temporally and 
spatially mostly consistent among each other (Yoshida and Tsuda, 1998). In addi-
tion, it was found that there are seven neutralizing epitopes on the glycoprotein 
G1, which are differently variable and conserved. Akashi et al. (1997) analyzed the 
sequence of the S segment phylogenetically that encodes the nucleocapsid-protein 
and found three clusters for 23 strains. These groups were defined more by spatial 
than by temporal proximity. Kono et al. (2008) came to similar results but identi-
fied only four phylogenetic clusters. 
At least since 1931, AHS has occurred in North Australia and since 1949, it has 
appeared in Japan. Furthermore, it can also be caused by other Simbu viruses (St. 
George et al., 1998). The AKAV was first isolated in Japan in 1959 followed by 
Australia and Africa in 1972 (OIE, 2008). During the infection periods of the years 
1972/73 and 1973/74 in Japan, epizooties occurred (Kurogi et al., 1977). Hitherto, 
this has been the largest outbreak of the disease and there are estimates of more 
than 42,000 affected calves (Kono et al., 2008). In 1984, there was another out-
break in Japan during which the Iriki-strain was isolated (Miyazato et al., 1989). In 
June/July 1992, the virus was first isolated in Taiwan (Liao et al., 1996). In July 




1998, there was a large outbreak in many parts of Japan (Uchida et al., 2000) and in 
2000/01 there was an outbreak of Akabane disease in Korea (Lim et al., 2007). In 
February 2002, Akabane disease was detected serologically in Israel, after AHS had 
occurred in 1969/70 (Brenner et al., 2004; Brenner et al., 2008). Tsuda et al. (2004) 
reported a continuous epizooty of several years in the South of Japan. Bryant et al. 
(2005) first detected the virus in Vietnam. In 2006, there was another large out-
break of the disease in the South of Japan (Kono et al., 2008). In addition, Aka-
bane disease occurred in the Middle East, Kenya, South Africa and on Cyprus. 
 
Epizootiology and epidemiology. The activity of the virus correlates with those of the 
vectors and starts in Japan during the summer months in July and August (Noda et 
al., 2001; Uchida et al., 2000). The infection of cows leads in pregnant animals to 
abortion or intra-uterine fetal infection (Noda et al., 2001). There are no breeds, 
which are highlighted as especially susceptible. However, if breeds are indicated, 
infections of Holstein Friesian and Japanese black cattle as well as of their hybrids 
are reported (Horikita et al. 2005; Kurogi et al., 1977; Uchida et al.; 2000). One line 
of the Japanese black cattle is market internationally as so-called “Kobe cattle”. 
Kono et al. (2008) did not find any correlation between the breeds or gender and 
an AKAV-infection, however, 77.8 % of 180 animals were aged less than 24 
months. Furthermore, antibodies were found in sheep, goats, horses, buffaloes, 
pigs, camels, and in many wild animals from the South of Africa (Lim et al., 2007; 
OIE, 2008; Yang et al., 2008b). The AHS, however, has been described only for 
cattle, sheep, and goats (Kirkland, 2008). Antibodies in the dam protect against 
fetal infection, thus epizooties sometimes occur with a few years interruption 
(OIE, 2008). Initial serological investigations in cattle in Indonesia revealed 80.0 % 
AKAV-positive sera out of 90 sera examined (Miura et al., 1982). Investigations of 
pigs in Korea showed that an AKAV-incidence of 37.4 % in 230 sera examined 
(Lim et al., 2007). In addition, co-infections with other arboviruses occurred rela-
tively frequently: Akabane disease and Ephemeral fever 25.5 %; Akabane and Chu-
zan virus 3.5 %; Akabane and Aino virus 1.2 %. In similar studies, 5.5 % out of 
804 sera of goats and 3.8 % out of 497 sera of horses showed AKAV-antibodies 
with low titers (Yang et al., 2008a, b). In Turkey, west of the Bosporus, AKAV was 
detected in cattle sera (Karaoglu et al., 2007). The first viruses isolations were suc-
cessful from pools of Culicoides (OIE, 2008). Culicoides oxystoma is a known vector in 
Japan, Culicoides milnei and Culicoides imicola are known in Africa, and Culicoides brevi-
tarsis and Culicoides wadei are known in Australia (Kirkland, 2008). In Vietnam, the 
virus was detected in mosquitoes such as Culex tritaeniorhynchus, Ochlerotatus spp., 
Anopheles vagus, and the subgroup Culex vishnui (Bryant et al., 2005). Moreover, in 
Kenya the virus was isolated from Anopheles funestus, while in Japan it was isolated 
from Aedes vexans and Culex tritaeniorhynchus (Kirkland, 2008). For some vectors, 
however, the confirmation of a biological transmission is still missing. There are no 
indications that Akabane disease is a zoonosis (Bryant et al., 2005). 
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Control and combat. Vaccinations can be used for control, e.g., before transporting 
susceptible animals to endemic areas (Kirkland, 2008). In order to prevent the 
occurrence of congenital symptoms, susceptible animals should only be transport-
ed to endemic areas when they are not pregnant or when the vectors are not active. 
Measures for vector control, such as repellents or the treatment of breeding 
grounds, are regarded as ineffective because of too short notice. 
3.4 Ephemeral Fever 
Pathogen. The Bovine Ephemeral Fever (BEF; also referred to as “Three-day sick-
ness”, “Bovine enzootic fever”, “Dengue fever of cattle”, “Lazy man’s disease” or 
“Stiffsiekte”) is caused by the Bovine Ephemeral Fever Virus (BEFV) of the genus 
Ephemerovirus of the family Rhabdoviridae (Della-Porta and Brown, 1979; Hsieh et al., 
2005; St. George, 1990; Walker et al., 1991; Hamblin, 2008). There is only one 
serotype. Isolates, however, can be assigned to different subtypes within this sero-
type. The virulence of individual strains has a large range. Another five serological-
ly similar viruses were isolated from the blood of clinically healthy cattle, whereas 
three are considered as non-pathogenic, for one strain bovine pathogenicity is still 
unclear and the Puchong virus can cause a BEF-similar disease. Virus particles are 
bullet shaped, enveloped with a length of on average 145 nm and a diameter of 70 
nm with not completely parallel sides as well as an inner capsid (Holmes and 
Doherty, 1970). Five structural proteins are encoded by the negative-sense single 
stranded RNA (–ssRNA) including a surface protein G (Hsieh et al., 2005) and a 
non-structural protein (NS) (Hamblin, 2008). Walker et al. (1991) found another 
protein with an unsolved function, which was detected in infected cells but not in 
virions. Viruses of the family Rhabdoviridae contain a non-segmented genome. The 
virus is sensitive to degreasing solvents and can be inactivated at pH-values of <5 
or >10 (St. George, 1990). Phylogenetic investigations showed low substitution 
rates indicating a slow development of the virus (Hsieh et al., 2005). BEF was first 
described in South Africa in 1906, even though it is known that it had appeared 
earlier. The disease was mentioned by Schweinfurth in 1867 and recognized in 
1895 in Egypt (St. George, 1998). In 1909, there was an outbreak in Egypt (St. 
George, 1990), in 1937 and 1967 epizooties appeared in Japan and Australia. In 
1966, the virus was first isolated by Van der Westhuizen in Onderstepoort, South 
Africa (St. George, 1990). In China BEF-symptoms have already been reported as 
from 1949, however, the virus was first isolated in 1976 (reviewed by Zheng et al., 
2009). During the recent 60 years, there have been many outbreaks in 25 Chinese 
provinces. In Taiwan the virus first occurred epizootically in 1967, after that, there 
were another three epizooties in 1983/84, 1989/90, and 1996 as well as three larg-
er outbreaks in 1999, 2001 and 2002 (Hsieh et al., 2005). In Saudi Arabia, out-
breaks are assumed to have taken place in 1980 and 1990/91 as they were diag-
nosed due to the symptoms described. Another epizooty in that country occurred 
in 1996 (Abu-Elzein et al., 2006). 




Epizootiology and epidemiology. The BEF is a disease of cattle and water buffaloes and 
has an acute course (Walker et al., 1991), while, aside from insects, the BEFV has 
been isolated only from cattle (St. George, 1990). In buffaloes the course of the 
disease is milder than in cattle (Hamblin, 2008). There is not any reliable infor-
mation about the differences in the susceptibility between European breeds and 
Zebu cattle. However, symptoms are more pronounced in fat animals than in oth-
er groups and calves seem to be infected more rarely as well as less severely (St. 
George, 1990). In contrast, antibodies were detected in diverse species, inter alia in 
different deer species such as African buffaloes (Syncercus kaffer), waterbucks (Kobus 
ellipsiprymnus), blue wildebeests (Connochaettes taurinus), and red hartebeests (Alcela-
phus buselaphus). Furthermore, there is a report about neutralizing antibodies in 
goats as well as about low antibody titres in kudu, scimitar-horned oryx, eland, 
impala, giraffe, and topi (Hamblin, 2008). These animals can constitute a large 
natural reservoir. In other species – sheep, mice, dogs and cats – viremia or symp-
toms were generated experimentally. Rats and rabbits produced antibodies in this 
way but no measurable viremia. So far, epizooties have occurred in China, Japan, 
Australia, Egypt, and South Africa (St. George, 1990). In China, the inter-epizootic 
periods have become shorter during the last 20 years. Therefore, epizooties only 
occur every three to five years, in a South-Eastern province of the country every 
one to two years (Zheng et al., 2009). According to reports from Taiwan and Aus-
tralia, the epizootic intervals have become shorter, too (Hsieh et al., 2005; St. 
George, 1990). The epidemiologic development of BEF-epizooties in Australia has 
led to an approximation of the course of the disease to tropical regions (St. 
George, 1990). First, rapidly spreading epizooties occurred every 20 years, but 
since 1967 every two to three years and only locally with highly variable incidence. 
The rate of spread of individual epizooties varies considerably. In Australia, a peri-
od of six weeks to two years was indicated for a distance of 3,000 km. The direc-
tion of propagation of epizooties is in general away from the equator. Already at 
the beginning of the last century, a vector-borne transmission of the disease was 
assumed. To date, an unambiguous function of insects as biological vectors has 
not been proven (Hamblin, 2008; St. George, 1990). Some species of the genera 
Culicoides, Anopheles, and Culex are known as vectors (Wang et al., 2001). The virus 
was isolated from Culicoides spp., Culicoides brevitarsis, two mosquito-genera, Anophe-
les bancroftii as well as from species of Culicine (St. George, 1990). As a persistent 
infection of cattle is not expected, it is assumed that the virus persists inside the 
vectors. Contagious transmission does not occur, nor is there any evidence for 
horizontal transmission (Hamblin, 2008). With regard to a new infection, it has not 
been clarified whether the BEFV is directly injected into blood circulation or 
reaches the latter via the lymph (St. George, 1990). However, BEF could be only 
generated experimentally by an intravenous inoculation and the virus cannot be 
detected in the lymph during the early viremic phase. Thus, mosquitoes are cur-
rently favored as vectors (Hamblin, 2008). The geographic distribution of BEF, 
however, exceeds those of the so far identified vectors. BEF occurs along rivers 
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like the Nile during summer or during the rainy season, while epizooties are nor-
mally stopped by cold spells. From a geographic point of view, BEF can be found 
in a large number of habitats. In tropical to tempered, humid to arid regions as well 
as in regions at sea level and in highlands. The prevailing wind direction and the 
weather conditions are considered as important factors for the spread of BEF 
beyond oceans possibly by birds, bats or insects. An investigation of 230 pig sera 
for arboviruses in Korea revealed an incidence of 15.7 % for Ephemeral fever as 
well as co-infections with the Chuzan virus (2.8 %) (Lim et al., 2007). In similar 
studies in five provinces of the European part of Turkey, 8.04 % of 557 bovine 
sera were tested positive. In that case, results were ranging between 2.5 % and 15.3 
% (Karaoglu et al., 2007). Earlier serological investigations in Indonesia revealed 
78.9 % positive samples of 99 bovine sera (Miura et al., 1982). 
 
Control and combat. For animal prophylaxis, maternal protection by vaccination is 
well suited. Low antibody titers caused by closely related viruses have to be taken 
into account as possible serological interference factors in control programs (St. 
George, 1990). Due to a lack of data, currently it is hardly possible to develop vec-
tor control programs. Nevertheless, insect-proof housing is worth consideration in 
case of valuable livestock (Hamblin, 2008). Due to the barriers, even eradication or 
limitation of BEF is not possible, although it seems to have been eradicated in 
New Guinea since 1956 (St. George, 1998). 
3.5 Crimean-Congo Hemorrhagic Fever 
Pathogen. The Crimean-Congo Hemorrhagic Fever (CCHF) was first described in 
the Crimean in 1944 (Al-Tikriti et al., 1981). The virus was first isolated in the 
Democratic Republic of the Congo (at that time Belgian Congo) in 1956 (Aidaros, 
2003). The clinical picture, however, had been known years before in the Central 
Asian republics of the former Soviet Union and possibly already in the 12th centu-
ry (Whitehouse, 2004). To date, the CCHF virus (CCHFV) has been the most 
closely examined virus of the genus Nairovirus of the family Bunyaviridae (Crabtree 
et al., 2009). It contains three individually encapsulated negative-sense single 
stranded RNA segments (–ssRNA) (Tonbak et al., 2006). Re-assortment was par-
ticularly detected for the M segment but there are also some indications for the L 
and S segments. In addition, there is some evidence for the re-assortment of short 
gene fragments of the S segment (Deyde et al., 2006). In 1979, CCHF was first 
diagnosed in Iraq (Al-Tikriti et al., 1981). Since several years, CCHF has been an 
emerging disease in Turkey (Estrada-Peña et al., 2007). Nearly 100 % of the cases 
occurred in Northeastern Anatolia. In 2008, however, a mild case of a Greek 
CCHFV strain that had been considered as non-virulent was identified in the Bal-
kan region near Istanbul (Midilli et al., 2009). The CCHFV strains that occured 
near the Black Sea were phylogenetically closely related to those from Kosovo, 
Bulgaria and Southern Russia (Tonbak et al., 2006). High homologies have also 




been observed between the strains from South and West Africa as well as between 
those from Iraq and China (Deyde et al., 2006). There is only limited serological 
evidence for the presence of CCHFV in France, Portugal, India, and Egypt 
(Whitehouse, 2004). 
 
Epizootiology and epidemiology. CCHF is a zoonosis that is widespread in the Mediter-
ranean area (Chaniotis, 2003). It is attributed to the hemorrhagic fevers (Tonbak et 
al., 2006). Beside cattle also sheep, goats, rabbits, birds, and rodents function as 
reservoir (Chaniotis, 2003). For domestic ruminants, the viremic stage lasts for 
about one week from infection (Aidaros, 2003). Furthermore, other domestic ani-
mals, ostriches, and mosquitoes can be infected. Human infections are often 
caused by tick bites, contact with body fluids or with tissue of infected livestock or 
contact with CCHF patients in the acute phase (Estrada-Peña et al., 2007; Yapar et 
al., 2005). Nosocomial outbreaks in humans can occur through the contact with 
infected blood and secretions but also veterinarians and slaughterhouse staff are 
exposed to a higher risk (Aidaros, 2003). The virus is normally transmitted by ticks 
requiring three hosts. CCHF was isolated from two Argasidae (soft tick) species and 
seven different genera of Ixodidae (sheep tick) (Whitehouse, 2004). Among others, 
Rhipicephalus bursa is known as vector. The virus can be transmitted especially by 
Hyalomma marginatum marginatum that is widespread in Eurasia and South Africa and 
remains infected during all development stages (Aidaros, 2003). In a tick study in 
Turkey, the virus was detected in Hyalomma marginatum marginatum and Rhipicephalus 
bursa of cattle and goats. In addition, Haemaphysalis punctata and Ixodes ricinus are 
regarded as source of infection in Europe. Transovarial transmission occurs with a 
high efficiency (Deyde et al., 2006) and also sexual transmission was detected in 
ticks (Aidaros, 2003). However, small vertebrate hosts are considered as the most 
important source of infection for ticks in instars (Aidaros, 2003; Nabeth et al., 
2004). Ticks are not only regarded as vectors but also as reservoir for the virus 
(Tonbak et al., 2006). Large outbreaks are associated with an abrupt increase in the 
population of ticks (Aidaros, 2003). This, in turn, can be attributed to appropriate 
environmental conditions such as dense ground vegetation and a high amount of 
intermediate hosts for nymphs. Causally, these developments can often be attribut-
ed to an extended movement of animals and humans, war or climatic changes. In 
Senegal a negative correlation between the sero-prevalence in sheep and precipita-
tion was found (Wilson et al., 1990). The low amount of non-fatal human cases 
despite high sero-prevalences indicated that the real incidence is unknown. Immu-
noglobulins (IgG) were detected in 21.1 % of the humans and in 21 % of the 
sheep examined dependent on the region. 
 
Control and combat. Due to its virulence and pathogenicity, CCHFV is regarded as a 
potential biological weapon of category C (Deyde et al., 2006; Whitehouse, 2004). 
Acaricides can be applied for combating ticks (Aidaros, 2003). 
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3.6 Kyasanur Forest Disease 
Pathogen. The Kyasanur Forest Disease (KFD) is a febrile, biphasic disease of mon-
keys and humans (NIV, 2005). Cattle don’t develop clinical symptoms. The spheri-
cal KFD virus (KFDV) is 45 nm in size, enveloped, and belongs to the family of 
Flaviviridae. Since 1955, the disease has been known in the Southwest of India. 
After comparing 48 KFDV isolates, it was concluded that the isolates from India, 
Saudi Arabia (Alkhurma virus) and China shared their last common ancestor 
around 1942 (Mehla et al., 2009). However, it should be added that the authors 
questioned the authenticity of the Chinese isolate due to its complete identity with 
the Indian reference strain isolated in 1957. 
 
Epizootiology and epidemiology. In recent times, cattle are not assigned a role in virus 
circulation, except the fact that they serve as nutritional basis for replication of 
ticks (NIV, 2005). The reason for this is the low viremia. In addition, it is consid-
ered possible that cattle play a role as amplification host (Mehla et al., 2009). The 
ratio of clinical and subclinical infections of >50 % is high (Pandit, 1960). The 
disease mostly occurs between January and May, which corresponds to the activity 
of nymphs (NIV, 2005). KFD was discovered in forest regions in the Southwest of 
India in succession of a high mortality of two monkey species, Hanuman langurs 
(Semnopithecus entellus) and Indian bonnet monkeys (Macaca radiata) (NIV, 2005). 
Cattle in that region are often heavily infested by ticks of the genus Haemaphysalis. 
They offered the highest percentage of positively tested sera in comparison to 
other species (Pandit, 1960). In that study, however, only neutralizing antibodies 
were detected and no positive results were achived in hemagglutination inhibition 
tests (HIT) or complement fixation tests (CFT). Ticks of the genus Haemaphysalis 
are known as vectors, in particular Haemaphysalis spinigera that are considered as 
anthropophilic (NIV, 2005; Pandit, 1960). The virus has been isolated from 16 tick 
species, it is transstadially persistent and transovarial transmission has only been 
detected in Ixodes petauristae (NIV, 2005). For humans, an incubation period of two 
to seven days is indicated. Diagnosis normally is mainly based on clinical picture. 
In humans, clinical symptoms occur fulminantly including shivering, frontal head-
ache, and high fever of >40 °C. Muscle pain, cough, vomiting, diarrhea, and pho-
tophobia last for 12 days or longer. There often is a relapse after one or two weeks, 
which lasts two to 12 days and partly leads to complications. The recovery phase is 
long. The number of human cases of the disease ranges from 40 to more than 
1000 a year with a mortality of four to 15 %. A similar mortality has only been 
detected in two native monkey species (Panidt, 1960). For laboratory diagnostics 
and antibody detection HIT, neutralization tests (NT), and immunofluorescence 
tests (IFT) are available (NIV, 2005). 
 




Control and combat. First attempts to develop a vaccine have been made in the 1950s 
(Pandit, 1960). Currently exists an inactivated vaccine, which stimulates the pro-
duction of neutralizing antibodies in approximately 70 % of the vaccinated persons 
(NIV, 2005). Forest clearing leads to changes in the population of ticks and is re-
garded as a risk factor for outbreaks. 
3.7  Dugbe Virus Infection 
Pathogen. The Dugbe virus belongs to the genus Nairovirus of the family of Bun-
yaviridae (Gonzales et al., 1989). Like CCHFV, the Dugbe virus has been thorough-
ly investigated (Crabtree et al., 2009; Marriott and Nuttall, 1996). Among others, 
this is due to the fact that the Dugbe virus is less dangerous than the CCHFV and 
therefore has often been used for basic research in nairoviruses (Gonzales et al., 
1989). The virions have a diameter of 90-100 nm (David-West and Porterfield, 
1974) and cause only a slight cytopathic effect on pig kidney cells and diverse 
monkey cell lines. However, cytoplasmatic inclusions with basophils are detectable. 
The virus is inactivated by 0.1 % sodium deoxycholate (10 min at 37 °C) or 0.1 % 
trypsin (60 min at 37 °C). In solution the virus is inactivated at 4 °C or -20 °C after 
two months or at 37 °C after 12 hours. At pH-values of <3, the virus is instable 
but remains infectious up to a pH-value of 9. The Dugbe virus has been the first 
completely sequenced member of the nairoviruses (Marriott and Nuttall, 1996) 
 
Epizootiology and epidemiology. The Dugbe virus was first isolated in Dugbe, Ibadan in 
Nigeria in 1964, afterwards, further isolates were obtained in other African states 
such as Senegal, Uganda, Cameroon, Ethiopia, and Kenya (Beran, 1994). The virus 
has often been isolated from cattle but also from humans and once from a Gambi-
an pouched rat (Cricetomys gamianus). The virus is regarded as a weak pathogen for 
humans and is associated with febrile diseases and thrombocytopenia (Sang et al., 
2006). The Dugbe virus has been isolated from ticks of the genera Amblyomma, 
Hyalomma, Ixodes, Rhipicephalus, and Boophilus (Beran, 1994). In Kenya, it was isolat-
ed from the species Amlyomma gemma, Amblyomma variegatum, Amblyomma lepidum, 
and Rhipicephalus pulchellus (Sang et al., 2006) as well as from Culicoides and Aedes 
aegypti (Beran, 1994). Gonzales et al. (1989) found that adult Amblyomma variegatum 
replicate the virus more efficiently than nymphs which contradicted previous stud-
ies. They explained their findings with possible differences in the used tick species 
or virus strains. In addition, the virus was found in eggs of these tick species indi-
cating a transovarial infection. Serological investigations in Nigeria revealed 29 % 
positive cattle out of 331 sera tested, 3.7 % positive goats and sheep out of 81 
animals tested but no positive result in humans (Beran, 1994). 
Control and combat. The virus is not attached much importance in terms of threat to 
human and animal health (Beran, 1994). 
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3.8  Kupe Virus Infection 
To date this virus has only been subject to two publications (Sang et al., 2006; 
Crabtree et al., 2009), while the latter provided its first characterization. The Kupe 
virus is a newly identified virus, which was first isolated from a pool of the tick 
species Amlyomma gemma and Rhipicephalus pulchellus in 1999 (Sang et al., 2006). It is 
a species of the genus Nairovirus of the family Bunyaviridae and is closely related to 
the Dugbe virus (Crabtree et al., 2009). Like the other members of the genus, the 
enveloped virus has three segments of a negative-sense single stranded RNA (–
ssRNA), which are designated according to their size with S, M, and L. The viral 
genome was completely sequenced. In cell cultures, the Kupe virus replicates faster 
than the Dugbe virus but then decreases faster in titre. None of both viruses repli-
cates inside mosquito cells. With the exception of BHK-cells, cytopathic effects 
were at first observed after infection with Kupe virus and the total damage in the 
cell monolayers was higher for this virus, too. The analyses indicated that the L 
segment of Kupe virus could have been obtained by segment exchange with the 
Dugbe virus. Although the Kupe virus showed a higher virulence in cell culture 
experiments than the Dugbe virus, its possible pathogenesis in mammals is not 
known yet. 
4 Transmission and surveillance of arboviruses 
The various exotic bovine arboviruses constitute a diverse group of viruses, which 
have developed different survival mechanisms. While some of them are already of 
international relevancy, in case of the others there is the risk of a potential estab-
lishment especially in the European Union (EU). A permanent establishment, 
however, first of all requires their introduction into the European region through 
one of the many possible ways of transmission. To date, there hardly exists any 
information about the vector capacity of the European arthropods for the men-
tioned bovine arboviruses. However, it can be assumed that both viruses and vec-
tors pass through mutual adaptation processes. Beside the urgently necessary ex-
pansion of the existing knowledge about arboviruses in cattle, the adaptation pro-
cesses require its constant actualization. The latter is very important as neither 
vector capacity nor geographic boundaries of the range of arboviruses can be con-
sidered as fixed values. Here molecular biological methods can make an important 
contribution since comparisons of various virus isolates enable phylogenetic anal-
yses. This makes it possible to clarify relations between geographically different 
strains as well as to understand long-term evolutionary processes. In order to ex-
pand and deepen the knowledge about arboviruses, inter-disciplinary wide-ranging  




studies may be advisable. Moreover, only in this way it is possible to encounter the 
complexity of the disease. Factors that influence the distribution pattern of diseas-
es are the level of population immunity, virus virulence, presence of vector species, 
relative transmission efficiencies of present vectors, vector habitat, geographic 
barriers, climatic conditions (St. George, 1990). With regard to the question in 
which ways a pathogen can reach its potentially new range next to the distribution 
patterns of diseases, also the fundamentals of the distribution are of considerable 
importance. This issue will explore trade, climatic conditions, socio-economic 
causes (land use, pasture shortage, ways of nomadic herds, trade of used tyres, rural 
exodus, drought, hunting bans), migratory birds and zoo animals. The observation 
of vectors and arboviruses is very important. Therefore, vector competence stud-
ies, on-site sampling as well as national and international institutions operating 
efficient databases must be established through special research programs. This 
also includes the development of parameters for early warning systems and remote 
sensing. Further development of prophylaxis conditions are also a main focus. 
They concentrate on modern protective vaccines and vaccination strategies, breed-
ing and breed optimization, minimization of exposure, as well as vector control 
with direct control measures or indirect control measures such as habitat control. 
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10 Maternal mortality:  
A consequence of  a lack of  reverence for life? 
Martin Tamcke 
1 Introduction 
Since its introduction by Albert Schweitzer, the concept of reverence for life has 
been widely received and has left its religious or ideological context to enter a 
number of state constitutions, as for example in Germany1.  Schweitzer saw the 
idea of taking the subject as a starting point captured in the simple formula: “Ich 
bin Leben, das leben will, inmitten von Leben, das leben will.” 2  Schweitzer’s ap-
proach tackles all those instances of apathy and the use of force that we have al-
lowed to become parts of social life either deliberately or unconsciously. The diffi-
cult social standing of women and children in many, if not all, important societies 
around the globe represents a fundamental contradiction with the postulate of 
reverence for life. This becomes most evident where life is coming into existence 
and thus should be given the highest measure of reverence – both with respect to 
the life of the newborn child and to the life of the mother who grants and nourish-
es this life with her body. 
Especially in this area, there certainly are slight differences in the progress on 
realizing reverence for life, but deficits are clearly noticeable worldwide. The Ger-
                                                     
1 Cf. Wilfried Härle, „Ehrfurcht vor dem Leben.“ Darstellung, Analyse und Kritik eines ethischen Programms, in: 
Marburger Jahrbuch Theologie IX: Leben, Marburg 1997, 53-81. 
2 Cf. Günter Altner, Leben inmitten von Leben. Die Aktualität der Ethik Albert Schweitzers, Stuttgart 2005. 
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man discussions about childrens’ rights following a series of infant deaths by star-
vation due to a lack of parental care are no less frightening than the structural vio-
lence that Indian mothers and infants have to endure. The Institute for Ecumeni-
cal Studies at the Georg-August-Universität Göttingen has successfully integrated 
Schweitzer’s concept into international cooperation. This was first achieved in the 
dialogue with our Muslim partners.3 Here, the concept proved readily accessible to 
Muslims with an affinity to mysticism, who sought more open religious concepts. 
The result was a local, active and independent reception of Schweitzer’s approach. 
4  Subsequently, the concept was tested in the Indian context. 5 Here, too, it was 
immediately adopted, although further development and adjustment of the ap-
proach is still called for. 6 There has yet been no application of the concept on the 
specific problem of maternal and infant mortality. It is to be an integral part of our 
future endeavors. 
2 The death of a mother 
“No more. We have lost her.” 7  These are the words author Abraham Verghese 
assigns to gynecologist Hema when, after a long medical battle following the com-
plicated delivery of twins, she has to witness the death of a mother, with whom she 
had a particularly close relationship. The death that Verghese relates is not one of 
the frequent deaths of young mothers in India, but that of a nurse who had emi-
grated to Ethiopia. She is a catholic nun, but has her roots in the old Syrian Saint 
Thomas Christianity of India. Her conversion to Catholicism had been a blow to 
her family, alienated her permanently from her social and geographic origin (Co-
chin in the state of Kerala) and led her first to Madras, Tamil Nadu and finally via 
Yemen to Ethiopia. The many storylines of the novel turned it into a worldwide 
bestseller. It compassionately describes the fate of a patient as well as the medical 
interventions, highlighting the attitudes and behavior of the medical and nursing 
personnel. This is precisely the program that made Abraham Verghese not only an 
                                                     
3 Martin Tamcke, Bir Mistik Teolog Olarak Albert Schweitzer (Transl. by Arst. Gör. Abdulmuttalip 
Baycar), in: Review of the Faculty of Theology, The University of Kahramanmaras Sütcü Imam 6.12, 
Kahramanmaras 2010, 137-146. 
4 Ece Neslihan Paköz, Research-Assistant of the Dean of the Faculty, wrote her final paper on Albert 
Schweitzer and for this purpose spent one year examining the texts at Göttingen. 
5 Martin Tamcke, Albert Schweitzer. The Defender of Life and its Diverse Expression, in: George Zachariah, 
Christian Witness in India Today. Challenges and Perspectives, Gurukul Journal of Theological Stud-
ies XXI, Chennai 2010, 71-78. 
6 Regarding the difficulties of the reception of Albert Schweitzer in India cf. Christoffer Grundmann, 
Monolog oder Dialog? - Zu Albert Schweitzers Auseinandersetzung mit der indischen Geisteswelt, in: W. E. Müller 
/ M. Ecker (eds.), Religion und Verstehen - Albert Schweitzers Religionsverständnis und der interre-
ligiöse Dialog, Beiträge zur Albert Schweitzer Forschung, Vol. 8, Frankfurt am Main et. al. 2001,  
39-67.  
7 Abraham Verghese, Cutting for Stone, New York 2009, 100 
 




exceptional littérateur but earned him considerable credit in academic circles. Ver-
ghese’s dramatic tale of the struggle to save the life of the dying mother focuses 
not primarily on her, but instead presents it as the crisis of the aides around her. 
According to the novel, medical expertise occasionally becomes useless be-
cause of human emotions, as for example in the case of a British clinician, who is 
at the same time the father of the twins and the representative of a postcolonial 
Indian view on the former colonists. Medical knowledge can be put to use me-
chanically in order to demonstrate one’s ability to act, but at times it may be aware 
of its own futility from the outset. This is illustrated by the Indian doctor Hema, 
who keeps trying to save dying patients, although it already dawns upon her that 
she will not succeed. The ability to take care of patients may be undermined by 
human consternation (the senior nurse faints, because she feels so close to the 
dying mother), or it may turn into incompetence where book knowledge and active 
knowledge are disconnected (e.g. the trainee nurse, who fails to observe important 
parts of the treatment). In the face of this dramatic situation evolving around the 
dying mother, medical intervention itself becomes the main issue. The author 
closely examines its limitations and its questionability.  
Human factors, however, which oscillate between interference and motivation 
for action, have their place only in a somewhat “unreal reality” aside from the 
medical interventions: the religious dimension. This dimension becomes acces-
sible in all its facets, i.e. the mystic religiosity of an Indian nun (the dying mother), 
the atheism of a British man (the medically and ethically failing father), the reli-
gious rituals of the doctor in charge, who experiences her limitations not only as a 
medic and deeply suffers from the events. She calls upon her favorite god Shiva, 
hoping that he will transform the situation and save the day. In fact, everything is 
lost at this point and the appellation merely paves the way for a shift of attention 
from the deceased woman to the surviving infants. In his incapacity to grasp the 
events, the Brit calls for a god from whom he had long distanced himself. The nun, 
as far as it is discernable at that point, dies in religious acquiescence. Every heart-
beat of her life is said to have been accompanied by divine actions. Always did she 
try to please God with her life. Following her passing away, an employee simply 
takes the rosary and conducts the rituals that are appropriate in this situation. The 
staff begins to chant the traditional dirges until they fill the entire hospital. 
Hema’s reaction, however, is to dance. Her answer to all this madness is the 
dance of Shiva, the imitation of his mask-like smile. She begins to sway and moves 
as though Shiva’s six arms and legs were dancing to an internal tune. Hema stomps 
with her heels and bends her knees – for her, this is the dance that holds the world 
together and saves it from extinction. Through her movements she joins into the 
rhythm of all living things: “What to do except dance, dance, only dance….”8  
                                                     
8 Ibid., 108 
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3 One Career, one program 
Verghese knows exactly why and what he is writing. He transcribes the reality of 
his daily experience on the job into the fictional universe of a novel. His answer to 
the question of how medical schools and their professors should call attention to 
the deficits in nursing and the health care system is characteristic of his position: 
“It’s a struggle […] but if you’re going to do it, you’re going to do it only by show-
ing them the charm and the magic of being at the bedside. There is no passion and 
romance that you can illustrate to them in front of a computer, which is, where a 
lot of care takes place these days. The only way to excite students about medicine it 
to do it one by one, by them seeing you being the kind of physician that they’d like 
to be.” 9 Even more explicit are his statements on the function and purpose of 
medicine in general. “It’s naive to think facts alone will change things. If facts 
alone would change things, then we would all eat healthy and wouldn’t smoke. 
Stories change things. Pain changes things. Suffering changes things. In many 
ways, that’s what I’m saying is happening in medicine. If it’s all about facts and 
numbers, it doesn’t move patients. Medicine is an art and not a science. The sci-
ence part is the numbers. But we can’t abandon the art part. It’s so important.” 10 
Elsewhere he states: “My desire to be a physician had a lot to do with that sense of 
medicine as a ministry of healing, not just a science. And not just a science and an 
art, but also a calling, also a ministry.” 11 He intends to correct a mechanical per-
ception of medical work, asserting, “You know, there are nuances to exam that no 
machine is going to give you.” 12 In this context, religion obviously takes a signifi-
cant role in correcting the tendency towards mechanization: “And I think when 
you’re in medicine, you agonize over matters of faith.” 13 Verghese ridicules the 
conduct of medical professionals, who have lost sight of the human dimension to 
their actions. “I joke but only half joke that if you show up in an American hospital 
missing a finger, no one will believe you until they get a CAT scan, MRI and or-
thopeadic consult.” 14 For him, rituals are a natural part of the healing process, 
especially in the sense of transformation. “Rituals are about transformation. […] If 
we short-change the ritual by not being attentive, you are inputting into the com-
puter while the patient’s talking to you, you basically are destroying the opportunity 
fort he transformation. And what is the transformation? It’s the sealing of the pa-
                                                     
9 Jessica Marcy, Checking In With Dr. Abraham Verghese On The Inportance Of The Bedside Manner, Inter-
view 09/15/2009, http://www.kaiserhealthnews.org/Checking-In-With/verghese.aspx (accessed 
online 07.01.2011). 
10 Ibid. 










tient-physician bond.” 15 Verghese seeks to achieve “powerful effect[s] on patients” 
through empathy on the part of the medical professionals. 16 He came to hold 
these opinions not through his studies in medicine, but through his practical work 
in nursing care. 17   
Today, Abraham Verghese is Professor for the Theory and Practice of Medi-
cine at Stanford University Medical School and Senior Associate Chair of the De-
partment of Internal Medicine. He received his medical degree (MBBS) from 
Madras University in 1979, was a resident of Johnson City, Tennessee (affiliated 
with East Tennessee State University) from 1980 to 1983, a fellow at Boston Uni-
versity School of Medicine in 1983 (he worked at Boston City Hospital for two 
years, concentrating on the urban epidemic of HIV). In 1985, he obtained a post as 
Assistant Professor of Medicine (later tenured) in Johnson City, working with rural 
AIDS. In 1991 he accepted a position as Professor of Medicine and Chief of the 
Division of Infectious Diseases at Texas Tech Health Sciences Center in El Paso, 
Texas. He lived there for eleven years and was awarded the Grover E. Murray 
Distinguished Professorship of Medicine at the Texas Tech School of Medicine. 
He became the founding Director of the Center for Medical Humanities & Ethics 
at the University of Texas Health Science Center at San Antonio in 2002 and held 
the Joaquin Cigarroa Chair and the Marvin Forland Distinguished Professorship. 
In 2007, he was recruited for Stanford University School of Medicine (Theory and 
Practice of Medicine and Associate Chair of Internal Medicine). His main area of 
interest and his primary goal is to ensure respectful and attentive treatment of the 
patients. His family originally comes from the Indian state Kerala, his parents emi-
grated at first to Ethiopia to pursue their teaching professions. 
4 Awareness for motherhood 
Verghese’s approach is presented here as one amongst other, similar models. Into 
his concept of attentiveness he integrates the religious ties of the patients as well as 
their rituals and treats these as constitutive elements of the process of treatment. 
One thing he only calls on the attending personnel to realize is the indispensability 
of all persons in the social network of an expectant mother, particularly where 
women deliver their children without gynecologic assistance. Against this back-
drop, our institute decided to participate in the effort to establish an attitude of 
                                                     
15 Ibid. 
16 Ibid. 
17 Cf. Powells.com Q&A, Abraham Verghese, http://www.powells.com/ink/abrahamverghese.html 
(accessed online 07.01.2011). “I would say it was being on orderly when my medical school education 
was interrupted. In the process of bathing patients, helping them get dressed, dealing with bedpans 
and all that, I began to see what it was the patient really went through in the 23 hours and 55 minutes 
of the day when the doctors were not around. I look back on that period as terribly important in 
teaching me humility about the doctor’s role and the importance of the role of the nurses and nursing 
assistants.” 
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attentiveness towards motherhood in India through accompaniment of the respec-
tive initiatives and scientific studies there. The intercultural orientation of the insti-
tute and our studies in the field of trans-culturality have the potential and the as-
signment to initiate reciprocal learning processes in the area of religion and culture, 
aiming at attentiveness towards motherhood, the particular requirements in India 
notwithstanding. 
The programs already existing in India have accomplished major results. Nev-
ertheless, models on the integration of religion and medicine are still underdevel-
oped. For this reason, our institute contributes to the planning of projects con-
cerning “Awareness for Motherhood” and draws upon the experience with its own 
research on women in South Andhra as well as on its director’s quarter-century of 
teaching activity at Indian universities. The international master’s program in “In-
tercultural Theology” that is associated with the institute runs projects for example 
on the Dalits and regularly dispatches students to India for the conduction of on-
site research, interviews and in order to arrive at a deeper understanding of the 
situation through participant observation. In cooperation with our Indian col-
leagues, a first outline for a project was devised, which will need further revision 
parallel to similar concepts designed for the African context. The following is 
quoted from an unpublished first draft that was developed together with our Indi-
an partners. 
 
“In most of the South Asian societies socio cultural and religious factors act as 
barriers for safe motherhood. Religious beliefs and practices, gender disparities and 
role expectations in the age of stratified families, apart from individual factors act 
as barriers to safe motherhood in case of Indian society. Though there are institu-
tional similarities in India there are regional specificities which create disparities 
such as difference between fertility rates in North and South India, for example. 
Such disparities are found even within the state and because of historical and cul-
tural background, accelerating change process becomes an issue. Research shows 
that impact of development indicators such as education or work may be effective 
some region but may not be so in another, due to cultural backgrounds. Hence it is 
necessary to examine how the social construction of concept of motherhood has 
taken shape in order to make an effective intervention.” 
The Indian researchers and the institute have also named provisional objec-
tives for the undertaking. “The project will assess the factors related to social con-
struction of motherhood in the selected two villages from two regions of Maha-
rashtra and one urban slum area. It will assess the factors related to the social con-
struction of motherhood. It will examine the positive or negative factors related to 
role expectations, knowledge and practices and emotional readiness/expectations 
by family, village, religious community and interest groups for marriage and moth-
erhood. Related to these, it will find out possibilities for interventions to reduce 
maternal mortality and child morbidity. Three generational perception of mother-
hood (past present future) taking into consideration caste (tribals), religion (the 




diverse traditions and possible cultural commonalities) and family background will 
be examined in the context of the village community. Is the perception changing? 
What generational conflicts exist? Against this backdrop, the transition of a girl to 
a wife and to motherhood will be traced in context of religious and socio cultural 
beliefs, practices of the village community. Perception of a daughter in law, of a 
would be mother and her role expectations, control of elders (especially the moth-
er in law) and the woman’s autonomy, her stresses, resilience and negotiations on 
the background of patriarchal family structure will be assessed in order to under-
stand her accessing of health facilities, knowledge of reproductive health (of wife 
and husband), and general well being. Thirdly, the role of factors such as educa-
tion, work participation or any other agents will be assessed to examine how barri-
ers can be changed for possible interventions. The influence of conceptions of the 
world as well as overcome practices and rituals will be investigated by means of 
oral traditions, the diverse media, religious set ups and schoolbooks. We will addi-
tionally examine the extent to which socio religious factors create barriers or offer 
opportunities for a strengthening of health measures.” 
Students from our institute will dwell directly at the locations that are being in-
vestigated and will participate in the examinations as far as the situation allows it. 
As an outcome, the institute expects a growing awareness for the necessity of 
global action. 
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11 Risk of  maternal mortality: Indian scenario  
Anjali Radkar  
1 Introduction 
At United Nations millennium summit, in September 2000, leaders of world’s gov-
ernments signed a declaration and committed themselves to a series of goals, 
namely Millennium Development Goals (MDGs). The goals are about eradication 
of poverty, imparting universal primary education, improvement in child and ma-
ternal mortality indicators, combating HIV / AIDS and ensuring environmental 
sustainable development. Fifth of the eight millennium goals addresses the issue of 
maternal health which states the reduction in maternal mortality ratio (MMR) by 
three quarters between 1990 and 2015 and achieve universal access to reproductive 
health by 2015. Midterm review indicated that maternal mortality is decreased by 
less than 1 percent per year between 1990 and 2005, which is far below the 5.5 
percent annual improvement needed to reach the target (United Nations, 2008). 
MMR is one public health indicator which shows maximum variation between 
developed and developing countries. Every time woman in the developing coun-
tries becomes pregnant, her risk of dying is 200 times more than that of risk of 
woman in developed countries. Developing countries carry the burden of 99 per-
cent of global maternal deaths. Thus the ultimate responsibility of reduction in 
MMR lies on developing world.  
Maternal death is an outcome of chain of events and disadvantages throughout 
women’s life (Motashaw, 1997). If everything goes well almost all theses deaths can 
be prevented. It is also observed over the years, where maternal mortality is high, 
deaths are rarely recorded and if they are, the cause of death is usually not reported 
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or misreported. Causes of maternal mortality are well established and are grouped 
as direct and indirect. Direct causes refer to those conditions or complications that 
arise during pregnancy like abortion, ectopic pregnancy, hypertensive disorders of 
pregnancy, ante partum and postpartum hemorrhage, obstructed labour and sepsis. 
Indirect causes are those problems which may be present even before pregnancy 
but are aggravated by pregnancy, which include heart disease, anemia, essential 
hypertension (high blood pressure of unknown origin), diabetes and certain other 
diseases of red blood cells. In fact the reasons of maternal death are multi-layered. 
Behind medical causes are logistic causes like not-so-efficient heath service delivery 
and lack of transport facilities and behind all this are social, cultural and political 
factors which together determine the status of women, their health, fertility and 
health seeking behaviour (WHO, 1991). 
During early twentieth century in Mumbai high maternal mortality is attributed 
to practice of early marriage, inferior status of women and tradition-bound health 
practices (Ramana, 2007). In the case study of India by Choe and Chen (2006) 
determinants of maternal mortality are listed as knowledge of reproductive health, 
access to and utilization of reproductive as well as medical health care along with 
the socio-economic and cultural factors associated with knowledge and use of 
services. The determinants of maternal mortality as portrayed by Jejeebhoy (1997) 
include women’s autonomy, role in decision making, mobility, control over eco-
nomic and other resources, gender and power relations, household economic sta-
tus, physical accessibility to health care services and quality of services. 
1.1 Objectives 
This study is designed to understand the levels of direct risk factors of maternal 
mortality in India. Specific objective of this work is to understand the lifetime risk 
of maternal death and the levels of various determinants of maternal mortality for 
India by socio-economic levels with special emphasis on the utilization of health 
services during pregnancy and childbirth. It also aims to look at biological risk 
factors of women to explore about share of high-risk pregnancies. 
1.2 Data 
For this study data on MMR comes from Sample Registration System (SRS) 
whereas for the determinants, it is from the National Family Health Survey – 3 
(NFHS-3), conducted during 2005-06.  
Sample Registration System gives the estimates of vital statistics since 1969 – 
1970 on a regular basis. It is a dual record system. National Family Health Survey – 
3 is conducted in India during 2005 – 2006. It was carried out in 35 states, covering 
99 percent Indian population. 
The sample of the NFHS – 3 consists of 109041 households with 124385 
women in the childbearing ages - 15 to 49 years. Out of all the women, infor-
Global Health – A Challenge for Interdisciplinary Research 
 
119 
mation has been collected from 56438 the women who have given birth(s) in the 
reference period of 5 years. It includes the detailed data about their antenatal care 
(ANC), delivery and also about postnatal care, if any.  It also gives information on 
biological characteristics of the woman. Since the data is collected from women 
about their births, it does not have data on actual maternal death, if at all it has 
occurred in the selected household.  
Biological characteristics include age of the women at the time of birth and 
birth order. Health service delivery indicators are ANC – its individual compo-
nents and complete ANC, institutional delivery or delivery attended by health per-
sonnel, check-up and pathological tests during pregnancy, awareness about preg-
nancy complications and what needs to be done then as well as postnatal care. The 
NFHS -3, gives information on the current pregnancy as well. Data on hemoglobin 
level and Body Mass Index (BMI) of pregnant women can portray their nutritional 
status during pregnancy which is a determinant of maternal and newborn health or 
even mortality 
2 Results and discussion 
2.1 Risk of maternal death 
Every year India witnesses about 65000 – 70000 maternal deaths.  Women here are 
60 to 70 times more likely to die a maternal death than that of women in devel-
oped countries. Pregnancy related mortality and morbidity continues to take toll on 
lives of women and newborns. Considering such a huge gap in the indicators in 
developed and developing countries and importance of a life that can be saved, the 
MDG 5 is set.  
In case of India, MMR was supposed to reach 200 by 2007 and should reach 
109 by 2015. MDG 5 is important for India because 20 percent maternal deaths 
take place in India, which is the highest number for any single country. Unless 
Indian figures improve it is impossible for the World to achieve the goal. National 
Sample Survey (NSS) estimates are the indirect estimates whereas SRS estimates 
are based on the sample. In India all fertility and mortality indicators are computed 
by SRS. MMR, maternal mortality ratio, number of maternal deaths per 100000 live 
births is declining over the period but the pace is not as expected, if the goal is to 
be achieved. 
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Table 1 Maternal mortality ratio, India, 1957 – 2006 
Year Maternal Mortality Ratio 
(MMR) 
Source 
1957- 1960 1321 NSS* 
1963 – 1964 1195 NSS* 
1972 – 1976 853 SRS 
1977- 1981 810 SRS 
1982 -1986 580 SRS 
1987 -1991 519 SRS 
1992- 1996 440 SRS 
1997 – 1998 398 SRS 
1999 – 2001 327 SRS 
2001- 2003 301 SRS 
2004- 2006 254 SRS 
2007- 2009 212 SRS 
*Based on indirect time series estimates 
 
India is one of the countries with high MMR though the recent estimates show 
sizeable decline from 1321 in 1957-1960 to 254 in 2004-2006 to 2012 in 2007-2009 
(SRS, 2006, SRS 2009, SRS 2011). Initially decline was faster compared to recent 
period, which is in line with the fact that as the estimates reach lower levels, it is 
difficult to maintain the same pace to take it down further. 
It is well documented that there are large disparities in the level of maternal 
mortality across states. Latest estimates of MMR, maternal mortality rates and life-
time risk are presented for India, Empowered action Group (EAG) states and 
Assam together, southern states and other states. EAG states are demographically 
backward states. The reason for the grouping is to highlight the differentials. EAG 
states are lagging behind in reproductive and child health related indicators and 
Southern states are well ahead. Remaining states are in-between. Assam is com-
bined with EAG states here because MMR of Assam is the highest in the country 
though it is not an EAG state. 
As regards MMR, during 1999-2001 there was increase in southern and other 
states however EAG states showed the declining trend. Share of maternal deaths 
for EAG states is much more therefore India estimate also shows the declining 
tend. For all other time periods, in general both MMR and maternal mortality rate 
are declining for all the subgroups. Both these indicators are sizably more for EAG 
states and least for southern states. 
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Life-time risk is defined as the probability that at least one woman of reproductive 
age (15 to 49 years) will die due to childbirth or puerperium assuming that chance 
of death is uniformly distributed across the entire reproductive span and has been 
worked out using the formula Life time risk = 1 – (1 - Maternal Mortality Rate / 
100000) 35 
 
Table 2 Maternal mortality ratio, maternal mortality rate and life-time risk for India 
and states subgroups, 1997 – 2009 
Year India EAG states and 
Assam 
Southern states Other states 
Maternal Mortality Ratio 
1997-1998 398 520 187 184 
1999-2001 327 461 206 229 
2001-2003 301 438 173 199 
2004-2006 254 375 149 174 
2007-2009 212 308 127 149 
Maternal Mortality Rate 
1997-1998 34.8 63.4 13.9 18.2 
1999-2001 31.2 57.8 15.3 19.2 
2001-2003 27.4 52.4 12.3 15.8 
2004-2006 20.7 40.9 9.3 12.7 
2007-2009 16.3 31.2 7.5 10.2 
Life-time Risk (in %) 
1997-1998 1.2 2.2 0.5 0.6 
1999-2001 1.1 2.0 0.5 0.7 
2001-2003 1.0 1.8 0.4 0.6 
2004-2006 0.7 1.4 0.3 0.4 
2007-2009 0.6 1.1 0.3 0.4 
 
As life-time risk is the function of maternal mortality rate, it behaves similarly. 
Slowly the risk is going down.  For southern and other group of states it has gone 
down but EAG states have to work more so that India figure would go down. The 
decline in the maternal mortality is also associated with decline in fertility (Bhat et 
al, 1995). It highlights the underlying fact that fertility decline of EAG states also 
needs attention. Once again it comes out that maternal mortality cannot be looked 
at in isolation. 
MMR 212 actually translates into huge figure of maternal deaths – over 55000 
a year, considering, in India approximately 26 million births take place in a year. 
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Ratio of maternal deaths to live births measures the risk of dying as a result of 
given pregnancy. Thus MMR 212 means that woman’s chance of dying each time 
when she becomes pregnant is 1 in 471. Her lifetime chance of maternal death  
depends on number of times she gets pregnant. Thus with the current TFR of 2.6, 
during lifetime, risk of maternal death is roughly 1 in 181 live births.  Though the 
decline in MMR is visible, it still has to go long way as it still has not reached 200, 
MDG for 2007 and is very far from 109 by 2015.  In order to reach the goal, pre-
cise identification of risk factors and its levels is necessary a step to plan the action 
strategies followed by its effective implementation.  
2.2 Levels of determinants of maternal death 
Share of causes of maternal mortality in India are hemorrhage 38 percent, sepsis 11 
percent, hypertensive disorders and obstructed labour 5 percent each, abortion 8 
percent and other conditions 34 percent (SRS, 2006). On this background, mater-
nal deaths can be reduced if the women receive proper ANC and deliveries are 
institutional, attended by health personnel conducted in aseptic conditions.  
 
Chart 1 – Causes of maternal mortality, India, 2006 
 
 
Similarly distribution of maternal deaths in India by timing of death shows that 
40.4 percent maternal deaths take place when woman is pregnant, 10 percent dur-
ing or after abortion, 15.4 percent during childbirth and 34.2 percent after 6 weeks 
of childbirth or at the end of pregnancy (Radkar and Parasuraman, 2007).  Antena-
tal and postnatal care would help reducing about three fourth of maternal deaths 
and other 25 percent by providing abortion and delivery care.  
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Chart 2 – Timing of maternal death, India, 2002-2004 
 
 
As discussed before, among the major risk factors of maternal mortality are, utili-
zation of health services before, during and after childbirth as well as the biological 
characteristics like age of the mother at the time of birth and birth order. Under 
reproductive and child health, apart from contraception a lot more emphasis has 
been given on all other aspects of safe sexual and reproductive practices. Repro-
ductive health encompasses a range of health concerns including the ability to go 
safely through pregnancy and childbirth and have best chance of having a healthy 
infant and the right of access to appropriate health care services as well as access to 
safe and affordable abortion facilities. Abortion is an area where getting infor-
mation in large sample surveys is difficult and in turn they are underreported. 
Whereas the data related to childbirth is comparatively easier to gather and is very 
useful as most of the maternal deaths are associated with births. The data would be 
analyzed by socio-economic characteristics of the women who have given birth in 
the reference period to capture the differentials. Among the socio-economic char-
acteristics, place of residence gives an idea about the accessibility of the services as 
also modern values, standard of living index captures the overall living standards of 
the household and wealth index portrays the economic condition. Education of 
woman is for awareness, perception and modernity whereas caste variable gives an 
idea about the accessibility and overall vulnerability. 
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2.3 Differentials by socio-economic level 
Table 3 portrays the extent of utilization of maternal health services as well as the 
share of births with selected biological parameters. Services include ANC and its 
components, whether the delivery is institutional or is attended by health personnel 
as also any postnatal care. To get clearer picture, based on the components of 
ANC, complete ANC is also presented. Complete ANC is defined as 3 Tetanus 
Toxoid (TT) injections, first antenatal visit in the first trimester, at least 3 visits and 
eating minimum 100 Iron and Folic Acid (IFA) tablets. If all this is followed, it is 
quite difficult to skip the complicated pregnancy and would definitely be referred 
for the delivery.  
Among the components of the ANC, TT injections are taken for more than 
half the births, followed by more than 3 visits (36.5 percent), early first visit (30.8 
percent) and then iron supplementation (10.7 percent). Extent of complete ANC is 
extremely low, just 7 percent. It is clear here that components of complete ANC 
individually are on lower side. Therefore combination of all is lower as expected. 
IFA consumption is making a dent on complete ANC, which is one of the major 
correlates of maternal health.  After that 39 percent deliveries are institutional 
whereas 47 percent deliveries are attended by health personnel like doctor, nurse or 
trained birth attendant. Less than half the women avail the assistance from health 
personnel at the time of delivery. If something goes wrong then women have to 
bear the consequences in terms of morbidity / mortality then or during postnatal 
period. In connection with maternal mortality, 42 days after delivery also are im-
portant. Postnatal checkup might bring out the complications during this period. 
As expected when ANC is not complete, very few would avail the postnatal 
checkup. Postnatal visit is reported in case of only 13.5 percent births. Postnatal 
checkup would be useful to arrest maternal deaths caused by infections, sepsis. 
However, attention is not paid towards postnatal visits which would bring out 
these complaints to the notice of health personnel. Utilization of the maternal 
health services is undoubtedly poor here.  
From maternal health point of view the births occurred in very young (i.e. be-
low 20) and old (35 and more) age are considered to be risky. This study shows 
that three fourth of the births take place in the right ages where a quarter are still in 
the danger zone. Births in the younger ages are because of low age at marriage and 
after 35 means higher fertility. Higher fertility means more pregnancies and thus 
more risk of maternal death. Biologically, the first birth as well as the births of 
higher order i.e. birth order 4 and more are considered as risky, whereas births of 
order 2 and 3 are relatively safe. Here 43.3 births fall in the safer category. Share of 
4 th or higher order births is over 26 percent. These births would affect maternal 
mortality statistics. 
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Table 3 Extent of utilization of health services and biological parameters of women 



















































































































































































































































































































































































































































































Total 53.6 36.5 30.8 10.7 7.4 38.7 46.6 13.5 74.7 43.3 
 
For all the socio-economic characteristics, the trend is clearly visible for every 
component of ANC, delivery practices and even postnatal care. Similar is the pic-
ture in case of biological parameters. Thus typically, women residing in rural areas 
having low living standards coming from backward castes and who are poor and 
illiterate are at the maximum of risk of maternal death. 
2.4 Maternal care and health problems 
Causes of maternal mortality include hemorrhage, sepsis, obstructed labour, hyper-
tensive disorders, abortion, toxemia, eclampsia and other conditions. If along with 
the ANC certain other tests are conducted then the women suffering or at least 
showing the symptoms of the above conditions can certainly captured and can be  
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referred and treated. Similarly if women are aware of the pregnancy complications 
and what needs to be done in these conditions also can help reducing maternal 
deaths. Information as collected in the NFHS – 3, has been compiled in Table 4. 
 
Table 4 Distribution of births by medical tests, ANC checkup and awareness about 
complications of mothers, 2005-2006 
 
Tests, checkup and awareness during pregnancy No. Percent 
During pregnancy - weighed 19356 34.3 
During pregnancy - blood pressure taken 19532 34.6 
During pregnancy – urine sample taken 17792 31.5 
During pregnancy – blood sample taken 18212 32.3 
During pregnancy given / bought iron tablets / syrup 25831 45.8 
ANC – Abdomen checked 22061 39.1 
ANC – Told expected due date 16539 29.3 
ANC – Advised to deliver in the hospital 16180 28.7 
ANC – Advised on pregnancy nutrition 20198 35.8 
Told about pregnancy complications 7521 13.3 
Told where to go for pregnancy complications 12588 22.3 
Alerted to pregnancy complications Vaginal bleeding 5093 9.0 
Alerted to pregnancy complications Convulsions 4714 8.4 
Alerted to pregnancy complications Prolonged labour 6149 10.9 
 
It is seen from Table 4 that only in about one-third of the births pathological tests 
are conducted and blood pressure measured whereas abdominal checkup has been 
conducted in 39 percent pregnancies. Iron supplementation is taken in 46 percent 
cases and nutritional awareness is created in 36 percent cases. When it comes to 
giving right information and alerting about the complications and danger signs of 
pregnancy, percentages suddenly drop. There seems to be no dialogue between 
health personnel and pregnant woman, which actually is necessary for woman to 
understand all this, especially if she is pregnant for the first time - which is risky, as 
well as she has no prior experience of childbirth. 
If women suffer from some problems or if they observe some symptoms they 
must actually report it to the health personnel and get the clarification and treat-
ment, whatever is required in the broader spectrum of maternal health. Because 
one can never understand whether these symptoms indicate something serious 
which need to be addressed immediately. It is also necessary to understand wheth-
er the safe delivery has been conducted or not as also whether the women had 
suffered after delivery. The data for such issues is complied in Table 5. It is by 
women who have specifically said ‘yes’ for the questions asked. 
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Table 5 Distribution of births by symptoms / health problems during pregnancy, 
care taken during childbirth and problems immediately after childbirth, 2005-2006 
 
Health problems during pregnancy, care 




Had difficulty with daylight vision 2497 4.4 
Had difficulty with night vision 3527 6.2 
Convulsions not from fever 4071 7.2 
Leg, body or face swelling 9971 17.7 
Excessive fatigue 18961 33.6 
Vaginal bleeding 1742 3.1 
During delivery 
Disposable delivery kit used 4800 8.5 
Clean blade used to cut umbilical cord 21353 37.8 
In first 2 months after birth 
Massive vaginal bleeding 4901 8.7 
Very high fever 5352 9.5 
 
During pregnancy about one-third reported to have excessive fatigue followed by 
swelling on legs, body or face (17.7 percent), convulsions (7.2 percent), night 
blindness (6.2 percent), difficulty with daylight vision (4.4 percent) and vaginal 
bleeding (3.1 percent). Any of these symptoms can lead to serious consequences, if 
ignored. During delivery it has been reported specifically that clean blade is used 
for 37.8 percent births and safe delivery kit used for 8.5 percent. In first two 
months after childbirth 9.5 percent women suffered from high fever and 8.7 per-
cent from massive vaginal bleeding. These postnatal problems of women need to 
be addressed on a priority because they can turn to be fatal. Many a times, women 
get less importance after the childbirth as focus then shifts from woman to the 
child. 
2.5 Reason for not using health facility for delivery 
Service delivery is not very efficient which also is reflected in the utilization. 
Among the total births 61.3 percent are not conducted in health facility. To under-
stand the view point of the users, information about the reasons of not delivering a 
child in the health facility is collected in the NFHS–3. In case of over 72 percent 
births the reason mentioned is ‘not necessary’ and in 6 percent cases it is ‘not cus 
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tomary’. In about 6 percent cases family did not support for the institutional deliv-
ery. In all these cases there is a need to increase awareness of advantages of institu-
tional delivery in terms of health of the mother and the newborn, especially in case 
of complications, in case emergency obstetric care is required. 
Most other reasons talk about the problems in institutional delivery. Major one 
among them is the associated costs (26.2 percent) followed by facility is far and 
there is no transport available (11 percent). Others include the functioning / tim-
ings of the facility (3.4 percent), unavailability of female doctor (1.1 percent) and 
the trust about the system (2.6 percent). These are the ground realities in utilization 
of services need to be addressed when one really wants to reduce maternal mortali-
ty. 
 
Table 6 Distribution of not institutional births by reason of not delivering in the 
health facility, 2005-2006 
 
Reason for not delivering in the 
health facility 
No. Percent * 
Cost too much 6066 26.2 
Facility not open 788 3.4 
Too far / No transport 2550 11.0 
Don’t trust facility 613 2.6 
No female provider 264 1.1 
Husband/family did not want 1371 5.9 
Not necessary 16627 71.8 
Not customary 1467 6.3 
Other 726 3.1 
* - Percentages will not add up to 100 because of multiple responses  
 
2.6 Nutritional status in pregnancy 
During the NFHS – 3, 6429 women (5.2 percent of women in reproductive ages) 
were pregnant. Among these 1631 were in first trimester (25.4 percent), 2470 in 
second trimester (38.4 percent) and 2328 were in third trimester (36.2 percent). 
Lesser number in first trimester could be attributed to poor registration rates in 
early pregnancy (Kapoor et al, 1996) or not being aware of the pregnancy. In Indi-
an setup, there is also a culture that women do not reveal pregnancy in the initial 
stages, especially to outsiders. 
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Table 7 Percent distribution of pregnant women by stages of pregnancy and body 




Underweight Normal Overweight Obese Total 
First trimester 65.4 31.6 1.9 1.1 1559 
Second tri-
mester 
44.1 50.9 3.8 1.2 2393 
Third trimester 20.8 70.7 6.0 2.5 2206 
Total 41.1 53.2 4.1 1.6 6158 
 
Data on the BMI as provided in the NFHS – 3 has been analyzed and presented in 
Table 7 by the trimester of pregnancy. BMI categorization for pregnant women is 
different than that of the categorization for not pregnant women, considering the 
allowance for expected weight gain during pregnancy. As per the standards, BMI 
upto 19.8 is underweight, between 19.9 and 25.9 is normal, between 26 and 29 is 
overweight and above 29 is obese (Institute of Medicine, 1990).  Among the 6429 
pregnant women height and weight is measured for 6158 women (95.8 percent), of 
which, 2533 (41.1 percent) are underweight, 3269 (53.1 percent) normal, 255 
overweight (4.1 percent) and 101 (1.6 percent) obese. Little over 50 percent preg-
nant women have normal BMI and the remaining are malnourished as per BMI 
classification. Of the malnourished, 41 percent are undernourished and only 6 
percent are over-nourished. Table 7 shows proportionately more women in the 
category of underweight for first trimester. This is the early phase of pregnancy 
and weight gain during this trimester could usually be less compared to other two. 
It is also possible because the special BMI categories of pregnant women are ap-
plied; number of first trimester women falling under the underweight category is 
more. However, share of underweight women gradually goes down as pregnancy 
advances. 
 
Table 8 - Percent distribution of pregnant women by stages of pregnancy and ane-
mia status, India, 2005 – 2006 
 
Stage of pregnancy Anemia No anemia Total 
Severe Moderate Mild 
First trimester 1.8 20.6 23.1 54.5 1542 
Second trimester 2.1 29.7 29.0 39.2 2346 
Third trimester 2.7 38.8 24.3 34.2 2140 
Total 2.2 30.8 25.8 41.2 6028 
 
To assess the nutritional status other more reliable indicator is biochemical param-
eters. The NFHS – 3 provides blood hemoglobin levels, which is used here to 
explore the prevalence of anemia. It is seen that 55.2 percent of all women in the 
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ages 15 to 49 years are anemic, whereas, prevalence of anemia among pregnant 
women is 58.8 percent. Categorization as per WHO classification of anemia is as 
follows. Hemoglobin level below 7 g/dl is severe anemia, between 7 g/dl and 9.9 
g/dl is moderate and between 10 g/dl and 11.9 g/dl is mild. Hemoglobin level 
above 12 g/dl is normal. It is seen that as pregnancy advances anemia increases. 
About 2/3 rd pregnant women are anemic in third trimester and in about 42 per-
cent cases anemia is either severe or moderate. Risk is more for this group though 
not perceived so. How underweight and anemic women would sustain the preg-
nancy and give birth to the healthy child when they themselves are not healthy. If 
things go wrong, in case of hemorrhage, will they be able to survive maternal 
death? 
3 Conclusions 
Globally, more than half a million women die each year because of complications 
related to pregnancy and childbirth. About half the maternal deaths occur in sub-
Saharan Africa alone and one third in South Asia. Causes of these deaths are hem-
orrhage -leading cause, sepsis, prolonged or obstructed labour, the hypertensive 
disorders of pregnancy, especially eclampsia, and complications of unsafe abortion. 
Goals for MMR for India are 109 by 2015 as set in MDGs and 100 by 2012 as in 
National Rural Health Mission (NRHM). According to the estimates by Murthy 
(2008) based on regression models, MMR 200 could be reached only by 2014-15 
and 109 by 2024-25 if this pace prevails. 
Maternal mortality is an important indicator of health of women and is also in-
dicative of the performance of health care systems. Levels of maternal mortality 
often reflect the overall performance of a country's national health system - partic-
ularly during pregnancy, delivery and in the postnatal period. It has come out from 
this data set also that if maternal health care delivery is efficient maternal deaths 
would go down. Service delivery is also reflected in fertility through contraceptive 
use. More the unmet need more the unwanted births and thus higher risk of ma-
ternal deaths. In all the developing countries infant as well as maternal mortality is 
high and their determinants are also same. Decreasing the level of risk factors can 
control both maternal and infant mortality. Reduction in infant mortality would get 
reduction in fertility and reduction in fertility would get down maternal mortality. 
Socio-economic status of women is strongly associated with maternal health. 
Thus increased awareness of components of maternal health and their utilization 
by women from the lower strata, would help reducing maternal deaths. Services 
should be provided typically to rural, poor, not educated women from backward 
castes of the society. Same is true with the states of India. Differentials in maternal 
mortality among the states are because of the differentials in development. 
Apart from health care service delivery, biological variables like age of the 
mother at the time of birth and birth order also play important role in explaining 
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the risk of maternal death. Similar is the case with anemia level and BMI. To sus-
tain the blood loss during and after childbirth woman should not be suffering from 
anemia. The situation is otherwise, as about 60 percent of women are anemic dur-
ing pregnancy in India. This really goes against maternal health. Underweight as 
well as overweight women suffer from associated maternal health problems. They 
are undoubtedly risk factors of maternal health. 
Maternal mortality also has its importance from child health point of view – in 
case of maternal death, life / health of the child is also at risk. Maternal deaths 
would go down for sure if the services during pregnancy and during and after 
childbirth improve. Every pregnancy has to be tracked, checkup along with patho-
logical tests should be conducted and nutritional awareness should be created. 
Complications during pregnancy and childbirth are unforeseen and can happen any 
time. Therefore its awareness, right perception and knowledge about necessary 
action to be taken then should be made universal as every life – of both mother 
and child - is valuable. 
4 The way forward 
Recognizing the importance of Health in the process of economic and social de-
velopment and improving the quality of life of our citizens, Government of India 
resolved to launch the NRHM to carry out necessary architectural correction in the 
basic health care delivery system. The Goal of the Mission is to improve the avail-
ability of and access to quality healthcare by people, especially for those residing in 
rural areas, the poor, women and children. It has made an impact in 5 years with 
the innovations like Janani Surksha Yojana (JSY) – cash incentives for poor and 
backward caste women and Appointment of ASHA for 1000 population.  These 
initiatives would certainly improve maternal health scenario in India. Both morbid-
ity and mortality would go down but such data is not available as yet. 
Historical evidence of developed countries suggests that significant decline in 
maternal mortality has been coincided with use of antibiotics, blood transfusion 
and management of hypertensive disorders of pregnancy. India still lacks in these 
interventions during pregnancy and childbirth. Undoubtedly a major factor which 
determines the pregnant women’s risk of death is the lack of access to well-
equipped health care services.  
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12 Neonatal infection in resource-limited countries 
Mercy J. Newman, Christabel C. Enweronu-Laryae and Nicholas T.K.D. Dayie 
Infections are a major cause of neonatal morbidity and mortality in low resource 
countries especially in sub-Saharan Africa. In this chapter we present an overview 
of neonatal infections and discuss challenges for interdisciplinary research. 
1 Introduction 
It is estimated that over three quarters of the global population live in the low and 
middle income countries in Africa, Asia and Latin America and the other one quar-
ter of the population live in the industrialized countries. There are major differ-
ences between the two groups, including wide differences in economic status and 
also maternal and child mortality rates. For example, World Health Organization 
(WHO) estimates maternal mortality ratio as 900 per 100,000 live births in sub-
Saharan Africa, about 100 times the ratio of the resource-rich countries which is 9 
per 100,000 live births (WHO, 2005).  
Neonatal mortality is defined as the number of babies dying in the neonatal pe-
riod (first 28 days of life) per 1000 live births. In Europe it is 11 per 1000, while in 
Africa it is estimated to be 44 per 1000 live births (Seale et al, 2009). Neonatal 
mortality is about 34% in Asia and 17% in Latin America. There are wide varia-
tions between countries in these regions as well as within the countries (Vergnano 
et al, 2005). For example in Africa neonatal mortality ranges from 11% in South 
Africa to 68% in Liberia (Costello et al, 2001). Table 1 shows the contribution of 
the majors causes of neonatal deaths in different regions. 
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In countries with high neonatal mortality, approximately 34% of all neonatal death 
are due to infections including diarrhea and pneumonia (Lawn et al, 2005, Lawn et 
al, 2008). Three-quarters of these infections occur within 7 days of birth. These 
early infections in newborns are closely related to maternal infections especially 
when there is inadequate perinatal care. In resource-limited countries, there are 
several gaps in the continuum of care of pregnant women. These gaps may be in 
antenatal care, delivery and postnatal care and may be related to socio-economic 
factors, lack of health facility or unskilled health care personnel. These gaps in the 
continuum of care adversely affect newborns and impact on early identification or 
appropriate treatment of early neonatal infections.  
Many newborns delivered in Asia and sub-Saharan Africa are not born in 
health facilities. Poor hygienic practices during the delivery process and traditional 
practices with regards to birth and care of the newborn increase the risk of infec-
tion in newborns delivered at home. In a study by Penfold et al on home delivery: 
women reported that only half of the attendants washed their hands with soap and 
water. The cord may be cut with unsterilized razor blade and tied with a piece of 
cloth, substances may be put on the cord to help healing (Penfold et al, 2010). All 
these factors could adversely affect the baby. 
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           a Extracted from Black RE et all, Lancet 2010; 275:1969-87 
 
Golbal Health – A Challenge for Interdisciplinary Research 
 
135 
2 Aetiology of neonatal infection 
Sepsis in neonates may be classified into three groups; congenital, early-onset and 
late-onset. Each group may have specific causative organisms. They could also be 
classified as viral, bacterial, fungal and others including congenital malaria. Al-
though sepsis can occur in any infant, it is more commonly associated with pro-
longed rupture of membranes, maternal infection and pre-term newborns. 
3 Congenital infections 
Congenital infections are very closely associated with maternal infection during 
pregnancy. TORCH is an acronym for a group of infections with a recognized 
pattern of clinical manifestations that could be acquired during pregnancy with 
devastating consequences for the infant. These are toxoplasmosis, rubella, cyto-
megalovirus (CMV) and Herpes simplex. In addition other infections like syphilis, 
varicella zoster, parvovirus, malaria, and HIV are also important especially in Afri-
ca.  
A study in the Gambia found 14% of babies infected with CMV, although 
87% of the mothers were antibody positive (Bello et al, 1991). In malaria endemic 
areas, up to one quarter of newborns may have parasitaemia. Fischer et al found 
7% of newborns had congenital malaria (Fischer, 1997).  
4 Early-onset sepsis (EOS) 
Few studies differentiate between early and late-onset infections (Vergnano et al, 
2005), but differentiation is important since early onset neonatal infection is more 
likely to be due to vertically transmitted infection from the mother (Penfold et al, 
2010). Risk factors for EOS are prematurity, premature rupture of membranes, 
chorioamnionitis, low birth weight and difficulties at delivery (e.g. obstructed la-
bour). Some of the risk factors for early onset neonatal bacterial sepsis in sub-
Saharan Africa are probably similar to those described in resource-rich settings, but 
in low-income countries the problem may be more complex since other factors 
like HIV, maternal undernutrition and placental malaria come into play (Seale et al, 
2009).There is paucity of published data on the etiology of early-onset disease in 
resource-limited countries due to lack of reliable microbiological data (Lawn et al, 
2005). Available data are often from single tertiary health facilities and these cannot 
be extrapolated to the general population. 
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5 Late-onset infections 
The source of late-onset infection is either nosocomial or community acquired; it 
usually presents as septicaemia, pneumonia or meningitis. Clinical features of septi-
caemia and meningitis may often overlap. These infections are due to common 
hospital organisms like coagulase negative staphylococci, Enterobacteria, viruses 
and fungi. Infections are common in babies with central lines and may be associat-
ed with prematurity, mechanical ventilation and admission to intensive care units. 
Community infection is associated with poor hygiene, poor cord care, and bottle 
feeding .The microorganisms vary in the different studies. Most reports on blood 
stream infections are mainly from individual health facilities and therefore cannot 
be accepted as national statistics. Table 2 shows common causative organisms 
from different countries. 
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6 Infection control 
Overcrowding is a common feature of newborn units in low-resource countries. 
This is mostly because few health facilities provide basic skills and equipment for 
the care of newborns. Cross infection is common because inadequate facilities for 
hand hygiene and shortage of staff. A few cases of outbreak of infection had been 
reported from intensive care units in Africa. In Ghana an outbreak of infection 
due to multidrug resistant Salmonella occurred in the neonatal intensive care unit 
(NICU) at a time when the ward was overcrowded with babies and cots were prac-
tically touching each other (Newman, 1996). 
The price of overcrowding in a neonatal facility is nosocomial infection be-
cause of the breakdown of standard operating procedure and quality control that 
result from overcrowding. It had been estimated that about 85% of all NICU sur-
faces will grow nosocomial pathogens (Chandrashekar et al, 1997). A South Kore-
an study reported that cumulative incidence rates were 30.3 and they also had 44.6 
infections per 100 admitted neonates (Jeong et al, 2006). An environmental study 
to determine the types of microorganisms in a NICU in Ghana showed that gram 
negative organisms known to cause nosocomial infection including Eschericia coli 
and Pseudomonas aeruginosa were found in the environment and on equipment in 
the ward (Newman, 2002). 
Although implementing infection control activities is challenging in developing 
countries because of the limited resources, they are nevertheless important for 
safety of patients and ultimately save resources. Hand hygiene is the simplest and 
most effective measure for prevention of hospital infection; sometimes compliance 
may be very low. In a study in Accra, Ghana, compliance to hand hygiene proce-
dures occurred in only 12.2% of high risk contacts (Asare et al, 2009). In addition 
to washing hands before and between handling babies it should also be done after 
handling any potentially contaminated objects like pens and telephones. Lack of 
time, understaffing and overcrowding are some of the reasons why health care 
staff may not comply with hand hygiene procedures. 
7 Laboratory services 
There is shortage of well equipped laboratories and skilled biomedical scientists in 
resource-limited countries. Some university hospitals and large private hospitals in 
capital cities may have well equipped laboratories. The laboratories in smaller re-
gional and district hospitals may have the capacity for general chemistry, haema-
tology and microbiology. Those in rural settings lack these facilities (Okeke et al, 
2006). Automation in chemistry and haematology makes it relatively easier to pro-
cess specimens, but performing culture, identification and sensitivity tests for bac-
teria may sometimes present problems due to shortage of good quality reagents 
and sensitivity discs. Equipment for the anaerobic culture may not be available 
even in the best equipped laboratories. Even when all requirements are available, 
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lack of trained technical staff and the inability of staff to use standardized tech-
niques, is another hurdle to be surmounted before appropriate results can be pro-
duced. These challenges make it difficult to determine accurate local susceptibility 
patterns of common infective agents. Without this information, it is difficult to 
select the most appropriate drug for empirical treatment. Therefore selection of 
antimicrobial agent for empirical treatment is not evidence-based. 
In Ghana, for majority of patients in the rural areas, the nearest laboratory may 
only perform blood smears for malaria, haemoglobin levels for anaemia and stool 
microscopy for parasites. When culture and sensitivity is required, patients have to 
be referred to regional hospitals. This may cause some delays and sometimes pa-
tients may be too poor to make the journey. 
8 Antibiotic susceptibility 
It is well known that selective pressure from antimicrobial drug use leads to devel-
opment of resistant strains. The WHO in 2001, developed a global strategy for 
containment of antimicrobial resistance (WHO, 2001). The interventions include 
creating a national task force, developing indicators to monitor and evaluate the 
impact of antimicrobial resistance and designing reference microbiological facilities 
that would coordinate effective surveillance of antimicrobial resistance among 
common pathogens. Unfortunately, most low resource countries have not imple-
mented these recommendations.  
To collect specimens, culture, identify and do sensitivity tests before treatment 
is almost impossible for most neonatal infections in low resource countries. Em-
pirical treatment with broad spectrum antibiotics is common practice. Therefore, 
even susceptible infections may be treated with broad spectrum and more expen-
sive drugs. In addition, there is patient pressure for antimicrobial prescriptions for 
even non-bacterial diseases. Finally, control of access to drugs is so weak that pa-
tients can buy drugs from pharmacies and drug stores without prescriptions, fur-
ther aggravating the problem of multiple drug resistance. In a nation-wide study 
from Ghana, (Newman et al, 2011) reported that, the presence of multidrug re-
sistance was widespread among different types of bacteria including strains of 
common infective agents like Staphylococcus aureus, Salmonella species, Esche-
richia coli and Streptococcus species. 
9 Management of neonatal infections 
Tests for investigation of infection in neonates include surface swabs, white cell 
count, culture of body fluids including blood, cerebrospinal fluid, and urine. Other 
tests are radiological investigations and other biomarkers of infection. The use of 
surface swab is not as important as it used to be. Some recent studies had conclud-
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ed that surface swab microbiology contributes little if anything to postnatal man-
agement (Zbinden et al, 2011)  
In well resourced countries neonatal sepsis is usually investigated but in devel-
oping countries early detection of infection is challenging. Sometimes parents and 
inexperienced health care providers may miss subtle signs of infection such as 
irritability, lethargy, and temperature instability (Ganatra et al, 2010).  Delay in early 
diagnosis may also occur because families may be reluctant to seek care outside the 
home in the early neonatal period because of local custom or superstition. 
The majority of neonatal infections are unlikely to be investigated. As suggest-
ed by Newton, when the aetiological agent is not known, it can be assumed that 
gram negative organisms are likely to be the causative agent in hospital and gram 
positives are likely in the community, this assumption can be used to tailor empiri-
cal treatment to site of infections (Newton, 2007). Scarce data from community 
sources poses a challenge for community-based treatment guidelines (Thaver et al, 
2009). 
10 Challenges to reducing the burden of neonatal infections 
It is not new knowledge that infections are the single most important contributor 
to the high morbidity and mortality of newborns in Africa and other low-resource 
regions. However, there remain major perennial challenges in preventing, diagnos-
ing and treating neonatal infections. Socio-cultural factors and inefficient health 
systems in these countries further complicates the situation. In this section we 
attempt to highlight these challenges and make suggestions for interdisciplinary 
research.  
11 Prevention of neonatal infections 
Prevention of infections in the newborn should be the goal. Though this may not 
always be possible, comprehensive continuum of care for maternal and newborn 
services could significantly reduce the burden of neonatal infections and other 
causes of neonatal mortality (Bhutta et al 2005, Darmstadt et al 2005). A compre-
hensive continuum of care intervention requires a health system that would pro-
vide essential facilities and logistics including continued health education for health 
care workers, mothers and the community at large. Though such programs do not 
presently exist in most of sub-Saharan Africa it has the potential to significantly 
reduce congenitally acquired neonatal infections, improve antenatal uptake of teta-
nus vaccination and prevent infestations like malaria (Osrin et al 2004). 
Implementing good hygienic practices in newborn nurseries and at birth irre-
spective of where the birth occurs remains a challenge. Such quality care is not 
only dependent on the availability of water, soap, gloves and clean equipment but 
also requires change in the attitude of health care workers to hand hygiene 
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(O'Boyle et al 2001, Maue S et al 2004). Promoting use of alcohol-based hand rub 
is a plausible option (Wisniewski et al 2007) but there are cost implications that 
may affect sustainability of the intervention in low-resource communities. 
Exclusive breast feeding reduces neonatal infections (Løland et al 2007). This 
effect is not only due to the anti-infective properties of human milk but it also 
reduces the exposure of the newborn to feco-orally transmitted pathogens. Pro-
moting exclusive breast feeding in affluent and rural communities remains a chal-
lenge (Gilmour et al 2009, Burns et al 2010). Unfortunately, rural communities 
usually lack clean water and adequate sewage disposal systems such that newborns 
are exposed to high risks of infection when given water to drink. 
Changing traditional and cultural beliefs and practices pertaining to childbirth 
and the newborn is somewhat a herculean task. Changing community attitudes to 
these beliefs and practices will increase facility-based births, promote early referral 
of sick newborns and reduce traditional practices that put newborns at risk of in-
fection (Thairu et al 2008, Agrawal et al 2006). 
12 Diagnosis of infection in the newborn 
Newborns are unable to mount adequate immunological response to infection; 
therefore early diagnosis of neonatal infections is a crucial step to reducing the 
burden of neonatal mortality. Early recognition that something is amiss in the 
newborn is a skill that is lacking in the community and among frontline health care 
workers (Choi et al 2010, Brousseau et al 2006). There are no pathognomic clinical 
signs for neonatal infection. Though fever is a significant sign, a common cause of 
low grade fever during temperature assessment in outpatient departments in Afri-
can newborns is overwrapping with layers of clothing. 
There has been extensive research on early markers of neonatal infection in 
developed countries (Ng et al 2010, Vouloumanou et al 2011, Popowski et al 
2011). However, many health facilities in rural and even urban settings in Africa do 
not have the capacity to do basic laboratory investigations. Clinical recognition of 
illness in the newborn remains a vital tool for diagnosis in these settings. Algo-
rithms for identification of illness in the newborn are needed (Mullany et al 2006, 
Bang et al 2005, World Health Organization 2003). The effectiveness of these 
clinical tools in sub-Saharan Africa rural settings needs evaluation and if found to 
have significant predictive value the use of these tools should be scaled up. Innova-
tive ways to diagnose infection in newborns in low-resource settings are urgently 
needed. 
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13 Treatment of neonatal infections 
Evidence-based choices for antimicrobial drug use in specific geographical loca-
tions at all times would be ideal. Appropriate use of antimicrobial drugs requires 
good knowledge of local flora and drug susceptibility. Unfortunately, choices for 
antimicrobial use in many low-resource countries are based on data from large 
tertiary health facilities in that country or developed countries. Few studies have 
examined the aetiology and drug susceptibility of pathogens causing neonatal infec-
tions in rural settings (Zaidi et al 2009). 
Effective treatment of neonatal infections requires quality drugs that are avail-
able and affordable at all levels of health care delivery including rural populations. 
Few drugs meet these criteria. Even though gentamicin, ampicilin and penicillin are 
widely available and affordable and have been recommended by the World Health 
Organization, many bacterial pathogens are now resistant to these drugs (Thaver et 
al 2009, Darmstadt et al 2009). Also, these drugs are given parenterally such that 
skills required for their administration may be lacking at the point of need in the 
community. The bioavailability of orally administered antimicrobials in the new-
born is uncertain and requires more research (Darmstadt et al 2009). 
14 Health systems and the neonatal health 
The World Health Organization defines a good health system as one that “delivers 
quality services to all people, when and where they need them...provides a robust 
financing mechanism; a well-trained and adequately paid workforce; reliable infor-
mation on which to base decisions and policies; well maintained facilities and logis-
tics to deliver quality medicines and technologies” (WHO 2010). Such a system 
defends the population against what threatens its health and protects them against 
the financial consequences of ill-health. It also provides equitable access to health 
services and involves the community in decision making. Health systems in Africa 
are woefully deficient in meeting these criteria. Where good systems exist newborn 
health services are not usually given the priority it deserves. 
15 Interdisciplinary research 
The mystery of tradition, spirituality and science intertwine neonatal health in Afri-
ca. While this remains a significant underlying factor for the slow progress in im-
proving newborn health in Africa it is also a goldmine for interdisciplinary re-
search. 
If social scientists could improve our understanding of cultural beliefs and 
practices about pregnancy, childbirth and neonatal illness, implementation scien-
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tists and policy researchers would be able to come out with interventions that best 
suit a community. Research into methods of teaching and the curriculum for front-
line health care workers especially at the primary level of care is needed. Medical 
education researchers could work with social scientists and psychologists to design 
training programs that enable health care workers to apply knowledge to practice 
with the right attitude to newborn care. 
A seamless link between community and facility health services for maternal and 
newborn health in the context of continuum of care is urgently needed. Public 
health researchers need to work with all stakeholders to make this a reality. Re-
search into this area of public health delivery is urgently needed to guide policy. 
Laboratory scientists, the pharmaceutical industry and clinicians need to find 
simple, cheap and sensitive markers of neonatal infection that can be used in rural 
settings to identify affected newborns before they develop overwhelming sepsis. 
Safer simpler effective ways of delivering antimicrobial drugs that are bioavailable 
without the use of parenteral injections in rural settings are needed. 
16 Conclusion 
Neonatal infections are a major threat to achieving the fourth MDG by 2015 in 
low-resource countries. Even though complex factors underlie this disease, con-
certed efforts by all involved in the formulation and delivery of health care can 
overcome this challenge if we work in tandem. 
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13 Reducing child and maternal undernutrition  
in the context of  food security programmes – 
ongoing activities of  FAO 
Hartwig de Haen 
1 Introduction 
In spite of much progress in economic development in many parts of the world, 
child and maternal undernutrition still take a terrible toll on societies of many de-
veloping countries.  
I will first briefly recall the quantitative order of magnitude of the global prob-
lems. I will then provide some information about current international efforts, 
mainly within the United Nations system, to reduce hunger and malnutrition 
among children and mothers. My focus will be on actions taken in the broader 
context of programmes that seek to achieve food security. I will specifically refer to 
initiatives involving the Food and Agriculture Organization (FAO) of the United 
Nations. I am grateful to my former colleague, Ms. Ellen Mühlhoff in FAO’s Nu-
trition and Consumer Protection Division, for relevant information, in particular 
about current programmes of FAO in the field of nutrition. 1  
                                                     
1 For more information about FAO’s Nutrition and Consumer Protection programmes see: 
http://www.fao.org/food/human-nutrition/en/ 
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2 Food security and nutrition situation 
Regarding the extent of hunger and malnutrition in the world, available indicators 
give us orders of magnitude, but we do not know with a high degree of accuracy 
how many people are suffering, who they are, where they live and what the specific 
expressions and causes of their nutrition problems are.  Indeed, measurement and 
assessment is an area requiring more research2. Fortunately, the anthropometric 
measurements of nutritional status of children and mothers are relatively more 
reliable than some of the other indicators. 
Notwithstanding the need to improve the indicators, we can summarize the 
current state of food and nutrition insecurity as follows: 
 
• Many developing countries are currently experiencing a nutrition transition. Life-
styles are becoming more urban and sedentary with foods and drinks being 
more energy-dense and diets containing more processed foods, sugars, fats and 
animal products. The result is a triple burden of malnutrition3 : one part of the pop-
ulation is still chronically undernourished; many suffer from deficits of specific 
nutrients, in particular micro nutrients, whereas others are overweight. 
• According to available estimates, close to one billion people are chronically undernour-
ished. Their regular food intake does not cover the food energy required for an 
active and healthy life.  
• Almost 13 million children are born annually with low birth weight, due to poor mater-
nal nutrition.  
• Micronutrient malnutrition or “hidden hunger” affects over 30% of the world 
population4 . The consequences in term of diseases are serious. Just to mention 
some: Iron deficiency is affecting between 40 and 50% of pregnant women and 
preschool children in developing countries, causing retarded physical and cog-
nitive development of children and 20 percent of all maternal deaths. An esti-
mated 250 - 500 000 children become blind every year due to vitamin A deficiency. 
About 15% of people in developing countries lack adequate iodine, causing vari-
ous degrees of mental impairment.  
• On average, more than 12000 children die every day from weakness or diseases, 
which they would most likely survive if they were better nourished.  
                                                     
2 A recent publication by colleagues from two Departments at the University of Göttingen (respec-
tively de Haen and Qaim, Agricultural Economics and Rural Development, and Klasen, Economics) 
provides an overview and evaluation of relevant indicators: H. de Haen, Klasen, S. and Qaim, M.: 
What do we really know? Metrics for food insecurity and undernutrition. Food Policy Vol.-36 (2011) 
pp. 760-769 
3 Per Pinstrup Anderson, Understanding the Interactions between Agriculture and Health. IFPRI 
2020 panel discussion, Washington October 2010 
4 WHO, http://www.who.int/nutrition/topics/vad/en/ 
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• Two thirds of the world’s population is reported to live in countries where 
overweight and obesity kills more people than underweight5. According to 
WHO, nearly 43 million children under five were overweight in 20106. Overweight is the 
result of a combination of consumption of more highly refined and energy 
dense foods and lack of physical activity. It is associated with various non-
communicable diseases. These numbers underline the need to fight undernour-
ishment as well as overweight and obesity. 
 
What is so alarming is the fact, that poor foetal growth and child stunting can have 
an irreversible impact and perpetuate poverty if they are not addressed in early 
phases of life. They reduce young people’s physical and mental capacity which in 
turn impact negatively on health status and life-long income earning potential. 
Moreover, undernutrition passes from one generation to the next as maternal un-
dernutrition increases the risk of intrauterine growth restriction and low birth 
weight as a life-long handicap.  
Unless decisive remedy action is taken, the number of hungry people may be growing 
further in the foreseeable future.  
3 Joining forces to protect and improve nutrition 
FAO promotes food-based approaches to reducing undernutrition and micronutri-
ent deficiencies as part of broader strategies towards sustainable food and nutrition 
security.
 7 
Although food and nutrition problems are complex and action to overcome 
them cannot be limited to agriculture alone, the sector plays a fundamental role in 
their solution. This is so for two reasons: firstly, adequate food from domestic 
sources is essential for good nutrition and, secondly, the food and agriculture sec-
tor is the main source of employment and livelihood for the majority of the poor 
and undernourished worldwide. While urbanization is advancing more than two 
thirds of the poor are still rural people. 
According to the World Food Summit of 1996, food security exists when all 
people, at all times, have physical and economic access to sufficient, safe and nutri-
tious food to meet their dietary needs and food preferences for an active and 
healthy life. This definition depicts the entry points for nutrition interventions 
which may be any of the following four pillars of food security: 
                                                     
5 Ricardo Uauy, Measures of Overnutrition/Obesity. Paper presented at workshop on Measuring Food 
Insecurity and Assessing the Sustainability of Global Food Systems, organized by the national Acad-
emies, Washington, 15-16 February 2011 
6 World Health Organization, Obesity and overweight, Fact sheet N°311, March 2011  
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1 Supply of food: examples include diversification of farming systems, home 
gardens, bio-fortification of plant varieties with special micro-nutrients 
such as Vitamin A and post-harvest loss reduction.   
2 Access to food: examples range from general measures to reduce poverty to 
very specific ones such as school feeding. 
3 Stability of access:  examples include any actions that help to have a stable in-
come flow or entitlements to food assistance.  
4 Intra-household utilization of food: examples range from nutrition education to 
improving clean water supplies and household hygiene 
 
Very often, under- and malnutrition are not only a consequence of poverty, but 
also its major cause. Accordingly, FAO emphasizes the importance of twin-track 
strategies which comprise, on the one hand, longer-term investment in sustainable 
productivity growth benefiting in particular the smallholders in rural areas, and, on 
the other hand, social safety nets which ensure that even in times of particular food 
scarcity, the neediest, including especially elderly poor, children and their mothers, 
are given immediate access to essential food and basic social services, including 
health, water and sanitation. 
Together with WHO, FAO also has programmes to help countries enhance 
food safety and quality along the food chain and thus reduce the still heavy burden of 
food borne disease. There are two basic approaches through which the nutrition of 
mothers and children can be improved: one consists of general programmes that 
seek to improve the food security of all population groups; the other is a set of 
programmes targeted specifically on mothers and children. 
Generally, under-  and malnutrition must be addressed through integrated food 
and nutrition security, public health and social protection approaches, as acknowl-
edged by the UN Standing Committee on Nutrition at its High-level meeting in No-
vember 2009. The SCN calls for Government institutions, UN agencies, NGOs 
and CSOs to join efforts at regional, national and local level. 
It is in this spirit that FAO is an active partner in a number of recent initiatives 
addressing very specifically nutrition problems, including maternal and child nutri-
tion. These might be of special interest to the Göttingen International Health 
Network being launched today. Let me briefly list a few: 
 
1. The REACH Initiative (Renewed Efforts Against Child Hunger) has been endorsed in 
2008 by FAO, WHO, UNICEF and WFP.  REACH facilitates joint action at 
country level to reduce under-five child malnutrition in the context of MDG1. 
FAO is currently involved in 24 UN Joint Programmes (UNJPs) for the the-
matic window Children, Nutrition and Food Security.  These are funded by the 
UNDP/ Spain Fund for the Achievement of the Millennium Development 
Goals. 
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2. FAO also contributes to the Scaling-Up Nutrition (SUN) movement, a collaborative 
process including governments, academia, research institutions, civil society, the 
private sector, UN organizations and the World Bank. SUN addresses the con-
tinuing high levels of under-nutrition and the uneven progress towards the 
MDGs. The SUN roadmap provides practical guidelines for joint action to be 
adapted on a country-by-country basis.  
 
3. International Conference on Nutrition – 20 years later (ICN+20). To give new impetus 
to political action and commitment to ending hunger and malnutrition, FAO 
and WHO have decided to jointly convene a second International Conference 
on Nutrition, twenty years after the first ICN was held in 1992.  The ICN+20, 
to be held in Rome in 2012 will review progress in efforts to address global nu-
trition problems, identify emerging challenges, recommend actions and  mobi-
lize the political will and resources necessary for achieving the nutrition-related 
MDGs.  
 
4. A programme funded by Germany aims to improve dietary intakes and nutri-
tional status of infants and young children through improved food security and 
complementary feeding counselling. One important set of activities under this 
programme are “Trials of Improved Practices” (TIPs).  
 
5. TIPS stands for feeding recommendations that have been developed and tested 
through a participatory research process, which uses several quick, interactive infor-
mation-gathering methods with family members, especially mothers and other 
key people. FAO has been using it to promote improved complementary feed-
ing in Afghanistan, Cambodia, Laos and Zambia. Families learn how to enrich 
young children’s diets using locally available nutrient-dense foods. To date, the 
results suggest that families are very interested. However, they also face major 
constraints of seasonal food scarcity and lack of affordable sources of micronu-
trient-rich foods.  
 
6. The German Ministry of Food, Agriculture and Consumer Protection 
(BMELV) is funding a three year research project to study the impact of joint food 
security and complementary feeding interventions for children, 6-23 months of age, in 
two countries, Malawi and a country to be chosen in Asia. The objectives are to 
improve our understanding of combining behaviour change communication 
with crop and dietary diversification and learn under which conditions im-
proved complementary feeding practices will be sustained over time. The re-
search is being undertaken through a partnership with the Institute of Nutri-
tional Sciences, University of Giessen, and a national research institution. 
 
There are many initiatives currently focusing on what has been termed the “1000 
day window”. The period from early pregnancy through to the first two years of life 
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of a child (or the 1000 day window) is a critical period for interventions to reduce 
and prevent undernutrition and micronutrient deficiencies. At the same time there 
is increased attention to the linkages between agriculture, health and nutrition. 
It would be an exciting and helpful research effort to document the effective-
ness of such approaches which combine food security and nutrition interventions. 
To conclude, taking action against child and maternal undernutrition is not on-
ly a moral imperative and not only an obligation of governments in the framework 
of the human right to food. As tolerating hunger and malnutrition has enormous 
economic costs, investment in improved nutrition and food security can be highly 
profitable. I wish you all possible success for the GIHN. 
 
 
14 Global policies and local implementation: 
maternal mortality in rural India 
Kim Gutschow and Padma Dolma 
1 The burden of maternal mortality 
 
Pregnancy or childbirth remains a leading cause of death, disease, or disability for 
women of reproductive age across the developing world (WHO 2010; Gill, Pande 
and Malhotra 2007). In fact, the fifth Millennium Development Goal (MDG)––
whose stated goal is to “improve maternal health” by reducing maternal mortality 
and providing universal access to reproductive health––is now regarded as the 
most off-target of the eight Millennium Development Goals (Graham 2009). Eve-
ry year, global pregnancies result in over 10 million maternal disabilities, 368,000 
maternal deaths, 46 million abortions, 2.6 million stillbirths, and 3.8 million neona-
tal deaths (WHO 2010; Lawn et al 2009, 2011). Many of these deaths can be col-
lectively prevented with basic care around pregnancy and childbirth.  India, our 
focus below, provides an excellent vantage point for studying these intertwined 
deaths as it accounts formore maternal deaths (63,000), more neonatal deaths (1.1 
million), and more births (27 million) than any other nation in the world (WHO 
2010; Lawn et al. 2009). 
These deaths are not without economic costs. Conservative estimates suggest 
that global maternal and neonatal mortality alone results in $15 billion in lost 
productivity each year (Gill, Pande, and Malhotra 2007). Despite these costs, a lack 
of political and financial will around maternal and neonatal mortality remains. The 
4.3 million mothers and newborns that die each year far outnumber the number of 
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people who die from HIV alone (2.9 million) or TB and malaria combined (1.7 
million and 1.3 million respectively). Yet global assistance still lags for maternal and 
neonatal health, which was $1.2 billion in 2006 compared with the $10 billion allot-
ted for HIV/AIDS in 2007 (Shiffman and Smith 2007).  Repeated calls to priori-
tize maternal health have led to suggestions that The Global Fund to Fight AIDS, 
TB and Malaria should include maternal and neonatal health under its rubric (Hor-
ton 2010, Costello 2005). After repeated concern about lack of progress on MDG 
5, the Secretary General of the United Nations proudly announced a pledge of 
over $40 billion towards the Global Strategy for Women’s and Children’s Health in 
September 2010. 
The twists and turns of what was first known as the Safe Motherhood Initia-
tive (SMI) and later branded as Making Pregnancy Safer (MPS) have been summa-
rized elsewhere (AbouZahr 2003; Shiffman and Smith 2007).  The SMI was found-
ed when three major multilateral aid organizations––the World Bank, the World 
Health Organization (WHO), and the United Nations Fund for Population Activi-
ties (UNFPA)––met in 1987 with the stated goal of reducing maternal mortality. 
This focus on maternal conditions arose after a landmark essay (Rosenfield and 
Maine, 1985) subtitled “Where is the M in MCH?” had argued that the focus on 
child health in MCH initiatives had come at the cost of women’s and maternal 
health. Yet progress would remain out of reach for some time due to the challeng-
es of bringing different agendas–––mother versus child, community-based versus 
clinical care, and primary health versus vertical programs––and different agencies 
under one initiative (Lawn et al. 2006; Starrs 2006; McCoy et al. 2010). By 2005, 
donors sought to combine funding by merging the SMI with other initiatives to 
create The Partnership for Maternal, Newborn & Child Health (PMNCH).  The 
PMNCH strategically linked maternal survival with newborn and child survival in 
order to better promote the linked MDGs 4 and 5 (McCoy et al. 2010).1 
2 Recent shifts in policy 
Maternal health policy has undergone a considerable shift in recent years towards 
privileging strategic adaptation to local context over global policies and solutions. 
As a key editorial (Costello et al. 2006: 1477) in the Lancet’s Maternal Survival Se-
ries warned: “We are concerned about the one-size fits-all core strategy and believe 
the policies need to be context-specific.” Another essay summing up maternal 
health policy noted without irony that policies should not be copied from one 
                                                     
1 The PMNCH was launched in 2005 to supercede three partnerships: (1) the Partnership for Safe 
Motherhood and Newborn Health hosted by the WHO, (2) the Healthy Newborn Partnership host-
ed by Save the Children, and (3) the Child Survival Partnership hosted by UNICEF.  The first part-
nership itself grew out of the Safe Motherhood Interagency Group, which was comprised of the 
three founding agencies of the SMI––the WHO, the World Bank, and the UNFPA––along with 
UNICEF, UNDP, the Population Council, and the International Planned Parenthood Foundation 
(IPPF). 




country to the next because, “the devil is in the detail” and “context matters” 
(Penn-Kekana et al. 2007: 34). A key essay on the eve of the twenty-year anniver-
sary of the founding of the SMI summarizing decades of research on maternal 
mortality called for a renewed emphasis on implementation and context rather 
than a continued focus on global causes or solutions: 
 
“Implementation of maternal health services on the ground has been woefully 
neglected in the global safe motherhood community.... We are not advocating a 
single universal approach to implementation, but neither are we suggesting that 
every situation is so unique that it has to start from scratch. In short, we know 
what to do, but how to do it varies by context. Understanding context entails an appre-
ciation of the relation between supply and demand within the district level 
health system––ie, the continuum from home or community, up through health 
posts and health centres, to the first referral level facility” (Freedman et al. 
2007: 1384, my emphasis). 
 
The tack from „what to do“ to „how to do it“ shifts concern from broad causes 
and solutions towards local strategies of prevention and treatment.  However, the 
focus on supply and demand still emphasizes the reductionist views of economists 
and policy makers that frequently shortchange the role of culture, power, and 
agency. In short, the language of efficacy can elide the complex intersection of 
power, gender, culture, and social hierarchy that are central to critical medical an-
thropology (Pfeiffer and Nichter 2008; Inhorn 2006, 2007). Yet there are signs that 
policy makers and researchers are recognizing the role of quality and agency in 
determing access to obstetric care.   
 
“Ensuring the availability of a package of effective intrapartum interventions in 
health facilities does not guarantee an effect on maternal mortality, which is 
contingent on uptake by the target population, the quality of implementation, 
and the avoidance of harm introduction” (Campbell and Graham 2006: 1292). 
 
Campbell and Graham critically isolate the uptake of services to quality of services 
and avoidance of harm, while others (Thaddeus and Maine 1994) have shown the 
importance of transport, costs, and other social barriers to uptake. Quality of care 
has emerged as a key concern that must be balanced against the over-whelming 
drive to increase coverage. As Graham and Varghese (2011: 378, citing Godlee 
2009) recently argued, “the global insanity––continuing over and over again to 
deliver poor-quality health services for women and children and yet expecting 
results…” must give way to sustained efforts to provide high quality care, namely 
care that is “effective, safe, and a good experience for the patient”. The emphasis 
on quality of care draws on growing evidence that a significant fraction of maternal 
deaths are caused by clinical delays, omissions, and failures. 
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“Confidential enquiries into maternal deaths in a diverse range of countries, to-
gether with find-ings from clinical audits, suggest that the proportion of which 
substandard care played a substantial role is often more than a third. 
(Ronsmans and Graham 2006: 1196). 
 
The emphasis on quality of care is linked to the overwhelming push towards in-
creasing skilled attendance at birth across the globe. While institutional deliveries 
may appear to fulfill one core safe motherhood strategy––access to skilled intra 
partum care––they only do so if the staff, the clinics, and the protocols at such 
institutions actually deliver emergency obstetric care (Gabrysch et al. 2011). Safe 
motherhood policies have had to account for both high risk and low risk pregnan-
cies. After years of privileging either low risk or high-risk pregnancies/deliveries––
often at the expense of the other––it is now recognized that most deliveries and 
pregnancies fall along a risk continuum that can change in sudden and unpredicta-
ble ways.  Most importantly, it is difficult to predict which pregnancies will wind 
up as a high risk or low risk delivery. Although antenatal care does correlate with 
improved neonatal and maternal outcomes, studies have yet to show direct causal 
links between antenatal care and reductions in maternal mortality (Maine and 
Rosenfield 1999, Miller et. al. 2003). 
3 India and the JSY scheme 
The JSY scheme in India offers important lessons for the global attempt to in-
crease institutional deliveries within the home-to-hospital continuum of care.  
Launched in 2005 with World Bank funding, India’s Janani Suraksha Yojana (JSY) 
scheme is the largest conditional cash transfer program in the world in terms of 
beneficiaries. At a cost of roughly $134 million (15.4 billion Rupees) in 2009-10, 
the schema currently pays women in LPS (low performing states) like Jammu & 
Kashmir (our focus below) 1400 rupees per institutional delivery and 500 rupees 
for home births. The scheme also provides 600 rupees for the Accredited Social 
Health Activist (ASHA) who is supposed to accompany women to the hospital for 
delivery, 250 rupees to pay for emergency transport, and 1500 rupees to pay for an 
emergency cesarean if there are no free government services for cesareans.  
Plagued initially by bureaucratic inefficiencies and confusion over who qualified for 
the schema, the schema soon dropped the stipulation that women have a marriage 
certificate, a BPL (below poverty line) certificate, and be below 19 years of age.  
Yet it continues to be underused across India.  By 2009, less than 10% of eligible 
women benefitted in states that have high maternal mortality ratios such as Uttar 
Pradesh and Jharkhand (Lim et al 2010). 
While the JSY program did achieve an increase in institutional deliveries across 
India, persistent worries remained about the lack of medical staff, supplies, and 
quality of care at government institutions (Jeffery and Jeffery 2010; Das, Rao, and 




Hagopian 2010; Lahariya 2009). By including births in rural clinics or sub-centers 
in the definition of ‘institutional deliveries’, the JSY schema is paying women to 
deliver in a notoriously unreliable set of clinics at the bottom of India’s rural health 
care system. There is a serious danger in shifting births to clinics and hospitals that 
are underequipped to handle an increase in deliveries or emergencies (Jeffery and 
Jeffery 2010; Lahariya 2009). A recent study argued that if many obstetric wards in 
India are overwhelmed with two or more patients per bed, it is unclear how in-
creasing deliveries will improve maternal outcomes or quality of obstetric care 
(Lahariya, 2009: 16).  The JSY scheme has been correlated with improvements in 
perinatal and neonatal outcomes yet shows no correlation with improved maternal 
outcomes (Lim et al. 2010).  
These studies indicate that the very institutions where women are sent may 
lack timely or integrated basic or comprehensive emergency obstetric care.2 If ap-
plied in a timely and integrated fashion, basic or comprehensive emergency obstet-
ric care can treat all of the major causes of maternal mortality in India which are: 
hemorrhage (29.6%) anemia (19%), sepsis (16%), obstructed labor and ruptured 
uterus (9.5%), abortions (8.9%), and eclampsia (8.3%).3 The timing of interven-
tions is critical, as the median time from onset to death of an untreated hemor-
rhage is just six hours (Costello et. al 2006). Moreover, a single complication–such 
as post-partum hemorrhage–may require a combination of interventions, such as 
oxytocin to increase contractions and stanch the blood flow, removal of placenta 
and uterine products to limit source of bleeding, blood transfusion to make up the 
lost blood, and finally surgical hysterectomy if all else fails. Jeffery et al. (2007: 175) 
starkly note that “government institutions in Uttar Pradesh are currently incapable 
of accommodating routine deliveries, leave aside dealing with complications that 
require emergency care”. 4 The same study reports that one fifth of all community 
health centers in Uttar Pradesh were found to have even 60% of the equipment 
needed for handling basic obstetric emergency care and only a third of such cen-
ters had 60% of the medical staff required. Other studies have argued that the lack 
of timely transport or referral schemes constitute gross violations of obstetric care 
and human rights (Jeffery and Jeffery 2008, 2010; George 2007; Gutschow 2010). 
                                                     
2 Basic emergency obstetric care (BEOC) comprises six signal functions––parenteral antibiotics, 
parenteral anti-convulsants, parenteral oxytocin, manual vacuum aspiration, manual removal of re-
tained placenta, and instrumental vaginal delivery (forceps or vacuum), while Comprehensive emer-
gency obstetric care (CEOC) adds two more––cesarean sections and blood transfusion or blood 
products.  
3 Rawal (2003) cites the major causes of maternal mortality recorded by the the Registrar General of 
India using the Sample Registration System (SRS). The Federation of Obstetric and Gynaecology 
Societies of India (FOGSI) finds a rather different breakdown of causes: anemia, eclampsia, sepsis, 
hemorrhage, and abortion in declining order. 
4 Jeffery et al. (2007) also found inappropriate levels of injectable oxytocin use for the intrapartum 
period, without sufficient attention to the dangerous sequelae of such use. Compare Van Hollen 
(2003) and Jeffery, Jeffery, and Lyon’s earlier analyses of the shifting medicalization of birth in Tamil 
Nadu and North India (1989). 
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These anthropological critiques imply that the JSY schema may be doing little or 
nothing to reduce maternal deaths in some parts of India. 
4 The JSY in context: Ladakh  
Slightly smaller than Norway, but home to only 270,000 people, Ladakh consists of 
two districts, Leh and Kargil.  Each district has one government hospital based in 
the central towns, Leh and Kargil, from which the districts draw their names.  
These two hospitals currently provide the only comprehensive emergency obstetric 
care in the region. Yet many of community level health clinics and subcenters lack 
several measures of basic emergency obstetric care. While the auxilliary nurse mid-
wives (ANM), who attend most of the home and clinic deliveries, can provide 
basic intrapartum care including injectable antibiotics and oxytocin, they often lack 
the instruments or the skills to perform manual vacuum aspiration, instrumental 
deliveries, and other signal functions of basic emergency obstetric care.  In short, 
many rural clinics and midwives in Ladakh are ill prepared to save the mothers and 
neonates who suffer life-threatening complications. This is significant given the 
obstacles to accessing hospitals or clinics in this remote, rural Himalayan region. 
Many valleys lack access to the hospital except on foot for six months every winter 
when passes are blocked and emergency helicopter services are unreliable. Women 
who live in remote parts of Ladakh, who are due to deliver between November 
and May, must make the decision (and have the financial resources) to leave their 
homes months before their due date if they wish to deliver at a hospital.  
This essay draws on fieldwork concentrated between 1994-2002 and 2006-
2011 at Leh hospital and in rural parts of Kargil district. Besides collaborating with 
the two chief obstetricians of Leh hospital since 1994, Gutschow has conducted 
extensive interviews with the nurses, nurse-midwives, and medical assistants who 
provide institutional and home-based antepartum and intrapartum care across 
Ladakh. Between 1994 and 2011, Gutschow interviewed more than 200 women in 
Ladakh and a range of tradi-tional ‘experts’ who deliver traditional healing in 
Ladakh including practitioners of Tibetan medicine, monks, nuns, and oracles 
about reproductive and maternal health (Gutschow 2004, 2006, 2010). 





Figure 1: 30 Years of data from Leh’s Government Hospital: 1979-2010. 
Kim Gutschow or Padma Dolma collected this data from hospital records in 
1995, 1999, 2006, 2007, 2009, and 2011. 
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This chart shows a steady rise of deliveries, live births, and cesareans as well as the 
more variegated rise and fall of family planning services at the Leh government 
hospital over the last 3 decades. The shift of birth from home to hospital in 
Ladakh long precedes the introduction of the JSY scheme into Ladakh in 2006 and 
outpaces the trend towards institutional birth across India. By 1995, while almost 
half of all deliveries in Leh district were facility-based, only 20% of all births in 
India were institutional (Wiley 2002).  By 2007, 74 % of all deliveries in Leh district 
but only 45.5 % of the deliveries in Kargil district were facility-based, even as the 
all-India rate of institutional deliveries remained less than 50% (Pathak et al 2010). 5 
What distinguishes Leh hospital from Kargil hospital has been the service of two 
obstetricians, aunt and niece who have dedicated their lives to providing quality 
obstetric care over the past three decades (Gutschow 2010). The different rates of 
institutional deliveries at Leh and Kargil hospitals imply that women prefer the 
quality of obstetric care at Leh hospital, which is born out by our interviews with 
patients at Leh hospital. Other studies indicate that rural women in India prefer 
home births to poor quality of care at institutions (Pathak et al. 2010; Jeffery and 
Jeffery 2008, 2010).  Other major factors contributing to the rise in institutional 
deliveries in Ladakh as in the rest of India include the greater value placed on each 
birth in a context of lowered fertility and improved income, education, access, and 
transport facilities (Gutschow 2010, Chawla 2006, Van Hollen 2003, Pinto 2008, 
Jeffery, Jeffery, and Lyon 1989). 
The perceived quality of care at Leh hospital is born out by maternal outcomes 
as well. Maternal mortality ratios (MMR) fell precipitously at Leh Hospital in the 
last 3 decades, from 746/100,000 in 1988 to 96/100,000 in 2006. There are no 
good statistics on neonatal and perinatal mortality at the Leh hospital, but the still-
birth rate ranged between 38 and 41/1000 between 2004 and 2007. In recent years, 
the MMR at Leh hospital was roughly half that found in the nearby but remote 
subdistrict of Zangskar and less than half that found in a government hospital in 
the state of Kerala, noted for its maternal health outcomes. 6 Observations and 
interviews in the labor and delivery wards at Leh hospital in the past 15 years con-
firm that most medical staff are able to provide evidence-based and quality obstet-
ric care in timely fashion. 
Yet these indications of quality of care starkly contrast with the notable decline 
in both abortions and tubal ligations at Leh hospital after 2003. When Dr. Lahdol, 
who served as the Chief Obstetrician at Leh hospital from its founding in 1979, 
retired in 2003, the provision of family planning services at Leh hospital took a hit 
                                                     
5 The rates of institutional deliveries and skilled attendance at birth are quoted from the Leh District 
Health Plan (Government of India 2007b: 49) and Kargil District Health Plan (Government of India 
2007a: 48). The report elsewhere mistakes the institutional delivery rate from pregnancies not live 
births; I have ignored those rates. 
6 The MMR recorded at Leh hospital between 2005 and 2007 (93.5/100,000) was less than half that 
found in rural Zangskar between 2006 and 2009 (225/100,000). The Leh hospital’s MMR was less 
than half that found at a teaching hospital in Trivandarum (215/100,000) and a fraction of that rec-
orded at a teaching hospital in Allahabad (3778/100,000) (Purandare (2007). 




from which it is yet to recover. Although Dr. Lahdol was awarded a Padma Shri, 
one of the highest civilian honors in India, her concerted efforts on behalf of ma-
ternal and reproductive health earned her increasing attacks by right wing religious 
and political groups. Since her retirement, the attacks on family planning have not 
abated and the number of abortions has continued to decline.  After nearly three 
decades of steady gains, the number of abortions reported in 2010-11 had sunk to 
a level not seen since 1979-80, even as the number of births increased fifteen-fold. 
This restriction on safe abortion services leaves women little choice but to travel 
days to reach a private hospital or clinic that in the nearby cities of Jammu, Srina-
gar, or risk an unregulated abortion in a private clinic. It is important to recall that 
abortion is one of the five leading causes of maternal mortality in India.  Signifi-
cantly, the JSY program seems to have had little impact on the provision of abor-
tions in Ladakh, one of signal functions of basic emergency obstetric care. 
The quality of care found at Leh hospital stands in contrast to the sub-standard 
care delivered across many rural centers.  Currently, many of the block level clinics 
or community health centers in Kargil lack the basic functions of emergency ob-
stetric care on a 24/7 basis. Official documents outlining district level provision of 
healthcare are littered with phrases such as: ‘capacity building in Emergency Ob-
stetric Care”, “all CHC [community health centers] to be developed as FRU’s [first 
responder units]”, and “PHC to be developed as 24x7 facilities” (Government of 
India, 2007b: 44). Yet even five years after the JSY has been introduced, these 
same centers were still found to be closed at night or staff unavailable on a 24x7 
basis. As such, women are being lured to deliver in facilities with limited or una-
vailable emergency obstetric care.  This is born out by the following admission in 
the Kargil District Health Plan’s section on maternal health: “The community does 
not have enough confidence in the government facilities since the personnel are 
not always available and also adequate infrastructure, equipment, and drugs [sic].” 
(Government of India, 2007a: 49). The Padum Community Health Center (CHC) 
still lacks a functioning operation theater and an anesthesiologist despite spending 
millions of rupees in upgrading the facility to a CHC. In short, despite the best 
intentions, the JSY scheme has not provided the emergency obstetric care required 
to sustain reductions in maternal and neonatal mortality. 
5 Conclusions 
While it may be true that many home births in India lack access to skilled or emer-
gency obstetric care, it does not necessarily follow that institutional births neces-
sarily involve access to emergency obstetric care. Further research is needed to 
evaluate whether the JSY scheme is improving maternal and neonatal outcomes 
across India and whether hospitals, clinics, and staff can provide the quality emer-
gency obstetric care they claim to. The experience in India and Ladakh suggests a 
degree of caution towards the inexorable push to institutionalize birth. Currently, 
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there simply are not enough facilities to accommodate India’s 27 million annual 
births. As Anthony Costello (2006: 1477) wrote in the Lancet’s Maternal Survival 
Series: 
 
“Intrapartum care based in health centers is appropriate for all as a longer-term 
strategy, but it might not be the best option for reducing maternal mortality in 
all contexts in the shorter term. In many communities with high maternal mor-
tality this strategy is simply not achievable with current resources and infra-
structure.” 
 
A health center strategy is only the ‘best option’ for reducing maternal mortality if 
one can guarantee the quality of obstetric care in those centers. It is unclear that 
the push towards institutionalizing birth across India and the globe has yet to fully 
account for quality of care or skill of health care providers at the relevant facilities. 
Until women are guaranteed quality and respectful care, they will continue to 
choose home births over institutional births (Campbell and Graham 2006). Until 
then, one needs more qualitative and systematic studies comparing quality of care 
across the continuum of care from home to hospital or those comparing low risk 
home and hospital births in low resource settings. Similar studies in high re-source 
settings comparing low risk home and hospital deliveries have shown lower rates 
of maternal interventions and similar rates of neonatal mortality and morbidity 
(Janssen et al. 2009, De Jonge et al. 2009, Johnson and Daviss 2005).  Clearly, ef-
forts to improve quality of care (Graham and Varghese 2011) must coexist with 
the ongoing efforts to institutionalize birth if we are to see progress in maternal 
and neonatal outcomes in India. There is a need to measure both the quality and 
quantity of obstetric care if the 5th MDG is to be met in time in India as elsewhere 
across the globe.  
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15 Research as a tool to tackle maternal health 
problems in resource-poor settings 
Azucena Bardají 
1 Background 
Improving the health of the most vulnerable populations continues to represent a 
huge global health challenge. Maternal and children mortality and morbidity rates 
remain unacceptably high in the developing world.  
Decrease of children and maternal mortality, and attainment of universal ac-
cess to reproductive health are key objectives of the Millennium Development 
Goals (MDGs).[1] Despite some progress, global efforts to adequately address 
reproductive, maternal and perinatal health problems have been revealed to be 
insufficient and often fragmented, particularly in improving maternal mortality and 
morbidity (MDG5).[2, 3] 
Annually, approximately 8 million women suffer from pregnancy-related com-
plications, of which nearly half a million die.[4] Everyday, 1000 maternal deaths 
occur worldwide, most of them (99%) in developing countries where the maternal 
mortality ratio (MMR), number of maternal deaths per 1000 live births, is up to 
100 times higher than in developed countries.[5] In 2008, around 20 developing 
countries held MMRs higher than 1000 per 100.000 live births, and more than 50% 
of all maternal deaths were concentrated in just six countries; India, Nigeria, Paki-
stan, Afghanistan, Ethiopia, and the Democratic Republic of the Congo.[6]   
The United Nations annual statement of progress on the MDGs released on 
23rd June 2010 showed that the rate of drop was short of the 5% annual reduction 
needed to reach the target under MDG5, for diminishing maternal mortality rates 
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by three quarters between 1990 and 2015.[7] It has been suggested that a reason 
why MDG4 and MDG5 will not be reached according to latest projections is that 
the current global aid structure for reproductive, maternal, newborn and child 
health is not structured in a way that optimally allows mobilization of financing 
and rapid scale-up.[8] 
In fact, maternal health has been a neglected area in many ways, not only in fi-
nancing. Often, when it has been tackled, this has occurred through a children’s 
health approach, both in terms of policy making, advocacy and research. An ex-
ample is that pregnant women have been excluded systematically from clinical 
trials due to security concerns. Similarly, issues regarding women’s health have 
become a highly politicized topic, with the subsequent slow advancement on effec-
tive maternal health policies.  
2 Emerging and increasing focus on maternal health  
On the grounds of the slow steps forward being seen on key global health chal-
lenges, maternal health issues have begun to increase awareness and to attract in-
ternational attention. It has become a top priority. Civil society, academia and re-
searchers, global leaders, the United Nations, private foundations and health care 
professionals are joining efforts in making a difference towards an improvement of 
women’s health and put it on top of the global agenda.[8]   
In the last years initiatives such as the Partnership for Maternal, Newborn and 
Child Health (PMNCH), the IMMPACT project (a global research initiative for the 
evaluation of safe motherhood intervention strategies), the Centre for Maternal, 
Reproductive and Child Health (MARCH), Women Deliver, or the International 
Health Partnership (IHP) among others, are providing higher visibility to health 
needs in developing countries with focus on the most vulnerable. This culminated 
in the Global Strategy of United Nations Secretary General Global Strategy (Au-
gust 2010) that set out the key areas where action is urgently required to enhance 
financing, strengthen policy and improve service delivery for MDGs 4 and 5 to 
trigger a decisive move to improve the health of women and children. Another 
major converging platform is the H4+, that brings together World Health Organi-
zation (WHO), the Joint United Nations Programme on HIV/AIDS (UNAIDS), 
UNFPA, UNICEF, and the World Bank, which is also a promising initiative.[8]  
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Figure 1: Clinical evaluation of a new 
born at Manhiça District Hospital, 
Mozambique 
© ISGlobal 
Figure 2: Evaluation of a blood smear for 
malaria parasitaemia determina- tion in the 
laboratory of the Manhiça Health Research 
Cen tre (CISM), Mozambique 
3 The role of research to improve the health of the most  
in need  
Women and their children are those that principally concentrate the unacceptably 
effects of the vicious cycle of poverty and disease in developing settings. Biomedi-
cal research in developing countries represents a challenge at the same time that an 
enormous opportunity to make a difference about the health of the most in need.  
In many occasions decisions about women’s health are determined by policy 
makers based on merely political agendas, but not data-informed. Public health 
policies on maternal health will also affect undeniably their offsprings and need to 
be evidence-driven. It is crucial making available clear data to highlight why it 
makes sense to spend in the health of women. Research on maternal health prob-
lems needs to be one of the priorities of the international community since women 
are the cornerstone for the social and economic development of low-income coun-
tries. 
In the last decade, academic and research centres have strengthened a network 
of north-south or south-south partnerships that have promoted excellence through 
multidisciplinary, translational and cross-cutting research with the aim to improve 
global health. In this picture, capacity building through training of local health 
leaders has been a main cornerstone in their missions.  
An example of this it is the Manhiça Health Research Centre (CISM) in South-
ern Mozambique that was created to promote and conduct biomedical research in 
priority health areas.[9] The improvement of maternal health is one of the priori-
ties of the CISM research agenda. Some of its contributions have been the investi-
gation of the impact of malaria during pregnancy on maternal and infant health, of 
new drugs for intermittent preventive treatment during pregnancy, the impact of 
maternal HIV infection on infant health and mechanisms involved in the mother-
to-child-transmission of the HIV infection, and the understanding of the causes of 
maternal deaths.  
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4 Priority areas on maternal health research 
Pointing out the priorities on maternal health research requires mapping of the 
foremost health problems affecting those most at risk, and identifying the 
knowledge gaps and evidence needed in areas critical to reducing maternal and 
newborn mortality and morbidity.  
Research agenda on maternal health should include the understanding of the 
causes and mechanisms of diseases affecting pregnant women and their newborns, 
the evaluation of efficacious treatments, as well as of effective preventive strate-
gies, and through an interdisciplinary approach. 
Some areas that can be envisaged as priorities in maternal health research are 
the following: 
 
 Maternal mortality. Understanding the specific causes of maternal deaths in the 
most affected areas can provide genuine data that may contribute to the priori-
tization of public health strategies to reduce the unacceptably high rates of ma-
ternal deaths in the sub-Saharan region, and achieve one the key MDGs.[10] 
This may include identifying the constraints of available resources of infor-
mation on the aetiology of maternal deaths as verbal, autopsies, clinical records 
or necropsies. It is also necessary to ascertain and measure the determinants of 
maternal mortality such as health care access barriers, the quality of care in the 
delivery of preventive and curative interventions and the economic costs and 
affordability of maternal health care.  
 
 Perinatal and neonatal mortality. Lowering child mortality increasingly depends on 
tackling perinatal and neonatal mortality. Reducing neonatal deaths requires 
knowing its causes.[11]. Establishing the causes of perinatal and neonatal mor-
tality is crucial to ascertain the prioritization of specific interventions and ap-
proaches. This also should include the identification of the available sources of 
information on the burden and determination of the causes of deaths, to evalu-
ate the impact of vertical transmission of non-HIV sexually transmitted infec-
tions and to measure the determinants of perinatal and neonatal survival, health 
care access barriers and economic costs associated with neonatal care. Similarly, 
it is necessary to assess the impact of point-of-care testing during pregnancy to 
reduce infant survival and maternal morbidity. 
 





 Maternal morbidity. Annually hundreds of thousands of women suffer from 
pregnancy-related complications and diseases. To establish the major causes of 
maternal morbidity is key information in order to optimize resources for ante-
natal care and minimize its impact on infants and mother’s health. Other areas 
that deserve attention is to identify best practices to introduce maternal care in-
terventions and integrating them into existing maternal health programmes, and 
to determine the economic impact of maternal morbidity at community, na-
tional and regional level. 
In many parts of Southern Africa, more than 30% of pregnant women at-
tending the antenatal clinics are infected with HIV.[12] This makes HIV infec-
tion one of the most common and important complications of pregnancy in 
these settings. To investigate the impact of HIV/AIDS epidemic on maternal 
health, birth outcomes and infant survival constitutes one of the cornerstones 
in research agendas. Similarly, it is crucial to understand the mechanisms in-
volved, and the most efficacious and effective strategies to prevent the mother-
to-child transmission of HIV infection. 
Malaria during pregnancy is associated with maternal and foetal morbidity 
and mortality through its contribution to maternal anaemia, low birth weight 
and prematurity.[13, 14] In high transmission malaria endemic areas, as sub-
Saharan Africa prevention of malaria during pregnancy is a public health priori-
ty.  Some of the key research areas may include 1) the understanding of the 
burden and impact, and the pathophysiological mechanisms of malaria during 
pregnancy and its contribution to maternal and infant mortality and morbidity, 
© A.Bardají 
Figure 3: A low birth weight baby born 
at the maternity of a district hospital in 
Madang, Papua New Guinea 
© A.Bardají 
Figure 4: A pregnant woman is invit-
ed to participate in a study aimed to 
assess the burden of P.vivax malaria 
during pregnancy in Bikaner, Raja-
sthan, India 
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both in high and low transmission settings, and 2) the assessment and devel-
opment of new strategies on malaria control in pregnant women.  In addition, 
the evaluation of the cost-effectiveness of malaria control tools during preg-
nancy is necessary to facilitate in the decision-making process. 
 
 Sexual and reproductive health. Closely related to maternal health, women´s 
health issues that deserve major attention are the 1) evaluation of the burden 
and impact of sexually transmitted infections in young adolescents and adult 
women, 2) to identify best practices to reinforce adolescent sexual health for 
equitable and responsible relationships, 3) to evaluate the access barriers to 
reproductive health services, 4) to assess the epidemiology of human papil-
lomavirus infection (HPV) and to identify best practices for delivery, pre-
vention, screening and treatment interventions, 5) to evaluate the integration 
into reproductive health care programs of chronic diseases affecting women 
also in developing countries as breast cancer and cervix cancer, and 6) inves-
tigate the impact of violence against women, pregnant and non-pregnant, on 
women´s health. 
 
 Health systems strengthening and implementation. A major question for the success 
of maternal health interventions is to ascertain the role of social determi-
nants in the use of health systems, such as the barriers to access to health 
care and association with poor health outcomes, and the economic factors 
related to poor delivery of health care. Also it is crucial 1) to understand the 
links between poverty, vulnerability and gender inequality, 2) to assess the 
role of women in the health care system (from providers of care, to power 
professional health positions), and 3) the financing mechanisms for repro-
ductive, maternal and neonatal health delivery. 
5 The need for a prioritized research agenda:  
The role of academia and research institutions 
When it comes to maternal health, and the same applies to women´s health, re-
search efforts have been set up, more often than desired, without much coordina-
tion, leading to fragmentation of resources, redundancy of evidence and conse-
quently to having a lesser impact.  
If research agendas on maternal health at country, regional and international 
level are not guided by a common scheme, the limited available resources will be 
inadequately distributed.  A common strategy will enable to inform policy makers 
and donors on assigning and investing specific responses more successfully and 
equitably to improve maternal health. This highlights the need for a coordinated 
and prioritized research agenda in areas critical to reducing maternal morbidity and 
mortality and accelerating access to reproductive health. 





Figure 6: Engaging global leaders 
on women´s health. Plenary ses-
sion at 7th European Congress on 
Tropical Medicine & International 
Health, Oct 2011, Barcelona, Spain 
On the ground of the current situation on women’s and children’s health,[3] the 
United Nations Secretary General, revitalized the international community pledges 
by launching the Global Strategy at the MDG Summit in 2010. Within this strategy 
it was stated the role that research and academic institutions are expected to play, 
and these were asked to deliver a prioritized and coordinated agenda, promote 
increased budget allocation for research and dedicate efforts on building capacity at 
research institutes in low and middle income countries.  
Thus, the role of academia should be to facilitate a multi-disciplinary, participa-
tive and inclusive process towards the delivery of a global agenda on the basis of 





Figure 5: Colombian re-
searchers processing samples 
collected from pregnant 
women infected with malaria 
for immunological assays 




In the 21st century, we are probably the first generation with the sufficient tools 
and knowledge to overcome main inequities in health and wealth. However, ma-
ternal health still holds a wide range of unconquered challenges being some of the 
most representative the lesser advances on main outcomes such as maternal sur-
vival or universal access to reproductive care.  
Public health measures need to be evidence-driven and biomedical research 
represents a huge opportunity to have an effect on improving maternal health in 
developing countries. Pointing out the priorities on maternal health research re-
quires the mapping of the foremost health problems, identifying the knowledge 
gaps and evidence needed, and political commitment and investing from donors 
on specific and coordinated responses. Lastly, the academia, through the set up of 
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16 The agriculture and health program of  the 
International Institute of  Tropical Agriculture  
(IITA), a CGIAR institution in Africa 
Victor M. Manyong., Bussie Maziya-Dixon, Ranajit Bandyopadhyay and Rous-
seau Djouaka 
Abstract 
The agriculture and health program of the International Institute of Tropical Agri-
culture (IITA) is one of the eight research for development (R4D) programs im-
plemented by IITA in the humid and sub-humid tropics of sub Saharan Africa. 
The overall goal of this program is to improve diets, health, and productivity 
through research in micronutrients content, food toxins, nutrient patterns and 
science-based evidence policy advocacy. 
This paper explains the rationale of this program, the main objectives, key re-
search areas and expected outputs. It also briefly presents examples of highlights 
from implementing R4D activities on key research areas. 
1 Introduction 
Agriculture can play a major role for the health of African people, not only by 
providing food for sufficient macro-nutrition (calorie sufficiency), but also by 
providing food that reduces micro- nutrient deficits and enhances health of specif-
ically vulnerable groups like women and children. 
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The global hunger index for 2008 (von Grebner et al. 2008) shows a large majority 
of countries in sub-Saharan Africa in either alarming (hunger index of 20.0 to 29.9) 
or extremely alarming (hunger index of equal or more than 30.0) situations. Glob-
ally, 35 to 55 percent of all childhood deaths are related to malnutrition, which 
affects roughly one third of all children in developing countries (Lancet 2008). 
With the recent food and financial crises, an estimated 1.02 billion people, the 
highest number since 1970, suffer from hunger (FAO 2009). According to official 
statistics, about half of the Sub-Saharan African population suffers from iron defi-
ciency (Harvest Plus 2007), mostly women and children, and more than five per-
cent of Africans are at risk from Vitamin A deficiencies and resulting blindness, 
again most of them children, with one third of children under the age of five af-
fected (Harvest Plus 2007). Zinc deficiency affects presumably two thirds of the 
African population, resulting in stunting and morbidity (Harvest Plus 2007). 
Recent estimates suggest that vitamin A and zinc deficiencies in young children 
contribute significantly to the global burden of diseases, and between 4-6% of all 
under-five deaths. Iron deficiency also leads to 115,000 maternal deaths or 2.4 
million disability adjusted life years (DALYs) (Black et al. 2008).   There is increas-
ing evidence that other deficiencies in micronutrients such as riboflavin, calcium, 
and vitamin B12 are also widespread and resulting in poor health outcomes among 
vulnerable populations (Dewey and Brown 2003; McLean et al. 2008). Heavy reli-
ance on monotonous plant-based diets and the lack of access to diverse diets are 
primarily responsible for the widespread micronutrient deficiencies affecting poor 
populations in developing countries. 
Many regions of the world, including sub-Saharan Africa, continue to be over-
burdened by nutritional and nutrition-related health problems, most of which can 
be traced to insufficient intake of micro-nutrients (vitamin A, iron and zinc in par-
ticular), and in recent years – over- consumption  of  energy-rich,  often  cheap,  
foods  leading  to  increased  incidence  of  chronic diseases, particularly in urban 
areas. But malnutrition occurs also in many families that are not poor – because 
people do not always know what food or feeding practices are best for their chil-
dren or themselves, and because people cannot easily tell when their children are 
becoming malnourished, since faltering growth rates and micronutrient deficiencies 
are not usually visible to the untrained eye. 
At an immediate level, an individual becomes malnourished because of inade-
quate or in appropriate dietary intake ill health or both.  These two factors often 
interact in a negative synergy.  Illness reduces appetite and increases nutrient re-
quirements, while inadequate intake of food (quantity or quality) makes the body 
susceptible to illness. Underlying this vicious cycle are household or community 
deficits in food security, inadequate access to health and environmental services, 
and household childcare behaviors and practices.  These underlying factors often 
summarized as “food, health and care also interact, and they too are under pinned 
by more basic causes relating to the amount, control, and use of resources and 
capacity in societies. 




In many African countries, rates of hunger and under nutrition are increasing.  The 
importance of this issue is reflected in the Millennium Development Goals 
(MDGs) established by the United Nations General Assembly at its Millennium 
Summit. Indicators for meeting the target of reducing hunger are stated in terms of 
under nutrition and inadequate food consumption – reducing the prevalence of 
underweight children, and reducing the proportion of the population below the 
minimum level of dietary energy consumption.  Under nutrition have multiple 
causes, both direct - including food consumption, care and health, and indirect - 
such as agricultural production, employment opportunities, women’s status, and 
service delivery systems.  Thus, cross-sectoral and inter-institutional collaborations 
are essential to addressing this complex problem, and must involve all relevant 
players, women as well as men. 
Good nutrition underpins progress towards each of the first six MDGs – The 
evidence suggest that good nutrition status reduces poverty by boosting productiv-
ity throughout the life cycle and across generations (Goal 1), that it leads to im-
proved educational outcomes (Goal 2), that dealing with malnutrition typically 
empowers women (Goal 3), that malnutrition is associated with about 60% of all 
child mortality (Goal 5) and that good nutrition status slows the onset of AIDS in 
HIV – positive individuals, increases malaria survival rates (Goal 6) and lowers the 
risk of diet related chronic diseases (Goals 1, 4 and 6). 
At the policy implementation level, there is poor awareness on the link be-
tween agriculture, nutrition, health and gender. Policy makers appear not to be 
fully aware of the gender division of labor, the gendered distribution of and access 
to resources as they relate to food security and malnutrition. Consequently, there is 
still much to be done in improving the policy advocacy and community based 
program to improve the nutritional status of women and children. 
Dietary consequences of socio-cultural and economic changes across all devel-
oping countries contribute to many of the health problems faced especially by the 
poor. Unfavorable changes in food habits of both urban and rural households and 
over-dependence on a few staple food crops have resulted in lack of diversity in 
diets, micronutrient malnutrition and an exceptional increase in diet-related chron-
ic diseases. It is well acknowledged that the nutritional quality of foods in develop-
ing countries depends on the diversity within the traditional food systems. Agricul-
tural biodiversity provides an important safety net to resource-poor communities 
and engenders food and nutritional security for poor households.  Diversity in a 
community’s food supply contributes to the dietary diversification that can in turn 
contribute to ongoing efforts at addressing under nutrition and diet-related chronic 
diseases. 
Food and food fortification is another important entry point to mitigating 
malnutrition, as it is more cost-effective than medication, e.g. in the case of iron-
deficiency, where food bio-fortification costs are at less than 10 percent of medica-
tion/supplementation, and reaches vulnerable groups more efficiently than medical 
supplements (Harvest Plus 2007). 
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Apart from imbalanced diets in terms of macro- and micro-nutrition, there is the 
important issue of food safety, and related issues of health as well as regional and 
global trade. One of the most prominent problems is the one of mycotoxins, in 
particular aflatoxins. Aflatoxins are potent human carcinogens and have great acute 
toxicity causing death. It is also reported to be associated with stunting in children 
and suppression of immune system. The extent of aflatoxin contamination is high 
in food and feed in sub-Saharan Africa. The population is exposed to unacceptable 
aflatoxin levels throughout their lives including prenatal exposure of the fetus and 
the consequences have been largely ignored. (Bhat and Vasanthi 2003). Recent 
outbreaks of acute aflatoxicosis in Eastern Kenya, underline the urgency of the 
problem. 
Aflatoxin contamination in particular of groundnuts but also maize imposes a 
barrier to domestic, regional and international trade. The 2004 Kenya case of afla-
toxins in maize and subsequent ban of maize imports from neighboring Uganda 
gives an example of regional trade restrictions, whereas in 2010 the Kenyan gov-
ernment declared 2.3 million bags of maize as non-tradable in the domestic market 
due to unacceptable levels of aflatoxin contamination. The largest number of rejec-
tions reported in European Union’s Rapid Alert System for Food and Feed 
(RASFF) are for aflatoxins (European Commission, 2011). In 2010, none of the 
aflatoxin-related rejections were from Africa. It is unclear if lack of rejection from 
sub-Saharan Africa is related to reduced agriculture trade between Africa and EU 
for aflatoxin-sensitive crops. 
Apart from the negative effects of some food characteristics in Africa, there 
are also potentials for new food markets that are related to health implications, 
recently referred to as ‘nutri-business”. One of these that came up in the nineties is 
the idea of “functional food”, for example flavonoid rich food that is said to pre-
vent heart diseases, or gluten-free food components. This could open up new 
markets for African products, given that quality standards are met. 
IITA is one of the 15 international agricultural research centers of the CGIAR 
group. The IITA mission is to increase agricultural production, food security and 
income in the tropics, especially sub-Saharan Africa. IITA activities are clustered 
under eight programmes. One of these programs is on agriculture and health. This 
program operates at the interface of the two sectors as agriculture is essential to 
good nutrition and health and good health is an outcome and major input into 
agriculture. 
2 Agriculture and health program at IITA 
There are basically three components of the Agriculture and Health programs: 
screening and breeding for biofortification, food safety, as well as HIV/AIDS and 
malaria impacts on agricultural productivity. The former two components were 
integrated in the breeding programs up to 2006, whereas the latter two compo-




nents were a part of the social sciences program. In early 2006, the program was 
created to allow for better monitoring and evaluation of the respective activities, 
but also to create a research field that could prove as an innovation platform to go 
into until then under-explored issues of food and agriculture.  
 
The program pursuits three main objectives as follows: 
 
 To improve nutrition quality, in particular by seeking ways of providing a high-
er diversity and density of micronutrients in human diets, as well as by reducing 
food toxins 
 To increase the knowledge on nutrition patterns and distribution of food and 
nutrients within social systems, in particular with respect to human nutrition 
across social strata and gender 
 To research ways to overcome labor force bottlenecks in farms and households 
affected by HIV/AIDS or malaria or Buruli ulcer through appropriate technol-
ogies  
 
The expected outputs are: 
 
 Varieties with enhanced nutritional quality and reduced anti-nutritional factors 
and toxic substances;  
 Diets of nutritionally disadvantaged populations and human health improved, 
and market opportunities increased;  
 Health risks from mycotoxins reduced;  
 Impact studies, advocacy and policy dialogue for better health 
 
2.1 Key research areas undertaken at IITA 
Key Research area 1: Characterization and development of varieties with enhanced nutritional 
quality and reduced anti-nutritional factors and toxic substances 
 
This key research area is basically on the characterization and development of crop 
varieties germplasm for micronuntrients (vitamins, minerals), as well as macronu-
trients (protein, energy etc.), while at the same time countering anti-nutritional 
factors such as trypsin inhibitors and toxic contents of crops. The main target 
crops are maize (Picture 1), cassava (Picture 2), and banana/plantain. In 2011, 
Nigeria has officially released the first biofortified cassava varieties.   






Key research area 2: Strategies to enhance the diets of nutritionally disadvantaged populations, 
improve human health and increase market opportunities 
 
This research area focuses on the downstream aspects of food and nutrition. Key 
elements are research on reduced anti-nutritional compounds in processed foods; 
enhanced bioavailability of nutrients in processed foods and on increased diet di-
versity through food-to-food fortification. For example we used cost effective in 
vitro methods to demonstrate that the bio-accessibility of β-carotene (BC) in boiled 
cassava from various cultivars is highly correlated with its content. We also investi- 
Picture 1: New orange maize rich in Vitamin A 
Picture 2: Range of cassava varieties from deep yellow rich in Vitamin A and 
white poor in Vitamin A 




gated three traditional styles of preparation by fermentation and roasting and the 
potential to differentially affect both retention and bio-accessibility of BC. The 
calculated retinol activity equivalence per 100 g dry weight was 272 and 255 for 
boiled cassava and fufu, respectively, but only 131 for gari due to loss during prep-
aration. 
The ability of high-β-carotene cassava to prevent vitamin A deficiency has not 
been determined. In our research we found that biofortified cassava adequately 
maintained vitamin A status and was as efficacious as β-carotene supplementation. 
 
Key research area 3: Food safety to reduce health risks 
 
This research area addresses issues related to food safety and occupational hazards. 
Key research areas are on increased food safety, reduced factors negatively affect-
ing bio-availability, reduced toxic substances in food (such as mycotoxins – Picture 
3 ), and judicious pesticide use and reduction of related risks (food, feed safety and 
occupational hazard). 
 
IITA in collaboration with USDA and University of Arizona has developed 
Aflasafe, a biological control technology to reduce toxic strains of aflatoxins in the 
fields (Picture 4). 
Picture 3: Groundnut kernels (left) and maize grain (right) infested by Aspergillus 
flavus fungus 
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Picture 4: A farmer holding a box of Aflasafe 
Key research area 4: Impact on human health, advocacy and policy advice 
 
This research area focuses on determining the impact of agricultural developments 
on human health, including nutrition and food safety (e.g. Figure 1 for reducing 
malaria in agro-ecosystems). Results from this research area should help to better 
justify and focus research in the project, and also allow for better communication 
with the public, including donors and policy makers to increase the project’s pro-
file and investor awareness. Another important issue is the targeting of particularly 
vulnerable groups. 
We have recently launched an agro-eco-health system thinking initiative for 
controlling malaria and Buruli ulcer in wet agro-ecosystems (Picture 5). The initia-
tive  is a trans-disciplinary and multi-country program which brings together  sci-
entists with diversified backgrounds (agronomists, epidemiologist, clinicians, socio-
economists, and biologists, environmentalists) and focuses on the analysis of link-
ages between poor agricultural practices and the emergence of human diseases. 
This initiative is also focused on the identification of environmentally sound and 
cost effective innovations for preventing and controlling Buruli ulcer and malaria 
in wet agro-ecosystems. 
 






Figure 1: Impact pathways for Research for Development (R4D) Strategies for 
Reducing Malaria in agro-ecosystems. 
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3 Partnership 
Partnership is particularly important as IITA as such does not have the capacity to 
work on all the issues related to agricultural and health so that such research fields 
have to be covered by partner institutions. 
IITA has been working in partnerships with universities such as Vienna Uni-
versity of Technology (Austria), University of Arizona (USA), University of Thies 
(Senegal) (in aflatoxin research) and University of Leeds, UK (Faculty of Medicine 
and Africa College:  epidemiology on bioavailability of nutrients and tools for im-
pact); government organizations in the north and the south such as USDA-ARS in 
aflatoxin research (Determination of Aflatoxin-Resistance and Marker Identifica-
tion in IITA Maize Breeding Materials, and aflatoxin biocontrol research), research 
institutes such as KARI (Kenya), INERA (Burkina Faso) and DPV (Senegal) for 
aflatoxin research, and PRONANUT for nutrition studies in DRC; CG centers 
(e.g. CIAT) and African ARIs provide technologies like germplasm  (e.g.  CRBP 
Cameroon) and services (e.g. University of Zambia), WHO Geneva for Buruli 
ulcer in wet agroecosystems, and University of Gottingen Health International 
health network (GHIN). Other important partnerships are with bureaus of stand-
ard, drug and health agencies, as well as the related ministries. 
Picture 5: Agro-eco health platform for sustainable agricultural productivity in 
West Africa. 
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17 Aspergillosis : a major challenge for public health 
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1 Introduction 
Aspergillus species are common pathogens that cause a wide spectrum of diseases in 
the host (Pfaller et al, 2004). Among the genus Aspergillus, four species are found to 
be most pathogenic in humans: Aspergillus fumigatus, Aspergillus flavus, Aspergillus niger 
and Aspergillus terreus. Particularly, A. fumigatus is prominent and in fact, reported to 
be responsible for more than 90 % of Aspergillus induced infections. This marked 
predominance of A. fumigatus in clinical samples is also reflected by its environ-
mental preponderance over other pathogenic Aspergillus’ species (Latge, 1999). In 
addition, the incidence of A. fumigatus induced infections has increased to an alarm-
ing rate in the past decades (Abad et al, 2010). Such an increase in the prevalence 
of aspergillosis has been attributed to the growing number of transplant recipients, 
neutropenic individuals, allergic patients and those treated with corticosteroids, or 
other immunosuppressive drugs (Denning, 1998). Despite a better understanding 
of pathology and epidemiology of Aspergillus induced infections, there are persist-
ing diagnostic limitations (Sarfati et al, 2006). 
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2 A. fumigatus as a pathogenic mould for humans  
A. fumigatus sporulates abundantly to release large numbers of tiny conidia (2-3 μm 
in size) into the environment. Once the conidia are released into the air, their small 
size renders them buoyant and keeps them as airborne microparticles, both in-
doors and outdoors (Latge, 1999). Since the conidial production of A. fumigatus is 
highly prolific, the human respiratory tract always remains at risk of acquiring As-
pergillus infection (Latge, 2001). Environmental surveys have indicated that all hu-
mans inhale at least several hundred conidia of A. fumigatus every day (Chazalet et 
al, 1998). In upper airways, conidia may cause respiratory discomfort due to con-
tact irritation and allergic responses. A pictorial presentation of A. fumigatus asexual 
life cycle in the environment including the infection of a human host, leading to 
the development of an invasive disease is shown in Figure 1. A. fumigatus is able to 
establish infections in various organs like lungs, paranasal sinuses, brain, skin, 
heart, eyes etc. However, the lungs are the prime target due to uptake of conidia by 
inhalation via the internasal route. The characterization of A. fumigatus infections is 
based on the site of infection and extent of mycelial colonization, which are influ-
enced by the immune system of the host (Taylor et al, 2009). Generally, a hyperac-
tive immune system leads to allergic manifestations, whereas individuals with an 
impaired immune system develop invasive forms of the disease. However, the 
immunocompetent host may also acquire an infection (Latge, 2001). “Invasive 
aspergillosis” (IA) is considered to be the most devastating form of the disease, 
which may develop in any part of the body by dissemination of A. fumigatus species, 
frequently present in severely immunocompromised patients (Steinbach et al, 
2003). 
 




3 Allergic aspergillosis 
The initial allergic responses of the host to A. fumigatus are accountable for the 
development of four distinct and clinically recognizable forms of hypersensitivity 
disorders of the respiratory tract i.e., allergic bronchopulmonary aspergillosis 
(ABPA), allergic Aspergillus sinusitis, IgE-mediated asthma, and hypersensitivity 
pneumonitis (Shah and Panjabi, 2002). In atopic individuals with diseases of al-
tered lung function, such as asthma and cystic fibrosis, A. fumigatus can cause 
ABPA, which is a hypersensitive response to fungal components. It is the most 
severe allergic pulmonary complication caused by Aspergillus species. The first cases 
of ABPA were reported in England by Hinson et al (1952) and in the USA by 
Patterson and Golbert (1968). In India, the first three cases of ABPA were identi-
fied by Shah (1971). The clinical course of ABPA is known to range from mild 
asthma to fatal destruction of lungs with bronchiectasis and fibrosis (Rosenberg et 
al, 1977). Several attempts have been made to determine the prevalence of ABPA, 
but the lack of uniform diagnostic criteria and standardized tests represent a chal-
lange(Bedi and Bedi, 2007). Aspergillus hypersensitivity (AH) is characterized by the 
presence of an immediate type hypersensitivity reaction to A. fumigatus antigens and 
is the first step in the development of ABPA (Patterson and Golbert, 1968). 
Agarwal et al (2009) reported ABPA a prevalence of 27.2% in their study of 564 
asthmatics in North India. The overlapping clinical features of ABPA with other 
Figure 1: Asexual life cycle of A. fumigatus showing infection of the human host 
by conidia leading to development of a disease. 
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respiratory disorders mainly with tuberculosis, quite often leads to its misdiagnosis 
which is the main reason for considering ABPA as less important as it truly is.  
The factors considered to be important with respect to high incidence of 
ABPA in the Indian subcontinent are (i) high prevalence of tuberculosis (TB) and 
(ii) radiological similarity between ABPA and TB. Therefore, most patients are 
erroneously diagnosed with TB and keep on receiving anti-tuberculosis treatment 
(ATT) over long periods. Studies have indicated that ABPA was misdiagnosed as 
TB in as many as 17-50% of cases (Bedi, 1994 and Behera et al 1994). The symp-
toms of ABPA are quite nonspecific and an overlap of its clinical and radiological 
features has been reported (Delhaes et al, 2010 and Agarwal et al, 2008). In addi-
tion, corticosteroids are easily available as over the counter drugs in India (without 
a physician’s prescription), leading to a gross misuse in asthmatics and increases 
the risk of Aspergillus infection. In the absence of a widespread availability of my-
coserological tests and computer tomography (CT) scans these conditions of 
ABPA get masked and is only diagnosed at its late stages (iv). 
4 Aspergilloma and chronic pulmonary aspergillosis (CPA) 
Aspergilloma, generally referred to as “fungus ball,” may be formed due to repeat-
ed exposure to conidia and targets preexisting lung cavities, such as the healed and 
non-healed lesions, or cavities in tuberculosis, sarcodiosis, or other bullous lung 
disorders and chronically obstructed paranasal sinuses (Addrizzo-Harris et al, 
1997). In the early 1950s, aspergilloma was considered as the classical form of 
aspergillosis. In the current scenario 10-15% of patients with cavitating lung dis-
eases may develop this syndrome (Latgé 1999). 
CPA is described as a slightly different condition than aspergilloma, due to 
slow progression of infection by damaging the lung tissues, which may result in 
fibrosis and inflammation., The global prevalence of CPA, together with aspergil-
loma, estimated over a 5 year period in countries exceeding a population of more 
than 50 million was reported in 2005 by Denning et al (2011). The 5-year (2005-
2010) estimated prevalence of CPR per 100 000 population was 23.1 in India and 
0.6 in England (Denning et al, 2011).  
5 Invasive aspergillosis (IA) 
The occurrence of IA is usually observed in settings of immunocompromised 
states, but rarely found in immunocompetent hosts (Karim et al, 1997). Indeed, IA 
has become a leading cause of deaths, mainly among patients suffering from hema-
tological disorders. Within this group for example, the incidence of IA ranges be-
tween 7.9% to 11% (Pappas et al, 2010). IA also occurs in patients with nonhema-
togenous underlying conditions; increasingly reported in AIDS patients (1 to 12%) 
(Nash et al.1997) and has been a common infectious complication (25% to 40%) 




of chronic granulomatous diseases (Denning et al, 1998). Despite the remarkable 
advancement in the field of diagnostic medicine, the diagnosis of IA remains diffi-
cult even today, especially in its early stages. A definitive diagnosis of IA requires 
histopathological demonstration of mycelial growth in tissues. This is not possible 
in most patients, due to the serious nature of underlying conditions which often 
contraindicate tissue biopsy. Thus, IA is mostly diagnosed only during postmortem 
autopsy (Groll et al, 1996). The mortality rate in IA is high, generally greater than 
50%, which may reach upto 95% in certain cases (Maschmeyer et al, 2007). Due to 
the difficulty in diagnosis and rapid progression (1 to 2 weeks from onset to 
death), clinicians have no choice but to treat patients with suspected IA empirically 
rather than waiting for the diagnosis to be established. Moreover, waiting until 
diagnosis is confirmed will subject the patients to a greater risk of untreatable IA, 
since the fungal burden might reach a level too high for antifungal therapy. 
6 Chemotherapy for aspergillosis 
The various agents available for treating Aspergillus infections include  
 
a. Polyenes: Amphotericin B.  
b. Azoles: Voriconazole, Itraconazole, Posaconazole.  
c. Echinocandins: Caspofungin, Anidulafungin  Micafungin.  
 
Amphotericin B is one of the polyene groups of antibiotics produced by several 
species of Streptomyces (Hamilton-Miller, 1973). Amphotericin B and other polyenes 
bind to sterol in plasma membranes, thereby leading to alterations in the mem-
brane permeability and cell lysis (Kinsky, 1970). It has the broadest spectrum of 
antifungal activity, but severe side effects. Particularly nephrotoxicity following 
amphotericin B usage is very common. To increase the efficacy and reduce the 
toxicity, several newer formulations of amphotericin B have been developed; the 
most promising approach involved the modification of the physical state of am-
photericin B in different formulations with lipids. The examples of such formula-
tions include amphotericin B-lipid complex, amphotericin B colloidal dispersion 
and liposomal amphotericin B (Clark et al, 1991, Coukell et al, 1998 and Lopez-
Berestein, 1987). Azoles are synthetic derivatives of imidazole and have a wide 
range of antifungal activity. Particularly, voriconazole, itraconazole and posacona-
zole have been found to act against Aspergillus. Currently, voriconazole is the drug 
of choice for invasive IA.  The echinocandins are a newer class of antifungal agents 
with caspofungin, anidulafungin and micafungin exerting activity against Aspergillus. 
Caspofungin, posaconazole and AmB are considered second line agents for treat-
ment of IA. In addition, a combination therapy is increasingly used in IA (Her-
brecht et al, 2002). The rationale for combination therapy is that different classes 
of drugs act on targets of different pathways. 
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The antifungal agents are also used to treat allergic aspergillosis with the rationale 
that by reducing the fungal load, less antigenic stimulation will take place and 
hence a reduced inflammatory response as observed in ABPA. However, the 
treatment of ABPA with most fungicidals has been found to provide very low 
efficacy only (Malo, 2003). Therefore, glucocorticoids remain the mainstay of 
treatment for ABPA. But even in addition to glucocorticoids, the patient often 
requires treatment for long periods, there are high relapse rates on withdrawl and a 
state of steroid dependence is developed quite frequently (Agarwal et al, 2006). 
Itraconazole has been used as a corticosteroid-sparing agent in patients on 
long-term oral prednisolone treatment (Leon and Craig, 1999). An Indian study by 
Rai et al (2004) demonstrated that itraconazole improved symptoms, lung function, 
and the radiologic picture in patients of ABPA. A decline in exacerbation rates was 
seen in patients as well. It was also inferred from the Cochrane database review 
that itraconazole in addition to modifying the immunological activation associated 
with ABPA, improved clinical outcome (Wark et al, 2004). Therefore, it is suggest-
ed that until further results are available from large multicentre randomized clinical 
trials, the use of itraconazole should be restricted as a steroid-sparing agent to only 
those clinical settings where steroids are contraindicated or have intolerable side 
effects. The beneficial effect of antifungal agents in treating aspergilloma has not 
been indicated and so far it always requires surgical excision. 
7 Clinical diagnosis 
This issue has been haunting clinicians since the recognition of the disease as a 
distinct entity and even today there is no single test available, which can establish 
the diagnosis of ABPA. The diagnosis of ABPA usually relies on a set of criteria. 
Following criteria take clinical, radiological and serological features into account 




• Presence of transient pulmonary infiltrates (fleeting shadows) 
• Immediate cutaneous reactivity to A. fumigatus 
• Elevated total serum IgE 
• Precipitating antibodies against A. fumigatus 
• Peripheral blood eosinophilia 
• Elevated serum IgE and IgG specific to A. fumigatus 
• Central/proximal bronchiectasis with normal tapering of distal bronchi 





• Expectoration of golden brownish sputum plugs 
• Positive sputum culture for Aspergillus species 
• Late (Arthus-type) skin reactivity to A. fumigatus 
8 Serodiagnosis 
The diagnosis of A. fumigatus infections has been based on the clinical features, and 
on in vivo (skin prick test and intradermal test) and in vitro tests (radioallergosorbent 
test, enzyme linked immunosorbent assay ELISA and Western blot). Sensitization 
of hosts with allergens of A. fumigatus may induce elevated levels of total serum IgE 
and Aspergillus specific IgE and/or IgG antibodies. Many of these molecules have 
been shown to be useful in the serodiagnosis (Sarfati et al, 2006). The detection of 
total IgE and Aspergillus specific IgE and/or IgG antibodies in sera has been con-
sidered to be important immunodiagnostic criteria for ABPA (Kurup, 2006) and 
IA (Reiss, 2000 and Stynen et al, 1995). However, still there is a lack of antigenic 
standardization between laboratories, because of the use of local antigen prepara-
tions (de Oliveira et al, 2007). The crude extracts used at different centers for sero 
diagnosis are not comparable in their protein composition, due to use of different 
strains (Steringer et al, 1987) and even batch-to-batch variations of same strains 
have been quite common (Vailes et al, 2001). The fungal extracts mainly produced 
from mycelial cells and/or spores may differ in their protein pattern (Paris et al, 
1990). On the other hand, growth conditions, protein extraction methods and 
storage conditions are critical with respect to the quantity and existence of individ-
ual allergens in fungal preparations (Horner et al, 1995, Ferreira et al, 2004). In this 
context use of recombinant protein provides an alternative which is worth to ex-
plore. 
9 Recombinants proteins of A. fumigatus 
A large number of immunoreactive allergens/antigens of A. fumigatus have been 
identified (Crameri 1998, Vailes, 2001, and Crameri et al, 2006) and a brief descrip-
tion of A. fumigatus allergens is summarized by Abad et al (2010) and is shown in 
Table 1. 











Function Pathogenesis related 
activity 
1 Asp f1 Restrictocin,  
Ribonuclease  
Mitogillin 




Type 1 hypersensitivity 
2 Asp f2 ASPND1 Fibrinogen bind-
ing protein 
Adhesion, 
Type 1 hypersensitivity 








Type 1 hypersensitivity 
4 Asp f4 Hypothetical protein  Type 1 hypersensitivity 
5 Asp f5 Metalloprotease Protein degrada-




Type 1 hypersensitivity 
6 Asp f6 Mn superoxide dis-
mutase 




7 Asp f7 Secreted and cyto-
plasmic proteins 
 Type 1 hypersensitivity 





9 Asp f9 Cell wall glucanase, 
Crf1 
Cell wall assembly Type 1 hypersensitivity 




Type 1 hypersensitivity 










12 Asp f12 Heat shock protein 
P90,  
65 kDa IgE-binding 
protein 
Chaperone Chaperone activity and 
protein transport in 
growth at 37 ºC, 










In addition to the allergens of A. fumigatus, a large number of potential virulence 
factors are described in the literature (Abad et al, 2010). Some of these molecules 
have been shown to be useful in the serodiagnosis (Sarfati et al, 2006). However, 
there exists a lack of antigenic standardization between laboratories, because of the 
use of local antigen preparations (de Oliveira et al, 2007). This frequently results in 
variability of such antigenic preparations and thus, in a limited sensitivity and spec-





Protein name Function Pathogenesis relat-
ed activity 























15 Asp f16 43kDa protein 












17 Asp f18 Vacuolar serine 
protease 




18 Asp f22 Enolase Glucose metabolism Type 1 hypersensitiv-
ity 
19 Asp f23 Ribosomal protein 
L3 
Protein synthesis Type 1 hypersensitiv-
ity 
20 Asp f 27 Cyclophilin Peptide synthesis 
Chaperone 









22 Asp f 29 Thioredoxin Protein disulphide 
reductase 
Not known 
23 Asp f 34 PhiA cell wall pro-
tein 
Cell wall protein Not known 
       Adapted from Abad et al (2010)  
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(Sharma and Sarma, 1993). The diagnosis of ABPA still remains difficult, due to an 
overlap of its clinical and radiological features with cystic fibrosis (Delhaes et al, 
2010). It is also often misdiagnosed as tuberculosis, because of similar symptoms 
and therefore, treated incorrectly (Agarwal et al, 2008). In fact, a cross reactivity 
due to sharing of common antigenic epitopes of A. fumigatus allergens with other 
fungal and bacterial allergens renders it difficult to use all A. fumigatus allergens for 
diagnostic purposes (Crameri et al, 2009). In the absence of ideal antigenic prepara-
tion the crude antigenic fractions of A. fumigatus are commonly used for diagnosis 
of ABPA. Several biotech companies offer tests based on the crude antigens of A. 
fumigatus. The ELISA and radioimmunoassay based on the few recombinant aller-
gens (rAsp f1-f4 and rAsp f6) of A. fumigatus have also been used commercially for 
diagnosis of allergic aspergillosis (Kurup et al, 2006, and Knutsen et al 2004). The 
use of recombinant allergens, however, has been limited to the IgE detection only 
(Sarfati et al, 2006). Therefore, more effort is required to produce the recombinant 
antigens, which should provide more standardized diagnostic tests. 
Global efforts are made to identify antigenic preparations of A. fumigatus with 
therapeutic potential (a details see, Ito et al, 2006, Ito et al, 2009 and Montagnoli et 
al, 2006). Most studies carried out so far on vaccination, have been limited to ex-
perimental animals only and not even a single protein has yet been identified to 
develop immunoprotection in humans. Therefore, more A. fumigatus proteins from 
the crude fractions of A. fumigatus are needed to be screened from conidial, secret-
ed and cytosolic fractions to identifiy the potential immunotherapeutic molecules. 
10 Identification of new molecules and their possible use in 
diagnosis and therapy  
The release of 29.4 megabase genome has reported the presence of 9,926 genes in 
A. fumigatus (Nierman et al, 2005). The products of many of these genes have not 
yet been identified and only just predicted. The recent update in a public resource 
for genomic data of various Aspergillus species provided an array, The Central As-
pergillus Resource (CADRE) of online tools for searching and visualizing features 
of the significant fungal genus to understand the pathogenic components of A. 
fumigatus (Mabey Gilsenan et al, 2011). The Aspergillus genome database (AspGD) 
has now completed a comprehensive review of the entire published literature on A. 
fumigatus and multispecies information. The AspGD facilitates comparative ge-
nomics by providing a full-featured genomics viewer, as well as matched and 
standardized sets of genomic information for the sequenced species of Aspergillius 
(Arnaud et al, 2011). This information could be considered as a tool for identifica-
tion of molecules which are not yet known. But their sequences have been identi-
fied in A. fumigatus genome which might play crucial role in the development of 
Aspergillus induced allergic and invasive disorders. A review of literature has shown 
that out of the known allergens of A. fumigatus, a single molecule may not be suffi-




cient for universal use in the diagnosis of ABPA at initial stages of infection (Ku-
rup, 2005). Thus the less explored cytosolic antigenic fraction in combination with 
secreted molecules may form a panel of potential key determinants for the selec-
tion of universally reacting molecules for wider application, as well as for early and 
more specific diagnosis of A. fumigatus induced disorders. A recent report discussed 
the comparison of conventional diagnostic criteria, which included detection of 
anti-A. fumigatus IgE, IgG, precipitins and IgE against recombinant A. fumigatus 
allergens and/or detection of thymus and activation regulated chemokine to diag-
nose ABPA in CF patients (Delhaes et al, 2010). Investigators used the cDNA 
library screening approach in order to improve available diagnostic tools, but se-
lecting the right protein target using cDNA screening has proven to be difficult 
(Glaser et al, 2009 and Glaser et al, 2008). Recent advances in technologies intro-
duced microarray-based allergen chip diagnosis that made it possible to detect IgE 
against a multiple number of allergens in small amounts of serum (Ott et al, 2008). 
Though this approach appeared to be very promising, it still requires evaluation 
and optimization (Schneider et al, 2006). In fact cloning and expression of all anti-
gens/allergens of A. fumigatus to elucidate their biological functions is not feasible. 
Therefore dependence on available, less useful few recombinants may continue for 
some time.  
First reports on the proteomics based identification of A. fumigatus molecules 
have appeared only in the last decade (Bruneau et al 2001). The possible reason for 
such delay was unavailability of the proteomic based information on A. fumigatus, 
difficulty in sample preparation from its fractions (cell wall, secreted, cytosolic and 
mycelial) and poor separation of fungal proteins by two dimensional gel electro-
phoresis (2DE) (Kniemeyer et al 2008). In a recent report Vodisch et al (2009) 
generated a proteome map of A. fumigatus from cytosolic and mitochondrial frac-
tions. Teutschbein et al (2010) identified proteins from dormant conidia to provide 
complete profiling of A. fumigatus conidial fraction. Gautam et al (2007) identified a 
panel of secreted antigens as potential allergens of A. fumigatus by IgE reactivity 
with sera of ABPA patients. Kumar et al (2011) also identified secreted antigens of 
A. fumigatus by immunoreactivity with ABPA patients and hyper reactive animal 
sera. A detailed account of vaccine candidates from cell wall-associated (Asif et al, 
2006) and immunoprotective molecules from cytosolic fraction (Asif et al, 2010) 
has been reported by our group. A comprehensive identification of potential aller-
gens/immunogens from secreted and cytosolic fractions of A. fumigatus on the 
basis of IgG and IgE reactivity with sera of ABPA patients was carried out and 
identified 101 molecules (Singh et al, 2010a and 2010b), including 35 secreted and 
66 cytosolic allergens/immunogens. These identified panels of immunoreactive 
molecules could be promising in developing a chip assay and diagnostic peptides 
for better management of A. fumigatus induced infections.  




Aspergillosis is a complex disorder, which is difficult to treat and various limita-
tions remain associated with the use of existing allergens/immunogens of A. fu-
migatus as diagnostic and therapeutic molecules. The recent developments in the 
high throughput techniques, such as immunoproteomics, have introduced hun-
dreds of new antigenic proteins, few of which are already characterized for diag-
nostic utility, but are found to be of limited use. Hence selection of newly identi-
fied antigenic/immuogenic proteins for recombinant production and their detailed 
characterization for their immunological properties will be promising in diagnosis 
and desensitization therapies of aspergillosis.  
 
 
Figure 2: Approaches for identification of diagnostic and therapeutic mol-
ecules for better management of Aspergillus induced infections. 
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18 IGHEP – a partnership on health education 
between Indonesian and German universities 
Ichsan, Marut Tangwattanachuleeporn, Abu Tholib Aman, M. Nasrum Massi, 
Mohamad Yani, Syrhul, Christiane Hennecke, Natalie Diffloth, Uwe Groß and 
IGHEP members 
1 Introduction 
In late 2004, the coastal areas of many countries situated along the Indian Ocean 
were devastated by a tsunami. Located near the epicenter of the causative earth-
quake, the Aceh province in northern Sumatra/Indonesia suffered most. In Banda 
Aceh alone, the capital of that province, more than 250,000 fatalities or missed 
people were counted. Amongst these were numerous students and lecturers from 
the local universities. 
2 The first step – a partnership between two universities 
Shortly after the tsunami catastrophy, the Georg-August-University Göttingen 
initiated a Fact-Finding-Mission composed of three representatives from the Faculties 
of Medicine, Agriculture, and Forestry. In early 2005, this group evaluated the 
possibilities of a partnership with the Syiah Kuala University (UNSYIAH) in Ban-
da Aceh. As one result, a Memorandum of Understanding between the Medical Faculty 
of UNSYIAH (UNSYIAH-MED) and the University Medical Center Göttingen 
(UMG) was signed. A first summer school was organized in 2006 in Banda Aceh. 
This outlined the themes for which further academic and educational support from 
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UMG and its German partners could be provided to UNSYIAH-MED. At that 
time, neither a Department of Infectious Diseases, nor Tropical Medicine, nor an 
isolation ward for highly contagious infections were available at UNSYIAH-MED. 
Likewise, no Master’s or PhD program could be offered to the medical  students in 
Banda Aceh. Instead, all medical students were offered a four-year Bachelor pro-
gram that was followed by a two-year period of clinical practice in order to become 
a physician. 
As a consequence, the major aims of the Göttingen-Banda Aceh partnership 
were to develop educational programs on infectious diseases and tropical medicine 
and to guide the process of implementing an interdisciplinary Master’s program on 
Molecular Tropical Medicine at UNSYIAH — one that would allow the universi-
ty’s students to obtain a Master’s degree, which is a prerequisite for applying for 
PhD study programs in Germany and elsewhere. 
Starting in 2007, the German Academic Exchange Service supported the part-
nership financially through its Physicians Program. By this means, regular summer 
schools and workshops on the management of defined infectious diseases were 




Figure 1: Courses on microscopy (H. Fleischmann, 2009) and tuberculosis (O. 
Zimmermann, 2009) in Göttingen 
 
Training units on specific subjects related to infectious diseases have been con-
ducted in Göttingen and Banda Aceh – covering laboratory-related topics such as 
cultivation of bacteria and polymerase chain reaction (PCR) (Fig. 2), but also clini-
cally related techniques such as ophthalmology, ultrasound and laparoscopy 
(Fig. 3).  
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Figure 2: Practical teaching in cultivation of bacteria (M. and O. Bader, 2008) and 
in PCR (J. I. Dasti, 2008) in Banda Aceh. 
 
E-learning modules on (i) basic molecular biology and (ii) applied molecular biolo-
gy related to specific tropical infectious diseases were developed. In addition, In-
donesian faculty members were able to join UMG in order to obtain their Master’s 
or PhD degrees. Reciprocally, via medical rotations in Banda Aceh, German medi-
cal students have been able to take advantage of the opportunities offered by UN-
SYIAH-MED to learn more about practical aspects of tropical infectious diseases. 
 
Figure 3: Training units on ultrasound (H. Sudeck, 2008) and endoscopy (A. Guen-
thert, 2010) in Banda Aceh. 
 
Another accomplishment was the establishment of a Department for Tropical 
Medicine as well as an isolation ward – especially for patients with suspected bird 
flu – in the New Hospital RSUD Dr. Zainoel Abidin. This hospital was construct-
ed in the post-tsunami era through the financial support of the Federal Republic of 
Germany. Since its founding, it has served as the teaching hospital of UNSYIAH-
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MED. Finally, the partnership supported the development of a road map foresee-
ing the implementation of the above-mentioned Master’s program on Molecular 
Tropical Medicine at UNSYIAH. 
3 The second step – the establishment of the Indonesian 
German Health Education Partnership (IGHEP) 
By opening the summer schools to lecturers and participants from other universi-
ties, the original partnership between UNSYIAH-MED and UMG matured into a 
network of more than 15 Indonesian and eight German biomedical institutions 
(Fig. 4).  
 
Figure 4: The Indonesian-German Health Education Partnership (IGHEP) as is in 
2010. 
 
Starting in 2010, a migrating summer school was established that took place in 
Banda Aceh and Yogyakarta/Indonesia. In addition, this network decided to des-
ignate itself the “Indonesian German Health Education Partnership, IGHEP” and 
to create its own website (http://ighep.wordpress.com) in order to establish a clear 
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organizational identity and platform for communicating and sharing information 
among stakeholders. 
Having established a bi-national medical network, a focus had to be decided 
upon for medical themes that had a high socio-medical impact. Apart from infec-
tious diseases, (which in densely populated tropical countries represent a major 
factor in morbidity and mortality), infant and maternal health was determined as an 
issue playing a critical role. 
Indeed, in 2000 the member states of the United Nations agreed upon the 
Millennium Development Goals (MDG). The MDG hopes to attain specific goals 
by 2015, among them MDG 4 and 5, which are still far from achieving their de-
sired targets. While MDG 4 hopes to reduce the under-five mortality rate by two-
thirds between the years 1990 and 2015, MDG 5 aims to improve maternal health 
and reduce maternal mortality by three-quarters by 2015.  
Improving health care, food production and basic economic conditions are 
key goals in international development. IGHEP is committed to addressing the 
improvement of maternal-child health in Indonesia through an integrated ap-
proach that brings together medicine and natural science, as well as social and eco-
nomic science, under one roof.  
 
Table 1: Data by country for MDG 4 
 1990 (2003-) 2008 Goal 2015 
Germany 9 4 3 
Indonesia 91 41 30 
 
Table 2: Data by country for MDG 5 
 1990 2003-2008 Goal 2015 
Germany 22 8 5 
Indonesia 650 230 165 
Data source: www.unicef.org/infobycountry and www.mdgmonitor.org 
 
Although Indonesia is on track regarding MDG 4 and 5 (Table 1 and 2), when 
compared with the situation in Germany, mother-child health in Indonesia leaves 
considerable room for improvement. It is expected that broad variation exists for 
the conditions and basic indicators of maternal-child health within the different 
regions of Indonesia. Therefore, including participants from the major Indonesian 
islands in the Indonesian-German Health Education Partnership allows us to ad-
dress geographic differences regarding maternal-child health within a territory as 
broad as Indonesia. 
 
Causes of maternal and child morbidity and mortality in countries such as Indone-
sia are complex, but are highly dependent upon access to and quality of medical 
care, as well as upon specific environmental conditions. Most important is access 
to fresh potable water and to safe, high quality food. Medical study programs are 
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often limited to addressing health issues as such, but neglect issues indirectly asso-
ciated with health. For these reasons, the Indonesian-German Health Education 
Partnership intends, through discussion and collaboration, to elaborate interdisci-
plinary approaches for improving health by implementing strategies that combine 
medicine, veterinary sciences, agricultural and forest sciences, geography, and the-
ology, as well as social and economic sciences. Through this interdisciplinary ap-
proach, the close interconnection of the health-associated MDGs 4 and 5, along 
with MDG 1 on nutrition, MDG 3 on gender equality, MDG 6 on AIDS/HIV, 
tuberculosis and malaria, and MDG 7 on environmental sustainability, will be tak-
en into account. 
Based upon our initial partnership program which had a focus on infectious 
diseases, the Indonesian-German Health Education Partnership aims to concen-
trate its future programs on infectious diseases that are relevant for maternal and 
child health — especially under tropical conditions such as those found in Indone-
sia, including for example malaria, dengue fever, HIV/AIDS, tuberculosis, typhoid 
fever, and STDs. Since issues such as (i) access and quality of medical care, and (ii) 
access to and risk assessment of drinking water and nutrition are relevant to the 
development of these diseases, we believe a multidisciplinary, biomedical approach 
will be appropriate for developing adequate problem-solving strategies — ones 
that include an assessment of the impact of socioeconomic, ethnic and gender 
issues on the respective diseases. 
In order to facilitate this multidisciplinary approach, members of the UMG 
and its local partners, the Faculties for Agricultural and Forest Sciences, Geogra-
phy, Social and Economic Sciences, as well as of the Faculties of Biology and The-
ology of the University of Göttingen have established the Göttingen International 
Health Network. Together with its partners from other German and Indonesian 
institutions, this network aims to substantially contribute to the development of 
interdisciplinary strategies on ways to improve health within the above-mentioned 
context. 
Following the summer schools in Banda Aceh (2006, 2007, 2008, and 2010), 
Göttingen (2009), and Yogyakarta (2010), the DAAD supported a second round of 
partnership within its program PAGEL (Partnerschaften für den Gesund-
heitssektor in Entwicklungsländern; Partnerships for the Health Sector in Devel-
oping Countries). In line with this broadened program, the first summer school 
was organized within the context of the Indonesian-German Health Education 
Partnership in Makassar/Sulawesi in 2011. More than 130 participants presented 
and discussed issues related to maternal-child health. The presentations compiled 
information on the following subjects: 
- the epidemiology of infections affecting maternal-child health under tropical 
conditions in Indonesia (e.g. malaria, dengue fever, HIV/AIDS, tuberculosis, 
typhoid fever) 
- the epidemiology of pregnancy-related infections that occur worldwide (e.g., 
group B streptococci infection, listeriosis, CMV, toxoplasmosis) 
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- potential risk factors that are of relevance to the above-mentioned diseases  
- presently employed measures and strategies for improving health, access to 
quality nutrition and to clean drinking water  
-  veterinary medicine and agriculture within the context of the overall health of 
the ecosystem (human health, animal health, and plant health) and also related 
to infections influencing maternal-child health 
- the impact of gender, economic and religious issues on the above-mentioned 
diseases. 
 
In addition to presentations, and laboratory courses, case records were discussed in 
small groups and medical consultations were provided during ward rounds. Joint 
research projects with a focus on maternal-child health were initiated and a mycol-
ogy-related network of young scientists including the nomination of Young 
ISHAM' representative for Southeast Asia was established during this first IGHEP 
summer school.  
Taking a long view, the Indonesian-German Health Education Partnership has 
a broad and diverse catalog of aims. Among them is to highlight the most preva-
lent infectious diseases affecting maternal and child health in different regions of 
Indonesia. In this context, potential risk factors influencing maternal and child 
morbidity and mortality should be discussed, and the impact of gender, economic 
and religious issues on health should be evaluated. Here it is also important to 
identify needs and knowledge gaps, especially when it comes (i) to tools and meth-
ods for adequate diagnosis of disease and (ii) to risk assessment regarding water 
and food, including methods of molecular biology. The group’s goals also include 
the discussion of possible integrated and sustainable strategies for the prevention 
and management of infectious diseases of mothers and their children. 
On a structural level and over the long run, the Indonesian German Health 
Education Partnership should be stabilized and extended organizationally. This 
should include the funding of a network of biomedical alumni from German uni-
versities across Indonesia. Further, regional support should be augmented through 
the strengthening of subject-focused local networks — thereby leveraging benefits 
for stakeholders on different levels in research, education, society, business and 
politics. Together, this will increase awareness of and willingness to improve ma-
ternal-child health in Indonesia. 
4 IGHEP members 
Indonesia: 
E. Amalia (Palembang), A. T. Aman (Yogyakarta), R. Amtarina (Riau), N. M. An-
dalas (Banda Aceh), N. A. Audah (Kalimantan), Azwar (Banda Aceh), A. Budianti 
(Jakarta), S. M. T. Chalid (Makassar), Chrysanti (Bandung), H. Dimiati (Banda 
Aceh), I. B. N. P. Dwija (Denpasar), D. B. Febriani (Makassar), Franciscus (Me-
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dan), M. Gaffar (Makassar), P. Hadi (Semarang), I. Hafizah (Kendari), I. Handaya-
ni (Makassar), R. Hapsari (Semarang), Hasmiwiati (Padang), Z. Hayati (Banda 
Aceh), M. Hendrayana (Bali), Ichsan (Banda Aceh), R. Indah (Banda Aceh), I. 
Iqbalawati (Banda Aceh), A. Indrayati (Bandung), K. F. Jamil (Banda Aceh), F. 
Jamal (Banda Aceh), F. Juliantina (Yogyakarta), M. J. Kurnia (Banda Aceh), D. C. 
Lestari (Jakarta), T. Mahdi (Banda Aceh), M. Masri (Makassar), M. N. Massi (Ma-
kassar), Mulyadi (Banda Aceh), H. Munirwansyah (Banda Aceh), A. K. Ningrum 
(Jakarta), H. Nirwati (Yogyakarta), L. Nurbati (Mataram), Nurfadly (Medan), P. B. 
Purnomo (Surabaya), A. E. Putra (Padang), Rahmiati (Banjarmasin), L. P. Riski 
(Yogyakarta),  Rusmunandar (Banda Aceh), R. Sadeli (Bandung),  L. Salawati (Ban-
da Aceh), L. Saptawati (Solo), E. N. Sholikhah (Yogyakarta), M. P. L. Suriana 
(Denpasar), I. K. Swastika (Denpasar), Syrhul (Banda Aceh), B. Wahydin (Makas-
sar),  S. Widad (Yogyakarta), A. D. W. Widodo (Surabaya), M. A. Wijayanti (Yog-
yakarta), Yadi (Samarinda), D. Yahwardiah (Medan), A. Yaman (Banda Aceh), M. 
Yani (Banda Aceh), Y. Zenia (Riau), Zubir (Lhokseumawe) 
 
Germany, Switzerland:  
M. Bader (Göttingen), O. Bader (Göttingen), G. Braus (Göttingen), T. Buhl (Göt-
tingen), J. I. Dasti (Göttingen), N. Diffloth (Freiburg), J. Dreesman (Hannover), T. 
Fleige (Göttingen), M. Grade (Quakenbrück), U. Groß (Göttingen), A. Günthert 
(Bern/CH), M. Hufnagel (Freiburg), G. Jahn (Tübingen), M. Kirchner (Hannover), 
R. Kuehne (Göttingen), M. Loebermann (Rostock), A. Malik (Göttingen), A. Mül-
ler (Würzburg, J. Petersen (Göttingen), E. Reisinger (Rostock), C. Schroeder (Göt-
tingen), F. Schwab (Bern/CH), N. von Steinbüchel (Göttingen), A. Stich (Würz-
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19  Usefulness of  microbiological laboratories in  
a rural African setting 
Uwe Groß, Marco Schulze, August Stich and Ortrud Zimmermann 
1 Introduction 
Infectious diseases account for a major proportion of morbidity and mortality in 
African patients. According to a WHO estimate for 2008, infectious and parasitic 
diseases including respiratory infections are responsible for more than one fifth of 
worldwide deaths but in Africa for even more than 50 % of all deaths (WHO, 
2008). Especially invasive bacterial infections may be an underappreciated cause of 
death (Petti et al. 2006).  
A limited number of diagnostic tests like blood films for malaria, microscopy 
of stool samples and urine for detecting parasites and worm eggs, microscopy of 
acid-fast stained sputum smears for TB diagnosis as well as rapid tests for diagnos-
ing HIV infection and syphilis are available in most African hospitals (Bates and 
Maitland, 2006). In contrast, facilities to perform bacteriology are restricted only to 
larger hospitals or university health institutions in most countries of sub-Saharan 
Africa. Indeed, laboratory services are one of the most neglected areas of health 
care provision in sub-Saharan Africa and are disproportionately affected by (i) staff 
shortages, (ii) low enthusiasm, (iii) poor communications, (iv) lack of training, and 
(v) inadequate equipment that all have an influence on those involved in delivering 
health care in African countries under resource-poor conditions (Bates and Mait-
land, 2006). In line with this grievance is the fact that only relatively little funding 
has been allocated to build laboratory capability in contrast to disease prevention 
and provision of care (Petti et al., 2006). It is therefore not surprising that the vast 
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majority of small hospitals especially in rural and resource-poor settings lack ap-
propriate laboratory facilities and skills in bacteriological diagnosis (Okeke, 2006). 
The situation is even worse when it comes to the diagnosis of fungal infections. 
Based on these limitations in laboratory diagnosis, valid epidemiological data 
on most infectious diseases other than malaria, tuberculosis, syphilis and 
HIV/AIDS are rarely available for Africa, and even those might not be reliable. In 
fact, it is widely accepted that febrile episodes are usually classified as malaria but 
are in reality often the result of systemic bacterial infections. Treatment guidelines 
for infectious diseases in Africa either rely on so-called historical data or expert 
opinions, single case-based criteria, data derived from European or US American 
studies, or just do not exist. Consequently, without proper epidemiological baseline 
information and reliable diagnostic tools, treatment of infectious diseases might be 
inadequate resulting in a high burden of morbidity and mortality and the emer-
gence of antibiotic resistances (Okeke, 2006; Petti et al., 2006). 
For these reasons and starting as a pilot project in the year 2000, the University 
Medical Center Göttingen together with the Medical Mission Institute Würzburg 
established laboratories for microbiological diagnosis in missionary hospitals in 
rural settings of Ghana which since then run continuously and provide service at 
adequate standard. Here, we describe the implementation process and discuss the 
necessity for appropriate microbiological diagnosis under resource-poor settings. 
2 Establishing microbiological laboratories 
2.1 Prerequisites  
Motivation for laboratory staff depends on several aspects, amongst them (i) self-
confidence in her/his own knowledge and technical skills, (ii) an adequately 
equipped and maintained laboratory, (iii) appreciation of their work by the physi-
cians, and (iv) an appropriate salary. 
 
For these reasons, prerequisites to establish a microbiological laboratory were de-
fined by us as follows: 
 
• sufficient expertise of the laboratory staff in basic and advanced laboratory tech-
niques (e.g. biochemistry, serology, microscopy, parasitology); 
• existing and good communication structures between physicians and laboratory 
staff;  
• an interest of both, physicians and laboratory staff, to participate in the compre-
hensive training courses; 
• a well-functioning general laboratory for clinical chemistry, haematology, blood-
transfusion, HIV and syphilis serology, and parasitology; 
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• two air-conditioned rooms (one for use as media kitchen, the other for culture 
and differentiation techniques, as well as for sensitivity tests; Fig. 1). If possible, 
solar energy supply in connection with a storage battery should be considered for 
the air condition and electronic equipment. 
• laboratory glassware and equipment (including pressure cooker as autoclave, 
incubator, hot oven for sterilization, water bath and microscope). The costs for 
hardware were about 15.000-18.000 €. In addition, a refrigerator with freezer de-
partment should be bought in the given country. Description of electronic 
equipment should be available in English, French, or the language that is official-
ly been spoken in the given country. Routine maintenance and spare parts should 
be available for all equipment.  
• reagents for culture media and differentiation. The starting costs for these were 
about 5.000 €. 
• laboratory glassware and especially the reagents should be available in the given 
country to assure independence of the laboratory which is key for sustainability 
















Figure 1: Microbiological laboratory in Eikwe; media kitchen (left) and training 
course in the main laboratory room (right). 
 
In Ghana, the three Catholic Mission hospitals in Assin Foso, Eikwe and Nkaw-
kaw met these criteria and were therefore selected for the implementation of mi-
crobiology. At these hospitals, a basic bacteriological laboratory was established 
and three training courses were conducted on standardized operational procedures 
(SOPs) to ensure an inexpensive and appropriate diagnostic program of high quali-
ty even in resource-poor settings.  
In addition to the training courses, the leading laboratory technician together with 
the financial administrator was instructed on how to properly calculate the costs 
for microbiological diagnosis and how to charge the patients for this diagnostic 
service. This strategy also helped to reconsider the salary scheme for those labora-
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tory personnel who showed outstanding engagement in implementing innovative 
diagnostics of infectious diseases.  
2.2 Overview of the implementation concept 
Basic understanding of (i) the principles of infectious diseases, (ii) clinical presenta-
tions of the most prevalent infectious diseases, (iii) adequate selection of specimens 
to be taken, and (iv) pathogen distribution in regards to defined diseases had to be 
imparted to physicians and lab personnel. Therefore, these pre-analytical aspects of 
infectious diseases were taught and discussed in joint courses allowing also a team 
building process between physicians with a special interest in infectious diseases 
and the laboratory personnel. In the African situation, where the number of physi-
cians is often limited, and depending on the clinical presentation, the sampling of 
specimen was delegated to the lab technicians in defined cases. Therefore, these 
joint courses also included ward rounds in order to demonstrate adequate speci-
men sampling and to demonstrate the significance of microbiological diagnosis to 
both, the physicians and the lab personnel.  
In addition, separate courses were given (i) for lab personnel on analytical as-
pects, e.g. diagnostic methods, quality control measures and how to write the lab 
report, and (ii) for physicians on post-analytical aspects, such as the rational use of 
antibiotics and the development of antimicrobial resistance.  
The entire implementation of appropriate microbiology took two courses (first 
year = basic medical microbiology and analytical methods; second year = applied 
and clinical microbiology) and was completed by a third course in which the lab 
personnel was taught on how to train other lab members as well as personnel from 
laboratories of other hospitals. Each course lasted around 4 weeks and was given 
by a physician specialized in “microbiology, virology and epidemiology of infec-
tious diseases” and a technician with special expertise in medical microbiology. 
Upon successfully passing the theoretical and practical examination, the partici-
pants received a certificate.  
2.3 Analytical procedures 
Microbiological diagnosis was restricted to life-threatening or highly prevalent 
infections, such as blood-stream infections, meningitis or wound infections. This 
also had the advantage of not interfering significantly with the existing workload of 
the laboratory staff, because they should also continue to perform clinical chemis-
try and other laboratory techniques at high quality. 
In order to keep costs low, no ready-made test kits were used. Instead, the im-
plementation of in-house tests for the identification of bacteria was favored and 
the media were prepared locally in the laboratory. Media preparation was always 
done during day-light times and in a room with closed windows (air condition!) in 
order to minimize the risk of contamination by flying or crawling insects. For in-
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Put 3 or 5 ml blood in 30 or 50 ml BHI bouillon 
and store the blood culture at 37oC for up to 7 days
The blood culture bottle has to be inspected twice daily: 
Evidence of bacterial growth (e.g., turbidity or gas production):
Microscopy of a Gram-stained 
slide from the blood culture
and culture on chocolate agar
After 24 hrs: 
Microscopy of a Gram-stained slide 
and culture on chocolate agar
After 72 hrs: 
Microscopy of a Gram-
stained slide and 
culture on chocolate 
agar (in critical cases 










ternal quality control, all agar plates were incubated overnight at 37oC in order to 
exclude contamination prior inoculation.  
The following flow chart and table demonstrate the algorithms that were used 
to investigate blood-stream infections (Fig. 2) and to identify bacteria belonging either 
to the normal flora or to the most prevalent pathogens (Table 1). The applied basic 
bacteriological tests guaranteed that laboratory personnel with even lesser qualifica-
tions could easily be trained as supporting staff.  
Figure 2: Algorithm for diagnosing blood-stream infections 
 
Microscopy was done from all pre-incubated blood cultures and sediments of CSF. 
Depending on the microscopic result, a first report could be given to the physician 
in charge (see box below). That, however, had to be subsequently confirmed by the 
results from culture and differentiation assays. 
 
  Gram: + cocci in clusters -> suspect of Staphylococcus aureus /S. epidermidis 
 + cocci in chains  -> suspect of streptococci / enterococci 
 + diplococci  -> suspect of pneumococci 
-  diplococci  -> suspect of meningococci 
-  rods   -> suspect of Salmonella Typhi, E. coli and others 
-  rods, pleomorphic -> suspect of Haemophilus influenzae 
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Table 1: Algorithms for bacterial differentiations in a resource-poor setting (for cost 
effectiveness, the microscopic diagnosis of blood culture or CSF guides the selec-
tion of subsequent agar plates; in indeterminate cases, both blood agar and 





























+ cocci -> golden colonies 
with hemolysis 






+ cocci -> white colonies 
w/o hemolysis 


























+ cocci  
in chains 
















+ cocci  
in chains 




bile esculin + 
NaCl 6.5%+ 
Enterococci 




-> use S. aureus as 
wet nurse for 
satellite phe-
nomenon 
no growth X-, V-, XV+ Haemophilus 
influenzae 
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Microbiological diagnosis of meningitis was performed from cerebrospinal fluid 
(CSF). Following centrifugation, the sediment was used for microscopy and culture 
on chocolate agar. In some cases, we observed that meningococci could not be 
cultivated on chocolate agar plates, when these were prepared from blood derived 
from human donors. Further investigations showed that inhibitory substances, 
most likely antibiotics, were present in the blood. Therefore, blood for preparing 
media plates should be drawn from sheep, which are inexpensive and should be 
kept for this purpose on the hospital ground or laboratory ward. 
For diagnosing wound infections, swabs were taken from the suspected ana-
tomical site and cultivated on blood agar and McConkey agar plates for at least 2 
days. 
In general, chocolate agar allows growth of nearly all facultative anaerobe and 
aerobe bacteria including meningococci and Haemophilus influenzae as well as fungi. 
The same bacteria (excluding meningococci and Haemophilus influenza w/o wet 
nurse bacteria) and fungi grow on blood agar. However, blood agar has the ad-
vantage that - if present - the type of hemolysis can be used for diagnostic purpos-
es. Finally, McConkey agar was used as a selective media for gram-negative rods, 
allowing also the differentiation in lactose-positive and negative bacteria. 
Biochemical differentiation of enterobacteriaceae was achieved using an in-
house biochemical differentiation system that consisted of five tubes: Kligler agar 
(glucose, gas formation, lactose and H2S formation), glucose bouillon, citrate, urea, 
and MIO (motility, indole, ornithine). If the biochemical differentiation test re-
vealed the species Salmonella enterica or Shigella spp., subsequent serotyping was per-
formed using defined antisera (Table 2). 
 
Table 2: Serotyping scheme of Salmonella enterica and Shigella spp.  
 
 A-67 B 09 Vi  ShigI ShigII 
S. Typhimurium + + o o    
S. Enteritidis + o + o    
S. Typhi (most strains) + o +/o +    
S. Paratyphi A + o o o    
S. Paratyphi B + + o o    
S. Paratyphi C + o o +/o    
Citrobacter freundii (+) o o o    
Proteus vulgaris (+) (+)      
Shigella flexneri/S. sonnei      + o 
Shigella dysenteriae      o + 
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2.4  External quality control 
A key element of the implementation of microbiological diagnosis was the com-
mitment of the laboratories to participate in regular external quality controls that 
were provided biannually by the Institute of Medical Microbiology of the Universi-
ty Medical Center Göttingen. These quality controls consisted of three bacterial (or 
yeast) species. The laboratories had to identify the correct bacteria (or had to give 
Candida in case of yeasts) and had to achieve the correct sensitivity test results in 
order to receive their certificate (Fig. 3). Our strategy to begin the pilot phase with 
three hospitals assured that in case that one of the participating laboratory failed 


























Figure 3: Certificates for successful participation in external quality controls on 
display in one of the laboratories. 
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3 Microbiological investigations and results 
In order to motivate the participating physicians and laboratory staff, minor epi-
demiological projects were initiated. These were also used to evaluate the analytical 
performance of the laboratories. 
3.1 Bacterial colonization of the nasal mucosa  
The first event of bacterial infection is the colonization of the mucosa or skin. In 
order to evaluate the potential risk of infection, the colonization of the nasal mu-
cosa was investigated. For this, swabs from the nasal mucosa of 200 individuals 
present at the outpatient area of the St. Martin de Porres Hospital in Eikwe/Ghana 
were analyzed for the most prevalent bacterial species. As a comparator, 101 indi-
viduals were analyzed, who were present at a meeting of the Medical Mission Insti-
tute in Würzburg/Germany. Significant differences in the colonization of the nasal 
mucosa between Ghanaen and German individuals were obvious (Table 3). 
Whereas Staphylococcus aureus and CNS were found in both study populations at 
similar ratios, the nasal mucosa of Ghanaen individuals was significantly more 
often colonized with nonfermenting bacteria (including Pseudomonas spp.) and En-
terobacteriaceae (Groß and Seeba, unpublished). 
At the time the swabs were taken (2001/2002), chloramphenicol was widely 
used in Ghana but not in Germany anymore. In contrast, the chinolon ciprofloxa-
cin was already available in Germany but not in Ghana at that time. As expected, 
the ratio of chloramphenicol-resistant enterobacteriaceae that were found on the 
nasal mucosa was significantly higher in Ghana than in Germany (62% versus 5%), 
whereas the ratio of ciprofloxacin-resistant CNS was significantly higher in Ger-
many when compared to Ghana (20% versus 5%) (Groß and Seeba, unpublished).  
 
Table 3: Colonization of the nasal mucosa in German and Ghanaen individuals 
 
Bacterial species Individuals from 
Ghana 
(n = 200) 
Individuals from  
Germany 
(n = 101) 
Coagulase-negative staphylo-
cocci (CNS) 
49.0% (98) 49.5% (50) 
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3.2 Blood-stream infections 
The results obtained from the nasal swabs suggested that the spectrum of bacteria 
that colonize mucosal surfaces might have a direct impact of invasive infections. 
Indeed, own data from a subsequent investigation of blood cultures indicated that 
the ratio of Gram-negative rods causing bacterial blood-stream infection is higher 
in African than in German patients (37-55% versus 20-40%).  
Similar to the situation of bacteria that were cultivated from the nasal mucosa, 
a high ratio of chloramphenicol resistance was also found in those bacteria that 
were isolated in Ghana in 2001/2002 from blood cultures (Zimmermann et al., 
2005). Following the introduction of the chinolon ciprofloxacin in 2004 and an 
increased use of cefuroxime in Ghana, the rate of chloramphenicol-resistant bacte-
ria causing blood-stream infections in 2009 did not change significantly (Groß et 
al., 2011). However, significantly more bacteria causing blood-stream infections 
















Figure 4: Resistance rates of bacteria causing blood-stream infections in patients 
from the participating hospitals in 2001/02 versus 2009. 
3.3 Wound infections 
In contrast to Germany, wound infections are widespread in rural African settings. 
The reasons for this are obvious, e.g.: (i) low standard of personal hygiene, (ii) 
high-risk activities such as using the bush knife without protection, (iii) reduced 
health-seeking behaviour, and (iv) in many cases, the so-called traditional healer or 
herbalists is the first person to be contacted and who might provide inadequate 
primary care (Fig. 5). Although Enterobacteriaceae were again found to dominate 
in these infections, other pathogens such as Staphylococcus aureus or Streptococcus py-











AMP = ampicillin,  
CEF = cefuroxime,  
GEN = gentamicin,  
SMX=trimethoprim 
-sulfamethoxazole, 
CMP = chloramphenicol, 
CIP = ciprofloxacin 
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Figure 5: Infection of a large wound that was initially treated by a traditional healer 
with herbs and other plants as well as tar-like materials (left). Microbiological diag-
nosis revealed massive growth of Klebsiella spp. (right). 
3.4 Impact of the establishment of microbiological diagnosis 
Statistical data of the three pilot hospitals clearly showed positive developments 
since microbiological laboratories were established: (i) mortality numbers were 
reduced, (ii) the average hospital length of stay was significantly shortened, and (iii) 
the costs of antibiotics were considerably diminished. Figure 6 shows the mortality 
numbers in one of the hospital. Here, the average length of stay also decreased 
from 5.8 days in 1998 to 3.5 days in 2007.  
 










Microbiology in placeTraining 
phase
Figure 6: Data on patient mortality in one of the participating hospitals 
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4 Discussion 
Starting as a pilot project in the year 2000, we established microbiological laborato-
ries in three Catholic Mission hospitals in Ghana. Using the achieved laboratory 
competence, we analyzed the spectrum of bacteria that colonize the nasal mucosa 
and we performed an epidemiological survey on bacterial blood-stream infections. 
Thereby and in comparison to German individuals, we found a significantly higher 
ratio of Gram-negative rods on the nasal mucosa and in blood cultures of individ-
uals and patients in Ghana. In line with this observation is also the finding of a 
previous study showing that Enterobacteriaceae contribute to a large extend to 
bacterial blood-stream infections in Ghana (Marks et al., 2010). Likewise, Entero-
bacteriaceae also dominated in Nigerian patients who suffered from septicemia 
(Adeyemi et al., 2010). This is in contrast to the situation in The Gambia, where 
grampositive cocci, especially pneumococci and Staphylococcus aureus, were identified 
as the major causes of bacterial blood-stream infections (Hill et al., 2007).  
Although the distribution of pathogens that cause blood-stream infections 
might differ between the studies that were performed in sub-Saharan Africa, all of 
them confirm an alarming trend of increasing antimicrobial resistance, especially 
against first-line antibiotics, such as chloramphenicol that still is widely in use in 
sub-Saharan Africa  (Adeyemi et al., 2010; Hill et al., 2007; Mandomando et al., 
2010; Marks et al., 2010;  Moyo et al., 2010), indicating the need to re-evaluate the 
current treatment guidelines. A similar trend has also been shown for bacteria iso-
lated from other clinical materials (Yismaw et al., 2010) as well as from CSF of 
patients who suffered from meningitis. Here, like in Germany, Haemophilus influen-
zae, pneumococci, and meningococci are most prevalent in the respective patients 
in sub-Saharan Africa (Laganju et al., 2008; Roca et al., 2009). 
Even in sub-Saharan Africa, microbiological diagnosis must not focus on 
blood-stream infections and meningitis alone. In most of the respective countries, 
wound infections are more prevalent than in Europe making it necessary to also 
monitor pathogen distribution and antimicrobial resistance rates in these cases. 
Again, a recent study on wound infections performed in Nigeria confirmed our 
findings and showed that more Gram-negative rods were isolated than any other 
bacterial groups (Ojo et al., 2010).  
So far, most studies on epidemiology of infectious diseases caused by bacteria 
that have been performed in sub-Saharan Africa were from larger hospitals, mostly 
from university hospitals. The epidemiological situation in urban areas might differ 
significantly from the one in rural areas. Our program of establishing microbiolog-
ical laboratories in Catholic Mission hospitals in Ghana showed that this kind of 
diagnosis can even be used for epidemiological studies in a resource-poor setting in 
rural areas. Through these, more representative data on pathogen distribution and 
antimicrobial resistance rates can be obtained than when only focusing on data that 
were obtained from a few or even a single national  hospital. We therefore suggest 
to establishing microbiological diagnosis even in smaller hospitals in order to ob-
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tain valid data that might help policy makers to re-evaluate their strategies on how 
to manage infectious diseases and allow them to adapt regional or national treat-
ment guidelines. 
The observation that since 2000/2001 mortality rates and the average length of 
stay significantly decreased in the hospitals that participated in our program indi-
cates that the establishment of human capacity building in microbiological diagnos-
tics in district hospitals in resource-poor settings has a positive impact on health 
and socioeconomics. We therefore conclude that the implementation of microbio-
logical diagnostics in concert with regular biannual quality control measures is a 
valuable instrument to improve health conditions even in rural and resource-poor 
settings. 
Finally, gaining robust data on the epidemiology of infectious diseases will help 
decision makers to establish strategies on how to prevent the relevant infectious 
diseases. Given the facts that typhoid fever was highly prevalent in our blood-
stream infection study and is a water-borne disease, improvement of water canali-
zation and sanitation systems in line with adequate educational programs are mean-
ingful and effective control instruments (Fig. 7).  
 
Figure 7: Improvement of water canalization and sanitation systems in the small 
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20 Rapid diagnostics for resource-poor settings 
Manfred Weidmann and Frank T. Hufert  
1 Advances of infectious disease diagnostics and current state 
of the art 
In the developed world laboratory diagnosis of infectious agents has developed 
rapidly. In serology methods experienced a leap forward with the introduction of 
monoclonal antibodies and the enzyme linked immunosorbant assay (ELISA), 
which partly lead to automation of serological testing in big commercial or gov-
ernmental diagnostic centres. The cytometric bead array (CBA) is the latest devel-
opment and its fluid phase kinetics produce even more clear-cut results but has not 
yet reached the diagnostic laboratory. 
Western blots have passed through 3 generations to the currently available line 
assays and first steps towards chip based protein arrays. Lateral flow dipsticks are a 
parallel development, which combines the advantages of western blots with chro-
matography allowing for very short assay times which has opened the way for 
point-of-care testing (POC). 
Similarly the arrival of b-DNA, PCR and real time PCR boosted the accuracy 
of molecular diagnosis of infectious agents also driving high throughput solutions 
in centralised diagnostic laboratories1. The combination of the PCR technique with 
microfluidic lab-on-a-chip platforms,2 microarrays3 or more recently oil emersion 
droplet systems4 may pave the way for the next step of this development. Microar-
rays seemed a promising approach for diagnostics but have not met the expected 
hopes as only amplification-microarrays (PCR, MLPA ect.5-7) manage to perform 
in the sensitivity range required. Truly diagnostic microarrays have not yet made it 
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to the market and there are few publications. More recently a flurry of develop-
ments for isothermal amplification with real time fluorescent monitoring offers the 
possibility to use smaller affordable benchtop devices and even simpler microfluid-
ic lab-on-a-chip solutions than for PCR8. 
2 The potential of point-of-care diagnostics 
In contrast to this shiny new world of modern diagnostic laboratories the situation 
in developing countries is drab and complicated due to a mix of missing basic in-
frastructure, training and experience. In fact transferring the current state of the art 
diagnostics to this setting would be too costly and probably fraught with failure at 
many levels right from the start. So how could the possibilities of the new methods 
be used to meet the requirements of diagnostics in resource poor settings? 
In the developed world current diagnostic laboratories depend on delicate in-
struments, well trained staff, a stable supply of electricity and a reliable cold chain 
for reagents. Here point-of-care (POC) testing could help to optimize diagnostics 
at the GPs office or at centralized laboratories by improving the turn around time 
for results, and is perceived as a means towards a personalized medicine strategy, 
providing specialized point-of-care tests (POCT) all day all week. 
In developing countries the low amount of benchtop gadgetry available, too 
tends to be centralised but is therefore less accessible and the capacity on site is 
usually overwhelmed by the amount of sample input. 
The situation is additionally aggravated by the conditions of sample transport, 
which needs to be paid for, organised (or rather improvised) to cover long distanc-
es, leading to improper transport conditions (cooling, UV exposure) and eventually 
unreliable results due the state the samples are in when finally subjected to testing. 
Backflow of results is often very late leading to patients lost to follow-up. 
In summary, whereas point-of-care diagnostics in the developed world is con-
ceived as a new market for economically sound diagnostic concepts in the increas-
ingly expensive health care systems, point-of-care diagnostics in the developing 
world could basically help to supply affordable accurate medical treatment to a 
much bigger population than hitherto possible9-11. 
3 Introduction of first generation POCT  
Due to the lack of available timely diagnostics and out of sheer necessity a policy 
of syndromic treatment has prevailed e.g. for malaria, tuberculosis and other dis-
eases during the last decades. This however has lead to widespread overtreatment, 
which is a waste of resources, causes morbidity and mortality e.g. in patients treat-
ed for malaria instead for bacterial infections, and in the case of antibiotics and 
anti-malarials is conducive to the generation of resistances. 




The first wave of POCT introduced in the last decade basically consisted of im-
munological assays like agglutination assays, optical immunoassays, lateral flow 
assays. Many turned out to be less sensitive and specific than laboratory based 
assays. A good example in the developed world are the POC antigen detection 
assays for Influenza A virus which show very poor performance12. 
In the developing world many of the first wave immunological POCT showed 
low sensitivity and specificity. Nevertheless the wide spread use of POCT con-
firmed that for example most malaria treated children don’t have malaria and actu-
ally suffer from bacterial infections causing high mortality due to inappropriate or 
no treatment9, 13. 
The first generation POCT also showed weaknesses in the stability of compo-
nents and in handling and results were partly shown to depend on the handling 
skill of the operator 14. This has lead to the impression that as a rule POCT might 
be less efficient and error prone when handled by non-laboratory staff. 
Cost-effectiveness studies however indicate that the use of POCTs for a par-
ticular disease may indeed reduce costs in high prevalence areas by improving ac-
curate treatment and reducing overtreatment whereas in low prevalence areas they 
may increase costs10, 15. The first lesson therefore is that POCT need to be adapted 
to the local health situation. 
4 Specifications of next generation POCT 
Successsful POCT need to be implemented in handheld or small mobile benchtop 
devices that have to be resistant to heat and humidity and are maximally driven by 
small batteries as currently used for mobile phones. Electrical wire taping to main-
tain mobile phone charge is a widespread skill. 
The design of the sampling procedure needs to meet several requirements. 
Sampling time should be brief and feasible with minimal invasiveness (ideally a 
finger or earlobe prick), it should be biosafe to avoid infections and it should have 
an identification system allowing for sample identification and sample manage-
ment. 
Sample preparation i.e. concentration, purification and extraction of the infec-
tious agent for nucleic acid or antigen assays, or separation of plasma and/or se-
rum for serological assays should be integrated and require no extra skills from the 
operator. 
In a two components approach with a disposable cartridge for sample prepara-
tion and assay biochemistry (less than 25$) plus handheld or portable reader for 
detection and reporting, widespread use by non specialized staff could be feasible 
and would obliterate the inefficiencies of few centralized laboratories as described 
above11. Disposable units would also contain potential infectious material and al-
low for biosafe waste treatment. 
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Small sample volumes however means that the detection methods need to be high-
ly sensitive which points towards nucleic acid detection. The superiority of nucleic 
acid detection over serology has been described and discussed in many instances16. 
POCT need to be rapid not only because of economic constraints but essen-
tially because of concerns of patient care. Due to regionally very poor medical 
infrastructure people will travel or basically walk for very long distances in search 
for medical help for children, themselves or relatives. Good medical anamnesis and 
reliable rapid tests offer the possibility to suspect, confirm and possibly treat infec-
tious disease on the same day, literally before the patients walk home again. Deci-
sion time for treatment is also critical since many patients in developing countries 
present themselves in an advanced stage of disease and in life threatening sepsis 
the critical time window for appropriate treatment may be as small as 6 hours. 
Speed is also imperative for viral diseases since the peak of viraemia may be on the 
downswing at the time of presentation and only just detectable by nucleic acid or 
antigen assays. 
Ideally POC system should be able to perform syndromic multiplexing since it 
would help to reduce costs by addressing differentials. Finally an automatic report-
ing system for more sophisticated sample management and epidemiological sur-
veillance and analysis at a centralised base could be possible via mobile phone 
technology. 
All of this has already been laid down in the ASSURED criteria (Affordable, 
Sensitive, Specific, User-friendly, Rapid, Equipment free, Delivered to those in 
need) which are the current specification lead for POCT17. 
The necessity for such a concept has been demonstrated by the first wave of 
serological POCT which due to their lack of sensitivity and specificity actually have 
created suspicion concerning their accuracy and consequently reduced trust in 
obtained results. One of the measures taken by the WHO to solve this situation 
was the creation of the Diagnostic Expert Evaluation Panel at the WHO-TDR 
(DEEP). Here evaluation results of POCT can be reviewed and recommendations 
on additional validation offered to POCT developers. Unfortunately currently the 
continued funding of DEEP is unclear and it can be only hoped that this very 
important review board will be maintained. 
The next generation devices need to be more easy and cheaper to implement 
and maintain while providing the same level of accuracy and reproducibility, sensi-
tivity and specificity required for a diagnostic assay. Only the introduction of well-
evaluated POCT into the health care setting of developing countries would basical-
ly jump the current level of instrumentation and infrastructure common in the 
laboratories of the developed world9, 11. 
Finally these devices could also help to increase the level of identification and 
monitoring of several sexually transmitted and blood borne diseases if useable by 
visiting doctors to facilitate home testing. 




Simply publically going to a certain laboratory which is known e.g. to perform 
Hepatitis B testing may cause social isolation since cultural and religious and / or 
ethical concepts are quite disparate from the practices in the developed world. 
5 Minaturising molecular diagnostic assays 
Since the introduction of molecular diagnostics ample proof of its sensitivity and 
specificity has been generated. Indeed partly molecular diagnostics are deemed 
superior to bacterial culture techniques or serological diagnostics16, 18, 19. Some au-
thors have even opted for entirely eliminating the old methods to streamline cen-
tralised laboratories for molecular diagnostics 1, 20, 21. 
In particular PCR has been very successful and therefore many approaches to 
miniaturisation have tried to include PCR in micro total analysis system (µTAS), 
micro–electro-mechanical-system (MEMS) and lab on a chip (LOC) platforms. 
On-chip PCR by using either electrophoresis, hybridisation (microarray), fluo-
rescence or electrochemical readout, have been explored. The challenges encoun-
tered are the choice of low cost thermoplastic polymeric materials used for fabrica-
tion such as polymethlymethacrylate (PMMA), polystyrene (PS), polycarbonate 
(PC), cyclic olefin copolymer (COC) and the inert and non-toxic polydime-
thylsiloxane (PDMS), which is also thermal stable and has very good optical char-
acteristics. Apart from soft lithography (PDMA), injection molding, lot embossing, 
laser ablation (PMMA, PC), and blister packaging technology using thin films have 
been used22. 
In all cases however a major obstacle is the increase of the surface to volume 
ratio inherent in the miniaturisation of cavities, leading to unspecific adsorption 
and depletion of enzymes from the reaction mixture and subsequent loss of reac-
tion efficiency, and to impediment of actuation of the fluids in the microdevices. 
Therefore a lot of attention and detail is paid to structuring and coating the surface 
of the channels and chambers in the micro devices. 
The three temperature cycles needed for PCR demand quite some engineering 
and are either provided by heating reaction chambers or by meandering the reac-
tion volume in a continuous flow through fixed temperature fields. Use of micro-
fabricated thin film heaters, metal blocks or peltier elements for direct heating have 
achieved impressive results with very fast cycling. Infrared, laser or microwave 
assisted indirect heating may be slower but might make less elaborately engineered 
devices possible. The combination with the latest developments of droplet based 
PCR seem promising. 
The flurry of activity in this field has however not yet provided a complete in-
tegrated device dealing with all steps from sample entry to test result. Bulky acces-
sory devices to maintain actuation via gas or mechanics are in many cases still far 
from the disposable cartridge and battery driven handheld or mobile benchtop 
device. 
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Altenative several isothermal amplification methods that have been developed in 
the recent decade include T7 promotor driven amplifcations (TMA, NASBA, 
SPIA) strand displacement methods (SDA, LAMP, SmartAmp), helicase depend-
ent amplification (HDA), recombinase polymerase amplification (RPA) and several 
rolling circle amplification (RCA) methods23-27. 
Most fluorescent formats for isothermal amplification use non-specific interca-
lating fluorophores or fluorescent primers (LAMP, SDA, HDA, RCA). For specif-
ic detection probe formats have been developed for NASBA, RCA, HDA, and 
RCA28-32. 
In contrast to PCR the reaction kinetics of these methods are not marred by 
ramping rates as ramping is not necessary which in turn makes minaturisation 
more easy from the engineering side than for PCR since rapid heating and cooling 
is simply not required. The only constraints given are the enzyme activity rates and 
indeed some of the isothermal methods show very fast reaction kinetics of below 
10 minutes run time down to the limit of sensitivity. Miniaturisation efforts for 
NASBA, LAMP, HDA, SDA, RCA and RPA have recently been reviewed8. In 
principle the low temperature isothermal method such as SDA, NASBA, RCA and 
RPA show an advantage for minaturisation as they need much less energy input 
and are therefore much better candidates for battery driven handheld devices than 
high temperature isothermal reactions (LAMP, SmartAmp, HDA). 
At present there are only few real ‘sample in – result out’ systems and hardly 
any have reached clinical evaluation. An interesting approach is the use of centrifu-
gational LabDisks as described for RPA33. This type of cartridge could come close 
to the requirements for simple benchtop devices formulated above if sample prep-
aration were included. It would come closest to a lab on a cartridge in contrast to 
the majority of systems for miniaturized molecular assays currently developed 
which have aptly been  described as ‘chip in lab’ rather than ‘lab on chip’ plat-
forms8. 
The current efforts for the development of POCT system need to be consid-
ered in the light of feasibility and sensibility. The developments have reached a 
stage were real ‘sample in – result out’ systems applicable in the clinical setting are 
beginning to look feasible in the upcoming decade, however POCT systems will 
only be successful in both the industrialised and the developing world if the assays 
implemented reflect the health needs or in another word make sense. The key 
words are differential diagnostics and syndromic assay panels. 
Indeed the most pressing needs for diagnostics in the developing world have 
been identified for prenatal care, HIV, sexually transmitted diseases and neglected 
tropical diseases9, 11. As pointed out previously POCT could also help to improve 
diagnostics in the developed world and this is particularly the case for respiratory 
tract infections. A recent Dutch study shows that current laboratory based PCR 
diagnostics for respiratory diseases are of no avail as to clinical outcome whether 
there is immediate or delayed reporting of results to the GP 34. This strongly indi-
cates that if at all, molecular diagnostic POCTs need to be possible on site at the 




presentation of the patient in order to reduce overprescription of antibiotics. In 
contrast, in developing countries POCT for respiratory infections would make 
indicated antibiotic treatment at all possible. 
However developed platforms need to be flexible as distinct panels e.g for en-
cephalitis causing agents may be needed for Europe, Asia, Africa or the two Amer-
icas due to the regional occurrence pattern of the agents implied. 
6 Conclusion 
Improving health will help economies of developing countries to pick up 
speed35,36. One way of improving health is to provide infectious disease diagnostics 
to a larger population by jumping the current state of laboratory techniques and 
providing them in next generation POCT devices into a basically non-existing 
laboratory infrastructure lacking resources and trained staff. 
The current speed of the development of POCT at all levels currently is still 
driven by a microsystem engineer’s point of view with an emphasis on feasibility.  
Strategy and design of research consortia that assemble to develop platforms that 
may be eligible for marketing are all to often influenced by companies participating 
in these consortia which naturally have an eye on the profitable markets in the 
developed world where POCT are seen as a means to streamline and optimise 
current diagnostics. 
The ASSURED criteria have however not been developed to mainly boost 
these developments but rather the development of POC diagnostics for a much 
larger market in the developing world. New POCT platforms will only be success-
ful if they provide sensible concepts to answer diagnostic questions. Therefore 
development strategies and design of new POCT need to be developed in close 
partnership with clinicians from the developing world to improve acceptance and 
trust into and eventually the success of POCT. 
Sensible syndromic or differential panels used on a large scale will help to levy 
the epidemiological data that are missing from many countries, therefore result 
data flow and analysis will develop into an important feature of POC testing. 
 
 




Example of resource poor laboratories in a health station without electricity in 
South-East Senegal (left) and a better equipped laboratory of a primary health care 
centre in West India (right). 
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21 Urinary tract infections in Tanzania:  
diagnosis, pathogens and susceptibility pattern 
Stephen E. Mshana 
1 Introduction  
Tanzania is one of the sub-Saharan African countries most affected by bacterial 
infectious diseases. Communicable diseases dominate the pattern of overall mor-
bidity and contribute to over 49% of the total burden of diseases [1]. Irrational 
drug use as well as the presence of counterfeit drugs on the local market has been 
shown to be the main factors in the emergence of multi drug resistance (MDR) 
bacteria. Worldwide, more than 50% of all medicines are prescribed, dispensed or 
sold inappropriately, and 50% of all patients fail to take them correctly [2]. As a 
consequence, the prevalence of antimicrobial resistances is an emerging threat, 
with resistances of up to 70-90% to original first-line antibiotics [2]. 
In Tanzania, high prevalence of nosocomial infections caused by Klebsiella 
pneumonia, Escherichia coli and Staphylococcus aureus has been reported in tertiary hospi-
tals affecting many departments especially, Intensive Care Unit (ICU), post-
operative, burned, and pediatric patients [3, 4, 5]. Studies in Tanzania have docu-
mented a high prevalence of ESBL in tertiary hospitals. Prevalence of ESBL at the 
Muhimbili National Hospital (MNH) is about 40% [6]. At the Bugando Medical 
Centre (BMC), prevalence is 25% for Escherichia coli and 50% for Klebsiella pneumonia 
[4].  
The absence of a national survey for antibiotics resistance patterns in Tanzania and 
lack of routine culture to diagnose infections may underscore the magnitude of the 
multi drug resistant bacterial infections and its morbidity Tanzania. In this review 
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we present in summary the diagnosis, pathogens and susceptibility pattern of 
common isolates involved in urinary tract infection in Tanzania. 
2 Epidemiology of urinary tract infections in Tanzania 
Urinary tract infections with its diverse clinical syndrome and affected host groups, 
remains one of the most common but widely misunderstood  and challenging in-
fectious diseases encountered in clinical practice. Urinary tract infection (UTI) is a 
common and important clinical problem in most health facilities in Tanzania [1]. 
Urinary tract infections may complicate to renal scarring, hypertension and end 
stage renal diseases [7].  
UTI is a common problem among children and pregnant women in Tanzania 
[3, 8, 9, 10]. Other special groups like diabetic women have been found to suffer 
UTI significantly [11]. In 1992 among 164 children with severe malnutrition UTI 
was the commonest infection [12]. Recently at Bugando Medical Centre the preva-
lence of UTI among febrile children has been found to be 39.7% [9], while at Ma-
kongoro clinic-Mwanza, the prevalence of UTI among febrile children is about 
20.3% [10]. As describe in previous studies, in these two studies [9, 10] female 
children were significantly more affected than male children [7]. The prevalence of 
UTI among pregnant women in Tanzania varies from one region of the country to 
another; it was observed to be 13% among women attending Bugando Medical 
Centre Mwanza [8], while at Muhimbili National Hospital in Dar es Salaam the 
prevalence observed was 21% [3]. UTI is responsible for majority of infectious 
diseases seen at Bugando Medical Centre; out of 389 urine specimens processed 
between July and August 2008; 38.8% were found to have significant bacteriuria 
i.e. >105CFU/ml. Large proportion of infections occurred  among children below 
10 years [13]. Other special groups like diabetic women have been found to suffer 
from UTI significantly in Tanzania [11].  Asymptomatic bacteriuria has been ob-
served in 13.4% of diabetic women in Dar es Salaam [11]. Table 1 
Different factors have been found to be associated with UTI in children; pro-
longed fever, diarrhea, female sex and age below 2 years have been found to be 
risk factors of UTI in children [9]. Other parameters found to predict significant 
bacteriuria are positive nitrite test and positive white blood cells in urine [9, 13]. In 
pregnant women, no significant factors have been found to be associated with 
bacteriuria among pregnant women [3, 5]. In diabetic women, age above 50 years 
and glucosuria were significantly found to predict UTI, while level of education, 
blood glucose level and BMI were not associated with significant bacteriuria [11]. 
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3 Sensitivity of urinalysis in the diagnosis of UTI in 
Tanzania  
Urinalysis either microscopy or using dip stick is the commonest test used to diag-
nose UTI in Tanzania. Routine urine culture is done in few centers in Tanzania, 
mainly in referral hospitals, few regional hospitals and few private hospitals. The 
sensitivity of urinalysis in the diagnosis of UTI was found to range from 29.7 to 
58% with specificity of 86-92% [8, 9, 11, 13]. This poses challenges in many set-
tings in Tanzania were these methods are used to diagnose UTI. Large number of 
false negative children and pregnant women will lead to UTI associated complica-
tions among Tanzanian children and pregnant women.  
4 Pathogens associated with UTI in Tanzania  
Various pathogens have been found to be involved in UTI in Tanzania. In the 
study by Isaac et al 1992 [12], which involved malnourished children admitted at 
Muhimbili Hospital the common pathogen from urine was Escherichia coli followed 
by Klebsiella pneumoniae.  In the same hospital between June 2003 to July 2004 Esche-
richia coli and Klebsiella pneumoniae contributed to 44.75% and 33.0% of the total 400 
isolates obtained from urine specimens [16]. Among pregnant women between 
January 2007 and December 2009 at Muhimbili National hospital, Escherichia coli 
were the commonest pathogen causing significant bacteriuria in pregnant women, 
followed by Klebsiella spp [3]. 
Similar observations were observed in Bugando Medical Centre; between July 
and August 2008; of 151 pathogens isolated from urine specimens 60% were Esche-
richia coli followed by Klebsiella pneumoniae which contributed to 24%. Gram positive 
bacteria were found only in 4% of the total isolates [15]. At Bugando Medical Cen-
tre out of 36 isolates from 247 pregnant women 47.2% were Escherichia coli, fol-
lowed by Enterococcus spp 8/36 [8]. Escherichia coli also was found to be the common-
est isolate causing UTI in children at Bugando Medical centre; of 147 isolates 
43.5% and 35.4% of isolates were Escherichia coli and Klebsiella pneumoniae respective-
ly [9]. Escherichia coli (16/41) were also found to be the commonest isolates at Ma-
kongoro Clinic, in Mwanza city [10]. 
In summary, of 1241 isolates from urine specimens in Tanzania, Escherichia coli 
contributed 46.7% while Klebsiella spp contributed 31.1% o total isolates; therefore 
more than 77% of isolates from urine specimens are gram negative enteric bacte-
ria. Table 1 
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5 Susceptibility of Escherichia coli and Klebsiella spp from 
urine specimens 
There is an increase trend of these isolates to become resistant to commonly used 
antibiotics in Tanzania.  In 1995-1996, 17.4% of Escherichia coli from Northern rural 
Tanzania were resistant to ampicillin [15]; in the same study 4.3% of Escherichia coli 
were resistant to nitrofurantoin. In 2003 at Muhimbili it was found that 92% 
(165/179) of Escherichia coli were resistant to ampicillin, similar resistance pattern 
was observed at Bugando Medical Centre whereby more than 92.7% of Escherichia 
coli isolates from urine specimens were found to be resistant to ampicillin [9].  The 
resistance of Escherichia coli to amoxicillin/clavulanate in Tanzania ranges from 
37.5% among diabetic women in Muhimbili to more than 85% among children at 
Bugando Medical centre [9, 11]. In Escherichia coli, the rate of gentamicin resistance 
ranges from 6.9% at Muhimbili in 2003 to more than 44% in the same hospital in 
2011 [11, 14]. At Bugando Medical Centre the gentamicin resistance ranges from 
5.9% among pregnant women to 21.9% among febrile children [8, 9].  The re-
sistance of Escherichia coli to SXT has been found to range from 50% in diabetic 
women to 97% among children from community at Ma-kongoro Clinic in Mwanza 
city. Escherichia coli were found to be more susceptible to ciprofloxacin with re-
sistance rate between 8.1%-30.4% [9, 11]. At Bugando the rate of resistance of 
Escherichia coli to ceftriaxone was observed to range from 14% to 29.4% [8, 9] while 
at Muhimbili 50% of Escherichia coli from urine specimens were resistance to cefo-
taxime in 2008 [6]. In all studies higher resistance rates to common antibiotics were 
observed among Klebsiella spp isolates. Table 2 
6 Conclusion 
UTI is the commonest cause of fever among children and women in Tanzania and 
is caused by multi drug resistant Escherichia coli and Klebsiella spp. Due to low sensi-
tivity of urinalysis in the diagnosis of UTI,  urine culture should be routinely per-
formed to diagnose UTI in febrile children and pregnant. Continuous surveillance 
of Escherichia coli and Klebsiella spp from urine specimens to monitor susceptibility 
pattern is urgently needed in Tanzania and other developing countries in Africa. 
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22 Rapid screening and mapping of  urinary 
schistosomiasis prevalence at the village  
scale in the Sourou Valley, Burkina Faso:  
Adapting the school-base questionnaire method 






Urinary Schistosomiasis which is responsible for the largest proportion of schisto-
somiasis infection remains largely unstudied in Burkina Faso. This fieldwork was 
initiated to bridge the paucity of epidemiological data on urinary schistosomiasis 
and to set up a database with more recent cases at a fine local village by village 
scale for 29 villages in Sourou Valley. The school based questionnaire method was 
adapted to the academic research context to rapidly screen and map the prevalence 
of the disease in 22 primary schools all located in the Sourou Valley.  
Results showed that the questionnaire approach was applicable to 79% of the 
villages (23/29), and the method was not extendable to 21% (6/29) of the villages. 
Reported blood in urine rates varied between 10.62% and 100%, with 30.14% as 
global prevalence rate for the 23 villages. Results also showed that boys reported 
more urinary schistosomiasis symptom than girls did: 33.83% vs. 26.33% (OR= 
1.26, p < 0.001). Peaks of prevalence rates depended on children age (R2= 0.156, 
p= 0.162); 13 years for boys (42.70%), 9 for girls (30.67%) and 11 years for all ages 
(35.04%). The questionnaire sensitivity and specificity were 65% (95% CI= 44 – 
86) and 55% (95% CI= 46 – 64) respectively. 
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Urinary schistosomiasis/illness – prevalence determination – self-report question-
naire – primary schools – mapping – Sourou Valley – Burkina Faso.  
1 Introduction 
Compared to the rest of the world, the burden due to schistosomiasis (also bilhar-
ziasis) is an issue of growing public health concern in sub-Saharan Africa (SSA), 
where 97% of the globally 201.5 million infection cases were estimated to occur 
with about 150,000 deaths yearly (Engels et al., 2002, Van der Werf et al., 2003; 
Gryseels et al. 2006; Utzinger et al., 2009; Hotez & Kamath, 2009). Because of 
their adverse effects on child cognitive development, pregnancy outcome, and 
agricultural worker productivity, schistosomiasis together with other neglected 
tropical diseases (NTDs) represent a major reason why the ‘‘bottom 500 million’’ 
people in SSA cannot escape poverty (Hotez et al., 2008; Hotez & Kamath, 2009;  
Savioli et al., 2009). 
Despite this alarming picture, insufficient resources have been allocated for re-
search and control since schistosomiasis was firmly placed back on the internation-
al health agenda by the World Health Assembly Resolution 54.19 in 2001 (Utzinger 
et al., 2009; Savioli et al., 2009). Therefore, schistosomiasis (and many other 
NTDs) became the forgotten disease of forgotten people largely confined to the 
rural areas of the developing countries (Hotez, 2007; 2009; Hotez & kamath, 
2009). As a consequence, urinary schistosomiasis which is responsible for the larg-
est proportion of schistosomiasis infection remains largely unstudied and not well 
documented, particularly in Burkina Faso with more than 2 million reported hae-
maturia cases associated with Schistosoma haematobium infections (Poda, 1996; Van 
der Werf et al., 2003; Garba et al., 2006; Koukounari et al., 2007; Schur et al., 
2011). 
While trying to study geographical determinants of human schistosomiasis 
transmission in Sourou Valley, Burkina Faso we encountered a scarcity of epide-
miological data across the country in general and at the community by community 
level like in Sourou Valley in particular. Hence, this fieldwork was initiated to 
bridge the paucity of epidemiological data on urinary schistosomiasis and to set up 
a database with more recent data at a fine local village by village scale in Sourou 
Valley. For two reasons, past studies were found to be of little help. Parasitological 
studies had been carried out in a very limited number of villages (manly irrigation 
sites) located on the east bank of the Sourou River.  Series of MDA with pra-
ziquantel done throughout those studies and by the national control program 
(PNLSc) have introduced changes in the disease prevalence in the local community 
(Poda et al., 2001; Poda et al., 2004; Poda et al., 2006; Koukounari et al., 2007; 
Touré et al,. 2008; Clements et al., 2008; Koukounari et al., 2011). The question 
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was how to fulfill this urinary schistosomiasis prevalence data gathering mission, 
village by village, in a context of very limited resources? 
Numerous researchers were probably looking for a way to overcome the scar-
city of schistosomiasis prevalence data, but we owe to Lengeler and colleagues, 
who were the firsts to work out an inexpensive and simple tool, a school-based 
questionnaire used to detect urinary schistosomiasis prevalence (Lengeler et al., 
1991a, b). The questionnaire method is based on the reported blood in urine, since 
it is not a symptom of other common diseases in children. The health state of an 
individual is the resultant of a complex multifactor system and healthy/illness sta-
tus is an eminently variable appreciation (Amat-Roze, 1998).  The BU associated 
with S. haematobium is too habitual in endemic areas that it is easily perceived indi-
vidually and collectively (Amat-Roze, 1998; Lengeler et al., 2002; Poda et al., 2006). 
This humanistic approach, in a health context, sees people as continually engaged 
in the construction of health/illness knowledge (Stainton, 1991, cited Gatrell, 2002, 
p. 32). Consequently the views of ordinary people, even referred to as “subjective” 
or “lay”, have as much status as those of the health professionals (Gatrell, 2002).  
It has been well established that the presence of blood in urine is a reliable, indirect 
indicator of infection. The questionnaire method has been extensively replicated 
and successfully validated in different geographical settings throughout SSA such 
as in Cameroon, Côte d’Ivoire, Malawi, Nigeria, Congo, R.D. Congo, Tanzania, 
Zambia, and Zimbabwe (Ansell et al., 1997; Guyatt et al., 1999; Lengeler et al., 
2002; Brooker et al., 2009). Indeed, the World Health Organization (WHO, 1995) 
recognized this approach as standard in rapid identification of schools with high 
prevalence for warranting mass drug administration (MDA) with praziquantel. 
Primary schools are ideal for schistosomiasis prevalence rates determination 
for four reasons: 1) schools are accessible and receptive; 2) the highest prevalence 
levels of urinary schistosomiasis infection are found among school-age children; 3) 
data collected in this age range may be used to evaluate not only if schistosomiasis 
threatens the health of school-aged children, but also if there is need for interven-
tion in the community as a whole; 4) children in intermediate grades (generally 
between ages 9–12) allow for the accompaniment of treatment impact over one to 
two years, before they leave school (Savioli et al., 2005, cited Koukounari et al., 
2011, p. 11). 
Initially designed for control strategy development purpose (WHO, 1995), the 
questionnaire approach has been used in the present study within a framework of 
academic research. Also, the questionnaire has been adapted to the particular situa-
tion of Sourou Valley and focuses on symptoms aiming to identify high-risk com-
munity, rather than infected individuals. Therefore outcomes of the present study 
have to be interpreted with caution. 
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2 Materials and methods 
2.1 Study area  
The present study was undertaken in the Sourou Valley, north-western Burkina 
Faso – a land-locked country. The study area is marked by a tropical savanna with 
an intercalation of two seasons, a long dry season and a contrasting short raining 
season (June-September). The daily temperatures vary between 11-45° C. The 
mean annual precipitation is 675mm (1980-2010). The Sourou Valley, home of 
anthropogenic and demographic changes, remains one of the most important wet-
lands in the country. Centered on the Sourou River (main water flow in the study 
area) that flows north to south (about 65 km) and becomes a tributary of 
Mouhoun River (the most important and permanent water flow in the country), 
the area meets potentialities for hydro-agricultural development, which first at-
tempt dated roughly back to 1950s by the colonizers. The irrigation project took 
off veritably in 1984 through a radical hydrological modification. The natural flow 
of the Mouhoun River was modified using a canal that forced it to pour the totality 
of its water into the Sourou River. The back flow of the water from the Sourou 
into the Mouhoun was controlled using vanes installed near the confluence (GIRE, 
2001; Bethemont et al., 2003; Legare, 2003). Once the water was sufficiently avail-
able for irrigation, series of hydro-agricultural development projects have been 
carried out. Following this development, the local government, via the Sourou 
Valley Management Authority (AMVS), had organized farmers’ immigration. Irri-
gation projects have helped to give pieces of lands and resettled thousands of fami-
lies recruited across the whole country (GIRE, 2001; Legare, 2003; Cissé, 1999). 
Fishing remains the principal professional activity for men in traditional villages, 
while growing irrigated rice and other garden products is the essential professional 
occupation in agricultural villages (Guièdougou, Débé, Niassan). The Sourou Riv-
er, as well as irrigation canals and ponds are mostly used by women to accomplish 
domestic tasks and favour recreational swimming activities particularly among 
school-age children.  
Administratively, Sourou Valley belongs to the region of Boucle du Mouhoun 
divided in six provinces: Balé, Banwa, Kossi, Mouhoun (the region capital), Sourou 
and Nayala (see Figure 1). Locally Sourou Valley is mainly shared by Kossi and 
Sourou provinces, and Nayala for a small piece. Each province is divided into ur-
ban and rural communes. At the communal level, five rural communes share the 
Sourou Valley: Barani (47,991 inhabitants) and Sono (7,317) on the western bank; 
Di (23,864), Lanfièra (18,817) and Gassan (37,873) on the eastern bank (INSD, 
2009). Rural communes are composed of villages with or without school. School 
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(DEP, 2011). Primary school attendance net rate varied according to gender. Both 
boys and girls proportions are high in Sourou compared to Kossi at the provincial 
level.  
 
Table 1: Schooling net rates (%) at the provincial, regional and national levels 
 
  Schooling net rate (%) 
Level Boys Girls Total 
Kossi 55 53.2 54.1 
Sourou 71.2 68.2 69.7 
Boucle du Mouhoun Region 63.4 61.1 62.3 
National 65.1 60.9 63.1 
2.2 Schools sampling  
Figure1 shows our area of interest (AOI) which encompasses 30 villages which 
were selected based on a distance criterion fixed to 6 km from the main water 
flow. A total of 23 primary schools are found within this AOI, but 22 located in 18 
villages were investigated (see Table 2). Di, Guièdougou, Gouran and Niassan are 
localities with two separate schools each (“A” & “B”) at the time of the survey. All 
classes in each school were enrolled (N= 89). A total of 6,918 pupils were sampled 
(51% boys and 49% girls). The overall sex ratio was 1 and the mean size per class 
room was 78 pupils.  Each school is under the responsibility of a headteacher. The 
sampled schools belong to four primary education districts with each having an 
inspector as the head.  Provincial directions of primary school of Kossi and 
Sourou occupy the upper level in the primary education structure at the provincial 
scale. Further high ranks in the administrative structure are the regional direction at 
the Boucle du Mouhoun Region level and the ministry at the national level.  
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Figure 1: Map of the AOI showing villages and schools location 
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Illa 3 190 65 35 1.8 63 
Koubé 3 80 50 50 1.0 27 
Total 1 2 6 270 60 40 1.5 45 
Nouna IV 
Bantombo 3 99 65 35 1.8 33 
Sono 6 366 44 56 0.8 61 
Kouri 4 213 44 56 0.8 53 
Total 2 3 13 678 47 53 0.9 52 
Di 
Benkadi 6 344 49 51 1.0 57 
Bouna 1 85 55 45 1.2 85 
Débé 6 643 52 48 1.1 107 
Di "A" 6 694 50 50 1.0 116 
Di "B" 5 477 52 48 1.1 95 
Niassan "A" 6 633 52 48 1.1 106 
Niassan "B" 5 323 49 51 1.0 65 
Oué 3 334 49 51 1.0 111 
Total 3 8 38 3533 51 49 1.0 93 
Kassoum 
Bissan 1 66 55 45 1.2 66 
Gouran "A" 6 476 45 55 0.8 79 
Gouran "B" 1 67 54 46 1.2 67 
Guièdougou 
"A" 6 793 56 44 1.3 132 
Guièdougou 
"B" 3 296 51 49 1.1 99 
Koumbara 3 206 44 56 0.8 69 
Lanfièra 6 242 55 45 1.2 40 
Nion 2 113 49 51 0.9 57 
Yaran 4 178 61 39 1.5 45 
Total 4 9 32 2437 52 48 1.1 76 
TOTAL  
1+2+3+4 22 89 6918 51 49 1.0 78 
Sources: SSCE/Kossi & Sourou, 2011 
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2.3 Data collection  
 Questionnaire survey  
 
Enough questionnaires and 89 posters were designed, printed and distributed to all 
schools at the beginning of April 2011. The questionnaire was designed in simple 
table and printed on white paper (A4 format). Teachers had to fill lines by writing 
down names of children one line per child. Additional individual data were indicat-
ed by column headers: sex, age, village of origin, quarter in the village and self-
report status. Poster (see Figure 2) was artistically drawn on white paper (A3 for-
mat) and designed in three main parts:  
 
- at the top: a school building with a teacher and late comer-pupils running, means 
that they are the targeted persons;  
- at the middle: a pop-up that depicts the transmission route and shows school 
children (boys and girls) playing in a contaminated surface water, their often daily 
recreational activities after school; 
- at the bottom: the hematuria symptom is displayed, two pupils (a boy and a girl), 
urinating with blood in their urines,  and thinking about their activities after clas-
ses. This also shows that both sexes can contract the disease.  
 
 
The questionnaires were administrated by teachers by interrogating children direct-
ly on their current urinary schistosomiasis status based on a daily recall-period in 
eight different days.  
Day “0”: the first time to present the poster to pupils. The teacher presented the 
poster pedagogically from top to bottom as follows: “That is our school (1), and 
those of you who like playing or swimming in surface water (2), run a risk to be 
infected by a disease which manifests by abnormal red urines sometimes accompa-
nied with pains when urinating (3)”. The hematuria symptom on the poster was 
made clear using the local meaning of the disease “Gnèguèni-Ouillé” (GO) which 
means red urine. After having explained the content of the poster, the teacher 
asked children if they have noticed such manifestations when urinating yesterday 
or today. Answers were then written down individually using the following codes:  
 
0 = did not report any symptom; 1 = have reported BU or GO only; 2 = have 
reported only pains when urinating; 3 = have reported BU or Go and pains when 
urinating. 
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At the end of this session, i.e. Day “0”, the teacher kindly asked children to ob-
serve their urines and pay more attention to the symptoms displayed on the post-
ers. With two days interval between each session and for the remaining seven ses-
sions, the children were only asked whether or not they have noticed changes in 
their disease status the day of the interrogation or the day before. 
 
Figure 2: The poster accompanying the  Figure 3: A seven year old school boy    
questionnaire     having reported GO 
 
All questionnaires, correctly filled, were gathered at the end of April 2011. But the 
posters were given as present to all children of the classrooms; particularly those 
suffering from urinary schistosomiasis disorders (see Figure 3). Teachers were 
asked to hang up the poster on the classroom walls, so that it could each day re-
mind the children of the danger. Schools coordinates (longitude and latitude) were 
obtained using a global positioning system (GPS Garmin 60CSx) device. 
 
 Parasitological survey 
 
Randomly, 124/847 subjects (~15%) were selected, with 60 having reported symp-
toms and 64 having not. Children’s sampled urines for microscopy examinations 
were from the five primary schools, all located on the western bank of the river: 
Bantombo (N=20), Koubè (N=13), Kouri (N=12), Illa (N=54) and Sono (N=25). 
Because of partial-non-availability of lab technicians and their involvement in other 
routine studies and works, and the villages accessibility, remoteness from the la-
boratory (minimum distance = 50 km, maximum = 70 km), bad state of rural 
paths, the urine samples gathering was extended to four consecutive days (16-19 
Mai 2011); so that samples could be collected and analyzed within the same day. 
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The first two days were dedicated to Koubè and Illa, the third day for Kouri and 
Sono and the fourth day for Bantombo. The field team included two lab techni-
cians, one geographer and a driver. However, the team was supported on the field 
by teachers to facilitate data collection. Before collecting urine samples pupils were 
asked to do some physical activities to increase the chance of dropping eggs in 
their urines. Each child was given a wide-mouthed polythene bottle and asked to 
urinate into it. After urine collection, an individual code was written on the bottle.  
All urine samples were collected between 10-14 a.m., and kept at 4° C using cooler 
and ice-boxes. The urine samples were then brought to the laboratory located in 
Nouna health district hospital using a car (4x4). In the laboratory, urine samples 
were centrifuged to check for S. haematobium eggs under microscopy. Children 
whose urine contained one or more eggs were defined as infected; if no eggs were 
seen, children were defined as uninfected.  
2.4 Legal and ethical aspects of the study 
 Ethical approval 
 
The full proposal of the present study was submitted to the local ethic committee 
(CLE) of the Nouna Health Research Centre (CRSN)/Ministry of Health. On the 
demand of the CLE’s president, a meeting took place at CRSN conference room 
on March 29th, 2011 in order to present orally the proposal to the CLE members 
and to bring responses to their arising questions. After this meeting the study won 
the CLE approval (N°2011-04/RBMH/PKSS/CRSN/CLE-CRSN). 
 
 Legal authorization 
 
After having addressed to them an official letter requesting the permission to in-
volve the schools in the study, authorizations was obtained from the two provin-
cial directions of the primary education of Kossi and Sourou (N°2011-
024/MEBA/RBMH/DREBA/DPEBA/KSS and N°2011-251/MEBA/RBMH/ 
DREBA/DPEBA/SUR). Leri School was not investigated because we had no 
authorization from the provincial direction of Nayala since we could not travel to 
Toma, capital province of Nayala. 
Information circulars were sent by the provincial directors to all district inspec-
tors, town councils, school headteachers and presidents of the association of 
school children parents. The names of the investigated schools, the topic and ob-
jectives of the study, the references of the study principal investigator were clearly 
mentioned in the circulars. The school children were neither obligated to partici-
pate in the study nor to give an answer if the teacher asks them.  In particular, 
pupils were free to provide urines samples or not. 
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2.5 Data analysis 
All questionnaire data were digitalized using a Microsoft Access 2003 database. 
Pupils were identified by a unique code so that the data could be anonymously 
entered in the computer and still avoiding pseudo replications. Prevalence rates of 
reported BU or GO were calculated for each school and village following the 
WHO (1995) expression: Number of positive answers divided by number of chil-
dren interviewed, multiplied by 100. For that answers 1, 2 and 3 of self-reported 
status were re-codified as having reported BU or GO, by attributing them the same 
code. In fact, it is not common for school-aged children to report having BU or 
pain when urinating without having urinary schistosomiasis (Brooker et al., 2009). 
Lengeler et al. (1991a) also concluded that pain in the lower abdomen and dysuria 
are others powerful predicators and that hematuria was not the only symptom 
perceived by children with urinary schistosomiasis. Further, children coming from 
villages of our AOI were selected to compute the prevalence rates at the village 
scale. The sensitivity and specificity of the questionnaire were calculated as formu-
lated by Ansell et al. (1997): sensitivity: the number of infected children who re-
ported BU or GO divided by the number of children who reported BU or GO 
plus the number of infected children who did not report BU or GO; specificity: 
the number of uninfected children who reported not having BU or GO divided by 
the number of uninfected children who reported not having BU or GO plus unin-
fected children who reported BU or GO. Villages were mapped in five groups 
using ArcGIS, version 9.3. 
3 Results 
3.1 Questionnaire survey participation level 
Table 3 shows a global participation rate of 89%. The rates varied at the school 
level from 53 to 100%. At Gouran “A” School, the class 3 (with 93 children) was 
not investigated due to health problems of the teacher. Absence of children during 
the survey period or simple abandons were other reasons explaining the participa-
tion rate under 100%. Table 3 also shows that in 81% (18/22) of schools, partici-
pation rates above 90% were recorded. 
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Bantombo 99 99 100 
Benkadi 344 324 94 
Bissan 66 66 100 
Bouna 85 83 98 
Débé 643 492 77 
Di "A" 694 671 97 
Di "B" 477 459 96 
Gouran "A" 476 252 53 
Gouran "B" 67 64 96 
Guièdougou "A" 793 746 94 
Guièdougou "B" 296 214 72 
Illa 190 180 95 
Koubé 80 75 94 
Koumbara 206 195 95 
Kouri 213 199 93 
Lanfièra 242 226 93 
Niassan "A" 633 632 100 
Niassan "B" 323 321 99 
Nion 113 113 100 
Oué 334 299 90 
Sono 366 294 80 
Yaran 178 172 97 
Total 6918 6176 89 
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3.2 Constancy and frequency of reported BU or GO 
Figure 4 shows the questionnaire administration session to session, the global 
number of children having reported BU or GO which had varied between 1,264 
and 1,371 with 1,341 as mean value per session. The lowest reported cases of the 
day “0”, is notable. There were progressive inputs, new cases detection with maxi-
mum numbers reached at the fifth session (day “4”).  Based on the daily mean 
value, five sessions out of eight (62%) recorded reported cases above the mean 
value. Below mean value was only observed for day “2” and “5” and showed a 
slight output. Table 4 shows the variation of the frequency of reported BU or GO 
and the correspondent prevalence rates, when counting the minimum, maximum, 
or computing the mean or taking into account all children having reported at least 
one time BU or GO.  According to these four numbers, global prevalence rates 


























Figure 4: Total number of reported BU or GO cases per session 
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Table 4: Daily change of reported BU or GO per school after the daily minimum, 
maximum, mean and final cases (TR: Total Respondents, N: absolute number, P: corre-
sponding prevalence) 
3.3   Frequency of reported BU or GO 
  Minimum Maximum Mean Final cases 
Schools TR N P N P N P N P 
Bantombo 99 26 26.26 30 30.30 28 28.16 34 34.34 
Benkadi 324 153 47.22 190 58.64 176 54.32 194 59.88 
Bissan 66 5 7.58 10 15.15 7 10.61 15 22.73 
Bouna 83 34 40.96 40 48.19 38 45.93 65 78.31 
Débé 492 50 10.16 81 16.46 62 12.68 101 20.53 
Di “A” 671 143 21.31 160 23.85 149 22.17 190 28.32 
Di "B" 459 51 11.11 67 14.60 57 12.39 94 20.48 
Gouran “A” 252 90 35.71 97 38.49 93 36.81 111 44.05 
Gouran "B" 64 15 23.44 20 31.25 19 29.10 21 32.81 
Guièdougou 
“A” 746 27 3.62 57 7.64 43 5.70 93 12.47 
Guièdougou 
"B" 214 2 0.93 22 10.28 15 6.83 35 16.36 
Illa 180 106 58.89 155 86.11 147 81.67 162 90.00 
Koubè 75 4 5.33 10 13.33 7 9.33 11 14.67 
Koumbara 195 20 10.26 44 22.56 26 13.33 49 25.13 
Kouri 199 17 8.54 28 14.07 24 12.12 31 15.58 
Lanfièra 226 17 7.52 31 13.72 23 10.07 39 17.26 
Niassan 
“A” 632 107 16.93 152 24.05 143 22.63 172 27.22 
Niassan “B” 321 59 18.38 81 25.23 68 21.03 96 29.91 
Nion 113 2 1.77 10 8.85 5 4.54 12 10.62 
Oué 299 125 41.81 135 45.15 130 43.35 176 58.86 
Sono 294 12 4.08 54 18.37 27 9.06 67 22.79 
Yaran 172 48 27.91 68 39.53 56 32.70 91 52.91 
TOTAL 6176 1264 20.47 1371 22,20 1341 21.70 1859 30.10 
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3.3   Spatial homogeneity or heterogeneity of schools’ sizes   
13 out of 22 schools (59%) had a spatial homogeneous sample. All respondents 
were from the villages within which schools were located. Nine (41%) had a spatial 
heterogeneous sample; respondents formed a melting-pot of children coming from 
different villages. Figure 5 shows schools prevalence rates based on the final cases. 
Figure 5: Distribution of schools after their final prevalence rates  
(Black bars: spatial homogeneity; dotted bars: spatial heterogeneity) 
3.4 Distribution of reported BU or GO per village  
According to respondent’s provenance, 99% of the children (6,144/6,176) were 
coming from 23 out of 29 villages within our AOI, (79% of the total villages). 
Among the 23 villages, 78% have schools and 21% (N=5) have pupils but there 
were no schools (figure 6). Over 99% of the participants that have reported BU or 
GO, dwelled in our AOI (1,855/1,859) with an overall prevalence of 30.14% 
(1855/6155). Figure 6, also shows that nine villages (39%) had reported BU or GO 
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Figure 6: Distribution of total prevalence rates ranged descending per village (Black 
bars: villages having schools; hatched bars: villages without schools) 
 
 Relationship between children sex and frequency of reported BU or GO 
 
Among the AOI respondents, 3,169 were boys (51%) and 2,986 were girls (49%). 
The sex ratio varied extremely from 0.3 at Zampana to 2 at Illa, with overall sex 
ratio of 1.1. Globally, there were more BU or GO reported by children on the 
western bank than on the eastern one: 36.88% vs. 29.35% (OR = 1.26, p <0.001). 
Figure 7 shows the unequal rate of reported BU or GO among boys and girls. We 
observed a big difference among boys, and according to the bank location. Contra-
ry to the boys, girls reported rates that were similar (26.44% on the East and 
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boys than girls. In addition, boys’ proportions overtook the total rates (boys + 
Girls). The prevalence rates varied among boys and girls according to their perma-
nent residence within the AOI. Table 5 shows that 16/23 villages (70% of villages) 
presented high proportion among boys while the contrary was observed in seven 
villages. In three villages from the seven, cases were reported only by girls (i.e., Lô, 




































Figure 7: Distribution of prevalence rates by bank according to gender  
(East = Sourou province, West = Kossi province) 
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Boys Girls Total (Boys + Girls) 
TB RB 
PB 
(%) TG RG 
PG 
(%) TT RT PT (%) 
Bantombo 64 19 29.69 35 15 42.86 99 34 34.34 
Benkadi 129 99 76.74 127 68 53.54 256 167 65.23 
Bissan 36 7 19.44 30 8 26.67 66 15 22.73 
Bouna 74 64 86.49 61 39 63.93 135 103 76.30 
Débé 249 51 20.48 234 49 20.94 483 100 20.70 
Di 587 173 29.47 587 126 21.47 1174 299 25.47 
Gouran 85 35 41.18 107 39 36.45 192 74 38.54 
Guièdougou 606 108 17.82 508 86 16.93 1114 194 17.41 
Illa 120 110 91.67 60 52 86.67 180 162 90.00 
Koubè 36 6 16.67 39 5 12.82 75 11 14.67 
Koumbara 86 29 33.72 109 20 18.35 195 49 25.13 
Kouri 68 19 27.94 101 8 7.92 169 27 15.98 
Lanfièra 96 17 17.71 94 14 14.89 190 31 16.32 
Lo 3 0 0.00 2 1 50.00 5 1 20.00 
Niassan 477 156 32.70 469 111 23.67 946 267 28.22 
Nion 55 6 10.91 58 6 10.34 113 12 10.62 
Oué 125 75 60.00 123 64 52.03 248 139 56.05 
Ouérin 6 0 0.00 4 1 25.00 10 1 10.00 
Sono 135 37 27.41 144 23 15.97 279 60 21.51 
Soro 5 0 0.00 12 3 25.00 17 3 17.65 
Toma-
Koura 11 6 54.55 11 5 45.45 22 11 50.00 
Yaran 109 52 47.71 63 39 61.90 172 91 52.91 
Zampana 1 1 100.00 3 3 100.00 4 4 100.00 
TOTAL 3163 1070 33.83 2981 785 26.33 6144 1855 30.19 
 
Table 5: AOI: Spatial distribution of prevalence rates per village following the 
gender (TB: Total boys, RB: Reported cases Boys, PB: Prevalence Boys, TG: Total 
Girls, RG: Reported cases Girls, PG: Prevalence Girls, TT: Total boys + girls, RT: Re-
ported cases Total, PT: Prevalence Total) 
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 Relationship between child age and reported BU or GO  
 
The school children ages varies between 5 and 18 years (mean = 11.5). The 9-year-
old children represented the majority of the pupils (1,047) while only one child was 
18 years old. 
Figure 8, shows the age-dependence on reported BU or GO rates (R2= 0.156, p= 
0.162). Among boys, the peak of 42.70% was reached at 13 year old (114/267). 
Among girls, the highest rate, 30.67%, was observed at 9 year old (146/476). For 
both boys and girls put together, the peak of 35.04% was reached at 11 year old 
(246/702). On the contrary, troughs of prevalence rates were observed among 6-
year-old school children. From 17 years, prevalence rates decreased considerably. 
None of the boys have reported BPS or GO (0/4) and only 1/11 girls has reported 
urinary schistosomiasis symptoms. 
 
Figure 8: Distribution of prevalence rates per age after the gender 
3.5 Accuracy between BU or GO and infection  
Figure 9 shows the gap between self-reported and infection prevalence rates (Pear-
son r= -0.049, p= 0.937). At Bantombo School, the questionnaire approach under-
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check out, 34.34%  reported BU or GO vs. 70% infected children. The opposite 
was observed at Illa and Koubè Schools, 90% vs. 5.56% and 14.64% vs. 0% re-
spectively.  However, the questionnaire approach gave a good approximate figure 
for the prevalence of infected children at Kouri School, 15.58% reported BU or 
GO vs. 16.67% infection. The reported BU or GO prevalence on this bank was 
over-estimated, i.e. 36.88% obtained with questionnaire vs. 16.13% obtained by 
parasitological examinations.  
 
 
Figure 9: Comparison between questionnaire and parasitological outcomes  
for five schools 
 
On the western bank of the Sourou River, parasitological examinations revealed 
that 21.7% (13/60) of children having reported BU or GO were infected. The 
sensitivity of the questionnaire on this bank was moderate 65% (13/20) (95% Con-
fident Interval CI: 44 – 86).  On the other hand, 89% (57/64) of children who did 
not report BU or GO were found uninfected. The specificity of the questionnaire 
was 55% (95% CI: 46 – 64). Among the rest 30% children that provided urine 
samples, 87% of them have reported BU or GO but were found uninfected and 
13% of them were infected but they did not report having BU or GO. 
3.6 Mapping reported BU or GO prevalence 
Figure 10, maps five groups of villages. The first group, 38% (N= 11) has villages 
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The second group, 17% (N= 5), represented villages in which symptomatic cases 
were reported from 25% to 49% by children. The third group of villages, 14% 
(N= 4), concerned those where reported BU or GO rates were between 50% 
and74%. The fourth group, 10% (N= 3), represented villages where the question-
naire has screened 75% and more of reported hematuria. The remaining 21% of 
villages (N= 6) for which the questionnaire method was not applicable represented 
the fifth group (no data). 
 
 
Figure 10: Spatial distribution of villages after the reported BU or GO prevalence 
rate 
4 Discussion 
Children of school ages are known to harbor the highest infection rates of urinary 
schistosomiasis in endemic communities and therefore the prevalence of infected 
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children will give a very good idea of the overall prevalence (WHO, 1995). We 
found through this fieldwork that the school-based questionnaire is an appropriate 
approach on which to base the estimates of urinary schistosomiasis prevalence 
rates village by village, but with some limitations.  
The questionnaire was applicable to 79% of our AOI villages (23/29). Among 
these villages, 78% (N= 18) have schools. The highest respondents’ samples were 
encountered in those villages. We encountered some small numbers problems 
(Gatrell, 2002) in the remaining 22% (N= 5) villages that had no schools and chil-
dren attended classes in the neighboring villages. The lowest numbers of partici-
pants were encountered in those villages (see Table 5). However prevalence distri-
bution did not depend on whether schools were sited in some villages or not (see 
figure 6). 
Primary schooling net rates of Kossi and Sourou provinces were 54.1% and 
69.7% respectively. But, those net rates were higher among boys than girls.  Like 
all studies that were based on primary schools, we may have certainly missed an 
important proportion of infected school-aged children (mainly girls) who did not 
attend classes (Lengeler et al., 2002; Koukounari et al., 2011). School based sur-
veys, underestimate the total number of infected people, as younger and older 
people were excluded from the study (Lengeler, 1991a). The legal age to be en-
rolled in primary school in the country is 6-7 years old. From 14-15 years old, pu-
pils leave the class 6, the last class in the primary education system, for the gram-
mar school. This explains the small number problems (Gatrell, 2002) we encoun-
tered for investigation of pupils under 6 and over 15 years old. Therefore the rep-
resentativeness of the questionnaire survey was higher among pupils of 6-15 years 
old. The rising tendency of S. haematobium infection in childhood and declining in 
adulthood has been observed by other field studies (NAUS et al., 2003; Kapito-
tembo et al., 2009). Similarly we found that the global prevalence curve showed an 
increasing trend of reported BU or GO among children from 6 years to eleven 
years with a decline from 14 years. However, symptoms manifestation persisted in 
time among boys than girls. 
On the other hand, the questionnaire method did not work in 21% of the AOI 
villages, i.e. the no data group in Figure 10. At the time of the questionnaire survey, 
no single child from those villages did attend classes. Four of them are lakeside 
villages that were found as high-prevalence settings (PODA et al., 2004). It means 
that the questionnaire technique was not extendable to all villages in the study area. 
Therefore, the number of villages with high-prevalence of urinary schistosomiasis 
was probably under-estimated. 
In the present study, results showed few oscillations of answers between ques-
tionnaire sessions, suggesting consistent and more reliable answers. It means that 
the daily recall-period used was overlapped to the circadian variation of the pres-
ence of blood in urine (Doehring et al., 1985; Lengeler et al. 1991, cited Lengeler et 
al., 1991b). Apparently, the pupils were not lying. For example, during a compound 
survey in Niassan village where parents were asked if certain members currently 
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suffer or have experienced urinary schistosomiasis (results are not presented here), 
a mother responding by the negation was automatically contradicted by her seven 
year old child (see Figure 3).  Asking him why, he simply answered that he fre-
quently sees blood in his urine. Further questions allowed us to know that he was a 
primary school boy of the class 1. This daily recall-period, coupled with the several 
times interrogations, allowed us to detect more positive cases (see last column of 
Table 4). 
Two main reasons could explain the moderate sensitivity and specificity of the 
questionnaire. First, the use of the centrifugation method instead of filtering has 
probably diminished the change to detect more infected cases during the laborato-
ry examinations. Second, the small number of urine samples, coupled with a single 
testing day. Even by urine filtration, one misses about one-third of the egg-positive 
people on a single testing day (Lengeler, 1989, cited Lengeler et al., 1991a). That is 
because of the circadian variation of eggs excretion (McMahon, 1976; Doehring et 
al., 1985). However, it is difficult to say that results obtained by the parasitological 
approach were more objective than those obtained using the self-report question-
naire because eggs were identified in the laboratory by human eye. Nevertheless, 
the parasitological survey allowed us to ensure that school children who reported 
BU or GO were infected at about 21.7%.  
During the questionnaire gathering at the end of the survey, teachers gave 
feedback about their experiences in carrying out the study. Some of them confided 
in us that once the first courageous child raised his hand, all others having the 
symptoms began to raise theirs as well. Not only positive feedbacks were given, 
there were certain teachers that complained about older-girls in classes 5 and 6. 
They thought they probably had urinary schistosomiasis and were ashamed to tell 
the truth publically, and that they have just written down what the older-girls re-
ported. These feedbacks were proofs of the adhesion of both teachers and children 
to the study, and that teachers have not modified children answers nor influenced 
them. No only teachers and children, but also the central authorities at the provin-
cial direction level have manifested their interest in the study. The idea to couple 
the questionnaire with a poster to clearly show symptoms to children was suggest-
ed by those pedagogic authorities. However, we could not evaluate whether the 
poster was helpful or not because it was systematically used in all classrooms. 
However, it provided a good basis for practical and water-related diseases-oriented 
health education. We also hope that growing awareness about the danger of uri-
nary schistosomiasis will go a long way in encouraging pupils to feel free and not 
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the questionnaire survey. Many thanks indeed to each of the 6,176 school children 
who participated in the study. 
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23 Schistosomiasis around the Lake Victoria, 
Northwest Tanzania 
Humphrey D. Mazigo and Martin Kappas 
1 Abstract 
Schistosomiasis is among the most prevalent afflictions of humans who live within 
the Lake Victoria basin, north-western Tanzania. Over 20 millions people living 
within the basin are at risk of the disease and significant numbers have the chronic 
complications of the disease. Two forms of the disease exist, urinogenital and in-
testinal schistosomiasis, both cause severe morbidities in individuals with moderate 
to heavy infection intensities. Because of the geographical overlap of schistosomia-
sis and other tropical diseases within the lake regions, co-infections are common. 
However, little informations are available on schistosomiasis epidemiology in the 
form that can be accessed easily. Informations on the epidemiology of schistoso-
miasis around the Lake Victoria are highly needed for understanding and planning 
for integrated control approaches. In the present review, the epidemiology, co-
infections, morbidities and control of schistosomiasis within the Lake Victoria 
basin are discussed. 
2 Background 
Schistosomiasis or bilharziasis is a chronic tropical parasitic disease caused by the 
blood dwelling dioecious flukes of the genus schistosome. The disease is highly 
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endemic in sub Saharan Africa and worldwide, it is estimated that over 200 million 
people are affected by the disease, of whom 97% are resident of sub-Saharan Afri-
ca [1]. Over 700 millions people are estimated to be at risk of acquiring the disease 
worldwide (85% in sub-Saharan Africa) [1].  Four species of schistosomes are re-
sponsible for causing schistosomiasis, includes:- Schistosoma haematobium which 
cause urogenital schistosomiasis while Schistosoma mansoni, S. intercalatum, S. mekongi 
and S. japonicum are the causative agents of intestinal schistosomiasis [1, 2, 3]. 
3 Methods 
Data for this review were identified and collected using manual and electronic 
search strategies of published and unpublished sources. Electronic data search was 
done using PubMed and MEDLINE databases for both urogenital and intestinal 
schistosomiasis. Manual search for unpublished surveys, conference abstract and 
university thesis was done at the National Institute for Medical Research, Mwanza, 
Tanzania. To identify relevant studies on schistosomiasis in Tanzania, the terms 
schistosomiasis, bilharzia, schistosomiasis epidemiology and Tanzania/Tanganyika, 
Schistosoma mansoni and Tanzania/Tanganyika were used. Only population based 
studies, malacological and morbidities studies were included in the review.  
4 Biology and life cycle of schistosomes  
In general, all members of the genus Schistosoma have a complex life cycle which  
involves a phase of sexual reproduction by adult schistosomes in the definitive 
host (human or other primates), and an asexual phase in the intermediate host, a 
freshwater planorbid snail (Figure 1) [4,5,6,7]. After copulation, depending on 
species, the female schistosome produces hundred to thousands of eggs per day 
(300 - 3,000 per day) [6]. The eggs of schistosomes are species specific and each 
contains a ciliated miracidium larva [5, 6].  The ciliated miracidium secretes preote-
olytic enzymes, which together with host blood pressure and presence of spines 
help the eggs to migrate and penetrate into the mesenteric venous plexus for spe-
cies causing intestinal schistosomiasis into the lumen of the intestines or in the tiny 
venules of the vesical plexus for species causing urogenital schistosomiasis [8]. It is 
assumed that approximately 50% of the eggs pass through the colon, the walls of 
the bladder or the genitourinary apparatus and are excreted by faeces or urine [6]. 
The remaining 50% of the eggs are trapped within the tissues of these organs [6].In 
contact with fresh water and guided by light and other chemical stimuli, they hatch 
to release a miracidium, a free-living larval form of the parasites. It will swim, 
search and penetrate a compatible intermediate host, freshwater snails. Over the 
period of 3-8 weeks, within a snail, miracidium multiply by asexual reproduction 
and develops through primary (mother sporocyst) and secondary (daughter sporo-
cysts) sporocysts into thousands of cercariae characterized by bifurcated tail [6]. 
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After 4-6 weeks, these are shed from the snails into water and can survive in water 
for about 72 hours searching for definitive hosts [5]. Cercarial shedding process is 
stimulated by the presence of light and occurs mainly during the daytime. Infected 
snail can continue to shed cercariae every day for months. When in contact with 
the skin of the definitive host, the cercariae penetrate and shed their tails and are 
transformed into schistosomula (Figure 1). The schistosomula migrate passively 
into the lymphatic system or blood vessels to the heart and then to the lungs [6, 7]. 
From the lungs are carried to the liver where they grow and mature into adult in a 
period of 4-6 weeks. In the portal vein, the female schistosome becomes enclosed 
within the gynaecophoric canal of the male schistosome. The paired adult schisto-
somes mate and migrate from the liver to settle in the venous plexus or mesenteric 
where the life cycle starts again. The entire life cycle is completed within 2-3 
months [6]. The lifespan of the adult schistosome in the definitive hosts is estimat-
ed be on average 3 - 5 years [6] but may live for up to 30 - 40 years [8, 9]. 
 
Figure 1: Schematic diagram of life cycle of schistosomiasis [10] 
5 Schistosomiasis in Tanzania 
In Tanzania, schistosomiasis has long been recognized as a serious public health 
problem with high transmission rates accompanied by severe morbidities in differ-
ent regions. The disease is second only to malaria in term of causing morbidities. 
Only two species of schistosomes, Schistosoma haematobium and Schistosoma mansoni 
are responsible for causing urogenital and intestinal schistosomiasis (Figure 2) [3, 
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11, 12, 13]. Of the two species, Schistosoma haematobium is widely distributed while 
Schistosoma mansoni is focally distributed [14]. The wide distribution of intermediate 
snails host in the country determines the distributions of the disease [14]. The 
whole Tanzanian population of over 38 millions people is at risk countrywide and 
in 2000; over 15.2 million people were estimated to be infected with both urogeni-
tal and intestinal schistosomiasis [3]. In the country, the young age groups (< 16 
years) or school age children carries the largest burden of the disease and the infec-
tion prevalence decreases at older ages. Gender variations on the disease preva-
lence are common observation in endemic communities [15, 16]. Behavioral medi-
ated variations in exposure to risk areas can in part explain the differences of infec-
tion between age and sex [15, 16].  
6 Epidemiology of schistosomiasis around the Lake Victoria 
The Lake Victoria area is on the north-western part of the country, it comprises 
the regions of Kagera, Mwanza, Mara and Shinyanga [11-13]. The first three re-
gions are located along the southern and western shore of the Lake Victoria. Over 
20 million people inhabit the region and the main occupation of the two third of 
the population are farming within the basin of the lake, fishing, livestock keeping 
and small scale business [11-13]. 
Schistosomiasis was first described in the region in 1905 in the irrigation 
scheme around the southern shore of the Lake Victoria [17]. The disease was iden-
tified to be highly endemic within the irrigation scheme with both S. mansoni and S. 
haematobium being common [17]. Over 50% of individuals examined had urinary 
schistosomiasis, with majority being males aged > 5 years old [17]. The distribution 
of the disease in the region is mainly determined by the distributions of the inter-
mediate snail hosts [18, 19]. Schistosoma mansoni is highly endemic immediately along 
the southern shore of the lake and decreases with distance from the shorelines 
[15]. Communities living along the shores of the lake in all the three regions are 
highly affected by intestinal schistosomiasis [11, 12]. Similarly, communities living 
in small islands within the Lake Victoria such as Ukerewe, Ukara and Kome are 
highly endemic to intestinal schistosomiasis [20, 21]. At Ukerewe island, of the 
1,659 villagers examined for S. mansoni, over 86.3% had infections and the preva-
lence did not differ between gender but males had higher eggs output (median in 
infected males 208 egg per gram of feaces versus 144 epg in females) [22]. In term 
of age, the prevalences varied with age, with a maximum in adolescence and a de-
cline in older age groups [22]. The age group 21- 40 years and >40 years had 86.7% 
and 84.2% rates of infections respectively [22]. In term of median egg output (epg), 
the age group < 10 years and 11- 20 years had 216 epg and 320 epg while the high-
er age groups had lower eggs per gram of feaces [22]. At Msozi and Sangabuye 
villages, located within and immediately along the lake shore, of the 984 and 504 
individuals examined for S. mansoni at Msozi and Sangabuye, 78% and 38% were 
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found infected [21]. The geometrical mean intensity of those infected between the 
two villages were 156 epg and 47 epg respectively [21].  In the two villages, males 
and the higher age groups (> 30 years) had higher prevalence and infections inten-
sities [21]. However, among those with heavy infections intensities in both villages 
were in the young age group (14 - 19 years old) [21]. Similarly, in Kome islands, of 
the 206 individuals examined, 88.3% had S. mansoni infections and over 35% of 
them had heavy infections, excreting > 400 epg [23]. In Sengerema district, of the 
400 school children (aged 6-17 years old) attending primary schools located within 
a radius of 5km from the lake shore, 64% had S. mansoni infections and males chil-
dren had higher infections intensities [23]. Differences between frequency of expo-
sure to water contact between male and female or age groups observed within the 
communities living within the lake basin may account for such differences in the 
prevalence of S. mansoni [15]. Young age groups contact water more frequently 
than the other age groups and hence are more likely to have higher infection inten-
sities compared to any other age groups. For older age groups and gender, in-
volvement in risky economic activities such as fishing and rice cultivations may in 
part explain the sex predominance observed on the prevalence of S. mansoni.  
Incontrast, the prevalence of S. mansoni in the hinterland area is very low, for 
instance in Misungwi district, intensive epidemiological studies in children age 6 – 
16 years, 78% of the children had S. haematobium infections and only 12 children 
had S. mansoni infections [24]. Similarly in the hinterland area of Magu district, 
southern shore of the Lake Victoria, of the 6,897 school children (aged 7 – 20 
years) examined only 11% had S. mansoni and majority had S. haematobium [15]. By 
contrast, in Kagera region, the prevalence of intestinal schistosomiasis is very low 
despite the availability of the intermediate hosts in most of the studied villages 
along the Lake shore [25].  
In the region, S. haematobium is also highly endemic and the risk of acquiring 
urogenital schistosomiasis increases with increase of distances from the shorelines 
of the Lake Victoria [26]. The distributions of the snails intermediate hosts which 
transmit S. haematobium are confined in the hinterland, thus transmission and preva-
lence of the disease is high in communities living away from the lake shore [15, 26]. 
Areas along the southern shore of the Lake Victoria or the Sukuma plains in 
Mwanza and Shinyanga regions are highly endemic to urogenital schistosomiasis 
 Humphrey D. Mazigo and Martin Kappas 
 
288 
[26]. The results of the earlier studies in the hinterland, on the southern shore of 
Lake Victoria reported the prevalence of S. haematobium to range from 60% to 96% 
[27]. The incidence of S. haematobium was highest in the age group 6-12 years (78%) 
and the group had the highest infection intensity. The other age groups > 13 years 
had low prevalence and infection intensity respectively [24]. Recent studies, in the 
hinterland areas, among primary school children have reported the high prevalence 
of S. haematobium (56.5%) [15]. The S. haematobium infection intensity was observed 
to decrease with increase in age, with the young age groups reported to have low 
infections intensities as compared to older age groups [15]. There are was a signifi-
cant relationship between prevalence of S. haematobium infections and age and sex, 
with high prevalence observed in males [15]. The sex predominance could be at-
tributed to male’s prolonged exposure to infested water, especially for swimming 
during the dry seasons when the temperature is high in the region. The observation 
of dropping of prevalence and infection intensity with increase in age was associat-
ed with development of immunity [24].  
In Kagera region, transmission of S. haematobium does not occur [25]. Multiple 
factors have been associated with the virtual absence of schistosomiasis, such fac-
tors are soil profile, rainfall patterns, vegetation, general topography and human 
population. However, the absence of snails in the inland waters of Bukoba were 
directly or indirectly associated with the absence of the diseases in the area [28, 29]. 
In general, the observed spatial distribution of schistosomiasis within the Lake 
Victoria basin may be explained by the occurrence of their snail intermediate hosts 
and their ecological relationship between different types of water bodies [15]. 
The entire population living within the lake basin is at risk of the disease. 
However, children between the ages of 6 to 14 years (school age and school chil-
dren) carriers the largest burden of the infections [15, 16]. The prevalence of the 
disease decreases with increase in age and the age pattern of infection levels can be 
influenced by age-related immune responses. Similarly, age pattern is observed in 
areas where adult individuals have higher water contact due to fishing activities like 
in the small islands within the lake, the prevalence of infections is higher in the 
older ages but yet the young age groups will carry the heavy infection intensities 
[21]. Gender difference in the prevalence of schistosomiasis can be observed in 
school children or adult population [15, 16, 21]. Several factors such as behaviour 
or immunology may be important for the observed differences between male and 
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female may account in term of prevalence and intensities of schistosomiasis [15, 
21]. In fact, within the lake basin, fishing activities are mainly carried out by male 
individuals and thus they have higher frequency of exposure to schistosomes in-
fested water than females. This could in part account for the gender differences in 
prevalences of disease observed. 
Several individuals and community factors are associated with the continuity of 
schistosomiasis transmission within the lake basin. Human economic activities 
such as flooding rice cultivation practices, fishing within the Lake Victoria, small 
seasonal rivers and stream flowing down to the lake and road side ditches whichare 
created by road contractors, collects water during the rain seasons and acts as good 
breeding sites of the intermediate snails hosts [14, 30-32]. Furthermore, the in-
crease in population and population movements, swimming in lake especially for 
the children during the dry season (Figure 3) and introduction of the irrigation 
schemes in the hinterland contributes to the transmission of the disease [14, 30 - 
32]. The wide distribution of the intermediate snails hosts of both urogenital and 
intestinal schistosomiasis within the lake basin contributes significantly to the 
transmission dynamics of schistosomiasis [19, 20]. Poor hygiene practices charac-
terized by the lack of safe tape water supply, absences of toilets and use of water 
direct from the lake are common observations among communities living within 
the basin. In fact, majority of the community members are knowledgeable of dis-
ease and its symptoms, but this does not prevent the inhabitants to come into 
contact with lake water [33]. This is due to the fact that, the endemic communities 
have no alternatives for safe water supply, thus they continue to depend on schis-
tosomes infested water for their domestic use. In addition, endemic communities 
do not have any alternative economic activities for income generation other than 
fishing and paddy cultivation, which are among the risk factors for schistosomiasis 
transmissions.  
In the region, S. mansoni is known to be zoonotic and affecting different spe-
cies of monkeys and baboons [34, 35]. In Gombe stream National Park located 
within the Lake Victoria basin, of the 206 olive baboons screened for S. mansoni, 
69% had positive stool samples [35]. Baboons get infections through water contact 
during playing and fighting [35]. In the area, juveniles’ baboons are commonly 
observed to play in water and hence are reported to have high prevalence of the 
disease [35]. However, in the region, the potential roles played by baboons as res-
ervoir host of human schistosome infections require further investigations. The 
movement of baboons from the national parks to human settlement may establish 
transmission of intestinal schistosomiasis in areas known to be free of the disease, 
especially if the intermediate snail hosts are present in the area. Thus, advanced 
studies are required to understand the roles played by baboons/monkeys in the 
dynamics transmission of intestinal schistosomaisis.  
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Figure 2. Distribution of schistosomiasis in Tanzania [16] (Source: Doumange 
1987) 




Figure 3: Active water contact at active sites for intestinal schistosomiasis transmis-
sion. Young children (pre-school and school children) and adult washing their 
clothes and playing along the southern shore of Lake Victoria, Northwest Tanza-
nia. 
7 Intermediate hosts of schistosomiasis within the Lake 
Victoria basin 
The earlier studies on intermediate hosts transmitting schistosomiasis within the 
Lake Victoria basin began in 1950’s [19, 20]. The two Planorbidae species were 
identified to transmit S. haematobium and S. mansoni within the region [19, 20]. For 
S. mansoni, Biomphalaria choanomphala in Lake Victoria, and Biomphalaria sudanica, 
which is found adjacent to the lake, are the main intermediate snail hosts of S. 
mansoni in the area [15, 30-32, 36]. Biomphalaria pfeifferi, which occurs in permanent 
ponds, has a sporadic distribution and is responsible for only seasonal transmission 
of S. mansoni [15, 30-32, 32,]. In fact, in Ilemela and Nyamagana district, within 
Mwanza city, Biomphalaria pfeifferi is not found in the inland water bodies, instead is 
commonly seen in permanent water-bodies with moderately abundant aquatic 
vegetation [24]. 
This distribution of Biomphalaria spp. hosts might, at least in part, explain the 
high prevalence of S. mansoni at the lakeshore and the low prevalence of S. mansoni 
in communities living away from the lakeshore [15, 26].  
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In contrast, for S. haematobium, the main snails intermediate hosts are Bulinus nasu-
tus, Bulinus africanus and Bulinus globosus [36, 37]. The most abundant and widespread 
is Bulinus nasutus, which is found in temporary habitats throughout the inland water 
bodies because of its ability to survive the long dry season by aestivation [15, 24]. 
Bulinus africanus occurs in temporary streams, while Bulinus globosus colonizes per-
manent ponds [15]. Thus, the snail intermediate hosts of S. haematobium occupy a 
mosaic of habitats throughout the southern shore areas [15]. In fact, on the shores 
of Lake Victoria in Mwanza region, S. haematobium does not occur due to the ab-
sence of Bulinus spp. but does occur in inland small, static water-bodies which har-
bour the species [38]. The distribution and density of the snail intermediate host is 
an important determinant, accounting to a large extent for the seasonal transmis-
sion of the disease especially S. haematobium within the region [20]. In addition, the 
transmission seasons varies between the wet rain (January to May) and dry (June – 
September) seasons, high transmission peak is observed after the rain season be-
tween June and September [24]. The distribution pattern of the snail intermediate 
hosts may in part account for the observed widespread distribution of S. haematobi-
um infections on the hinterland areas located on the southern part of the Lake 
Victoria [15, 24, 26]. 
8 Co-infections of schistosomiasis with other tropical diseases 
within the Lake Victoria basin 
The Lake Victoria basin is also endemic to a number of tropical parasitic, viral and 
bacterial diseases [15, 16, 39]. Malaria is highly endemic and the region is classified 
in stable perennial malaria transmission zones where malaria transmission occurs 
through out the year [40]. Soil-transmitted helminths, Ascaris lumbricoides, Trichuris 
trichiura and hookworms (Ancylostoma doudenale and Necator americanus) are also high-
ly endemic in the region [15, 16]. Of all the soil-transmitted helminths, hookworms 
are the most predominant and are highly endemic along the lake shore due to the 
ability of the larvae stages to survive in sand beaches [15, 16]. For the viral and 
bacterial infections, Human Immunodeficiency Virus- 1 (HIV-1), tuberculosis and 
sexual transmitted diseases (such as gonorrhea, syphilis and Chlamydia infections) 
present a serious public health concern in the region [41, 42]. Because of high 
prevalence of these diseases, co-infections with schistosomiasis are probably com-
mon.  In fact, among the primary school children within the region, co-infections 
of intestinal or urogenital schistosomiasis with either malaria or soil tranmitted 
helminth has been reported [15, 16, 39, 41]. Of the 6,897 primary school children 
examined within the lake basin, 22.1% had co-infections of S. haematobium and 
hookworms infections [15]. Similarly, within the region, of the 400 school children 
studied, 26.5% harbored two parasite species and combination of S. mansoni and 
hookworm co-infections was the most common (69%) [16]. The other co-
infections observed were between S. mansoni and P. falciparum (22.6%), hookworm 
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and P. falciparum (5.7%) and for triple infections of P. falciparum, S. mansoni and 
hookworm, the prevalence was 2.8% [16]. Furthermore, in fishing communities 
along the lake shore, co-infections of schistosomiasis and HIV-1 are common [41]. 
Of the 457 women of reproductive age examined, 5.7% had urogenital schistoso-
miasis and 5.9% had HIV-1 infections [41]. Among women with HIV-1 infections, 
15% were co-infected with urogenital schistosomiasis. Importantly, urogenital 
schistosomiasis was associated with HIV-1 infections (OR = 4.0, 95%CI, 1.2–13.5) 
[41]. Based on the fact that urogenital schistosomiasis can act as a risk factor for 
HIV-1 transmissions, these findings may have important public health implications 
for prevention of HIV infection. 
9 Schistosomiasis related morbidities in communities living 
within the Lake Victoria basin 
Morbidities due to S. haematobium and S. mansoni are often associated with inflam-
matory responses against parasite eggs trapped in host tissues either within the wall 
of urinary bladder or intestinal organs [21]. For S. haematobium, the main clinical 
signs or symptoms seen in the majority of the primary school children within the 
Lake basin are gross or microhaematuria (urine containing blood) [37,43-45,47]. 
Other symptoms observed related to S. haematobium are dysuria, pain during mictu-
ritions, urine incontinence and urethral dysuria [37, 43-45, 47]. The chronic mani-
festations of S. haematobium reported in children and adult individuals are calcified 
urinary bladder, calcified and distorted ureters, hydronephrosis, non-functioning 
kidney and granulomatous pseudopolyps in the bladder [37, 43-45, 47]. The survey 
of Forsyth and MacDonald at Usagara around the south part of Lake Victoria, 
where 87% of school children had S. haematobium infections (prevalence increased 
from 79% in standard 1 children to 100% in those in standard 4) identified 22% of 
the school children with various urological abnormalities [47]. The common 
urograms abnormalities were calcified urinary bladder, calcified and distorted ure-
ters, hydronephrosis and non-functioning kidneys [47]. In addition, multiple or 
bilateral lesions were also identified, includes calcified bladder (7%), deformity of 
the ureter (10.3%), hydronephrosis (9.2%) and non-functioning kidneys (0.3%) 
[47]. The prevalence of hydronephrosis was lower in girls (3.7%) compared with 
13.7% in boys. A direct relationship between intensity of infection and the abnor-
malities of the urinary tract was observed, in which calcified urinary bladders, de-
formed ureters and hydronephrosis were significantly more common in school 
children who excreted > 250 eggs/10ml of urine [47]. It was concluded that occur-
rence of urological abnormalities related to S. haematobium was associated with the 
intensity of infection [47]. A community based survey in the same locality, using 
pyelograms noted a number of children with urological abnormalities. The com-
mon urological lesions observed were calcification and distortion of the ureters, 
urinary bladder calcifications, hydronephrosis and non-functioning kidneys [36]. 
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The majority of children (aged 3-12 years) with heavy infections intensities of S. 
haematobium had urinary bladder calcification [36]. The prevalence of urinary blad-
der calcification was observed to decrease with increased age [36]. In males the 
prevalence of calcified bladders, damaged ureters and hydronephrosis was less in 
adult than in young males [36]. In hospitalized cases, co-infections or co-
occurrences of urinary bladder carcinomas or adenocarcinomas of the prostate 
glands with eggs of S. haematobium have also been reported within the region (Fig-
ure 4) [45,47]. 
For S. mansoni infections, the earlier manifestations of the disease characterized 
by granuloma formation and obstruction of intestinal tracts were reported in 1958, 
at Ukerewe Island, which is within the Lake Victoria [48]. In outpatients cases the 
main complaints associated with S. mansoni are vague abdominal pain, general 
weakness, diarrhea, intermittent dysentery and blood/mucus in stool [49]. Detailed 
clinical, liver pathology, liver function and haematological findings associated with 
S. mansoni in north-west were described by McMahon in hospitalized cases [50]. Of 
the 640 participants, 65.2% had S. mansoni infections and the majorities were 
asymptomatic, other complaints were vague abdominal pain, general weakness, 
diarrhea, intermittent dysentery and blood/mucus in stool [50]. The overall preva-
lence of hepatomegaly, splenomegaly and hepatosplenomegaly were 20.2%, 7% 
and 2.4% respectively [50]. The prevalence of hepatomegaly and splenomegaly 
were observed to decrease with increased age and were higher in the age group 5-
10 (28.3% and 9.7%) and 11-15 (19.3% and 6.9%) years [50]. The histological find-
ings demonstrated extensive fibrosis and granulomatous lesions in liver sections of 
individuals who had heavy infection intensity (≥ 500 epg) [50].  In addition, portal 
tract fibrosis was severe in liver sections with ≥ 250 eggs of S. mansoni per gram of 
feaces [50]. In hospitalized cases, appendicitis and obstructions of the intestinal 
tracts presenting as acute cases have been reported among the inhabitants of the 
region (Figure 6) [51, 52]. 
Community surveys, along the basin have reported lesions of the liver, portal 
vein, and spleen, leading to periportal fibrosis, portal hypertension, hepatospleno-
megaly, splenomegaly and ascites associated with S. mansoni infections (Figure 5) 
[16,21,22, 49,50,54]. These morbidities are common in individuals with heavy in-
fections intensities (≥ 500 eggs per gram of feaces) [22, 49, 54]. A community 
based study in Ukerewe Island demonstrated that 86.3% of 1,659 (geometric mean 
egg output was 514 epg and increased with age) had S. mansoni infections and other 
morbidities reported were diarrhea, bloody stools and blood vomiting [22].  The 
prevalence of hepatomegaly and splenomegaly by abdominal palpation was 9.6% 
and 42.8% respectively. Importantly, organomegaly was significantly more com-
mon in individuals passing more than 400 epg [22]. On ultrasonographical exami-
nation, the prevalence of hepatomegaly and splenomegaly was 35% and 83% re-
spectively [22].  A consistent increase in the proportion of hepatomegaly and sple-
nomegaly with increasing egg output was observed. Individuals excreting > 400 
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epg had higher prevalence of both hepatomegaly (42.5-50%) and splenomegaly 
(90.2%) [22]. 
Similar study in Kome Island within the Lake Victoria, a parasitological survey 
of 206 (104 females and 102 males) individuals identified 88.3% (182/206) with S. 
mansoni infections and 35% were heavily infected (excreting ≥ 400epg) [23]. Ab-
dominal palpation revealed hepatomegaly and splenomegaly at 34% and 62% re-
spectively. Periportal fibrosis or ultrasonographical signs of hypertension was ob-
served in 10 -15% of the study population [23]. In the same region, a community 
survey using ultrasonography reported the prevalence of periportal fibrosis to be 
41.5% and 16.7% in Msozi and Sangabuye villages [21]. In each of the two villages, 
males had higher prevalence of periportal fibrosis (50.5% and 33.9%) [21]. Hepa-
tomegaly was observed in 54.5% in Msozi and 46.4% in Sangabuye but was not 
associated with S. mansoni infections [21]. For splenomegaly, the prevalence was 
61% and 40.3% at Msozi and Sangabuye respectively [21]. 
Schistosoma mansoni in pregnancy is a public health concern in the region, not 
only is the cause of hepatosplenomegaly and other morbidities, but also is the ma-
jor cause of anaemia during pregnancy [53].  In Ukerewe Island, a cross-sectional 
survey of 972 pregnant women identified 63.5% excreting ova of S. mansoni and 
the prevalence decreased with increasing of age [53]. The overall prevalence of 
anaemia was 66.4% and heavy S. mansoni infection (≥ 400 epg) was associated with 
anaemia (OR=1.87, 95%CI, 1.07 – 3.27, P= 0.026) [53]. 
 
 
Figure 4: Arrows showing eggs of S. haematobium in the urinary bladder wall of 40 
years male reported at the Bugando Medical Center, north-western Tanzania with 
chief complain of genital mass and frequent micturitions. Histological (H & E) 
examination of urinary bladder biopsy revealed co-infections of urinary bladder 
carcinoma and S. haematobium eggs in the wall of the bladder and fibrosis (courte-
sy of Mazigo HD and others 2010). 




Figure 5. Gross reactive hepatosplenomegaly in two school boys with heavy infec-
tions of intestinal schistosomiasis (> 1000 epg), Sengerema district, northwest Tan-
zania. The photograph was taken during field studies carried out in 2009. (Courtesy 
of Mazigo HD, 2009). 
 
Figure 6: Arrows showing eggs of S. mansoni (with lateral spine) in the submucosa 
and mucosa of the ileum and caecum of 7 years old living within the Lake Victoria 
basin north-west Tanzania presented with intestinal obstructions (Courtesy of 
Mazigo HD and others, 2011) 
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10 Control of schistosomiasis around the Lake Victoria region  
The increased transmissions and public health concerns of schistosomiasis in the 
region have not been resulted into development and implementation of any effec-
tive control measures. The early years of 1960’s, the main control efforts against 
schistosomiasis in the region focused only on the intermediate snails hosts by using 
molluscicides. However, due to wide distributions of the intermediate snails hosts 
in the regions, coverage of the entire areas and the ecological effects of the mol-
luscicides lead to changes of the control measures [24].  
In 2004, the national schistosomiasis and soil-transmitted helminths control 
programme (NSSCP) under the Ministry of Health and Social Welfare was estab-
lished with support from the Schistosomiasis Control Initiative (SCI) [55]. The 
main interventions strategy used is annual treatment of groups at risks such as 
primary school children using praziquantel (40mg/kgBWT). The main aim of the 
treatment is to reduce morbidities by decreasing worm burden and intensity of 
infection, improve children health and prevent irreversible complications in adult-
hood [55]. The approach of delivering treatment to school children is the school 
based Mass Drug Administration (MDA) were all primary school children receive 
praziquantel (40mg/kgBWT) irrespective of infection status [55].  
11 Discussion and conclusion 
Intestinal and urogenital schistosomiasis continues to be highly endemic around 
the Lake Victoria and the entire population within the basin is at risk of the infec-
tions. School age children and other members of the communities carry the largest 
burden of the infections. The disease is associated with mild to severe morbidities 
with majority of the infected population remains asymptomatic and suffers from 
the chronic manifestation of the disease at older ages. Various social-economic and 
sociodemographic determinants are associated with disease transmission within the 
lake basin. However, only few have been identified and more research are required 
on this area.  
The control of schistosomiasis in the region and countrywide depends mainly 
on the reduction of morbidities through the use of annual single dose of pra-
ziquantel (40mg/kgBWT) which mainly target primary school children [55]. How-
ever, the major limitation of school-based treatment approach is that, it does not 
include the non-school going children [56]. In addition, other members of the 
endemic community are not included and thus, they save as carrier of the disease 
and continue to transmit it to other community members. The fact which cannot 
be avoided is that in the basin, infections with schistosomiasis start at very young 
age below five years and this group should be integrated in the treatment cam-
paign.  
Despite the fact that schistosomiasis is highly endemic within the Lake Victoria 
basin, the status of the disease in many of the areas are still unknown or un-
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mapped. For example, majority of the areas in Mara region remain unmapped and 
the status of the disease in communities considered at risk of acquiring the disease 
remain unknown. Thus, for planning meaningful and achievable control activities, 
targeted efforts are highly needed to identify and map the endemic communities 
within the lake basin. Furthermore, due to variations in behaviours and culture, 
risk factors associated with the transmission of schistosomiasis may vary between 
communities within the region, however, little is known on the socioeconomic 
determinants associated with the disease. On the other hand, the co-infections of 
schistosomiasis and other tropical diseases such as malaria, soil-transmitted hel-
minthiasis, tuberculosis and HIV are common in the regions, but how these dis-
eases interacts in a single hosts and causes multiple pathology remain a topic of 
further investigation. Because of high endemicity of schistosomiasis in the region, 
infections usually starts at very young ages and infants or pre-school children also 
harbors the infections, however, this group is often excluded from the treatment 
programmes using praziquantel. Thus, in order to henceforth justify inclusion of 
the preschool-aged children in mass treatment programmes using praziquantel, 
there is a need to obtain more information on the disease prevalence, efficacy of 
praziquantel, side effects and tolerability in the age group. 
To achieve maximum control of schistosomiasis, improvement of socio-
economic status and hygiene is highly required. Despite the distance of villages to 
the Lake Victoria, provision of safe tape water is urgently needed in communities 
living in the hinterland and shorelines of Lake Victoria. Furthermore, improve-
ment of preventive and curative health services should help to control the disease. 
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24 Malaria in Kossi Province, Burkina Faso:  
An investigation of  spatio-temporal  
incidence pattern 
Daniel Karthe, Issouf Traoré, Ali Sié and Martin Kappas 
Abstract 
By global standards, malaria transmission is intense throughout most of Sub-
Saharan Africa; at the same time, incidence pattern vary by magnitudes both in 
space and time. While disparities at the global and continental level are reasonably 
well documented (in the African case most notably by the MARA/ARMA project), 
it is the spatio-temporal variation of transmission pressure at the local and regional 
level that are most relevant for malaria control. The study presented is based on 
malaria case data collected by selected rural health centers in Kossi Province, 
Burkina Faso and assessed the relevance of different environmental (climate, vege-
tation, hydrology) and socio-economic (population density, practice of irrigated 
agriculture, preventative measures) factors. In case of Kossi Province, Burkina 
Faso, incidence rates were found to vary by a factor of more than 10, with the 
highest rates found in relatively densely populated but non-urban areas close to 
perennial rivers and irrigation sites. As expected, transmission peaked within two 
months of the rainy season’s onset, but the degree of seasonality varied both spa-
tially and inter-annually. Whereas the differences observed are of relevance for 
malaria control, the identification of geographic determinants of transmission (in-
cluding useful proxy variables), are important prerequisites for developing locally 
adapt malaria transmission models. 
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1 Introduction  
With an estimated 225 million infections in 2009, malaria remains among the most 
important infectious diseases in the world and is responsible for around a million 
deaths annually (WHO 2010). However, the malaria burden may actually be twice 
as high (Breman et al. 2007) as these official estimates suggest, and thus be greater 
than at any time in history (Hay et al. 2005). When compared to other important 
infectious diseases, malaria comes second only to HIV/AIDS in terms of disease 
burden and third in terms of mortality and is the most important vector-borne 
disease in both respects (Lopez et al 2006). The global malaria burden is distribut-
ed very unequally: 60% of all malarial infections, 75% of severe infections caused 
by Plasmodium falciparum and 80% of all malaria deaths occur in sub-Saharan Africa 
(Hay et al. 2000; WHO 2005). With a total population of about 300 million people, 
sub-Saharan West Africa represents the region with the largest population exposed 
to high levels of malaria transmission intensity in the world (Kleinschmidt et al. 
2001). This risk is far from evenly distributed across the region, and even within a 
single country, there may be large disparities in malaria incidence (fig. 1) which 
depend, among other factors, on the natural environment, landuse and human 





In Burkina Faso, more than 4.5 million (just above 45% of all) medical consulta-
tions are related to malaria, and 50.79% of all hospital deaths are caused by malaria 
(Direction Générale de l’information et des Statistiques Sanitaires 2010).  
Even though malaria remains a major public health issue in Burkina Faso, lim-
ited resources for public health expenditures mean priorities need to be set for 
Figure 1: Spatial pattern of malaria incidence in Burkina Faso (2008) 




their allocation. With an annual per capita GDP of $1160 in purchasing power 
parities, Burkina Faso ranges among the economically least developed countries in 
the world (Population Reference Bureau 2010). Almost half of the population live 
below the poverty line, which is currently defined as an annual per capita income 
of 82,672 FCFA (€ 126 or US$ 173 in January 2011). In such a socio-economic 
environment where the scopes for health spending are limited at both the govern-
ment and individual level, disease maps can help to determine suitable intervention 
strategies (e.g. magnitude, timing, spatial focus of control programs) and to assess 
control interventions. (Tatem et al. 2004). Hay et al. 1998 proposed the use of 
malaria risk maps for optimizing the distribution of antimalarials. Worrall et al. 
(2007) demonstrated that the effectiveness of indoor residual spraying (IRS) de-
pends on its timing. In resource-constrained environments, monitoring and predic-
tion systems therefore have the scope of becoming valuable decision-support 
tools. 
Because of its complexity, the transmission cycle of human malaria depends on 
a relatively large set of external factors and depends on their impact on both the 
malaria parasite and its vector. Even though several parasite and vector species do 
exist, in West Africa the malariologically most relevant species are Plasmodium falci-
parum and the mosquitoes of the Anopheles gambiae complex, respectively. 
The malaria transmission cycle starts when a parasite is ingested by a suscepti-
ble anopheline mosquito during a blood meal. The parasite then has to undergo 
further development (sporogony) until its infective form is secreted by the mosqui-
toes salivary glands. A bite of such an infective mosquito may lead to the injection 
of a parasite into the human bloodstream and thus cause malaria. The speed and 
integrity of this cycle are the key determinants of malaria transmission dynamics in 
a region. Since both the physical environment and a number of anthropogenic 
factors play a role for the dynamics of malaria transmission, an analysis of the spa-
tio-temporal pattern of malaria needs to take into account this complex and inter-
linked set of parameters. This is an important reason why despite all advances in 
this field, there is still no model of malaria transmission that works in any trans-
mission setting and can successfully be driven by a limited number of input param-
eters. An overview of important factors related to malaria epidemiology is present-
ed in table 1. 




Factor Malariological relevance References 
Temperature - governs the speed and completion of the 
sporogonic cycle (parasite development) 
- influences the development of the immature 
aquatic stages of the mosquito vector  




Bayoh  & 
Lindsay 2004; 





- surface water is the prerequisite for anophe-
line breeding and determines their habitats 
- different types of water bodies differ in their 
productivity 
- humidity extends the mosquito longevity 
(and may reduce the frequency of blood 
feeding) 
- extended periods of drought may substan-
tially reduce or eradicate a vector population 
Hoshen & 
Morse 2004; 





et al. 2005; 




- may create breeding sites for malaria vectors 
(particularly in case of rice)   
- may coincide with malaria control activities 
(e.g. provision of bednets, use of insectides) 
- may coincide with infrastructural improve-
ments and greater economic capacity (and 
thus better access to health care)   
Sissoko et al. 









- the flight range of mosquitoes is limited 
(around 2 km for most anophelines)  
- proximity of vector habitats/breeding sites 
to settlements or places of human activity 






- structural integrity determines the entry of 
vectors 
- crowding increases the risk of transmission 
to several hosts (i.e. infection of several 
household members) 
Keiser et al. 





- education helps to realistically assess risks, 
take appropriate preventative measures and 
react properly in case of infection 
- the use of (impregnated) bednets and appli-
cation of pesticides helps to reduce trans-
mission risks  
Okrah et al. 
2002, High-




Table 1: Malariological relevance of selected factors 




The effect of one individual factor can usually not described by a simple linear 
relationship. In fact, one factor such as temperature affects several processes relat-
ed to both the vector and the malaria parasite (see figure 2), and at different stages 
of their development, its effect may not be the same. At the egg stage, temperature 
has an effect on the duration of embryogenesis and mortality rates. Likewise, the 
duration of the aquatic larval stages is temperature dependent, with higher temper-
atures accelerating the development while beyond a critical level also increasing the 
mortality of the immature mosquitoes. Once they have reached maturity, tempera-
ture influences not only the longevity and biting behaviour of anophelines but also 
has an effect on the parasite development (sporogony) occuring in the mosquito 
vector. The impact of temperature on a selection of malariologically relevant fac-
tors is presented in figure 2. However, it should be kept in mind that under field 
conditions, various factors are effective at the same time. Adult mosquitoes may, 
for example, better tolerate a certain temperature if it is sufficiently humid than 
under dry conditions (Karthe 2010). 
 
 
The study presented first of all aimed at the identification of spatio-temporal pat-
tern of malaria incidence in Kossi Province (Burkina Faso) in order to assess the 
range of malaria incidence rates and differentiate between periods and areas of 
high and low transmission risks. The feasibility of obtaining and integrating data of 
multiple sources was then investigated. This included both the assessment of de-
terminants that are known to have a direct effect on malaria transmission dynamics 
and potential proxy variables which could be used as simple indicators of malaria 
transmission risks. 
Figure 2: Effect of temperature on selected malariologically relevant parameters 
Based on Gilles 1993 and Hay et al. 2000 
 




2.1 Study region and population 
Kossi Province (see figure 3) covers an area of 7,324 km² close to Burkina Faso’s 
western boarder with Mali. Currently counting about 278,546 (INSD 2008), its 
population grows at a rate of about 3.0% annually. Subsistence agriculture and 
pastoralism are the key economic activities of Kossi’s multi-ethnic population 
(Yahmed 2005). In Kossi, only the provincial capital of Nouna may be considered 
a semi-urban to urban region. Population densities tend to be higher in the south 
and west of Kossi, while the north is less densely settled. The only hospital in Kos-
si is located in Nouna; in the rest of the province, state-run health posts (CSPS, 
Centre de Santé et pour la Promotion Sociale) form the backbone of the health services. 
These CSPS provide basic medical treatment and may refer patients to Nouna 
hospital (Karthe & Traoré 2009). 
 
The region’s semiarid climate is characterized by a rainy season lasting approxi-
mately from June to September. About 90% of the annual precipitation of around 
800 mm fall during July, August and September (Griffiths 1972; Ingram et al. 
2002). While temperatures tend to vary relatively little around an average of 28°C,
Figure 3: Physical Map of Kossi Province (indicating location of CSPSs) 




the hottest months when temperatures may exceed 45°C occur just before the 
onset of the summer monsoon. The dry savanna, which is strongly influenced by 
human activities, is interspersed by gallery forests along the region’s two major 
rivers (Mouhoun and Sourou). Rainfed agriculture, in particular the cultivation of 
sorghum (Sorghum bicolor) and pearl millet (Pennisetum glaucum), dominates, but irriga-
tion has been introduced along the Mouhoun and Sourou and led to a diversifica-
tion of crop production in recent years. 
Malaria is holoendemic in Kossi Province and the transmission intensity typi-
cally ranges between 100 and 900 infective bites per person and year (Becher et al. 
2008). As in the rest of Burkina Faso, malaria is the main cause of morbidity and 
mortality in Nouna Health District (Tipke et al. 2008). 
Within the study region, the situation in two villages is exemplarily considered 
in more detail: Illa (population in 2006: 1536), located in the northeast of Kossi 
within the zone of Wèrèbèrè CSPS, is adjacent to a zone of swamps (to the north), 
the Sourou river and the irrigation perimeters of the Sourou Valley Authority (Au-
torité de Mise en Valeur du Sourou, AMVS; to the east). Toni (population in 2006: 
1979), on the other hand, is located in the southwest of Kossi, the seat of a CSPS 
and located in a region where agriculture is rainfed. In the recent past, plans to 
dam a nearby episodic stream and use its water for irrigation have been locally 
discussed but not yet realized. 
2.2 Data collection and analysis 
Various types of data were collected for the study which was conducted in the 
working region of the Centre de Recherche en Santé de Nouna (CRSN). Malaria case 
data were obtained from both the CRSN malaria database and local health centers. 
Personal interviews were carried out in two villages in order to assess both preven-
tative and curative practices. Topographic maps and high-resolution satellite im-
agery were obtained as the basis for spatial investigations, including the detection 
of aquatic vector habitats. Both terrestrial measurements and remote-sensing 
products were used for meteorological monitoring and the assessment of micro-
climatological information. As far as possible, data were then entered into a GIS 
(ESRI ArcGIS 9.3) in order to analyse spatio-temporal effects and links between 
malaria incidence and its potential determinants. 
In Kossi Province, malaria cases are routinely recorded and aggregated to 
monthly statistics at local health centers (CSPSs). Even though some active case 
detection data exist from previous case studies in the region, a complete coverage 
of the province is only feasible using passive case detection data. These represent 
presumed infections in patients reporting to health centers. The diagnosis of ma-
laria at all CSPS (except for Nouna) is symptomatic (usually based on a body tem-
perature of 38°C or higher, and potentially on additional symptoms), thus poten-
tially overestimating the malaria incidence. On the other hand, not all patients re-
port to a CSPS when they feel sick, thus resulting in an underestimation of the 
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actual burden. Both self-treatment and the consultation of traditional healers are 
common practice. Even though there is a lack of empirical proof, it is reasonable 
to assume that the two effects (under- and overestimation) counterbalance each 
other. 
Demographic base data were obtained from the CSPS, some of which are un-
der a demographic surveillance system (DSS) installed at the Centre de Recherche en 
Santé de Nouna. Since the last census in December 2006, data available for subse-
quent years are projections based on an estimated population growth rate of 2.61% 
annually. In two villages, Toni and Illa, interviews were carried out at selected 
households in order to obtain (among other information) data on preventative 
measures practiced. All households were georeferenced using by GPS. Even 
though this study (n=251 persons or 5,8% of the population) was not sufficiently 
comprehensive to provide representative data for the entire province (which was 
accomplished in surveys conducted by the CRSN and other research team), it was 
meant to provide an indication whether the differences observed could be large 
enough to be malariologically relevant. 
The latest editions of all topographic maps of the region were obtained at the 
Institut Géographique du Burkina Faso (IGB). Since these larger scale maps only 
covered a small part of the province, high-resolution satellite images (QuickBird 
and Ikonos) of Toni and Illa, two villages located in different ecological (and socio-
economic) settings, were acquired. After pan-sharpening, these images were used 
as the basis for mapping both the location of houses and potential mosquito habi-
tats. During ground surveys carried out during the dry and wet seasons of 2007 
and 2008, all depressions that covered about 0.5 m² or more and which were at 
least 20 cm deep were mapped and considered to be potential vector breeding 
sites. 
Climate data were retrieved from the meteorological station in Dédougou 
which is situated just outside the study area. Due to frequent malfunctions of the 
equipment and resulting data gaps, information from 10 meteorological stations set 
up in Kossi province itself were found to be of little use. To account for spatial 
varations of meteorological parameters, MODIS land surface temperature (LST) 
and vegetation index data were assessed regarding their usefulness as proxies for 
(air) temperatures and precipitation. High spatial resolution images (Quickbird, 
Ikonos) were used for the preparation of overview maps to be used for derivation 
of risk zones. Due to prohibitive costs, only two dry season scenes could be ob-
tained. Therefore, besides a general ground truthing, the mapping of potential 
mosquito breeding sites was carried out during both the dry and rainy seasons. 
All georeferenced data collected were entered into ArcGIS 9.3. While annual 
incidence rates were obtained for all 26 CSPS, the seasonality of transmission was 
investigated for 14 CSPS distributed throughout the province by calculating a ma-
laria seasonality index (MSI). Incidence maps were created using inverse distance 
weighted interpolation. A seasonality index was developed and calculated in order 
to account for differences in temporal distribution pattern. Regression analyses 




were carried out to identify correlations between external factors and the incidence 
pattern observed. However, this was found to be problematic because of differing 
spatial and/or temporal resolutions and references of the data. These findings are 
described in the results and discussion sections. 
3 Results 
3.1 Malaria incidence pattern 
Kossi Province is a region of holoendemic malaria and the transmission intensity 
typically ranges between 100 and 900 to 1000 infective bites per person and year 
(Kouyaté et al. 2008). In 2008, this resulted in an annual incidence rate of 137,6 
cases per 1000 inhabitants (Direction Générale de l'information et des statistiques 
sanitaires 2009), a figure which varies both spatially and interannually. At the same 
time, the climatic seasonality means that much of this burden falls into the weeks 
following the onset of the rainy season. 
 
Figure 4: Malaria incidence and seasonality pattern in Kossi Province 
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In general, the lowest annual incidence rates in Kossi were recorded in the north 
and west of the province, whereas the highest rates were found in the southeast 
(see figure 4). At Konkui-Kouro CSPS in Doumbala district (44 cases/1000 inhab-
itants) and Ira in Djibasso district (67 cases/1000 inhabitants), malaria incidence 
occurred at relatively low levels. This situation contrasts sharply to settings with 
very high incidence levels such as Bourasso CSPS in Nouna district (524 cas-
es/1000 inhabitants). The nearly 12fold difference between Konkui-Kouro and 
Bourasso CSPS compares to a distance of just 48 km between the two health cen-
ters and illustrates how little data at province level may reveal about local condi-
tions. 
Nearly three fourths of all malaria cases were observed during the second half 
of the year, with typically 20% to 25% of the annual cases falling into a single 
month, and incidence rates falling to low levels (but never zero) during the first 
half of the year (see table 2). A relatively low degree of seasonality was observed in 
Nouna, the only urban settlement in the province,  as opposed to otherwise high 
seasonality indices in the southern part of Kossi (e.g. Lékuy, Goni). 




3.2 Analysis of determinants and predictors  
In order to best target intervention efforts, a monitoring and/or prediction of both 
of the spatial and temporal pattern of malaria incidence may be valuable resources. 
Therefore, the observed incidence pattern were analysed in order to identify poten-
tial determinants and predictors. Since the present study did not aim at a transmis-
sion model, and because of the multitude of factors involved, each factor will be 
CSPS Malaria cases in 2008 Monthly cases Seasonality Index 
Total 
(Ct) 
Jul – Dec 
(C2) 









Barani 2095 1543 552 79 418 215,51 
Berma 2114 1627 487 64 397 226,16 
Bomborokuy 2020 1518 502 64 315 216,52 
Dara 1487 1128 359 32 235 227,74 
Dokuy 1485 1243 242 29 368 252,8 
Goni 790 677 113 13 161 256,45 
Ira 1867 1215 652 73 305 191,53 
Kienekuy 1110 867 243 21 217 238,57 
Labarani 1259 1009 250 29 272 241,02 
Lékuy 814 717 97 6 213 270,69 
Nouna 1341 471 870 15 194 155,89 
Toni 932 672 260 23 200 223,58 
Wèrèbèrè 930 648 282 33 183 208,8 
Yévédougou 948 653 295 22 187 216,71 




  218,5 
C1: cases during January to June period; C2: cases during July to December period; Ct: 
annual cases (total); Cmin: cases during the month of lowest incidence; Cmax: cases during 
the month of highest incidence; MSI = ([2C2 / Ct] + [Cmax -Cmin] / [Cmax +Cmin]) * 100 
Higher MSI values indicate a greater degree of seasonal variation of transmission.  
 
Table 2: Indicators of malaria seasonality 
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characterized briefly and its potential role for a transmission model / prediction 
system be outlined. 
Contrastive to previous works in the region (e.g. Yé et al. 2007, Gosoniu et al 
2009), temperature was not found to be a reliable and feasible predictor of the 
spatial pattern of malaria incidence. This was mainly due to two reasons: on the 
one hand, it was observed that microclimatological effects are substantial, and that 
meteorological stations (which frequently failed due to technical reasons) did not 
capture this spatial variability. On the other hand, for much of the year, tempera-
tures recorded were in a suitable range for malaria transmission but not stations 
not situated in locations representative of mosquito habitats. 
The availability of water was found to be a good determinant of both the spa-
tial and temporal pattern of malaria incidence. On the one hand, the seasonality of 
rainfall was, as expected, well associated with malaria incidence pattern which 
lagged behind around one month. Spatial pattern of precipitation were, however, 
difficult to assess because of a relatively coarse station network (often afflicted 
with data gaps). At the same time, distance to major water bodies, particularly the 
Sourou, and inundated rice fields were found to be related to higher incidence rates 
than in surrounding areas. Vegetation indices (particularly MODIS NDVI) were 
found to be a feasible predictor of malaria incidence for a number of reasons: in 
the dry savanna setting observed, 16 days’ MODIS NDVI composites (a) reflected 
water availability of any origin (precipitation and irrigation) in both its temporal 
and spatial pattern, (b) showed the same temporal response to rainfall (and proba-
bly the beginning of irrigation) as malaria vector populations and (c) were readily 
obtainable (at no cost). The NDVIs in a 5 km buffer zone around health centers 
were found to be the single best predictor of malaria incidence (r² > 0,5 were ob-
served for monthly malaria incidence and NDVI for 14 CSPS). 
High resolution satellite images were found to be a good alternative when oth-
er cartographic resources were scarce, particularly because they allowed the detec-
tion of major depressions suitable for mosquito breeding. In the Kossi context, 
excavation pits for clay or loam bricks could well be detected and were the malar-
iologically relevant topographic features not covered on existing topographic maps. 
Villages falling within a 2 km zone (equivalent to the reported flight range of 
Anopheles gambiae, the main vector of malaria in the region), were found to be par-
ticularly prone to high levels of malaria incidence. 
The limited data on prophylactic practices collected during interviews in the 
villages of Illa and Toni were not sufficient for an analysis of their impact but indi-
cated great inter-village differences. Whereas in Illa, 47.7% of the residents covered 
used a bednet, the respective figure for Toni was just 9%. This was partly related to 
a campaign providing bednets to pregnant women at Wèrèbèrè CSPS, the health 
center covering the population of Illa. A similar campaign has been started at Toni 
CSPS.  On the other hand, the use of insecticides was a much more common prac-
tice in Toni (protecting 80.0% of the study group) than in Illa (24.5%). In Illa, 
41.1% reported not to do anything to prevent malaria, as opposed to 18.0% in 




Toni. Even though there is controversy about the degree of protection offered by 
various strategies, the differences observed suggest that varying degrees of person-
al protection may contribute towards different levels of malaria incidence. 
4 Discussion 
In semi-arid regions, the dynamics of malaria transmission and incidence do not 
only vary seasonally but also exhibit spatial pattern involving differences of magni-
tude in neighbouring localities. Moreover, not only the incidence ratios but also 
their seasonality differ markedly even within relatively small regions. The complex 
set of factors governs the transmission dynamics of malaria mean that individual 
parameters are often of little value as predictors of the pattern found. Instead, 
integrated approaches incorporating the physical environment, socioeconomic 
realities and individual behaviour are required to explain the spatio-temporal pat-
tern of malaria incidence. Among the individual parameters investigated, the pre-
sent study identified vegetation indices as a feasible approach to routinely detect 
environmental conditions conducive to malaria transmission in dry savanna re-
gions. 
In the future, integrated but reasonably simple approaches will be needed for 
both the operation of malaria early warning systems and the development of con-
trol strategies. For the semi-arid parts of West Africa, land use changes will play a 
prominent role in this context. A growing population, rising food demand and 
previously unused potentials mean that irrigated agriculture is on the advance (Seck 
et al 2010). Malaria early warning systems and models will on the one hand need to 
be adapted to such developments, but could on the other hand provide valuable 
insights into epidemiological processes that may help to implement such projects 
in a way that negative health effects such as increasing levels of malaria transmis-
sion can be avoided. 
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25 Anemia –  
What has to be investigated in an African setting? 
Silke Kietz, Martina Lange, Ingrid Kühnle and Max Lakomek   
1 Introduction 
Anemias can be caused by several reasons, such as congential defects in erythro-
cyte enzymes or erythrocyte membrane, defects in haemoglobin, nutritional ane-
mias like iron defiency or autoimmune haemolytic disorders. Inherited anemias like 
hemoglobinopathies are found worldwide. Haemoglobinopathies are the most 
frequent genetic diseases in the world.  
Data from the World Health Organization show, that an estimated 250 million 
people, or 4.5 % of the world population, carry a potentially pathological haemo-
globinopathy gene. Every year, 300 000 infants are born with major haemoglobin 
disorders, the most common being the thalassaemias and sickle-cell disease. Preva-
lence varies from under 0.1 births per 1,000 in some parts of the world to more 
than 20 per 1,000 in parts of Africa. The highest prevalence is found in Africa, 
Asia and the Mediterranean basin. 
Worldwide the alpha and beta thalassaemias are the most common inherited 
single-gene disorders with the highest prevalence in areas where malaria was or still 
is endemic. The burden of this disorder in many regions is of such a magnitude 
that it represents a major public health concern. For example in Iran, it is estimated 
that about 8,000 pregnancies are at risk each year. In some endemic countries in 
the Mediterranean region, long-established control programs have achieved 80-
100% prevention of newly affected births.  
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Figure 1: Distribution of thalassemia worldwide 
 
Sickle cell anemia affects millions throughout the world. It is particularly common 
among people whose ancestors come from Sub-Saharan Africa, South America, 
Cuba, Central America, Saudi Arabia, India, and Mediterranean countries such as 
Turkey, Greece, and Italy. In the Unites States about 72,000 people are affected, 
most of whose ancestors come from Africa. The disease occurs in about 1 in every 
500 African-American births and 1 in every 1000 to 1400 Hispanic-American 
births. About 2 million Americans, or 1 in 12 African Americans, carry the sickle 
cell allele. 
Sickle cell disease can be diagnosed through a simple blood test. In many cases, 
sickle-cell anemia can be diagnosed when newborns are screened. To prevent ma-
jor complications, appropriate vaccinations and prophylactic antibiotics, as well as 
folic acid supplements should be administered. In case of vasoocclusive crisis pain 
should be managed appropriately. Blood transfusions are indicated for patients 
with severe anemia or neurologic/pulmonary complications. The only known cure 
at present is hematologic stem cell transplantation. 
Iron overload is the most common and severe complication of thalassemia ma-
jor, mainly due to the need of life-long blood transfusions required for the treat-
ment of the severe anemia and increased iron absorption from the G.I. tract. Iron 
chelation treatment is essential in the prevention of long-term organ damage due 
to iron overload. Iron overload may cause severe damage to almost all organs with 
subsequent failure of their function. Since the early 1990ies oral iron chelators are 
being successfully used. 
Another problem associated with thalassemia is the early development of oste-
oporosis. Ineffective erythropoiesis results in the dramatic expansion of the bone 
marrow which causes mechanical interruption of bone formation leading to corti-




cal thinning. This is considered as a main reason of distorsion and fragility of the 
bones in thalassemia patients. Other bony abnormalities such as spinal deformities, 
scoliosis, nerve compression, spontaneous fractures, have also been described in 
patients with thalassemia. Osteopenia and osteoporosis represent prominent caus-
es of morbidity in young adults of both genders with thalassemia major or thalas-
semia intermedia.  
Other problems in patients with beta-thalassemia are: development of diabetes 
and hypothyroidism, the parathyroid gland dysfunction, cardiomyopathy, impaired 
renal function and delay in sexual maturation. 
2  WHO report 2010 
In the latest WHO report of 2010 it has been shown that, in general, wealthier 
countries have far lower levels of child mortality than poorer ones – in low-income 
countries, the median level of child mortality in 2008 was 109 deaths per 1000 live 
births, compared with 5 per 1000 in high-income countries, representing a more 
than 20-fold difference. Several low-income countries have achieved comparably 
low levels of child mortality – with wide variation in levels of child mortality ob-
served in most of the country-income groups. In low-income countries, child mor-
tality in 2008 ranged from 14 to 257 per 1000 live births representing an 18-fold 
difference. Child mortality rates have fallen since 1990 in all country-income 
groups – with the rate of decline generally faster in high-income and middle-
income countries than in low-income countries. Median child mortality fell by 
almost 50% between 1990 and 2008 in lower middle-income countries, but by only 
31% in low-income countries. 
Despite ongoing efforts to enhance disease surveillance and response, many 
countries face challenges in accurately identifying, diagnosing and reporting diseas-
es due to the remoteness of communities, lack of transport and communication 
infrastructures, and shortage of skilled health-care workers and laboratory facilities 
to ensure accurate diagnosis.  
Health service coverage indicators reflect the extent to which people in need 
actually receive important health interventions. Such interventions include the 
provision of skilled care to women during pregnancy and childbirth; reproductive-
health services; immunization to prevent common childhood infections; vitamin A 
supplementation in children; and the treatment of disease in children, adolescents 
and adults. 
There are several resources available to the health care system – these include 
physicians; nurses and midwives; other health-care workers; and hospital beds. In 
general, countries with the lowest density for both physicians and nurses/midwives 
are in the WHO African Region. 
There are differences between rural and urban areas in coverage of key health ser-
vices such as skilled-attendant at birth and immunization – these differences are 
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more marked in low-income countries compared with middle-income countries. 
80% of urban births take place with the assistance of skilled health personnel 
compared with only 35% of births in rural areas. 
To further reduce child mortality neonatal mortality must be decreased. Glob-
ally about 40% of pediatric deaths under 5 years of age are estimated to occur in 
the first month of life; most within the first week. The under 5 years mortality rate, 
e.g. the probability of dying by age 5 per 1000 live births is estimated for example 
in Ghana with 76, and for Namibia with 42. Life expectancy at birth has been 
shown for low income countries like Ghana for both genders with 62 years and for 
upper middle income countries like Namibia with 63 years. There are big differ-
ences to high income countries like Germany where life expectancy at birth reach-
es 80 years. 
3 Diagnosis and prevention of rare anemias / 
hemoglobinopathies 
Diagnosis of complex haematological pathologies such as e.g. congenital haemolyt-
ic anemia caused by rare enzymatic defects and other haematological diseases 
which are difficult to categorize, requires the advice of dedicated specialists. Red 
cell morphology, when typical, is the first and foremost diagnostic tool. However, 
due to the wide heterogeneity of rare anaemias, an expert eye is required to draw 
exact diagnostic conclusions. For the diagnosis of hemoglobinopathies, Hemoglo-
bin-electrophoresis is needed.  
One aim could be to create an on-line image bank of peripheral red blood cell 
smears from affected individuals, consultable from all hospitals. 
 
Table 1: Tests used for Hematologic Diagnosis: 
 
• Complete Blood Counts 
• Peripheral Blood Smear Examination 
• Fetal Hemoglobin Estimation 
• Hemoglobin Electrophoresis or High Performance Liquid Chromatog-
raphy  
• and Screening of parents for carrier status 




Figure 2: Smear from a Thalassemia major case 
 
In sickle cell anemia, a newborn sickle cell screen, prepared from dried blood spots 
screening cards is possible. It has been established in the USA and European coun-
tries.  
Prenatal genetic diagnosis at the embryonic stage for example in ß-thalassaemia 
has been established in the Mediterranean countries. Chorionic villi samples biopsy 
during the first trimester of pregnancy can be used for that approach. New ap-
proaches are being developed obtaining fetal DNA from maternal plasma from the 
first trimester onwards. This approach is a useful tool for noninvasive prenatal 
exclusion of fetal beta-thlassaemia major. 
Genetic counselling helps individuals or couples to be fully informed of their 
genetic risk. It allows them to make appropriate decisions for their descendants. 
Genetic counselling must provide information on disease characteristics, evolution 
and treatments, genetic transmission and reproductive options, including prenatal 
diagnosis. Two main types of severe haemoglobin disorders must be considered: 
sickle cell anaemia and thalassemias. Sickle cell anaemia stems from a single ß-
globin gene mutation, but the resulting phenotypic expression is widely variable, 
ranging from severe haemolytic anaemia to individuals exhibiting very mild symp-
toms. The same clinical variability is observed among individuals affected with 
thalassemia, and this condition may result from heterogeneous genotypes of the 
alpha and beta globin genes. Moreover, several globin gene abnormalities can be 
found in a single individual modifying the clinical presentation and complicating 
the genetic transmission. Most of the haemoglobin disorders are recessively inher-
ited. Thus in the absence of preventive measures, a couple of heterozygotes for an 
Hb disorder has a ¼ risk to give birth to a baby affected with a severe disorder. To 
avoid having an affected child, a heterozygote has at least, three main reproductive 
options. The first one is to avoid marrying another heterozygote. This becomes 
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possible where premarital screening of heterozygotes is available. The second is to 
marry another heterozygote but avoid having children. This implies the use of an 
efficient contraception. The third option is to marry and have babies with another 
heterozygote, perform some kind of prenatal diagnosis, and, if the fetus is affected, 
decide to terminate the pregnancy. The challenge is for both, the genetic counsel-
lor and the couple. The woman or couple has to understand genetics and transmis-
sion and depending on their educational level this may not be easy. Cultural and 
religious specificity has to be taken into account. 
 
 
Figure 3: Carriers & patients 
4 Therapeutic challenges of rare anemias/hemoglobinopathies 
Treatment of patient with rare anemias / hemoglobinopathies requires preventive 
examinations in health centres supported by a doctor, supplementation with medi-
cines and blood. In the African setting, especially in rural areas there might be 
problems with blood supply because of limited number, lack of qualified staff, 
availability of blood donors, problems with quality control assays, and infrastruc-
ture. 
Ideally the transfusion therapy in thalassemia should fully compensate the 
anemia and suppress the thalassemic phenotype due to ineffective erythropoiesis. 
In practical this aim may be achieved in most thalassemia major patients by main-




taining a pre-transfusion haemoglobin level above 9,5-10 g/dl. This promotes 
normal growth and allows the patient a full integration in social life.  
Keeping that haemoglobin level can only be achieved by regular blood transfu-
sion every 3-4 weeks. There might not be enough blood supply in those countries. 
Blood transfusion-exchange is necessary in some situations for sickle cell ane-
mia, for example long periods of pain, priapisme, refractive ulcer, orthopaedic 
surgery, gall bladder surgery. 
Blood donor screening and improved infectious disease testing of blood units 
have contributed to the decreased risk of transfusion-transmitted diseases. Howev-
er, overall blood safety is threatened by the discovery of new hepatitis agents, the 
discovery of variant Creutzfeld-Jacob disease and the increasing threat of Chagas 
disease, malaria, babesia, ehrlichia and bacterial infections. Also Parvovirus B19 
infection, usually responsible for benign pathologies, may be transmitted by blood 
transfusion and may cause a serious clinical outcome in susceptible patients with 
shortened red cell survival such as thalassemia patients. The transfusion of pheno-
typed red blood cells (Rh, K) is very important for prevention of allo-
immunisation in beta-thalassemia patients and is an essential condition to improve 
the quality of their lives. 
5 Aims to improve national health according to blood 
disorders 
According to a study on thalassaemia, (Qamruz Zaman, Association between the 
Education & Thalassaemia: A statistical Study, Pak. j. stat. oper. res. Vol.II No.2 
2006 pp103-110 107), different suggestions are recommended to control the dis-
ease like rare anemias / hemoglobinopathies and its spread in the population.  
 
These are as follows: 
1. General awareness of the people regarding the features and complications of 
rare anemias / hemoglobinopathies, which can be carried out through different 
media like newspaper, television, radio etc. 
2. General health education among the people should also be carried out to ar-
range treatment for those suffering from blood disorders. This will help to pre-
vent spread of rare anemias / hemoglobinopathies. 
3. The Hospitals and welfare societies should cooperate with researchers, in order 
to reach a good data collection. There is a big need to build up a proper regis-
tration system. 
4. Every Hospital should maintain proper records of every individual`s case, so 
that the analysis based on those data is accurate. 
5. Properly trained persons should be appointed. 
6. Necessary medication, blood and disposable injections should be provided at 
the Basic Health Units, Centres and free dispensaries should be set up.  
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7. Se-up basic diagnostic possibilities and rules to detect blood diseases, like la-
boratory investigations of red cell morphology by blood cell smear, detecting 
pre-pregnancy Hb level, examinations of Hb electrophoresis. 
8. Most patients live in rural areas where easy access to the divisional head quarter 
hospitals is not possible at all times. It is suggested that there should be a stan-
dard Childrens hospital in every subdivision to provide blood products and 
other medications. 
9. Couples should go for a blood test to detect carrier status of the common 
blood diseases prior to planning to start a family. In that way they will be aware 
of the possible genetic disease that their children may be born with.  
10. Genetic counselling will then be able to advise and present the options for the 
couple. Prenatal diagnosis will also be able to detect any deformities or genetic 
disease of the child.  
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26 Two weeks cataract surgery in rural Ethiopia 
Jörgen Petersen 
1 Facts about Ethiopia 
Ethiopia is a strongly underdeveloped country being no. 174 of 187 states in the 
HDI scale (human development index of the United Nations) [1]. The CIA World 
Factbook [2] presents the following data (in parenthesis: Ethiopia´s rank compared 
to 238 states of the world): Fertility 6,02 children/wife (7); population growth 
3,194%/year (8); median age of population 16,8 years, life expectancy 56,19 y 
(195), population older than 65 years 2,7%. The mean income (gross domestic 
product “GDP” per capita) is 971US$ per year (212); 85% of the population work 
in agriculture. Literacy (age >15y) is 42,7%. Ethiopia´s health expenditures are 
3,6% of GDP (170). Arithmetically there is one physician available for about 
50.000 inhabitants (187) and one ophthalmologist for about one million inhabit-
ants. But really the majority of doctors practices in the capital Addis Ababa (2,9 
million inhabitants), while the 100 million people in rural Ethiopia outside Addis 
Ababa only have minimal access to medical care. And this applies even stronger 
for ophthalmology. 1,6% of the population is affected by blindness and 3,7% by 
low vision according to the “National Survey on Blindness, low vision and Tra-
choma in Ethiopia 2005-06” [3]. About one half in either group is caused by cata-
ract. These nearly 2,5 million cataract people are a huge challenge for Ethiopia, the 
international community and its program “Vision 2020 – global initiative for the 
elimination of avoidable blindness” [4]. 
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2 Eye hospital in Nekemte/Ethiopia 
Nekemte is located 250 km west of Addis Ababa at a height of 2100 m. It is an 
important traffic junction and market place and was the capital of the former 
Welega Province. The number of inhabitants is currently estimated at about 
100.000. There is a provincial hospital but no ophthalmic facility in it. 
 
An independent eye clinic was founded in oct 2007 by the “Mekane-Yesu-Church” 
of Ethiopia with support by several groups from Great Britain, Germany and 
Switzerland. The clinic is a bungalow building of about 200m². It has an outpatient 
area with two examination rooms, and an operation area with two operation 
rooms, both equipped with operation microscopes. A subsidiary building houses 
an optical workshop where spectacles are customized and repaired. Impressively 
the optical workshop is driven by a deaf-mute young woman. An adjacent bunga-
low bed house with 6 rooms was under construction in june 2010. The staff con-
sisted of one fully-fledged ophthalmologist, one cataract-nurse, 5 operation nurses 
and a lot of support personnel, altogether about 20 persons. Both, the ophthal-
mologist and the cataract nurse, were only temporarily engaged. The organizer and 
driving force of the clinic is the local priest of the protestant church, Kes Alemu. 
His most severe problem is to bind a fully educated ophthalmologist permanently. 
Ethiopian doctors do not want to remain at rural regions for a longer period of 
time but pursuit settlement in Addis Ababa. This is a severe drawback for the con-
tinuous patient care and constructive development of the Nekemte eye clinic. The 
Ethiopian state tries to counteract this general problem by means of the so called 
cataract nurses. These undergo a supplementary 2years education in ophthalmic 




Figure 1: Nekemte centre and typical dwelling cottage in rural area 




and bed house under construction 
Currently the clinic performs 10.000 out-patient treatments and 1000 cataract op-
erations per year. The material costs for a cataract operation – intraocular lens, 
viscoelastics and sutures, about 5 Euro each - amount to 15 Euro. The mean 
monthly income of the local population is about 13 Euro, for many individuals 
much less. So they are not able to pay the real costs. They contribute with 3,5 Euro 
for a cataract operation and 0,5 Euro for an eye examination. The rest is essentially 
financed by “Licht für die Welt” (Austria) [5], “Schweizer Blindenhilfe-Äthiopien” 
(Switzerland) [6] and “ Leuchtfeuer-Rotary Osterholz“ (Germany) [7]. Thus finan-
cial pressure is always present. The chance for cost reduction was the reason, why I 
was asked by “Leuchtfeuer-Osterholz” to visit Nekemte in order to instruct and 
train the local eye surgeons in sutureless cataract surgery. This took place 24.may -
10.june 2010. 
3 Teaching cataract surgery 
The peculiarities of cataract surgery in Ethiopia become best obvious by compari-
son. In western industry countries the indication for cataract surgery is blurred 
vision. Lowered visual acuity of 0,6 is generally accepted as a sufficient justification 
for an operation. Blindness because of cataract is a rare exception in Germany. The 
lenses are sufficient soft to be emulsified by ultrasound (phakoemulsification). The 
surgical steps are: 
 
1. Cutting a funnel shaped peripheral corneal incision of 2-3mm, sufficient for 
insertion of the phako-tip and implantation of a foldable lens. 
2. The anterior capsule is opened by CCC (continuous curved capsulorhexis). This 
technique is a precondition for a reliable in-the-bag-implantation of the artificial 
lens. 
Figure 2: Nekemte Eye Clinic:  
Outpatient area  
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3. Lens removal by phakoemulsification under closed-eye-conditions, which min-
imizes corneal endothelium damage. 
4. Cortex removal and capsule polishing under closed-eye-conditions. 
5. Implantation of a foldable lens into the capsular bag. 
6. Ready, no sutures, the corneal funnel is self sealing, the eye is watertight 
 
Cataract surgery in Ethiopia is different in many aspects. The indication for surgery 
is complete blindness in the majority of cases. Usually the lens is totally opaque, 
often dark brown and built up by an extremely hard nucleus only. Emulsification 
would not work. The lens can only be removed as a whole (“ExtraCapsular Cata-
ract Extraction” ECCE). The surgical steps as observed 4 years ago at Debre Mar-
kos/Ethiopia and now at Nekemte again are adapted to these conditions:  
 
1. 10 mm corneo-scleral opening of the anterior chamber using scissors. 
2. Opening of the anterior lens capsule by letter-box or can opener technique. 
3. Mobilisation and extraction of the nucleus using viscoelastics and lens loop. 
4. Cleaning of the capsular bag using a Simcoe cannula (suction by a manually 
operated syringe). 
5. Implantation of PMMA posterior chamber lens (not foldable PolyMethylMet-
Acrylat). 
6. Suture of the corneal wound using 10/0 polyamide thread. 
 
It should be emphasized that the “normal” cataract in Ethiopia would be regarded 
as a high risk case in the western world and that Ethiopian cataract surgeons are 
very skilled to manage it, though there is a high rate of complications to be de-
scribed later. The surgical technique would be nearly the same in Germany – with 
one exception: Even for a large entrance to the anterior chamber it is possible to 
construct the corneal wound as a self sealing tunnel without sutures. This is called 
“SICS” (Small Incision Cataract Surgery, even though the incision can be 8-10 mm 
broad). It was the aim of my visit to introduce SICS to Nekemte. Both cataract 
surgeons of the eye clinic learned this modification quickly. Thus the 10/0 polyam-
ide thread, that so far accounted for 25% of the material costs, could be saved.  
4 Outpatient statistics 
Besides the operations there are between 30 and 50 outpatients daily who get ther-
apy at the Nekemte eye clinic. I used the opportunity to examine 410 eyes of 205 
consecutive patients and document the results on a preformed data sheet. The 
frequencies of the most important diseases in this group were as follows: Cataract 
44%, glaucoma 10%, cataract and glaucoma simultaneously 7%, infections 16%, 
trauma 7%. The predominant importance of cataract becomes obvious here again. 
Glaucoma is certainly underrepresented. For it causes no or only little symptoms 




prior to blindness. Glaucoma usually is a casual diagnosis for patients who visit the 
clinic for other eye problems. About one half of the cataract patients had pseudo-
exfoliation, so the real frequency of glaucoma must be very high. This also be-
comes obvious from the statistics of blindness, where cataract and glaucoma nearly 
have the same weight: 19% of the new cases were blind in both eyes (mean age 
57,5 years). The underlying disease was cataract in 35%, glaucoma in 30%, trauma 
in 17% and corneal ulcer in 13%. Additionally it became obvious that blindness is 
associated with poverty: 48% of blind patients had no shoes, while the barefooted 
fraction in the whole outpatient group was only 25%.  
 
5 Quality of cataract surgery 
The patients came back for control 1day, 1 week and 1 month after cataract sur-
gery. So I could examine 73 recently operated eyes, 7 of which were perforating 
injuries. In 82% there was a posterior chamber lens implanted, in 10% an anterior 
chamber lens, and 8% remained aphakic. The following complications could be 
documented: Damage to the iris and pupil occurred in 47%; vitreous loss hap-
pened in 26%; vitreous incarceration into the corneal wound was visible in 16%; 
remnants of lens material relevant for visual acuity were present in 15%; irreversi-
ble damage and decompensation of the cornea occurred in 12%; a dropped nucle-
us or retinal detachment were seen in 3%, both. The functional results were satis-
factory (acuity >0,6) in 33%, intermediate (0,3-0,6) in 41% and insufficient (≤0,2) 
in 26%. 
These results would not be acceptable in Germany, of course. Nevertheless 
one should be careful not to judge too hastily. The positive message is: About 85% 
of previously completely blind people regained ambulatory vision, and in 74% 
acuity was principally even sufficient for reading. 
Figure 3: Outpatients with various 
eye diseases  
Cataract extraction in the operation 
theatre 
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6 Existing deficiencies and possible improvements 
There were two reason, why European standards in cataract surgery were not 
achieved: Insufficient control over refraction and inadequate management of in-
traoperative complications. 
There were a lot of problems with refraction. The existent autorefractor was 
defect, refraction measurements by the temporary staff was extremely unreliable. 
Originally ultrasonic biometry equipment had been available but was no longer 
functioning due to mechanical damage. So lens power calculation could not be 
performed. All patients got a standard lens of 21 D. As a result even keratometry 
was not performed neither before nor after operation. So there was no control for 
astigmatism, the more so as facilities for astigmatic spectacle correction were lack-
ing. 
The other point was intraoperative complications. Damage to the iris was a re-
sult of pupil constriction during operation. Even corneal damage is a consequence 
of such worsening of conditions. Insufficient mydriasis relies on the intense iris 
pigmentation in the African population that binds topical mydriatic agents effi-
ciently. Indeed I could observe that the preoperative drop application was not 
satisfactory. This could be improved easily. 
Vitreous loss is a consequence of the big and hard lens nucleus together with 
letter-box opening and zonula weakness due to pseudoexfoliation. These condi-
tions could be improved only by an earlier operation. But this is unrealistic with 
respect to the large number of cataract-blind people. Surgical management of vit-
reous loss can be optimized using vitrectomy instrumentation, so far not available 
at Nekemte. This would be an important step forward because 10% of vitreous 
loss eyes develop retinal detachment, in case of vitreous incarceration even more. 
The problem with vitrectomy is the high cost, again. 
There exist considerable uncertainty on the real position of the implanted lens. 
A small pupil during implantation and the ragged capsulotomy are high risks for 
partial or total dislocation of the lens haptics. It was not possible to gather sound 
data on this topic at Nekemte, but it is known from literature [8] that the risk for a 
final out-of-the-bag-position of the artificial lens is about 70%. Fortunately in most 
cases this has no serious consequences except for an elevated rate of aftercataract 
that can be assumed to be higher than 50% at Nekemte. And this points to anoth-
er problem: So far there is no YAG-laser available. As a side effect of my stay I 
instructed both surgeons how to deal with the aftercataract problem by opening 
the opacified capsule from behind using a pars-plana-needle. 
7 Summary 
The actual mission - introduction of sutureless cataract surgery in order to save 
costs - was successful. Additional teaching topics were surgery for aftercataract and 
combined surgery for cataract and glaucoma. But even severe shortcomings be-




came visible during my two weaks stay. The one is insensitive handling of the 
technical equipment resulting in mechanical damage of for example slitlamp, oper-
ation microscope, ultrasound biometry and autorefractor. As a result of my report 
the Austrian NGO “Licht für die Welt” thinks about a technical survey and repair 
service for their projects in the third world. The other shortcoming is fluctuation 
of the medical staff in rural Ethiopia. Surgical quality can only be enhanced on a 
sustainable basis if there is personnel continuity in the operation theatre. And last 
not least: The antagonism between quality and cost on one side and quantity on 
the other side is an absolutely unfamiliar problem to us and a challenge for 
optimization. 
Figure 4:  Farmer and his son after  
ox-ploughing  
On the way to the Nekemte market 





2. CIA World Factbook:  https://www.cia.gov/library/publications/the-world-
factbook/geos/et.html 
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27 Ultrasonography at a rural district hospital 
in sub-Saharan Africa – a mixed blessing? 
Werner Stein 
In developing countries health facilities are often poorly maintained, equipped, and 
staffed. Hence overall efficiency and effectiveness in health service delivery are 
often inadequate. This is in particular true for rural district hospitals in sub-Saharan 
Africa and especially applies for sonographic facilities at these hospitals.  
In developing countries, sonographic facilities are mainly available at tertiary cen-
ters and private hospitals. However typically district hospitals are the primary refer-
ral point and quite often district hospitals in rural areas are the only medical facili-
ties. In many developing countries, especially in sub-Saharan Africa sonographic 
service is frequently either inadequate or even nonexistent1. 
Sonography is a safe diagnostic imaging technique widely used in industrialized 
countries. For some diagnostic investigations, sonography has replaced other radi-
ographic imaging techniques and has become the method of choice.  
In skilled hands, sonography provides accurate and invaluable information that 
enables the diagnosis and management of a variety of conditions. Sonography has 
the potential of being crucial in decision making2. 
                                                     
1 Tsige M, Atnafu A. Status of radiological services in Addis Ababa public hospitals. Ethiop Med J. 
2011;49:257-63 
2 Mindel S. Role of imager in developing world. Lancet 1997; 350:426–429 
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Ultrasonography is easy to operate and requires very little patient preparation3. In 
general two transducers, usually a curved array for the range 3 to 5 MHz and a 
linear array for the range greater than 5 to 10 MHz can be used for examination of 
all body regions with the B-scan technique and suffice the requirements of a dis-
trict hospital. Power inconsistency is common and a voltage stabilizer to maintain a 




Modern ultrasound devices are usually equipped with Doppler function - col-
our Doppler and PW Doppler - which is in the setting of a sub-Saharan district 
hospital only of minor importance. The proper use of the Doppler implies deeper 
knowledge and advanced skills of the sonographer. 
Diagnostic and interventional sonography can be distinguished. Diagnostic so-
nography is characterized by plain imaging without further measures. Intervention-
al sonography is defined as an invasive procedure performed under sonographic 
guidance for any tissue or organ that is visualized by ultrasound. Interventional 
sonography can be further subdivided into diagnostic procedures and therapeutic 
procedures. A diagnostic ultrasound-guided aspiration is performed in order to 
gain fluid or a tissue sampling for further analysis. A therapeutic ultrasound-guided 
drainage is defined as the therapeutic removal of a large amount of pus for exam-
ple in order to accelerate the healing process or prevent imminent rupture of an 
abscess. A therapeutic ultrasound-guided drainage is sometimes accompanied by 
injection of medication – e.g. ethanol into a cyst in case of echinococcosis.  
Ultrasonography is the ideal tool to extent diagnostic and therapeutic opportu-
nities especially in a resource restrained setting. Therefore the implementation of 
an sonographic service should generally be recommended. Nevertheless sonogra-
phy at a district hospital in sub-Saharan Africa is a mixed blessing. Ultrasonogra-
phy has not only the potential to improve but also to be without any impact or 
even to deteriorate medical performance. 
Poor defined indication for sonography, misconception of sonography as a sta-
tus symbol, and insufficient training are potential pitfalls.  
Ultrasonography does not compensate poor physical examination. For exam-
ple gross ascites or foetal position are usually identified by clinical means. Only if 
medical history and physical examination are sketchy and inconclusive sonography 
would be appropriate. Indications for the use of sonography within diagnostic 
pathways have to be clearly specified.  
As personnel-intensive technology it might distract resources from other areas.  
Hence staff might be not available to address other and possibly more important 
needs. 
The perception of sonography as a status symbol is more likely in hierarchic socie-
ties as in sub-Saharan Africa and it is likely to hamper the full beneficial potential 
                                                     
3 [No authors listed]. Training in diagnostic ultrasound: essentials, principles and standards—report 
of a WHO Study Group. World Health Organ Tech Rep Ser 1998; 875:i–46 




of sonography. In case an ultrasound machine would be misconceived as a status 
symbol it might not be used by staff members who have to deal with important 
treatment decisions. For example the delivery room is usually run by midwives and 
a medical officer is mostly not available. Implementing sonography in obstetrical 
care in this setting can only be successful in participating midwives in performing 
sonography. The perception of an ultrasound machine as a status symbol would 
make it impossible for the midwives to use sonography.  
A sonographer is only able to interpret sonographic images correctly if he 
knows the differential diagnosis and what to look for. To translate a sonographic 
image into a diagnosis and consequently into a treatment decision is very challeng-
ing. Advanced molar pregnancy for example is a very difficult diagnosis by only 
clinical means but with sonography it is quite easy. In this case4 a pregnant woman 
presented at the hospital complaining missing foetal movement. By sonography 
neither foetal heart activity was registered nor foetal parts were seen. The image 
was afterwards described as snowy – the typical sonographic image of a molar 
pregnancy. Still assuming intrauterine foetal death a caesarean section was finally 
performed. Only then the diagnosis of a molar pregnancy was realized. Ideally the 
uterus would have been evacuated. Importance and difficulty to translate an so-
nographic image into relevant information must not be underestimated. 
 
Considering implementation of ultrasonographic service the following issues 
should be addressed: 
 
1. Is the hospital functional? 
2. Who should perform ultrasonographic examination - specialist vs. clinician? 
3. Who should undergo ultrasonographic examination - selective vs. screening? 
4. How to organize ultrasonographic training?  
1 Is the hospital functional? 
This question addresses the overall performance of an institution. A poor set up is 
not uncommon and accounts for a substantial part of mortality and morbidity. 
Already minor organizational changes could result in remarkable improvements. In 
a malaria ridden area children up to five years of age face the risk of severe anae-
mia. Many of them die shortly after arrival at the hospital. The reduction of the 
time interval between arrival and the time to give life saving blood is self-evident. 
It has been shown that a shortening of this interval below three hours resulted in a 
reduction of mortality by 30%5. A shortage of sodium citrate - which is necessary 
to produce blood bottles – ad the onset of the annual malaria epidemic is likely to 
                                                     
4 personal observation  
5 Own data, unpublished 
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result in many unnecessary death. To concentrate critical ill patients in one room 
rather than scattering them all over the ward ensures proper monitoring. To secure 
monitoring of women within the first hours after giving birth decreases the likeli-
hood to miss a life threatening postpartum haemorrhage.  
The above mentioned examples are self-evident. A common sense approach is 
a prerequisite of a functional hospital. But nevertheless the negligence of obvious 
organizational arrangements increases unnecessary morbidity and mortality. It 
seems obvious that it would be unwise to introduce a new technology to an institu-
tion that is not functional in this respect. 
2 Who should perform ultrasonographic examination – 
specialist vs. clinician? 
Ultrasonography could be performed either by a specialist or by a clinician. The 
specialist sonographer is typically qualified by a formal training, has a deeper 
knowledge and more advanced sonographic skills. He performs a scan in detail and 
is frequently not further involved in the clinical evaluation and the final manage-
ment decision. For example a detailed sonography of a specialist would be required 
to rule out fetal malformation in a pregnancy complicated by hydramnion. 
The clinician on the other hand knows the patient’s problem. If medical histo-
ry or the clinical examination are inconclusive an ultrasound examination would be 
appropriate. He is performing the sonography having a well defined problem in 
mind. For example fetal heart beat is not heard with the stethoscope in an obese 
pregnant woman. Intrauterine death could be easily confirmed or ruled out by 
sonography. A suspected liver abscess for instance could also easily confirmed with 
sonography on a basic sonographic level. 
3 Who should undergo ultrasonographic examination – 
selective vs. screening? 
In industrialized countries sonography is commonly performed as a screening tool 
in obstetrical care. It has been favoured to diagnose placental abnormalities, multi-
ple pregnancies, ectopic pregnancies, foetal abnormality, foetal growth retardation 
and to confirm gestational age. 
The introduction of routine ultrasound scanning in a resource-constrained 
health-care setting could place a large burden on available resources, detracting 
from other more beneficial services6. However it has been demonstrated that 
screening ultrasonography did not improve clinical outcome as compared with the 
selective ultrasonography. Selective use of ultrasound in antenatal surveillance can 
                                                     
6 World Health Organisation, 1994. Mother Baby Package: Implementing Safe Motherhood in Coun-
tries, Maternal Health and Safe Motherhood Programme. WHO, Geneva. 




be valuable in specific situations in which the diagnosis remains uncertain after 
taking clinical history and performing physical examination7. 
Nevertheless screening in early pregnancy in order to identify placenta praevia 
could be a useful indication. In this condition the placenta is covering the cervix 
and it is a leading cause of life threatening antepartum haemorrhage. Placenta 
praevia affects approximately 0.5-1% of all pregnancies. Only a minority of women 
with placenta praevia reaches a health facility in time and it could be assumed that 
the majority of women with this condition die before. However the value of ante-
natal sonographic screening for placenta praevia in sub-Saharan Africa has still to 
be confirmed in future studies. 
At present the routine use of ultrasonography as a screening tool cannot be 
recommended8. At a district hospital sonographic service should be strictly selec-
tive. Ultrasonography is personnel-intensive therefore ultrasonographic examina-
tions should only be performed in case a change in management seems to be likely.  
The indication to perform a sonography should clearly be defined. 
Other meanings to cut down on dispensable ultrasonographic examinations 
should be considered. For example urinary schistosomiasis causes urinary tract 
pathologies which can easily be identified by ultrasonography. However the meas-
urement of albuminuria has been suggested as an alternative tool for monitoring 
urinary tract pathologies9. Therefore in urinary schistosomiasis albuminuria assays 
could be used as a tool for selecting those with more chronic bladder-wall lesions 
without resorting to ultrasonography10. 
4 How to organize ultrasonographic training? 
Ultrasonographic training is of outmost importance and probably the most serious 
challenge in establishing a sonographic service. Without providing a proper train-
ing the implementation of sonography would probably do more harm than good. 
In sub-Saharan Africa sonographic training capacities, facilities and resources 
are insufficient11. Sonographic training abroad – in Europe or America – might be 
an alternative.  However the prevalence and incidence of diseases differ in devel-
                                                     
7 Stein W, Katunda I, Butoto C. A two-level ultrasonographic service in a maternity care unit of a 
rural district hospital in  Tanzania. Trop Doct. 2008;38:125-6 
8 WorlBelizán JM and Cafferata ML. Ultrasound for fetal assessment in early pregnancy : RHL com-
mentary (last revised: 1 September 2011). The WHO Reproductive Health Library; Geneva: World Health 
Organization 
9 Sousa-Figueiredo JC, Basáñez MG, Khamis IS, Garba A, Rollinson D, Stothard JR. Measuring 
morbidity associated with urinary schistosomiasis: assessing levels of excreted urine albumin and 
urinary tract pathologies. PLoS Negl Trop Dis. 2009;3:e526 
10 Sousa-Figueiredo JC, Basáñez MG, Khamis IS, Garba A, Rollinson D, Stothard JR. Measuring 
morbidity associated with urinary schistosomiasis: assessing levels of excreted urine albumin and 
urinary tract pathologies. PLoS Negl Trop Dis. 2009;3:e526 
11 Goldberg BB. International arena of ultrasound education. J Ultrasound Med 2003; 22:549–551 
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oping countries from those in developed countries. It would be therefore im-
portant to provide training appropriate to the environment. And it would be ideally 
if trainees could perform sonography in patients of their everyday practice. 
Hence the training is often individualized and carried out by enthusiastic pri-
vate persons. The Working Committee Ultrasound in Developing Countries 
(AKUSEL) has organized several ultrasonograhy courses in sub-Saharan Africa as 
in Blantyre, Dar es Salaam, and Nairobi. Filling in the need for training these 
courses were well attended. However single courses do not give the opportunity of 
a feed back for the trainees. 
Sonographic training program at the level of a district hospital has been 
demonstrated to be feasible12. Courses have been scheduled every 4 months for 2 
consecutive weeks each time. The sonographic training program lasted 5 years and 
was divided into three stages in which basic, advanced, and specialized courses 
were organized. In order to advance to the next stage a trainee had to pass a theo-
retical and a practical test at the end of every course. 
 
A two-level sonographic service in obstetrical care was shown to be feasible and 
effective13. The basic obstetric ultrasonograhy as a 24 hour service was performed 
by midwives. Their findings were controlled by a specialist sonographer. Basic 
sonography could be trained in a short time and successfully be incorporated in 
daily patient care. The continuous education on site has assured high quality in 
sonographic capabilities. 
                                                     
12 Ferraioli G, Meloni MF. Sonographic Training Program at a District Hospital in a Developing 
Country: Work in Progress. AJR 2007; 189:W119–W122 
13 Stein W, Katunda I, Butoto C. A two-level ultrasonographic service in a maternity care unit of a 
rural district hospital in  Tanzania. Trop Doct. 2008;38:125-6 
Picture 2: Hands on session at  
sonographic training in Eritrea 
Picture 1: Hands on session at so-
nographic training in Eritrea. Pregnant 
women with severe hydramnion. 




In Uganda the Ernest Cook Ultrasound Research and Education Institute 
(ECUREI) offers different ultrasound courses ranging from three month up to 
two years14. Doctors, assistant physicians, radiographers, nurses, and midwives are 
eligible for the diploma course. Nurses and Midwives account for more than half 
of all students. Non-modular and modular courses are offered. The non-modular is 
single continuous block of training lasting 6 months. The modular training lasts 1 
year, and is divided into six modules, each module lasting 2 weeks. 
5 Liver abscess 
Liver abscesses - amebic and pyogenic liver abcesses – are difficult to diagnose by 
clinical means resulting in high complication and fatality. Sonography has revolu-
tionized diagnosis and treatment of liver abscesses and will therefore be discussed 
in detail. 
6 Amebic liver abscess 
Entameba histolytica, the causative agent of an amebic liver abscess usually colo-
nizes the gastrointestinal tract without producing symptoms. In 1 to 10% an un-
treated, asymptomatic infection will change into an invasive disease, usually a liver 
abscess. 
Patients usually present with a combination of fever, right-upper abdominal 
pain, and hepatomegaly. Jaundice is only reported in 5% of the cases. The presence 
of jaundice may worsen the prognosis. Bacterial superinfection of an amoebic 
abscess is rare. Needle aspiration of a non-pyogenic liver lesion may accidentally 
introduce secondary bacterial infection. 
The lesion wall of an amebic liver abscess is fragile and because of inner pres-
sure, a rupture may occur at some point of the liver capsule, with extension into 
the surrounding pericardium, pleural and peritoneal cavities. Amebic liver abscess 
can lead an incidence up to 20% to several complications as peritonitis, pleural 
effusion, subphrenic abscess, pulmonary abscess, or empyema.  
Ultrasonography is the diagnostic tool of choice. The sonographic feature of 
an amebic liver abscess tends to be round or oval, hypoechoid, with well-defined 
margins. The hepatic lesion is usually solitary, and most frequently is located in the 
right lobe. 
                                                     
14 Kawooya MG, Goldberg BB, De Groot W, et al. Evaluation of US Training for the Past 6 Years at 
ECUREI, the World Federation for Ultrasound in Medicine and Biology (WFUMB) Centre of Excel-
lence, Kampala, Uganda. Acad Radiol 2010; 17:392–398 
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The definitive evidence of hepatic amebiasis is based on a demonstration of Enta-
moeba histolytica trophozoites. However, trophozoites will be found in only a 
small percentage. 
Metronidazole is the drug of choice for the treatment of hepatic amebiasis. In 
general patients respond to metronidazole therapy alone within a week. A diagnos-
tic aspiration of a presumed amoebic abscess is generally not required15. However a 
sonographic guided drainage is indicated in the following circumstances16: 
 
 Large liver abscesses of the right lobe in imminence of rupture; 
 Abscesses of the left lobe; 
 Amebic liver abscesses with pleuropulmonary complications; 
 Lack of clinical improvement. 
 
In absence of complications, rapid clinical improvement is seen. In large abscesses 
aspiration generally enhances clinical recovery and accelerates resolution. 
Hepatic cavity healing may occur within from 3 to 12 months and must be 
monitored by ultrasonography. The majority of amebic liver abscesses resolves to a 
sonographically normal parenchymal pattern. However, a small percentage devel-
ops focal hypo- or isoechoic areas surrounded by a hyperechoic wall17. These resi-
dues do not require further treatment. 
7 Pyogenic liver abscess 
Pyogenic liver abscess is the result of bacterial infection of the liver parenchyma, 
with subsequent infiltration by inflammatory cells and formation of pus. Pyogenic 
liver abscess is a serious, life threatening condition. Pyoogenic liver abscesses are 
likely to be fatal if left untreated. Poor nutritional status, an immunocomprised 
state and malignancies are factors contributing to the poor outcome. The clinical 
incidence varies from region to region, but has been reported up to 2.2% of the 
hospital admissions18. 
In the last decades a major paradigm shift has taken place in the diagnosis and 
management of pyogenic liver abscesses resulting in a significant improvement in 
its mortality. Before the 1970s open surgical drainage was often adopted for the 
treatment of pyogenic liver abscesses. With the development of imaging tech-
                                                     
15 Blessmann J, Binh HD, Hung DM (2003) Treatment of amoebic liver abscess with metronidazole 
alone or in combination with ultrasound-guided needle aspiration: a comparative, prospective and 
randomised study. Trop Med Int Health. 2003:8,1030–4 
16 De La Rey NJ. Indications for aspiration of amebic liver abscess. South Afr Med J 1989;75:376 
17 Blessmann J, Khoa ND, Van An L, Tannich E. Ultrasound patterns and frequency of focal liver 
lesions after successful treatment of amoebic liver abscess. Trop Med Int Health. 2006;11:504-8 
18 Huang CJ, Pitt HA, Lipsett PA, et al. Pyogenic hepatic abscess. Changing trends over 42 years. 
Ann Surg 1996;223:600-7 




niques minimally invasive approach combined with systemic antibiotics has be-
come the preferred treatment. Nevertheless pyogenic liver abscess remains a major 
diagnostic and therapeutic challenge. Early diagnosis and prompt therapy of pyo-
genic liver abscess are essential in order to reduce its complications as well as the 
associated morbidity and mortality. 
The symptoms are non-specific and include fever, nausea, vomiting, right up-
per quadrant pain or epigastric discomfort. Less frequently reported symptoms are 
cough or hiccups due to diaphragmatic irritation. 
Systemic antibiotic therapy is one mainstay of treatment. It must be targeted 
according to locally prevalent organisms and to specimen culture sensitivity. Ther-
apy below four weeks seems to be a significant predictor of failure, requiring sub-
sequent intervention. 
In the setting of a rural district hospital sonographic guided drainage of the liv-
er abscess is the first line intervention and it is compared to an open surgical pro-
cedure simpler and cheaper. Sonographic guided drainage is suitable to uni-locular 
abscess, to multiple unilocular abscesses and also to multiloculated abscesses. 
However surgical management may be appropriate as initial treatment in ruptured 
abscesses and complicated concomitant biliary disease. Otherwise surgery is in-
creasingly limited to cases of failed radiological management or to the management 
of complications. The failure of sonographic guided drainage can lead to uncon-
trolled sepsis. Nevertheless, sonographic guided drainage may be the initial line of 
drainage to stabilize high risk patients, definitive surgery may still be necessary. 
Sonographic guided percutaneous drainage and needle aspiration have emerged 
as appropriate alternatives to open drainage. Both procedures provide similar high 
success rates. The decision to perform repeated needle aspirations or to leave a 
drainage catheter in the abscess cavity following aspiration is disputed. 
Needle aspiration is the simpler and quicker method to perform with a de-
creased risk of procedural complications and post-procedural sepsis. However this 
approach requires careful follow-up, and often multiple repeat imaging procedures 
to monitor response to therapy. 
In large abscesses larger than 5 cm the insertion of a drainage catheter has 
been shown to be more effective than needle aspiration. The time to achieve a 
50% reduction in size of an abscess cavity was significantly longer and failure rates 
were higher with needle aspiration19 20. 
Nevertheless percutaneous catheter drainage has some disadvantages. Multiple 
percutaneous drainages may be required due to drainage tube block or inadequate 
drainage.  
                                                     
19 Rajak CL, Gupta S, Jain S, Chawla Y, Gulati M, Suri S: Percutaneous treatment of liver abscesses: 
needle aspiration versus catheter drainage. AJR Am J Roentgenol 1998, 170:1035-9 
20 Zerem E, Hadzic A: Sonographically guided percutaneous catheter drainage versus needle aspira-
tion in the management of pyogenic liver abscess. AJR Am J Roentgenol 2007, 189:W138-42 
 Werner Stein 
 
348 
Both procedures show equal comparable results with an equal failure rate of 3%21. 
The duration of antibiotic therapy may be shortened with effective drainage. The 
following management of pyogenic hepatic abscess has been proposed22: 
 
1. Immediate administration of empiric broad spectrum parenteral antibiotics; 
2. Ultrasound to confirm diagnosis, with simultaneous radiologically guided aspi-
ration of all abscesses > 5 cm23, +/- drain placement; 
3. Microbiological analysis of abscess aspirates and blood cultures: antibiotic reg-
imen should be adjusted according to culture results and sensitivities; 
4. Early recognition of septicemia or organ failure;  
5. Surgical intervention should be considered for patients with large, complex, 
septated or multiple abscesses, underlying disease or in whom  percutaneous 
drainage has failed. 
 
Management and prognosis of amebic and pyogenic abscesses are markedly differ-
ent, therefore the differentiation of both entities is very important. In case of any 
doubt it would be prudent to perform a diagnostic24. sonographic guided aspira-
tion. Epidemiologic and clinical information, in conjunction with positive amebic 
titers, may suggest the diagnosis. In non-endemic areas, a positive amoebic serolo-
gy is very likely to be diagnostic of an amoebic liver abscess. However, in endemic 
areas seropositivity may reflect prior invasive intestinal infection. Serological titers 
(indirect Hemagglutination) usually become negative within one year of acute in-
fection, but may remain elevated for five to six years after cure in some patients25. 
8 Conclusion 
Ultrasonography is an ideal diagnostic and therapeutic tool to improve patient care 
in many aspects. Nevertheless the decision to implement a sonographic service at a 
rural district hospital in sub-Saharan Africa should be individualized considering 
carefully potential pitfalls. Certainly sonography will not improve the outcome in a 
malfunctioning facility. Formal ultrasound training is still in the fledgling stages. 
Nevertheless ultrasound training is a precondition of an efficient sonographic ser-
vice and weaknesses or even lack of ultrasound training are still the main obstacle. 
                                                     
21 Yu SC, Ho SS, Lau WY, et al. Treatment of pyogenic liver abscess: prospective randomized com-
parison of catheter drainage and needle aspiration. Hepatology 2004; 39:932-8 
22 Heneghan A, Healy NA, Martin ST, et al. Modern management of pyogenic hepatic abscess: a case 
series and review of the literature. BMC Research Notes 2011; 4:80 
23 Chung YFA, Tan YM, Lui HF, Tay KH, Lo RHG, Kurup A, Tan BH. Management of pyogenic 
liver abscesses – percutaneous or open drainage? Singapore Med J Pictorial Essay 2007; 48:1158 
24 Ralls PW. Focal inflammatory disease of the liver. Radiol Clin North Am 1998;36:377–89 
25 Salles JM, Moraes LA, Salles MC. Hepatic amebiasis. Braz J Infect Dis. 2003;7:96-110 
 




Of outmost importance are strictly defined indications and the integration of so-
nographic findings into clinical management. 
Sonography has revolutionized diagnosis and treatment of liver abscesses that 




28 Medical geography and travel-related  
health risks in overseas tourism 
Daniel Karthe and Tobias Reeh 
Abstract 
Subtropical and tropical countries play a major role for the European long-distance 
travel market. Both statistical data and numerous case reports demonstrate that the 
multitude of destinations is reflected by a multitude of health problems experi-
enced abroad or imported into travellers’ home countries. Despite such evidence, 
relatively little is known about the links between travellers’ risk awareness, risk 
behaviour and health problems actually encountered. Interdisciplinary approaches 
integrating the perspectives of tourism research, health science and medical geog-
raphy are required for the assessment of travel-related health risks. A case study on 
Egypt, one of the most important overseas destinations for the European market, 




Overseas Tourism, Health Risks, Medical Geography 
1 Linking Tourism Research and Medical Geography 
The travel industry is a business selling positive holiday experiences (Bentley & 
Page 2001), and staying healthy is „an integral part of the ‘tourist experience’ which 
affects overall satisfaction levels of tourists and can ultimately affect their quality of 
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life. […] Adverse effects on the health of tourists may significantly tarnish the 
resulting experience of a holiday or destination” (Lawton & Page 1997: 89). Re-
gions for which tourists report a high incidence of health problems during their 
visit may ultimately face negative consequences (Bentley & Page 2001). Because of 
this, health issues associated with international and domestic tourism are now be-
ginning to attract the interest of researchers from a wide range of social science 
and medical disciplines (Lawton & Page 1997; Vingerhoets et al. 1997; Karthe & 
Reeh 2011). Increasing numbers of overseas travellers and the emergence of new 
tourist destinations mean that tourism now has a significant public health impact 
(Scharlach et al. 2010). One important reason is that trends like last-minute offers 
and online bookings result in insufficient time for preparation, including vaccina-
tions and information about potential health risks at destinations (Karthe & Reeh 
2011). Adequate analyses are needed to improve travel health advice (Cossar 1996).  
Since the turn of the century, several crises have put travel-associated risks into 
the focus of tourism science (Mansfeld & Pizam 2006). Consequently, the investi-
gation of these risks has become established as one branch of the discipline (Clift 
2000; Freyer & Groß 2004; Pechlaner & Glaeßer 2005; Becken & Hay 2007), with 
the key aspects being natural calamities, terrorism and crime, as well as healthy 
travel. There is a considerable need for research on travel-related health risks 
(Gach 2010). At the same time, the importance is manifested both in public health 






Table 1: Risk perception of travellers 
 
Risks perceived to be most fre-
quent 
Risks perceived to be most severe 
Disease (66.6%) 
Crime / Fraud (36.6%) 
Theft (35.4%) 
Problems with hotels (33.7%) 
Lost or damaged luggage (22.2%) 
Technical problem (15.2%) 
Natural calamity (incl. weather) 
(14.3%) 
Problems with tour operator (11.8%) 
Unrest / Terrorism (8.6%) 
Disease (66.2%) 
Accident (54.3%) 
Natural calamity (incl. weather) 
(44.4%) 
Crime / Fraud (36.4%) 
Unrest / Terror (35.1%) 
Theft (21%) 
Problems with hotels (14.2%) 
Lost or damaged luggage (7.7%) 
 




In the context of the SARS pandemic, Wilder-Smith (2007: 318) pointed out how 
close the connexion between tourism and health is: „SARS, travel and travel medi-
cine were intricately interlinked. Travelers belong to those primarily affected in the 
early stages of the outbreak, travelers became vectors of the disease, and finally, 
travel and tourism themselves became the victims.” According to the World Travel 
& Tourism Council, the impact of SARS in 2003 for the tourist industry was four 
to five times greater than that of the terrorist attacks on September 11, 2001 (Wilks 
et al. 2006). The H1N1 influenza virus (“swine flue“) in 2009 illustrated two signif-
icant relations: On the one hand, tourists are an important risk group (e.g., in Mex-
ico and Mallorca). On the other hand, international travel facilitated a rapid, global 
spread. Originating from Mexico, the virus quickly reached the industrialized na-
tions as the source markets of long-haul tourism. HIV/AIDS is another example 
of an infectious disease whose spread was partly driven by tourism (Kleiber & 
Wilke 1995; Clift & Carter 2000; Kumar & Pathania 2010). In the recent past, re-
search has concentrated on three major topics: (a) the assessment of travel-
associated health risks; (b) the investigation of risk awareness and behaviour 
among travellers; (c) the import of health problems by travellers.  
1.1  Assessment of travel-associated health risks  
Dawood (1989) pointed out that roughly half of all tourists who spend their holi-
days in overseas countries experience some sort of health disorder. Besides acci-
dents, common causes of morbidity among tourists include cardio-vascular prob-
lems related to heat-stress, skin damages due to overexposure to UV radiation, 
gastro-intestinal disorders resulting from the consumption of microbiologically 
contaminated food or water and vector-borne infectious diseases such as malaria 
or dengue (Shandera 1993; see table 2) 
Problems actually encountered Improvements desired 
Disease (45.5%) 
Problems with hotels (25.4%) 
Lost or damaged luggage (19.5%) 
Unrest / Terrorism (2%) 
Safety of public transport (55%) 
Safe food and water (44%) 
Flight safety (37.1%) 
Information (33.2%) 
Border controls (32.4%) 
Road safety (31%) 
Health (22.3%) 
Luggage Handling (19.3%) 
Source: Demski (2009) 




Table 2: Selected studies on travel and health 
 
Authors Study group and 
design 
Findings 
Cossar et al. 
(1990) (cited by 




after their return 
 36% reported illness 
 28% reported alimentary problems 
(diarrhoea and/or vomiting) 
Cartwright (1996) 
(cited by Lawton 
& Page 1997) 
  alimentary problems are the most 
common ailments (attack rates of 
≥ 50%) 
Bryant et al. 
(1991) (cited by 
Lawton & Page 
1997) 
Health clinic reports 
on Canadian travel-
lers after their re-
turn 
 ≥ 50% of the travellers visiting a 
health clinic after their return had 
experienced diarrhoea 
Werner et al. 
(1976), Dannen-
berg et al. (1982) 
Cruise ship passen-
gers 
 Gastroenteritis identified as the 
most common problem 
Shlim & Houston 
(1989) 
Trekking tourists in 
Nepal 
 Mean morbidity and mortality 
rates of 24.89 ‰ and 4.98 ‰ re-
spectively (per person year) 
 Acute mountain sickness as the 
main cause of morbidity 
Steffen et al. 
(1987) 
Europeans travel-
ling to developing 
countries 
 15% encountered health problems 
 8% consulted a doctor 
 3% were unable to work for an 
average of 15 days 
Steffen et al. 
(1987) 
Europeans travel-
ling to developing 
countries 
Mean monthly incidence rates 
 giardiasis 7 ‰  
 amebiasis 4 ‰ 
 hepatitis 4 ‰ 
 gonorrhea 3 ‰ 
 malaria 3 ‰ 
Hall & Mc Arthur 
(1991) (cited by 
Bentley & Page 
2001) 
  70% of all adventure injuries and 
50% of all fatalities in Australia as-
sociated with white water rafting 
Paixao et al. 
(1991) 
952 Scottish tourists 
who died abroad 
between 1973 and 
1988 
Causes of mortality: 
 69% cardiovascular diseases 
 21% accidents 
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During recreational travel, the risk for accidents is often higher than in visitors’ 
home countries. This is due several factors including the use of accident-prone 
forms of transport (e.g., off-road vehicles, motorcycles), inexperience or risky be-
haviour of travellers (e.g., motorcycling in shorts and without helmet, boating 
without nautical skills), poor road conditions or vehicle maintenance, adventurous 
activities (river rafting, bungee jumping, caving, mountain biking) and excessive use 
of alcohol (Dawood 1989; Shandera 1993). Particular risks exist in marine envi-
ronments, including strong waves or currents, bites as well as envenomations, and 
various types of diving injuries (Shandera 1993). 
1.2  Investigation of risk awareness and behaviour among travellers 
Many of the tourism-related health risks can be minimized because they are typical-
ly associated with specific risk behaviours (e.g., exposure to UV radiation or insect 
bites). Despite this, research on the links between risk awareness and behaviour is 
still in its infancy. In an explorative study, Schmude & Heumann (2009) identified 
(1) the individual inclination to take risks, (2) personal experience and (3) the per-
Hargarten et al. 
(1991) 
2463 deaths of 
American tourists 
who died overseas 
between 1975 and 
1984 
Causes of mortality: 
 mainly cardiovascular diseases 
 25% accidents 
Nichol et al. 
(1996) 
Medical record data 
of 7 regional hospi-
tals in Queensland, 
Australia admitting 
overseas visitors 
 37.6% of all admissions related 
to injuries and poisonings 
Bentley & Page 
(2001) 
Public hospital mor-
bidity data from New 
Zealand on non-
residents 
Causes of tourist injury morbidity: 
 motor vehicle accidents: 28.4% 
 sports accidents: 53% 
Cossar et al. 
(1990) 
13816 travellers re-
turning to Scotland 
(1977-1989)  
 36% experienced at least one 
health problem 
 28% reported gastro-intestinal 
disorders 
 higher attack rates among tour-
ists on package holidays 
Steffen et al. 
(1983) (cited by 





 28% reported gastro-intestinal 
disorders 
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ceived risk levels at the travel destination as important determinants of travellers’ 
risk behaviour. Three adaptation strategies to risks are distinguished in tourism 
geography (Adelphi Consult 2005; Petermann et al. 2005):  
 
1) Informed adaptation: Travel plans and preferences remain essentially unaf-
fected, but information on risks is actively sought in order to minimize 
risks. This pattern is frequently associated with individual travellers. 
2) Passive adaptation: Package tourists often feel overwhelmed by too much 
information and expect simple-to-follow recommendations from travel 
agents and tour operators.  
3) Risk-averse adaptation: In this case, people who used to travel much re-
duce or completely stop their travel activities. People who did not travel in 
the past see themselves reaffirmed in their position. 
 
About 50% of all European travellers seek information on health risks at their 
destination prior to departure, but only 14% consult a local health department or a 
centre specialized in tropical medicine (Europ Assistance 2008; Priese 2008). Inter-
views of long-haul travellers at Frankfurt International Airport (Gach 2010; Mi-
chels 2010) demonstrated that there is a great sensibility for travel-related health 
risks. At the same time, knowledge on the specific risks connected with the travel-
lers’ destination was often deficient, as was the practice of preventive measures. 
Health risks remain a taboo topic in the tourism industry and tour operators 
face a dilemma: On the one hand, they have a duty to inform their customers 
about the risks associated with specific destinations. On the other hand, they want 
to sell worry-free leisure time (Becker 2009). Interviews conducted at 24 randomly 
selected travel agencies in Lower Saxony and North Rhine-Westphalia revealed 
that 62% of their clients ask about health risks at their destination, while 71% of 
the staff interviewed replied that they informed customers about health risks (Mi-
chels 2010). An exemplary check of seven online travel portals popular in Germa-
ny showed that only four of them offered the possibility to get informed about 
health risks (Michels 2010). Therefore, long-distance travellers need to consult 
additional sources such as medical doctors or websites specialized in travel health. 
Risk awareness does not always translate into risk prevention. For example, 
79% of the travellers who were registered with malaria at the German Robert 
Koch Institute in 2007 did not use any chemoprophylaxis, and those who did of-
ten failed to comply with the recommended dosages (RKI 2008). The fact that it 
remains unclear to which degree this is a result of an information deficit illustrates 
the need for more research on the links between risk awareness and tourist behav-
iour. 
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1.3 Import of health problems by travellers 
„Speed is the new factor introduced by air travel. It is a matter of careful consider-
ation that aerial journeys from distant infected countries can now be accomplished 
in times less than the incubation periods of certain major infectious diseases.” This 
warning was spoken out in the mid-1920s, and led its author, a British Medical 
Service officer, to the conclusion that “the only safeguard which readily suggests 
itself for general application, is to impose observation at destination over an ap-
propriate period upon all those landed here by air from tropical countries” (Massey 
1929: 317f.) – a measure that is hardly feasible and desirable given today’s volume 
of international travel. Nevertheless, in a globalized world where a passenger can 
reach almost any place in the world within a day or two, it must be kept in mind 
that the same is true for many pathogens (Scharlach et al. 2010).  
Several infectious diseases are largely imported into countries of the Western 
world. In Germany, for example, about 40-50% of the Hepatitis A cases recorded 
in 2003 were acquired by tourists travelling to risk areas (“travel hepatitis”) (Wag-
ner & Hohmann 2004). 13.5% of the imported cases originated in Turkey, fol-
lowed by Egypt, Pakistan, Spain, Morocco, Italy, India, Tunisia and Russia (RKI 
2004). Steffen & Gyurech (1994) (cited by Iwarson 1998) estimated a risk of infec-
tion ranging between 3‰ and 20‰ among non-immune travellers. Even though 
absolute case numbers are low for Typhus abdominalis (59) and Paratyphus (72; 
data for 2007), the percentage of imported cases is very high at 89% and 84%, 
respectively (RKI 2008). In the case of schistosomiasis, all infections are imported, 
usually by travellers returning from West Africa (RKI 2002). Despite a generally 
low risk for tourists, a few studies (e.g., Jelinek et al. 1996; Potasman et al. 1996) 
demonstrated that adventure tourism may be associated with higher risks when it 
involves contact with contaminated water.  
2 Geographic determinants of travel-associated health risks  
Travelling carries with it the inherent risk for minor and major health problems. 
The health risks experienced by a traveller depend on several factors which can be 
categorized as environmental determinants and tourist behaviour as well as dispo-
sition (see figure 1). Whereas some environmental factors are more or less stable 
(e.g., landscape, hydrology), others are more variable (e.g., tourist infrastructure) or 
show seasonality (e.g., climate). Environmental factors are external and unchange-
able by the tourist, but each tourist makes individual decisions regarding his or her 
exposition to these environmental factors. Many factors also have a temporal di-
mension: Climatic seasonality for example influences the populations of disease 
vectors and determines UV radiation levels. Tourists are affected by the factor time 
as decisions influencing health risks are taken before (e.g., vaccination), during 
(e.g., sun protection) and after (e.g., hospital care) a vacation. Moreover, the time 
and duration of a visit plays an important role. 
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In order to determine travel-associated health risks, it is necessary to (1) observe 
preferred holiday activities and the linked spatial behaviour of tourists (exposition), 
(2) investigate health-related environmental variables in their spatial and temporal 
dimension and (3) assess the spatio-temporal pattern of the factual incidence of 
health problems encountered by tourists. Geographic information systems (GIS) 
can help to visualize and analyse such data (Kistemann & Schweikart 2010), and 




Figure 1: Model of tourism-associated health risks 
Source: Karthe et al. 2009 
3 Case study: tourism and health in Egypt 
In the 19th century organized tourism in Egypt started with „the development of 
package tours from [...] Europe and steamship services on the Nile established by 
Thomas Cook” in 1869 (Helmy & Cooper 2002: 518). During the 20th century, 
Egypt’s tourism industry experienced a massive growth, paralleled by a diversifica-
tion of the destinations and services offered to holidaymakers. By 2010, the num-
ber of foreign visitors had crossed the 14 millions mark (Egyptian Tourist Authori-
ty 2011), and Egypt has until recently remained one of the favourite overseas des-
tinations of European tourists. Nevertheless, there have been several setbacks 
caused by terrorist attacks and the consequences of the changing political situation 
remain to be observed. With regard to European visitors, at least three forms of 
tourism can be currently found in Egypt (Karthe et al. 2009; Karthe & Reeh 2011): 
 
1. Sun and Sea resort tourism (e. g., sunbathing and diving in Hurghada and  
Sharm El Sheikh) 
2. Cultural tourism and city trips (e. g., cruises in the Nile valley; visits to 
Cairo and Alexandria) 
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3. Individual and adventure tourism (e. g., safaris in the Libyan desert, 
trekking in the Sinai’s interior) 
 
Combined packages, including for example a Nile cruise, a beach holiday in one of 
the Red Sea resorts and short visits to Cairo/Alexandria or one of the desert re-
gions have become an important trend (Ibrahim & Ibrahim 2006). Moreover, tour-
ism in Egypt is in the process of a spatial expansion; new destinations within Egypt 
are added to the portfolio and existing capacities increased (Richter & Steiner 
2007). 
Egypt has a hot desert climate with a latitudinal gradient in temperature, rain-
fall and daily duration of sunshine. Figure 2 shows selected climate data for Aswan. 
During the summer months, the Egyptian climate may represent a severe thermo-
physical strain for visitors travelling throughout the country; during the winter 
months, visitors to southern Egypt may not be accustomed to prevailing tempera-
tures which may already exceed 40°C in February. Potential consequences of pro-
longed heat exposure are dehydration, sunstrokes and heat strokes which may be 
fatal (von Wichert 2008). 
 
Figure 2: Selected climate data for Aswan  
Source: Karthe et al. 2009 
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Due to Egypt’s geographic position, visiting tourists are exposed to comparatively 
high levels of UV radiation. Activities such as sunbathing and snorkeling lead to a 
particularly high exposure. The intensity of the UV radiation within Egypt depends 
mainly on the geographic latitude and increases from the North to the South. The 
highest average doses are measured in the South in July, the lowest in the North in 
December. The average daily UV radiation dose at the Mediterranean coast (Alex-
andria, El Arish) is 1800 J/m² in February and more than 7000 J/m² in Aswan in 
July (Basset 2007). For European tourists spending a lot of time outdoors, the 
critical dose (e.g., 250 J/m² for skin type II, i.e. people with a pale skin, light brown 
or blond hair and green or blue eyes) can thus be exceeded easily (Steinmetz 2000). 
For office workers, a three-week summer holiday on the Mediterranean coast may 
account for almost 50% of their annual UV radiation dose (Knuschke et al. 2007). 
One particular problem in this context is that sun blockers with high protection 
factors are quite costly in Egypt and hard to obtain outside major tourist centres. 
Food and water-borne infections, ranging from mild and self-limited diarrhoea 
to more severe infections requiring medical treatment are the most common health 
problem encountered by foreign visitors to Egypt. Foods served by street vendors 
and small restaurants are often particularly problematic (e.g., due to improper han-
dling, use of contaminated utensils and water) during preparation, storage and 
display (El-Sherbeeny et al. 1985). Bacterial contamination of food and drinks is 
quite frequent in Egypt. In recent years, there have been numerous reports of Eu-
ropean tourists returning with bacterial dysentery caused by Shigella sonnei, a severe 
form of diarrhoea that usually requires antibiotic treatment (McKeown et al. 2005). 
Other forms of Shigella are also common, including Shigella flexneri and Shigella dysen-
teriae (Abu-Elyazeed et al. 2004).  
High prevalences of hepatitis in Egypt are a major risk factor for non-immune 
visitors. Hepatitis A and E are of particular importance to tourists since they are 
typically transmitted by food and drink. A high prevalence of hepatitis A in the 
local population (exceeding 25% of the population in many North Egyptian com-
munities) combined with poor standards of hygiene mean that there is a consider-
able risk of transmission to visitors. Consequently, there are numerous reports of 
foodborne hepatitis. A major outbreak occurred between July and September 
2004, when at least 271 German tourists returning from the same hotel in Hurgha-
da were diagnosed with hepatitis A. All of them had spent between 6 and 21 days 
at the hotel, and interviews carried out in Germany revealed the consumption of 
orange juice as the most likely cause of infection (Frank et al. 2007). With preva-
lence rates of up to 60% in some communities, hepatitis E is another reason for 
concern (Fix et al. 2000). 
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Several vector-borne diseases, including schistosomiasis, filariasis and malaria, have 
been present in Egypt since pharaonic times (Nunn & Tapp 2000). While malaria 
has, after a massive decline of case numbers in the 20th century, almost disappeared 
today, other mosquito-borne diseases have become more frequent. Filariasis was 
considered to be almost eliminated in the 1960s (Weil et al. 1999), but Egypt expe-
rienced a resurgence of lymphatic filariasis after the completion of the Aswan High 
Dam in 1971, which changed both water levels in the Nile and irrigation practices 
(Molyneux 2006). Currently, about 44% of Egypt’s population are at risk of filaria-
sis infection (Lindsay & Thomas 2000), particularly in the Nile Delta (Weil et al. 
1999). As the disease is transmitted by Anopheles, Aedes and Culex mosquitoes and 
no vaccination is available, tourists travelling in these regions are also at risk. A 
rapid population growth, the absence of drainage provisions and higher water ta-
bles since the construction of the Aswan High Dam led to an increase of infections 
with Schistosoma mansoni in Egypt’s Nile Valley (El Katsha & Watts 1997). Skin 
contact with water infested by the vector of the parasite, e.g. when swimming, is 
the major risk factor (Panjarathinam 1990). More than 80% of all schistosomiasis 
infections imported to Germany are acquired in Africa, with Egypt being among 
the top five countries of acquisition (RKI 2002). Several other vector-borne diseas-
es have been recorded in Egypt, frequently in coastal areas, the Nile valley (particu-
larly the Nile Delta) and the oases. Visceral leishmaniasis, a chronic disease leading 
to irreversible damage to inner organs which is caused by protozoal parasites 
transmitted by sandflies of the genus Phlebotomus is found predominantly along the 
Mediterranean coast (El Sawaf et al. 1984; Killick-Kendrick 1999). While Leishma-
nia major has been present in the country for a long time, infections caused by 
Leishmania tropica were diagnosed for the first time in 2009 (Shehata et al. 2009). 
Moreover, mosquitoes of the genera Culex, Anopheles and Aedes may transmit sever-
al arboviral infections, including (potentially hemorrhagic) fevers such as dengue 
fever, chikungunya fever, sindbis fever (named after its first occurrence in a village 
30 km north of Cairo), Rift Valley fever and West Nile fever. While prevalence 
data from Egypt suggest that the risk for travellers of contracting any of these 
arboviral diseases is minimal, the combined risk of an arboviral infection is at least 
noteworthy (Darwish et al. 1987; Corwin et al. 1992). A differentiation between 
tourists’ travel motivations, which often determine the destinations visited and 
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Figure 3: Tourism and tourism-associated health risks in Egypt 
Source: Karthe et al. 2009  
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At popular destinations such as Hurghada or Luxor, local travel agencies offer 
short excursions which may bring tourists into regions they were not originally 
planning to visit. This aspect should be kept in mind when health advice is given to 
prospective tourists. 
4 Conclusions  
Medical geography offers a broad, holistic perspective on the relationship between 
health problems, environmental conditions and human leisure activities by inte-
grating and complementing the perspectives of clinical medicine, public health and 
tourism research. Health disorders during travel are often not registered in tourists’ 
home countries. Moreover, there is still a paucity of information on the risk aware-
ness and behavior of travellers. In this interdisciplinary field, several topics of geo-
graphic relevance have recently emerged.  
Currently, there is a considerable knowledge deficit related to travellers’ deci-
sion-making processes and health status. Little is known about risk awareness, 
information seeking and preparation of prospective overseas travellers and the 
links between these aspects. Moreover, there is a lack of empirical data on risk 
behaviour, preventative measures and the consultation of health services while 
travelling. In recent years, databases on travel and health have been established but 
are still not comprehensive.  
The role and importance of actors in the tourist industry (e.g., travel agencies, 
tour operators) are still poorly understood. Their range of influence, the quality of 
information provided and the reception of recommendations by tourists need to 
be investigated systematically. Moreover, the full supply chain, including restau-
rants and hotels/lodges, needs to be taken into account.  
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From the geographic viewpoint, systematic studies of health risks at specific tourist 
destinations are another necessity. These should incorporate the spatio-temporal 
stratification of risks and their dependence on different activities and forms of 
tourism. Even for popular travel destinations, it remains difficult to assess health 
risks for tourists. Local health statistics and other information sources on public 
health risks do not only vary greatly for different destinations but may in the end 
not be representative for the risks encountered by overseas travellers. Geographic 
information systems could be used to integrate data from various sources, perform 
analyses of spatial disparities in disease risks and their determinants. Ultimately, 
such information could be used for an individualized, differentiated health advice 
for prospective travellers. 
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with great potential which when guided can add value to the institutions they 
might work for in the future. This mentality has underscored the earnest desire to 
always go to the lecture room fully prepared with a clear cut objective to inspire 
and inform appropriately bacteriological techniques needed for their career.   In 
December 2010, I gained admission and received a Danish government scholar-
ship to pursue a PhD degree in the University of Copenhagen, Denmark. My re-
search interest lies in the field of antimicrobial resistance and molecular epidemiol-




Department of Microbiology, University of Ghana Medical School P O Box 4236, 
Accra Ghana,  
E-mail: nickdayie@yahoo.com  
 
Prof. Dr. Hartwig de Haen is retired Professor of Agricultural Economics at the 
Department of Agricultural Economics and Rural Development at the Georg-
August University of Göttingen. He has studied agricultural sciences and econom-
ics at the Universities of Kiel and Göttingen and at Michigan State Universi-
ty/USA. He holds a Ph.D. in Agricultural Economics (1970). Until 1990 he was 
professor at the Institute for Agricultural Economics in Göttingen, where his re-
search and teaching covered spatial economics, environment and development 
economics. He has undertaken research in a number of Asian and African coun-
tries, including extended periods in South Korea and Egypt. During his academic 
career he was a member of various research and policy advisory bodies, including 
the Chair of the Council of Scientific Advisors to the Federal Ministry of Econom-
ic Cooperation and Development. From 1990 until his retirement in 2005, de 
Haen was Assistant Director-General of the Food and Agriculture Organization of 
the United Nations (FAO) in Rome, where he was first head of FAO’s Agriculture 
Department and from 1995 in charge of the Economic and Social Development 
Department. The latter included responsibility for FAO’s work on development 
and food security policy, statistics, markets and trade policy, early warning, long 
term perspective studies as well as nutrition, consumer protection and food safety. 
Since his retirement he has been working mainly on issues related to food security 
analysis and policy. Since 2008 de Haen has been member of the Supervisory 
Board (Präsidium) of the German relief organization Welthungerhilfe. 
Department of Agricultural Economics and Rural Development,  
Platz der Göttinger Sieben 5, 37073 Göttingen, Germany 
Phone number: +49 551 39 4820,  
E-mail: h.dehaen@web.de 
 
Dr. med. vet. Ulrike Sigrid Diesterbeck studied Veterinary medicine at the Uni-
versity of Veterinary Medicine Hannover, Foundation until 2004. She graduated as 
a Dr. med vet in Hannover in 2006. Following Ulrike became a member of the 
working group of Claus-Peter Czerny. Her research focuses on livestock and horse 
infectious diseases and immunoglobulin genetics. 
Centre for Tropical and Subtropical Agriculture and Forestry (CeTSAF) -  
Animal Hygiene and Microbiology, Burckhardtweg 2, 37077 Göttingen, Germany 
Phone number:: +49 551 39 13958, Fax: + 49 551 39 13512 
E-Mail: udieste@gwdg.de 
 
Natalie Diffloth holds a B.A. degree in Sociology from Wesleyan University 
(Middletown, Conn., USA, 1987) and a degree in Graphic Design from the Massa-
chusetts College of Art (Boston, Mass., USA, 1995). Integrating these two disci-




plines in her work as a consultant, she focuses in the areas of communication 
strategy, visual design and online multimedia. Her clients include a broad selection 
of non-profit community organizations as well as NGOs working in South and 
Southeast Asia. She has a strong interest in transcultural projects and collabora-
tions — bringing together partners in both Western and developing countries to 
creatively address pressing needs. Recent cooperations include public health pro-
jects in Indonesia and Cambodia, a documentary film training venture in Afghani-
stan, and several programs supporting immigrant women in Germany. 
Freiburg, Germany 
E-Mail: natalie@diffloth.com  
 
Dr. Busie Maziya-Dixon After graduating with BSc (Home Economics), MSc 
(Food Science) and PhD (Food Science) degrees from Kansas State University, 
Manhattan, Kansas, USA, Dr. Maziya-Dixon worked as Associate Lecturer, De-
partment of Food Technology, University of Ibadan, Nigeria before joining IITA 
as Food Scientist in 1999. 
Dr. Maziya-Dixon, a citizen of Swaziland, conducts research on nutritional quality, 
processing, utilization, and product development and evaluation of IITA mandate 
crops (maize, cassava, yam, soybean, and cowpea). This is aimed at (i) providing a 
diversity of secondary food products to avail the market with either low cost staple 
food for the rural and urban poor or high value products for the richer urbanites; 
(ii) processing crops into higher value, more nutritious products that can open new 
opportunities for market sales and also offer the possibility of improving dietary 
intake. She also coordinates demonstrations to increase awareness of postharvest 
technologies developed at the institute and disseminates information to create 
awareness on nutritional quality of IITA mandate crops and their products.  
Dr. Maziya-Dixon has experience in managing projects that involve a variety of 
partners from national and international institutions, as well as colleagues with 
specialization in a range of disciplines. Among other things, these projects focus 
on enhancing levels of micronutrients in staple food crops through (i) identifica-
tion of the best maize and cowpea varieties; cassava and yam genotypes with high 
iron, zinc, and provitamin A content for multiplication and distribution to farmers 
(ii) improved processing and storage of maize flour and products, yam and cassava 
products and (iii) food to food fortification of cassava products and maize meal 
and flour with target micronutrients. Together with national partners, she is also 
involved in devising a mechanism for promoting strong linkages between agricul-
ture and nutrition with a gender perspective in order to reduce food insecurity and 
malnutrition on a sustainable basis. 
International Institute of Tropical Agriculture (IITA).  
PMB 5320 Ibadan, Nigeria  





Dr. Rousseau Djouaka borne in 1969 is resident and researcher in Benin. He had 
an Msc. Degree in Cellular Biology and Genetics from the University of Ibadan in 
2005. He completed his PhD program in the same University with most of his 
PhD research works conducted at the Liverpool School of Tropical Medicine, UK. 
Between 2006-2008. His PhD. Research works were focussed on the analysis of 
molecular basis of metabolic resistance in malaria vectors. Dr.Djouaka, has experi-
ence and expertise in various aspects of malaria transmission and control. He has a 
good knowledge on the analysis of links between poor agricultural practice and the 
emergence of water borne diseases. With a team from the Liverpool School of 
Tropical medicine, he pioneered in 2008 the discovery of candidate genes implicat-
ed in the detoxification of insecticides in resistant populations of Anopheles. With 
the active collaboration of WHO, he launched in 2011 an “Agro-Eco-Health Sys-
tem thinking” initiative for controlling diseases such as Buruli Ulcer and Malaria in 
wet Agro-ecosystems. He got several grants for research projects from World 
Health Organization (WHO) from 2003 to 2009. Member of many organizations 
involved in the study and the control of malaria, he has published 15+ papers in 
peer-reviewed literature. He has studied the effect of environmental changes on 
malaria transmission, and intensively collaborates with European institutions such 
as the Liverpool School of Tropical Medicine. He is involved in studies that eluci-
date the potential impact of agricultural/ecological transformations on malaria and 
Buruli Ulcer transmission. Dr. Djouaka joint the IITA team of Cotonou in Benin 
in 2009 where he leads activities on the development of environmentally sound 




Dr. Padma Dolma has served as chief obstetrician at the Sonam Norbu Memorial 
Hospital in Leh District, India since 2006.  She received her MBBS (Bachelor of 
Medicine, Bachelor of Surgery) from Lady Hardinge Medical College in New Delhi 
and completed a residency in Obstetrics at Safdarjung Hospital.  In 2011, Dr. 
Padma completed a DNB (Diplomate of National Board) at Safdarjung in Obstet-
rics & Gynecology with a PhD thesis on reproductive endocrinology.   
International Institute of Tropical Agriculture (IITA), BP 08-0932 Cotonou, Benin  
E-Mail: padmadolma@hotmail.com 
 
Christabel Enweronu-Laryea completed her postgraduate training in paediatrics 
in the United Kingdom in 1994 (MRCP, MRCPCH). There after she worked as a 
research fellow in child health and staff grade paediatrician until 1997 when she 
moved to United Arab Emirates as a specialist medical officer in neonatology at 
Tawam Teaching hospital. She returned to Ghana in the year 2000 and has been a 
member of the Faculty Child Health, University of Ghana Medical School and a 
practicing paediatrician and neonatologist at Korle Bu Teaching hospital in Accra, 
Ghana. She is presently a Senior Lecturer in Child Health and Consultant Paedia-




trician in charge of the neonatal unit at Korle Bu. Her research interests are broad 
but mainly focuses on neonatal health, infection control and rotavirus disease. She 
has been offering consultancy services on neonatal health in the sub-region to 
international non-governmental agencies since 2009. She is a member of the edito-
rial board of Ghana Medical Journal and an ad hoc reviewer for other medical 
journals. Christabel is a founding member of the Royal College of Paediatrician 
and Child Health of the United Kingdom and a founding fellow of the Ghana 
Dept of Child Health. 
University of Ghana Medical School P O Box 4236, Accra Ghana 
College of Physicians and Surgeons 
E-mail: chikalaryea@yahoo.com  
 
Elena Gross obtained a German Diploma degree in economics (5 year program) 
from the University of Göttingen in 2008. Since 2009 she is working as a research 
assistant and doctorate candidate at the Chair of Development Economics of Prof. 
Stephan Klasen, PhD. at the University of Göttingen. Her research interests are 
health economics and here especially the impact of water and sanitation infrastruc-
ture on health and well-being outcomes.  She gained first field and survey experi-
ence during a survey in 2008 in Vietnam on vulnerability to poverty in South East 
Asia (DFG-Project FOR 756). During her doctoral thesis she works on an impact 
evaluation project analyzing the impact of German Development Assistance in the 
water and sanitation sector in rural Benin (West Africa).  
Development Economics Research Group, University of Göttingen,  
Platz der Göttinger Sieben 3, 37073 Göttingen, Germany 
Phone number: +49 551 39 8175, Fax: +49 551 39 7302,  
E-mail: egross@uni-goettingen.de 
 
Prof. Dr. med. Uwe Groß has studied Medicine at the University of Hamburg, 
Germany, from 1980-1986 and earned his title M.D. through a scientific project on 
virulence factors of Yersinia enterocolitica. He extended his research as a postdoc-
toral fellow at the University of California at Los Angeles (UCLA), USA, from 
1987-1989 and as a visiting scientist in 1989 at the Palo Alto Medical Foundation, 
USA. Returning back to Germany, he began his medical specialization in microbi-
ology, virology, and infection epidemiology at the University of Wuerzburg, where 
he also initiated a research group on toxoplasmosis. Working on diagnosis and 
pathogenicity of this parasitic disease, Dr. Groß obtained the “venia legendi” for 
Microbiology and Hygiene in 1995 and became Professor for Parasitology at the 
University of Wuerzburg in 1998. Since 1999, he is appointed as Professor of Bac-
teriology and Head of the Institute of Medical Microbiology of the University 
Medical Center Göttingen (UMG), Germany. In addition to toxoplasmosis, he and 
his team have extended their scientific interest to include epidemiology, diagnosis 
and pathogenesis of mycoses and campylobacteriosis. As a consequence, Uwe 




since 2001 and the National Consulting Laboratory for Toxoplasmosis since 2002. 
In 2000, he began to establish microbiological laboratories in three Ghanaian mis-
sionary hospitals, which since then provide diagnostic service for their communi-
ties. Following the devastating tsunami in South-East-Asia in late 2004, Dr. Groß 
initiated a partnership between the Medical Faculty of the University in Banda 
Aceh/Indonesia and the UMG, which since then has been extended into the 
DAAD-funded Indonesian-German Health Education Partnership (IGHEP) 
which consists of seven German and more than 30 Indonesian biomedical institu-
tions. In 2011 and together with members of other faculties of  the University of 
Göttingen, Uwe Groß established the Göttingen International Health Network 
(GIHN) which aims to improve the health conditions of mothers and their chil-
dren especially in sub-Saharan Africa. 
Institute of Medical Microbiology of the University Medical Center Göttingen 
(UMG), Kreuzbergring 57, 37075 Göttingen, Germany 
Phone number: +49 551 39 5801/5806, Fax: +49 551 39 5861,  
E-mail: ugross@gwdg.de  
 
Prof. Dr. Kim Gutschow is the Chair of the Anthropology of Public Health at 
the Center for Modern Indian Studies at and a Professor at the Institute of Eth-
nology at Göttingen University.  Gutschow earned a PhD (1998) and MA (1995) in 
Social Anthropology from Harvard University, where she subsequently was award-
ed a three year post-doc at the Harvard Society of Fellows.  She is the author of 
Being A Buddhist Nun: The Struggle for Enlightenment in the Himalayas (Har-
vard University Press, 2004) which won the Sharon Stephen’s book prize in 2005 
from America’s oldest and largest association of socio-cultural anthropologist, the 
American Ethnological Society.  Her research interests span a number of disci-
plines including medical anthropology, gender and sexuality studies, public health, 
Asian studies, and South Asian religions.  She has authored over 20 other essays on 
diverse topics including maternal health, gender and the social economy of Bud-
dhism, the body and Tibetan medicine, Buddhist nuns and religious identity, 
Himalayan irrigation, and the relationship between social power, ritual, and gender 
in the Himalayas.  She is currently running a five year study of how maternal death 
reviews conducted in two Indian districts can tell us about the quality of obstetric 
and midwifery care at the community and facility levels and how such reviews can 
be tools for policy reviews and quality improvements in obstetric care across India.   
She received a Humboldt Fellowship for Experienced Researchers before joining 
Göttingen University for an ongoing study of the shift of birth from home to hos-
pital in India and the US. She is the Honorary Editor of Ladakh Studies, a journal 
published by the International Association of Ladakh Studies where she has been 
an executive board member since 1992, and she is a member of the American As-
sociation of Anthropology and the Society for Medical Anthropology. Since 1991, 
she has served as Project Coordinator for an NGO, Gaden Relief, in the Indian 




Himalayas dedicated to sustainable and appropriate technology in the such as pas-
sive solar houses, greenhouses, and plantation or water delivery projects. 
Universtity of Göttingen, Centre for Modern Indian Studies (CeMIS), Waldweg 26, 
37073 Göttingen, Germany 
Phone number: +49 551 39 20246/20236, Fax: +49 551 39 14215,  
E-mail: kgutsch@uni-goettingen.de 
 
Christiane Hennecke, University Medical Centre Göttingen, UMG, is Director 
of the Department of International Relations and the EU-Liaison Office at UMG. 
She studied Pedagogic, Child and Youth Psychiatry and Intercultural Didactics at 
the University of Göttingen and the University of British Columbia, Vancouver, 
Canada. She earned her MA Master Degree in 1990 at the University of Göttingen. 
During her career she gained extensive experience in project management and 
training. 
She established one of the first skills labs for medical training in surgery in Germa-
ny at UMG followed by a skills lab in cardiology with the patient simulator “Ha-
vey” and reformed the curriculum in surgery for the clinical part of the curriculum. 
She acts as project manager for the interactive CD-ROM “Surgery Interactive” 
together with Christoph Daetwyler, Philadelphia, USA and established a log book 
for the “Practical Year together with 6 European partners within the LEONAR-
DO DA VINCI programme complemented by a teacher training. 
She is the administrative Coordinator of several small and large scale European 
research projects coordinated at UMG and represents UMG in national and Euro-
pean advisory groups for the European Framework Programme. She is the admin-
istrative coordinator of the EUROLIFE network for UMG and Member of the 
External Advisory Board for PhD Studies at Trinity College Dublin. 
For more than 10 years she was acting ERASMUS Coordinator of the Faculty of 
Medicine at University of Göttingen. 
Together with Andrea Holzäpfel and Uwe Groß she initiated the Göttingen Inter-
national Health Network (GIHN) at UMG side which aims to improve the health 
conditions of mothers and their children especially in sub-Saharan Africa. 
University Medical Centre Göttingen, Dept. of International Relations, Robert-
Koch-Str. 40, 37075 Göttingen, Germany 
Phone number: +49 551 39 8770, Fax: +49 551 39 22593,  
E-mail: christiane.hennecke@med.uni-goettingen.  
 
Andrea Holzäpfel successfully completed a Triple Qualification course in Lan-
guages and Business at the University of Applied Sciences Cologne, Germany in 
2005 and was awarded a B.A. First Class Honours, a Maîtrise and a German Di-
ploma (FH-Dipl.). In addition, Ms. Holzaepfel earned a MSc in Public Health from 
the London School of Hygiene and Tropical Medicine (LSHTM) after studying for 
three years as a distance learning student while working in a fulltime position. The 




her first work experience in internships at the United Nations Information Service 
(UNIS) in Geneva, the German United Nations Association (DGVN) and the 
NGO Transparency International in Berlin. In 2006, she joined the Department of 
International Relations and EU-Liaison Office at the University Medical Centre 
Göttingen where she worked for 5 years as a project manager and Deputy Direc-
tor. During her time at the University Medical Centre she supported the founda-
tion of the Göttingen International Health Network (GIHN). Since 2011, she has 
been working for the KfW Development Bank in the Sector and Policy Division 
for Health, Education and Social Security in Frankfurt, Germany.  
Former Project Manager for GIHN 




Prof. Dr. Frank T. Hufert is acting head and professor at the Department of 
Virology of the University Medical Center Göttingen Germany. He obtained his 
medical degree at the University of Hamburg and received his MD working on 
Flavivirus epitope mapping at the Bernhard Nocht Institute (BNI) of Tropical 
Medicine. He also obtained a Diploma in Tropical Medicine from the BNI and is a 
Consultant of Medical Microbiology & Hygiene. His research interests range from 
the pathogenesis of HIV, HCMV and Arboviruses to the development of rapid 
diagnostic tools for use in clinical virology. He authored and co-authored 89 inter-
national scientific publications. 
Department of Virology, University Medical Center Göttingen, Kreuzbergring 57, 
37075 Göttingen, Germany,  
Phone number: +49 551 39 10550, Fax: +49 551 39 10552,  
E-mail: fhufert@gwdg.de 
 
Ichsan, after graduating from Medical Faculty of Syiah Kuala University, Banda 
Aceh - Indonesia (2005), Ichsan worked as a physician in Red Crescent Hospital in 
Banda Aceh District, Aceh Province. At the same year, he began his carrier as a 
lecturer in the Faculty of Medicine, Syiah Kuala University (UNSYIAH) appointed 
in the Department of Anatomy. In October 2006, he began his Master study in 
Molecular Medicine at Georg August University Göttingen, Germany to study 
Molecular Diagnosis of Mycobacterium tuberculosis in ancient bones. He received 
his Master degree in 2008. In 2009, he was enrolled as a PhD student in Molecular 
Biology at Georg August University Göttingen, Germany to study the adherence 
capacities in the cell wall of Candida glabrata. Currently, Ichsan is joining the my-
cology research group in the Institute of Medical Microbiology of the University 
Medical Center Göttingen (UMG). 
Medical Faculty, Syiah Kuala University, Banda Aceh, Indonesia 
E-Mail: ichsanmd_aceh@yahoo.com  
 




Dr. Julia Inthorn is a Medical Ethicist with a Background in Philosophy. She 
earned a Diploma in mathematics and statistics from the University of Munich, 
Germany in 1997. She also holds postgraduate degrees in adult’s education (1998) 
and philosophy (2000). She gained her PhD in philosophy of social sciences with a 
study on research methods in social sciences in 2010. The research was funded by 
a scholarship from the Bavarian state. After having been research assistant in ethics 
for Prof. F.W. Graf at the Faculty of protestant Theology, University of Munich, 
she worked with a DFG funded project on clinical ethical committees, which ana-
lysed organizational forms of Ethics and shared decision making processes on 
moral questions combining empirical research and philosophical questions in the 
field of ethics. 2007-2010 she was Research assistant at the Department for Ethics 
and Law in Medicine, University of Vienna. There she continued her focus on 
empirical ethics within several research projects, like the evaluation of the Austrian 
Law on Living Wills and End-of-Life-Decisions, a project on Decision-Making 
Processes in Child Protection Groups as well as media analysis of public debates 
on bioethical questions. Since 2010 she has been Research assistant at the Depart-
ment for medical ethics and history of medicine at the University Medical Center 
Göttingen. Her main research interests are Intercultural Bioethics, Empirical Eth-
ics, End-of-Life Decisions, Ethics of Genetic Testing as well as Perspectives on 
Health and Justice. Dr. Inthorn has been and is lecturer at various Universities in 
Germany and Austria mainly in the field of ethics for health care providers (medi-
cal students, nurses, dieticians, social workers etc.). Furthermore, Dr. Inthorn was 
Visiting Lecturer at the Ateneo de Manila University, Philippines in 2008. 
Department for medical ethics and history of medicine at the University Medical 
Center Göttingen, Humboldtallee 36, 37073 Göttingen, Germany,  
Phone number: +49 551 39 9008, Fax: +49 551 39 9554, 
E-Mail: julia.inthorn@medizin.uni-goettingen.de 
 
Prof. Dr. Martin Kappas earned a German Dipl.- Geography (six year running 
program) degree from University of Bonn, Germany in 1989 and a PhD in Envi-
ronmental Sciences/Climatology from the University of Mannheim in 1993. After 
his PhD (“summa cum laude”) Dr. Kappas started a six year running “habilitation” 
program at the University of Mannheim to obtain the international “venia legendi” 
for Geography in 1998. Since 2000 Martin has been a University Professor of Ge-
ography and the head of the Cartography, GIS and Remote Sensing Section of the 
Georg-August University of Göttingen. His Remote Sensing laboratory is a full 
member of EARSeL (European Association of Remote Sensing Laboratories) and 
takes part as active member of DesertNET (Competence Network for Research to 
Combat Desertification). Moreover he is the Director of the Institute of Geogra-
phy at the Georg-August University of Göttingen and a member of the Interdisci-
plinary Center for Sustainable Development and the Center of Applied Informat-
ics. His research interests are broad and include topics such as landscape evalua-




spectrometry). His main research theme is the use of Remote Sensing and GIS to 
study land cover / land use change. He is currently working on diverse projects in 
Kazakhstan (grassland carbon sequestration and ecological site classification), 
West- and East-Africa (ecosystem services for food security, health topics), Europe 
(South France, landscape degradation in the Mediterranean area) and Germany 
(mapping biomass potentials for future bioenergy use, advising the German Gov-
ernment of Lower-Saxony). In 2005 and 2009 Martin was a visiting Professor at 
the University of Colorado at Boulder and the National Center for Atmospheric 
Research (NCAR). He is a reviewer for the German Science Community (DFG) 
and the German Humboldt foundation. Martin serves also actively inside various 
societies such as the German Society of Photogrammetry and Remote Sensing or 
the Remote Sensing and Photogrammetry Society (UK). 
Institute of Geography, Dept. Cartography, GIS and Remote Sensing,  
University of Göttingen, Goldschmidtstr. 5, 37077 Göttingen, Germany, 
Phone number: +49 551 39 8071, Fax: +49 551 39 8020, 
E-mail: mkappas@uni-goettingen.de.  
 
Dr. Daniel Karthe earned his State Examination in Geography and English at 
Mannheim University, Germany in 2001. In 1999/2000, he spent two semesters at 
Presidency College in Kolkata, India and worked on the issue of water manage-
ment in megacities. A doctoral degree for the natural sciences was awarded in 2010 
by the Faculty of Geosciences and Geography at Göttingen University for research 
on the geographic determinants of malaria transmission in West Africa. Currently, 
Daniel works at the Helmholtz Centre for Environmental Research in Magdeburg 
where he coordinates a German-Mongolian research project on Integrated Water 
Resources Management. Key research interests include Medical Geography (par-
ticularly water- and vector-borne diseases), Water Management and Environmental 
Research and Education. Daniel currently lectures at both the University of Göt-
tingen and the German-Kazakh University in Almaty, Kazakhstan. Moreover, he is 
a speaker of the working groups on Hydrology and South Asia in the German 
Geographical Society.  
Helmholtz Centre for Environmental Research - UFZ,  
Department Aquatic Ecosystem Analysis, Brückstraße 3a, 39114 Magdeburg, 
Germany 
Phone number +49 391 810 9104,  
E-mail: daniel.karthe@ufz.de 
 
Prof. Dermot P. Kelleher took up position as Principal of the Faculty of Medi-
cine on 1 October 2012. A graduate of medicine from Trinity College, Professor 
Kelleher completed specialist training in gastroenterology in Dublin and subse-
quently received a Fogarty Scholarship for a research fellowship at University of 
California San Diego. He returned to Trinity in 1989 as the Wellcome Senior Fel-
low in Clinical Science and was subsequently appointed as Professor of Clinical 




Medicine in 2001. In 2006 he was appointed Head of School of Medicine and 
Vice-Provost for Medical Affairs. Professor Kelleher’s research has focused on the 
cell biology of immune responses both in terms of basic lymphocyte function and 
in relationship to mucosal immunology. His research has been focused on the 
immune response to many of the leading causes of infectious disease worldwide. 
He is the author of approximately 200 publications and 14 patents. 
Faculty of Medicine Office 
Level 2, Faculty Building 
South Kensington Campus 
Imperial College London 
Exhibition Road 
London SW7 2AZ 
E-mail: dermot.kelleher@tcd.ie 
 
Dr. Silke Kietz has studied medicine at the Martin Luther University Hal-
le/Wittenberg, Germany, (six year running program, finishing 1995 “cum laude”). 
After a preregistration period for physicians of 18 months she worked as MD stu-
dent at the Institute of Anatomy and Cell Biology of the Martin Luther University 
Halle/Wittenberg (1997 – 2000). The project “Alterations of gene expression in 
rabbit embryos after exposure to polychlorinated biphenyls.” was supported by the 
German Research Group DFG, (GK 416). The MD-Thesis was finished in May 
2000 (“summa cum laude”). From 2000 until 2003 she has been post-doctoral 
researcher in the group of Prof. Dr. J.-Å. Gustafsson at the Department of Biosci-
ences at Novum, Karolinska Institute, Stockholm. The project: “Crosstalk between 
aryl hydrocarbon receptor and estrogen receptors.” was supported by Marie Curie 
Fellowship, QLK4-CT-2000-52111. After one year of residency in Martin Luther 
University Halle/Wittenberg, Department of paediatrics, she moved to Göttingen 
and is working here in the hospital at the Department of paediatric hematology 
and oncology. Her research interests include haematological and malignant disor-
ders in infancy.  
Deptartment of Pediatric Hematology and Oncology, University Medical Center 
Göttingen, Robert-Koch-Str. 40, 37075 Göttingen, Germany,  
Phone number: +49 551 39 202, Fax: +49 551 39 6231,  
E-mail: silke.kietz@med.uni-goettingen.de   
 
Prof. Dr. Stephan Klasen is a professor of development economics at the Uni-
versity of Göttingen. He holds a Ph.D. in economics from Harvard University and 
has since held positions at the World Bank, the University of Cambridge, and the 
University of Munich.  His research focuses on issues of poverty, inequality, and 
growth in developing countries.  Of particular interest are policies to promote 
health and reduce gender bias in mortality in developing countries. 
Development Economics Research Group, University of Göttingen,  




Phone number: +49 551 39 7303, Fax: +49 551 39 7302,  
E-mail: sklasen@uni-goettingen.de  
 
Ingrid Kühnle, Dept. of Pediatric Hematology and Oncology, University Medical 
Center Göttingen, Robert-Koch-Str. 40, 37075 Göttingen, Germany,  
Robert-Koch-Str.40, 37075 Göttingen, Germany 
Phone number: +49 551 39 6202, Fax: +49 551 39 6231,  
E-mail: ikuehnle@med.uni-goettingen.de  
 
Prof. Dr. med. Max Lakomek, Dept. of Pediatric Hematology and Oncology, 
University Medical Center Göttingen, Robert-Koch-Str. 40, 37075 Göttingen, 
Germany 
Phone number: +49 551 39 6200, Fax: +49 551 39 6231,  
E-mail: lakomek@med.uni-goettingen.de 
 
Dr. med. Martina Lange is a paediatrician. She is working at the Department of 
Paediatric Cardiology and Intensive Care Medicine at the University Medical Cen-
ter Göttingen (UMG), Germany. She is specialized in neonatology, paediatric car-
diology and palliative medicine. Her research interests include life-threatening dis-
orders and coping strategies, which was also the theme of her MD-Thesis. She has 
visited several parts of Africa, on one hand for medical projects (e.g. participation 
in a project to improve neonatal care in a district hospital in Ghana), but also for 
research projects. 
Department of Pediatrics, Pediatric Cardiology and Intensive Care Medicine,  
Robert-Koch-Str. 40, 37075 Göttingen, Germany 
Phone number: +49 0551 39 6262,  
E-mail: mlange1@gwdg.de  
 
Victor M. Manyong holds a degree in agriculture from IFA Yangambi in the 
Democratic Republic of Congo (DRC) in 1978. He completed his national services 
for two years respectively with the extension services with the Ministry of agricul-
ture and the Ministry of education up to 1980. Thereafter, he was awarded an EU 
fellowship to complete both the MSc and PhD degrees in Agricultural Economics 
at Université Catholique de Louvain la Neuve (UCL) – Belgium in 1981 and 1986 
respectively. For six years he worked in various capacities with the private sector, 
foreign-based non-governmental organizations and as an independent consultant 
in DRC. He travelled extensively within the country. Early 1992, he was employed 
as researcher at the International Institute of Tropical Agriculture (IITA) covering 
14 countries of west and central Africa in a GIS-based characterization of farming 
systems. He progressively moved up on the ladder as a Senior researcher in agricul-
tural and health economics. His research experience has been on the economics of 
food crops in sub-Saharan Africa, market and impact studies, and analysis of pro-
duction economics. He has published extensively more than 150 articles in referred 




journals, books, chapter books, etc. He has also contributed to capacity building 
with supervision of more than 20 post graduate students (MSc and PhDs) and he 
organized several sessions on group training. He attended international confer-
ences, meetings and symposia in Africa, Europe, Japan, South Asia, North and 
South America.   He is a member of many scientific professional societies such as 
the International Association of Agricultural Economics, African Association of 
Agricultural and Resources Economics. He is the leader of the Social Science Re-
search Group and the Coordinator of research on Agriculture and Health in the 
same institute. As a research manager, he is the Director for East and Central Afri-
ca and member of the Research for Development Directorate at IITA, based in 
Dar es Salaam, Tanzania.  
Director, R4D Directorate, IITA Regional Hub, Plot 25, Mikocheni Light Indus-
trial Area, Mwenge CocoCola Road, Mikocheni B, P.O. Box 34441,  
Dar es Salaam (Tanzania) 
Phone number: +255 22 2700092, Fax: +255 22 2775021,  
E-mail: v.manyong@cgiar.org 
 
Muh. Nasrum Massi. After graduating from the Medical Faculty of Hasanuddin 
University, Indonesia (1994) Muh. Nasrum Massi worked as a physician in Nene 
Mallomo Hospital in Sidrap District, South Sulawesi. In 1996, he began his carrier 
as university lecturer of the Faculty of Medicine, Hasanuddin University (UNHAS) 
appointed in the Department of Microbiology. Until 2000, he jointed several infec-
tious disease studies in the field of microbiology (Leprosy and Salmonella). In April 
2000, he began his doctoral studies at the International Centre for Medical Re-
search (ICMR), Kobe University, Japan to study Molecular Diagnostic of Salmo-
nella typhi and received his Ph.D in 2005. In 2008, he was elected as a chairman of 
Microbiology Department, Faculty of Medicine, UNHAS and still hold this posi-
tion today. Currently, Muh. Nasrum Massi is working as a TB Clinical Investigator 
in Novartis Institute of Tropical Disease (NITD)-Hasanuddin University Clinical 
Research (NHCR), a unit affiliating to Wahidin Hospital and Hasanuddin Universi-
ty Hospital in Makassar concentrating on tropical diseases research. Since 2009, he 
was a member of National Committee of Emerging and Re-emerging Disease of 
Health Department of Indonesia. He was inaugurated as a Professor in Clinical 
Microbiology at the Medical Faculty, Hasanuddin University, Makassar, Indonesia 
in 2010. 
Hasanuddin University, Makassar, Indonesia 
E-Mail: nasrumm@hotmail.com 
 
Humphrey D. Mazigo trained at Sokoine University of Agriculture in Tanzania 
where he received a Doctor of Veterinary Medicine degree (2001-2006). Between 
May 2008 and November 2011, he received Master of Sciences in Medical Parasit-
ology and Entomology and Masters of Public Health from the Graduate School of 




Kenya and School of Public Health, Weill-Bugando University College of Health 
Sciences (by then a constituent College of St, Augustine University of Tanzania). 
He works as a lecturer in the Department of Medical Parasitology, Catholic Uni-
versity of Health and Allied Sciences, Tanzania and serves as a visiting lecturer to 
other medical schools in the country. He is currently a PhD fellow of THRiVE 
and WELLCOME TRUST for School of Public Health, Makerere University 
(Uganda) and the University of Cambridge, UK. His research interest focuses on 
neglected tropical diseases with focus on their interactions with disease which re-
ceived much priority example malaria and HIV. Since 2010, He has gained interna-
tional research experiences and has published over 25 publications in local and 
international peer reviewed journals on epidemiology of neglected tropical diseases, 
entomology and public health issues. He also serves as a reviewer in several jour-
nals of tropical medicines, parasitology and Public Health. 
Humphrey D. Mazigo* and Martin Kappas** 
Department of Medical Parasitology and Entomology, School of Medicine, 




Stephen Mshana, MD, M.Med, PhD. Dr. Mshana obtained his MD from Uni-
versity of Dar es Salaam, Tanzania, Master of Medicine in Microbiology (M.Med) 
from Makerere University, Kampala Uganda and his PhD from Saint Augustine 
University of Tanzania a sandwich programme with Institute of Medical Microbi-
ology Giessen, Germany. Dr. Mshana is Senior Lecturer in the Department of 
Microbiology at Weill School of Medicine of Catholic University of Health and 
Allied Sciences.  Dr. Mshana scientific interests are the mechanisms of antibiotic 
resistance among gram positive and negative bacteria and diagnosis of Infectious 
Diseases. Dr. Mshana is recipient of a number of personal (peer-reviewed) research 
grants from DAAD and National Medical Research (NIMR) Tanzania. He is the 
author and co-author of over 30 publications in peer-reviewed journals. 
Catholic University of Health and Allied Sciences-Bugando,  
Senior Lecturer Microbiology/Immunology, BOX 1464, Mwanza Tanzania,  
E-mail: mshana72@bugando.ac.tz 
 
Mercy Jemima Newman earned a Ghanaian medical degree from the University 
of Ghana Medical School (UGMS), Accra in 1974 and an MSc in Microbiology 
from the London School of Hygiene and Tropical Medicine, University of London 
in 1980. From 1980-1985, Dr Newman worked as a microbiologist in Hammer-
smith Hospital, London (Royal Postgraduate Medical School). As a consultant 
microbiologist, she returned to Ghana Medical School as a lecturer in 1986. She 
was appointed Associate Professor of Microbiology in 2001 and had also been 
head of department of Microbiology. In addition to teaching microbiology to med-
ical students and other health professionals, she had supervised several postgradu-




ates at the masters and doctoral levels. She had been an examiner for the School of 
Medical Sciences, Kwame Nkrumah University of Science and Technology, Ghana 
College of Physicians and Surgeons and West African College of Physicians. In 
1996-1997 Prof Newman was a visiting professor at the University of Virginia 
School of Medicine, Charlottesville (Dept of Geographic and International Medi-
cine). The UGMS and University of Virginia continues to collaborate in research 
and training of scientists. Prof Newman is an editor of the Ghana Medical Journal. 
She is currently the project Manager in charge of the Ghana component of the 
Antimicrobial Resistance (ADMER) Project, collaboration between Ghana and 
Denmark. Her research interest covers fungal and bacterial infections in neonates 
and the adult population in Ghana and other places. In addition to the ADMER 
project, her current research includes hospital and community infection, antimi-
crobial susceptibility, diarrhoea diseases and plasmids in enterobacteria. 
Department of Microbiology, University of Ghana Medical School  
P O Box 4236, Accra Ghana 
E-mail: newmerci@yahoo.co.uk  
 
Prof. Dr. med. Dr. h.c. Michael Oellerich is a chemical pathologist (Facharzt 
für Laboratoriumsmedizin) and chairman of the Department of Clinical Chemis-
try/Central Laboratory at the Medical Faculty (UMG) of the Georg-August-
University Göttingen, Germany. He received the honorary Fellowship of the Fac-
ulty of Pathology of the Royal College of Physicians of Ireland (FFPath RCPI) and 
the Fellowship of the Royal College of Pathologists (FRCPath) in 2006 as well as 
the honorary membership of the Romanian Society of Laboratory Medicine in 
2007. From 1996 to 1998, he served as dean of the Faculty of Medicine and as the 
deputy of the chief executive for research and teaching on the executive board for 
the Medical Center and Faculty of Medicine from 1999 to 2004. He was president 
of the International Association of Therapeutic Drug Monitoring and Clinical Tox-
icology (IATDMCT) from 1997 to 1999, president of the German Association for 
Laboratory Medicine from 2001 to 2002, president of the German United Associa-
tion for Clinical Chemistry and Laboratory Medicine (2003-2005), secretary-
treasurer of the World Association of Societies of Pathology and Laboratory Medi-
cine (WASPaLM) from 2005 to 2007, and president of WASPaLM from 2009 to 
2011. Currently he is the immediate past-president of WASPaLM. From 1999 to 
2010, he was a member of the Steering Committee of EUROLIFE, a network of 
European centers of excellence in life sciences. He is Editor-in-Chief of the journal 
Therapeutic Drug Monitoring and Associate Editor of Clinical Chemistry. He was 
Associate Editor of Clinical Biochemistry (1996–2007). His current research inter-
ests are in the fields of therapeutic drug monitoring, with particular focus on en-
dogenous biomarkers to achieve personalised immunosuppression in transplanta-
tion, as well as pharmacogenetics. Further topics include proteomics, analytical 
techniques (e.g. LC-MS/MS), and molecular diagnostics. He and his collaborators 




nals, book chapters, books edited). He served as External Examiner for the Second 
Professional Examination 2009/2010 of the Faculty of Medicine at the Chinese 
University of Hong Kong. He received the Ludolf-Krehl prize of the S.W. German 
Soc. for Internal Medicine in 1971, the IATDMCT Award, Cairns 1999, the 
IATDMCT Charles Pippenger Award for Outstanding Contributions to Therapeu-
tic Drug Monitoring, Washington 2001, the 2002 Canadian Society of Clinical 
Chemists Travelling Lectureship Award, the Professor-Landbeck-Award of the 
Society for Thrombosis and Hemostasis Research, Hamburg 2004, the Perth 
PathCentre Visiting Lectureship, Western Australia 2004, and the WASPaLM 
Medal of Honor, Las Vegas 2011. 
Department of Clinical Chemistry/Central Laboratory at the Medical Faculty 
(UMG) of the Georg-August-University Göttingen, Robert-Koch-Str. 40,  
37075 Göttingen, Germany 
Phone number: +49 551 39 8561, Fax: +49 551 39 8551,  
E-mail: Michael.Oellerich@med.uni-goettingen.de,  
 
Dr. Anna Okello graduated as a veterinarian at the University of Melbourne (Aus-
tralia) in 2002. After three years in mixed rural practice in New Zealand, Anna 
spent 12 months in north and west Africa working for a British Non Governmen-
tal Organisation (NGO).  After some time in private practice in the United King-
dom, Anna moved back to the NGO sector as a veterinary advisor for a large Brit-
ish organisation, working with veterinarians in Asia and East Africa to develop 
veterinary capacity within existing government and private systems. At this time 
Anna also undertook a part time Masters degree in International Animal Health at 
Scotland’s University of Edinburgh. Upon completion of her Masters degree, An-
na started a PhD at Edinburgh’s School of Social and Political Science, looking at 
public health policy, particularly the effects of global public health on developing 
countries and the potential role of integrated health systems. She is currently the 
project manager for the large collaborative European Commission seventh frame-
work programme “Integrated Control of Neglected Zoonoses” (ICONZ) – 
www.iconzafrica.org.  
Okello, AL, Gibbs, EPJ, Vandersmissen A, Welburn SC (2011) “One Health and 
the Neglected Zoonoses: Turning Rhetoric into Reality”, Veterinary Record, Vol 
169, pp 281-285, doi 10.1136/vrd.5378  
Global Health Academy, College of Medicine and Veterinary Medicine, The Uni-
versity of Edinburgh, Chancellors Building, 49 Little France Crescent; Edinburgh  
EH16 4SB 
E-mail: Anna.Okello@ed.ac.uk  
 
Jessica Olbrich is a state-certified Translator and Interpreter for German, English 
and Spanish. In June 2010, she graduated with a Master of Arts of the first class in 
International Management and Languages from Heriot-Watt University Edinburgh 
(Scotland) and received the Watt Club Medal for an excellent performance in her 




final examinations as well as for outstanding academic achievements in her Master 
thesis. Her main fields of expertise are economics, commerce and marketing. Since 
she joined the Department of Agricultural Economics and Rural Development of 
the Georg-August University Göttingen in September 2010, she expanded her 
expertise in the fields of agribusiness and risk management. 
Department of Agricultural Economics and Rural Development, Platz der Göt-
tinger Sieben 5, 37073 Göttingen, Germany 
Phone number: +49 551 39 4439,  
E-mail: jolbric@uni-goettingen.de 
 
Prof. Dr. Elke Pawelzik earned a German Dipl.-Engineer degree from the Hum-
boldt University of Berlin, Germany a PhD (Dr.-Ing.) in Food Technology from 
the same University. After her PhD Elke Pawelzik worked as postdoc at the Mos-
cow Technical University of Food Technology (former Soviet Union) as well as a 
senior engineer in the milling company of East Berlin. Afterwards, she started a 
“habilitation” program at the Humboldt University to obtain the “venia legendi” 
for Food Technology. Since 1995 Elke Pawelzik has been a University Professor 
of Quality of Plant Products at the Faculty of Agriculture of the Georg-August 
University of Göttingen. Her research interests focus on quality changes in the 
value added food chain with special emphasis of the pre- and postharvest periods. 
The main research theme includes topics such as nutrient effects, abiotic and biotic 
factors influencing the quality of plant products. She is currently the speaker of the 
Joint project Quality-related plant production under modified basic-conditions: 
mycotoxins in the context of production, quality and processing (FAEN-3, sup-
ported by the Government of Lower Saxony, Germany) and working there about 
the impact of pathogens on cereal grain and grain products quality. Furthermore, 
she is working on diverse projects as nutrient effects on potato quality and tracea-
bility of plant products. She has scientific cooperation’s with colleagues in several 
countries, e.g. in Indonesia, Brazil, Thailand and African countries. Elke Pawelzik 
is the speaker of the German Alumni Food Network (supported by the DAAD) 
and permanent visiting professor at the Chiang Mai University (Chaing Mai, Thai-
land).  
University of Göttingen, Department of Crop Sciences, Quality of Plant Products, 
Carl-Sprengel-Weg 1, 37075 Göttingen, Germany 
Phone number: +49 551 39 5545, Fax: +49 551 39 5570, 
E-mail: epawelz@gwdg.de 
 
Prof. Dr. med. Jörgen Petersen born 1943 at Lübeck; studies of physics and 
medicine at Kiel and Göttingen; PhD and MD; education in ophthalmology at 
Göttingen and Frankfurt, specialisation for vitreo-retinal surgery; advanced training 
in Boston, NewYork and Memphis/Tennessee. 1994 leader of the vitreo-retinal 
department of the Göttingen University Eye Clinic; 2004-2006 temporary head of 




Third world activities: 2 times surgical teaching and operation campaigns in rural 
Ethiopia; 2 times teaching in Indonesia, advanced surgical training of an Indone-
sian colleague at the Göttingen University Eye Clinic. 
Department of Ophthalmology, University Medical Center Göttingen,  
Robert-Koch-Strasse 40, 37075 Göttingen, Germany 
E-mail: jpet@med.uni-goettingen.de 
 
Dr. Anjali Radkar has completed her Masters in Statistics from University of 
Pune, India. After that, working in Population research for a few years she earned 
her masters in Population Studies followed by doctorate in Population Studies 
from International Institute for Population Sciences, Mumbai, India.  Anjali 
worked as ‘Independent Researcher’ after her doctorate for few years when she 
undertook studies in the areas of sex preference and women’s health. During this 
period she received the grant from MacArthur Foundation for the study on abor-
tions. Then she undertook a faculty position in Interdisciplinary School of Health 
Sciences, University of Pune. She has been teaching Biostatistics, Demography and 
Research Methods for postgraduate and doctoral students for many years now. She 
also is a visiting faculty in different departments of many universities in the state of 
Maharashtra. Her long time area of research has been maternal and child health, 
child survival and maternal and child nutrition. She also has worked on the health 
of urban poor and their cost of healthcare. Recently she completed two projects; 
one on consequences of adverse sex ratio on the marriages in Haryana and the 
other, evaluation of Safe Adolescent Transition and Health Initiative (SATHI) in 
Maharashtra. Most of her research work pertains to India where there is a diversity 
by area of residence, culture and social norms. She is a reviewer for both interna-
tional and national level journals on reproductive health and social sciences includ-
ing, Maternal and Child Health Journal. 
Gokhale Institute of Politics and Economics, Deccan Gymkhana, B.M.C.C. Road, 
Pune 411004 
Phone number: +91 20 25650287 or +91 20 25654288 
Fax: +90 20 25652579,  
E-mail: anjaliradkar@yahoo.co.in  
 
Dr. Tobias Reeh (Dipl.-Geogr., Dr. rer. nat.) is a lecturer at the Department of 
Human Geography, Georg-August-University of Göttingen since 2007. His main 
research themes are tourism geography, managing landscape change, environmen-
tal education and heritage interpretation. Currently he is working on diverse pro-
jects in Tyrol and South Tyrol (tourism and transportation), Lower Saxony (busi-
ness tourism, urban planning, heritage interpretation), Saxony-Anhalt (cultural 
tourism, sustainable regional development) and Thuringia (environmental history). 
Tobias Reeh is a member of the German Society of Tourism Research (DGT), the 
Working Group Leisure and Tourism Geography of the German Geographic So-
ciety, the Association for Pacific Studies (APSA), the Centre for Empirical Re-




search into School and Education of the Georg-August University of Göttingen 
(ZeUS) as well as the chief executive officer of the Centre for Environmental In-
terpretation and Tourism Göttingen (ZELT e.V.).  
Department of Human Geography, Georg-August-University of Göttingen,  
Goldschmidtstr. 5, 37077 Göttingen, Germany 
Phone number: +49 551 39 8074; Fax: +49 55139 12140,  
E-mail: treeh@gwdg.de  
 
Prof. Dr. med. Utz Reichard has studied medicine at Göttingen University, 
Germany, from 1980 to 1987. Thereafter he specialized for Medical Microbiology 
and Infectious Diseases first working at the Department of Internal Medicine for 
two years and subsequently at the Department of Medical Microbiology at the 
University Hospital of Göttingen. There he still cares for diagnostics of infectious 
diseases particularly at the German National Reference Center for Systemic My-
coses which is also located at the facility. In addition, he is running a research lab 
which is focused on improving understandings for the molecular basis of mecha-
nisms used by pathogenic fungi causing diseases in the human host. His research 
on Aspergillus fumigatus, which is the most threatening fungus for leukemia pa-
tients causing invasive diseases of the lung, is supported by the German José Car-
reras Foundation. In this field Dr. Reichard has broad experience and cooperation 
since years in particular with the Department of Clinical Chemistry at the Universi-
ty Hospital of Göttingen and with the Institute of Genomics and Integrative Biol-
ogy, New Delhi, India. 
University of Göttingen, Department of Medical Microbiology,  
Kreuzbergring 57, 37075 Göttingen, Germany 
Phone number: +49  551 39 5856, Fax: +49 551 39 5860,  
E-mail: utzreicha@gwdg.de 
 
Eva Schröer-Merker obtained a Master of Science degree at the Agricultural Fac-
ulty of Georg-August University Göttingen, Germany in 2009 investigating arbo-
viral diseases of cattle. Since 2009, she has been working at the IFCN (Internation-
al Farm Comparison Network) Dairy Research Center in Kiel, focusing her re-
search on dairy economics. She is currently leading the Dairy Sector Analysis team 
at IFCN. Her main research interest is the development of the dairy sector world-
wide based on the detailed analysis of approximately 90 countries. 
Dairy Sector Analysis, IFCN Dairy Research Center,  
Schauenburgerstrasse 116, 24118 Kiel, Germany 
Phone number: +49 431 5606260, Fax: +49 431 5606 262 
E-mail: Eva.Schroeer-Merker@ifcndairy.org  
 
Dr. Marco H. Schulze, MD, DTMH (Liv), specialist in internal medicine, infec-
tious diseases and tropical medicine. Working experience in Cameroon (2006-




health coordinator of Bamenda Ecclesiastical Province, and medical advisor of 
Bamenda Ecclesiastical Province Health Assistance, a mutual health organisation. 
Interests: development of appropriate microbiology in resource-constrained coun-
tries. 
University Medical Center Göttingen, Institute of Medical Microbiology, 
Kreuzbergring 57, 37075 Göttingen, Germany 
Phone number: +49 551 39 5810, Fax: +49 551 39 5861,  
E-mail: schulze.marco@med.uni-goettingen.de  
 
Prof. Gainda L. Sharma completed his Master of Sciences in 1976 from Kanpur 
University, India and Ph.D.  in Immunology from the Postgraduate Institute of 
Medical Education and Research, Chandigarh, India. After obtaining his Ph.D. in 
1983, Prof. Sharma was appointed as Scientist-B in Regional Research Laboratory, 
Jammu, India. In 1988, he joined as Scientist-C at Centre for Biochemical Tech-
nology, Delhi, India, now known as Institute of Genomics and Integrative Biology 
where he was promoted to higher positions. At present he is working as Scientist-
G and Senior Deputy Director at the same Institute. He was on deputation as Di-
rector of Institute of Biomedical Sciences, Jhansi, India from 2004-2005. He visit-
ed Thomas Jefferson University, USA in 1995 and worked on the development of 
transgenic systems. He was invited for a Meeting on advances against aspergillosis 
at Athens, Greece in February 2006.  From 2007, Prof. Sharma has been Principal 
Investigator of an Indo-German collaborative research project on immunoprote-
omics and has been visiting Georg-August University, Göttingen Germany very 
frequently. Prof. Sharma has been significantly contributing in the major research 
areas such as Proteomics, Drug Development, Experimental Immunobiology, 
Immunodiagnostics and Functional Genomics.  He is the life member of several 
academic bodies such as Association of Microbiologists of India, Association of 
Progressive Zoologists of India, Society of Biological Chemists of India, Associa-
tion of Clinical Biochemists and Indian College of Allergy and Applied Immunolo-
gy. He was awarded fellowship of Indian College of Allergy and Applied Immu-
nology for his scientific contributions. Prof. Sharma has published 57 research 
papers, 1 book and 13 national/international patents. He has also participated in 
more than 60 scientific conferences/symposia/seminars as invited speaker or 
chairperson. 
Institute of Genomics and Integrative Biology, University Campus,  
Mall Road Delhi-110007, India 
E-mail: drglsharma@hotmail.com  
 
Ali Sié, Centre de Recherche en Santé de Nouna,  
BP : 02 Nouna / Kossi – Burkina Faso 
E-mail: sieali@yahoo.fr  
 




Bharat Singh received Masters Degree in Biomedical Sciences from University of 
Delhi, India in 2003. In 2004 he joined as a research fellow in a Govt. of India 
Laboratory (Institute of Genomics and Integrative Biology, CSIR, Delhi, India) 
and worked on in vitro evaluation of genetically engineered drugs till 2007. In the 
same institute he joined an Indo-German collaborative research project (DBT-
BMBF funded) and also enrolled for PhD in University of Kurukshetra, India. He 
is recently working on the identification and validation of Aspergillus fumigatus 
immunogens for global application in diagnostics and therapeutics. He has also 
visited Department of Clinical Chemistry, UMG, Göttingen, Germany several 
times as a part of collaborative research work. He is specialized in the field of pro-
teomics and recombinant production of proteins from different sources. 
Institute of Genomics and Integrative Biology, University Campus,  
Mall Road Delhi-110007, India 
E-mail: bharatsingh1601@gmail.com  
 
Seema Singh earned post-graduation degree in Biomedical Sciences from Univer-
sity of Delhi, India in 2006. Being among the meritorious students of the batch she 
availed the CSIR-Catch them young fellowship throughout the Masters program. 
On completion of the course in 2006 she joined VP Chest Institute, University of 
Delhi, India as a project fellow. Later in 2007, she joined a Govt. of India Labora-
tory (Institute of Genomics and Integrative Biology, CSIR, Delhi, India) for her 
doctoral work and has been currently enrolled in the University of Pune, India.  
She is working on the screening, selection and characterization of antifungal mole-
cules for the treatment of infections due to a major fungal pathogenic mould As-
pergillus fumigatus. 
Institute of Genomics and Integrative Biology, University Campus,  
Mall Road Delhi-110007, India 
E-mail: seema.acbrdu@gmail.com  
 
Dr. med. Werner Stein has specialized in pediatrics as well in obstetrics and gy-
necology with the subspecialities of perinatology and gynecologic oncology. Cur-
rently he is establishing a department for endoscopic surgery. 
He has worked in several countries of sub-Saharan Africa concerning maternal and 
child health issues with a focus on the meaning of ultrasonography at rural health 
institutions. 
University of Göttingen (UMG), Department of Gynecology,  
Robert-Koch-Str. 40, 37075 Göttingen, Germany 
E-Mail: werner.stein@med.uni-goettingen.de 
 
Prof. Dr. med. August Stich was born in 1960 in Nürnberg, Germany. After his 
medical studies he specialised in internal and tropical medicine. In the last 20 years 
he had various assignments to tropical countries as medical doctor, health coordi-




Angola and Tansania. He has a Master of Science degree of the London School of 
Hygiene and Tropical Medicine where is still enrolled as lecturer. Today he lives 
and works in Würzburg, Germany, where he is the Head of the Department of 
Tropical Medicine of the Medical Mission Hospital (since 2004), the chairman of 
the Medical Mission Institute (since 2008) and Medical Advisor of the German 
Leprosy Relief Association (since 2009). He is currently vice-president of the Ger-
man Society of Tropical Medicine and International Health. Since 2012 he is also 
member of the Board of the multidisciplinary Africa Center of the University of 
Würzburg. He was awarded Full Professor in January 2012. 
Göttingen International Health Network, Medical Mission Institute,  
Salvatorstr. 7, 97074 Würzburg, Germany 
Phone number: +49 931 7912821, Fax: +49 931 7912826,  
E-mail: stich@missioklinik.de  
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Prof. Dr. theol. Martin Tamcke studied Protestant Theology, Philosophy and 
Oriental Studies. After PhD (1985) and Habilitation (1993), both at Philipps-
Universität Marburg, he was appointed Professor at Georg-August-Universität 
Göttingen (1999). Professor Tamcke is the Director of the Department of Ecu-
menical Theology and Oriental Church- and Mission-History. Maintaining a large 
network with universities all over the world, Professor Tamcke taught as Visiting 
Professor at numerous institutions in Europe, Asia, Near East and North America; 
he also teaches at Orthodox and Islamic Faculties abroad on a regular basis. Pro-
fessor Tamcke is Director of Studies both in the international “Intercultural The-
ology” M.A. programme and in the Erasmus-Mundus “Euroculture” M.A. pro-
gramme; both programmes of study were co-founded by him. He is Assistant Di-
rector of KEMA (Centre for the Study of the Cultures of Europe and the Mediter-
ranean in Antiquity). Additionally, he is member of several academic societies and 
is appointed to different functions for the Evangelical Church of Germany (Evan-
gelische Kirche in Deutschland). The focus of Professor Tamcke's research lies on 
the Christian cultures of the Near and Middle East, Eastern Europe, and India 
with special emphasis on interreligious coexistence, intercultural hermeneutics, and 
oriental-occidental relations, on which topics he has published widely. In recogni-
tion of his academic work, he was awarded a Doctorate honoris causa from the 
University of Joensuu (Finland) in 2009. www.theologie.uni-goettingen.de/tamcke  
University of Göttingen, Faculty of Theology,  
Department of Ecumenical Theology and Oriental Church and Mission History,  
Platz der Göttinger Sieben 2,  
37073 Göttingen, Germany 
Phone number: +49 551 39 7196, Fax: +49 551 39 7488 
E-mail: martin.tamcke@theologie.uni-goettingen.de 
 




Marut Tangwattanachuleeporn was born on March 18, 1981 in Bangkok, Thai-
land. He graduated with the Bachelor degree of Science in Microbiology from 
Burapha University, Thailand in 2003 and Master degree of Science in Medical 
Microbiology from Chulalongkorn University, Thailand in 2005. In 2006, he got a 
position to be a lecturer in the Department of Medical Science, Faculty of Science, 
Burapha University, Thailand. Since 2009 he has been a Ph.D. student in the Insti-
tute of Medical Microbiology, University Medical Center Göttingen. During his 
Ph.D. study, he is the representative for Southeast Asia of Young ISHAM (Inter-
national Society for Human and Animal Mycology) since 2011. His current re-
search interest is focusing on cell wall proteins of Candida. Moreover, he is investi-
gating the prevalence of pathogenic yeast infection and the prevalence of Crypto-
coccus in the environment in Southeast Asia, especially Thailand and Indonesia. 
E-Mail: poonkung1@hotmail.com  
 
Issouf Traoré is graduated from University of Ouagadougou, Burkina Faso. Mr. 
Traoré obtained his Master Degree in rural Geography (Maîtrise) with subject Ge-
ography of Health with the financial support of the Laboratory “Schistosomoses 
en Orbite” of the Health Sciences Research Institute (IRSS/CNRST-Burkina Faso) 
in 2004; and a Master of Advanced Studies (D.E.S.S.) in Sustainable Wetlands 
Management with subject Health Impact of Wetlands in 2009, co-funded by the 
Nouna Health Research Centre (CRSN-Burkina Faso) and the International Net-
work for the Demographic Evaluation of Populations and Their Health in Devel-
oping Countries (INDEPTH-Ghana). Since 2008, Mr. Traoré occupies the posi-
tion of Geographer at the CRSN with Environment and Health as strong point. 
Through the partnership between the CRSN and Universities in Germany, Mr. 
Traoré is, since April 2010, a PhD Candidate at the Department of Geography- 
University of Göttingen and supported by the German Academic Exchange Ser-
vice (DAAD).  
Institute of Geography, Department Cartography, GIS and Remote Sensing, 
Goldschmidtstr. 5, 37077 Göttingen, Germany 
Phone number: +49 551 39 8029, Fax: +49 551 39 8020 
E-mail: issouf.traore@geo.uni-goettingen.de   
 
PD Dr. rer. nat. Manfred Weidmann is a senior scientist at the Department of 
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H uman, animal and plant health is a fi eld of work which offers opportunities for in-ter- and trans-disciplinary research. The whole topic bridges the natural and social 
sciences. Today, in a world of global environmental change it is widely recognized that 
human societies and their wellbeing depend on a sustainable equilibrium of ecosystem 
services and the possibility of cultural adaptation to global environmental change. The 
need to identify and quantify health risks related to global environmental change is 
now one of the most important challenges of humankind. 
Describing spatial (geographic, intra/inter-population) and temporal differences in 
health risks is an urgent task to understand societies’ vulnerabilities and priorities for 
interventions better. The Göttingen International Health Network (GIHN) is a research 
and teaching network in relation to this cross-cutting topic. The book provides a coll-
ection of articles which contribute to this issue of overriding importance and presents 
an overview of the GIHN launch event.
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